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ABSTRACT OF DISSERTATION

Redox Proteomics Identification of Oxidatively Modified Proteins and Their
Pharmacological Modulation: Insights into Oxidative Stress in Brain Aging, Mild
Cognitive Impairment
The studies presented in this work were completed with the goal of
gaining greater insight into the roles of protein oxidation in brain aging and age-related
cognitive impairment. Aging is associated with the impairment of physiological systems
such as the central nervous system (CNS), homeostatic system, immune system, etc.
Functional impairments of the CNS is associated with increased susceptibility to develop
many neurodegenerative diseases such as Alzheimer’s diseases (AD), Parkinson’s disease
(PD), and amyotrophic lateral sclerosis (ALS). One of the most noticeable functional
impairments of the CNS is manifested by cognitive decline. In the past three decades, the
free radical theory of aging has gained relatively strong support in this area. Excessive
production reactive oxygen species (ROS) was demonstrated as a contributing factor in
age-related memory and synaptic plasticity dysfunction. This dissertation use proteomics
to identify the proteins that are oxidatively modified and post-translationally altered in
aged brain with cognitive impairment and normal aging brain.
Ongoing research is being pursued for development of regime to prevent
oxidative damage by age-related oxidative stress. Among which are those that scavenge
free radicals by antioxidants, i.e. α-lipoic acid (LA), and protecting the brains by

reducing production of neurotoxic substance, i.e. reducing production of amyloid β(Aβ).
Therefore, proteomics were also used to identify the alteration of specific proteins in aged
brain treated with LA and antisense oligonucleotides again amyloid protein precursor.
This dissertation provides evidences that certain proteins are less oxidatively modified
and post-translationally altered in cognitively impaired aged brain treated with LA and
antisense oligonucleotides against the Aβ region of amyloid precursor protein (APP)
(AO).
Together, the studies in this dissertation demonstrated that increased oxidative
stress in brain play a significant role in age-related cognitive impairment. Moreover, such
increased oxidative stress leads to specific protein oxidation in the brain of cognitive
impaired subject, thereby leading to cognitive function impairment. Moreover, the
functional alterations of the proteins identified by proteomics in this dissertation may
leads to impaired metabolism, decline antioxidant system, and damaged synaptic
communication. Ultimately, impairment of these processes lead to neuronal damages and
cognitive decline. This dissertation also show that several of the up-regulated and
oxidized proteins in the brains of normal aging mice identified are known to be oxidized
in neurodegenerative diseases as well, suggesting that the expression levels of certain
proteins may increase as a compensatory response to oxidative stress. This compensation
would allow for the maintenance of proper molecular functions in normal aging brains
and protection against neurodegeneration.
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CHAPTER ONE
Introduction and Research Aims
The studies presented in this work were completed with the goal of gaining
greater insights into the roles of protein oxidation in brain aging and age-related cognitive
impairment. Aging, defined as the gradual alteration in structure and function that occurs
over time, eventually leads to increased probability of non-disease or non-trauma related
death (Ashok and Ali, 1999). Aging is associated with the impairment of physiological
systems such as the central nervous system (CNS), homeostatic system, immune system,
etc. Functional impairments of the CNS are associated with increased susceptibility to
develop many neurodegenerative diseases such as Alzheimer’s diseases (AD),
Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). One of the most
noticeable functional impairments of the CNS is manifested by cognitive decline. As
most, but not all, people over age of 60 will attest, a decline in learning and memory is a
part of the aging process (Barnes, 1988). Using various learning paradigms, these
memory dysfunctions are recapitulated in aging rodents (Barnes, 1988). Several theories
have been offered to understand the phenomenon of aging. In the past three decades, the
free radical theory by Harman (Harman, 1956) has gained relatively strong support in this
area. Excessive production of reactive oxygen species (ROS) was demonstrated as a
contributing factor in age-related memory and synaptic plasticity dysfunction (Lynch,
1998).
Increased ROS causes oxidative stress in the CNS of aged subjects (Poon et al.,
2004a, b). Oxidative stress is manifested by protein oxidation in the CNS. Protein
oxidation is an exothermic event where peptides react with ROS. This reaction is mainly,
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though exclusively, mediated by the OH· free radicals, which is mostly produced by the
Fenton reaction through the decomposition of H2O2 in the presence of redox metals (Cu+
and Fe+) (Butterfield and Stadtman, 1997). Free radicals can attack peptides at two
locations: back bone and side-chain. Both of these oxidative modifications of proteins
generally cause the loss of catalytic or structural function in the affected protein and
contribute serious deleterious effects on cellular and organ functions (Levine and
Stadtman, 2001). It should be noted that the oxidative modification of proteins during
aging and age-related neurodegenerative disorders is specific (Stadtman, 1992; Agarwal
and Sohal, 1994; Agrawal et al., 1996; Butterfield and Stadtman, 1997; Stadtman, 2001;
Castegna et al., 2002b; Castegna et al., 2002a; Castegna et al., 2003; Keller et al., 2004;
Poon et al., 2004d).
Although protein oxidation in aged brain is well established, little is known about
the specific proteins that are oxidatively modified in age brain. Therefore, it is the
intention of this dissertation to identify the proteins that are oxidatively modified and
post-translationally altered in aged brain. Moreover, this dissertation will also identified
the proteins that are oxidatively modified and post-translationally altered in aged brain
with cognitive decline.
Ongoing research is being pursued for development of regime to prevent
oxidative damage by age-related oxidative stress. Among which are those that scavenge
free radicals by antioxidants, i.e. α-lipoic acid (LA) (Butterfield et al., 2002e; Butterfield
et al., 2002b); protecting the brains by reducing production of neurotoxic substance, i.e.
reducing production of amyloid β(Aβ) (Poon et al., 2004c). Interestingly, administration
of LA and reducing production of Aβ can improve the cognitive impairment observed in
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aged subjects (Ingram et al., 1987; Stoll et al., 1993; Castorina and Ferraris, 1994; Kumar
et al., 2000b; Farr et al., 2003). However, little is known about the mechanism of the
beneficial effects of these stratergies on brain aging. Therefore, we hypothesize that the
beneficial effects of these stratergies are due to alteration of specific proteins in aged
brain. This dissertation provides evidences that certain proteins are less oxidatively
modified and post-translationally altered in cognitively impaired aged brain treated with
LA and antisense oligonucleotides against the Aβ region of amyloid precursor protein
(APP) (AO).
In summary, this dissertation address the following questions:
1. Does oxidative stress play a role in age-related cognitive impairment?
2. Does oxidative stress leads to specific protein oxidation in the brain of cognitive
impaired subject, thereby leading to cognitive function impairment?
3.

Which proteins are oxidatively modified and post-translationally altered in the
aged brain with cognitive impairment and how these proteins contribute to the
functional impairment observed in aged brain?

4. Which protein are less oxidatively modified and altered in the aged rodent brain
treated with LA and AO and how these proteins contribute to the improvement of
the functional impairment in aged brain?
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CHAPTER TWO
Background
2.1 Biochemistry of Aging
One of the most fascinating topics that have interested philosopher and scientist
for centuries is aging. Over the past two decades, the interest in the aging process has
remarkably accelerated due to the increasing percentage of the elderly population and
their used of a disproportionate prevent of heath care costs (Knight, 2000).
What is aging? Although the term aging is generally understood in broad terms,
the aging process itself is extremely complex. Therefore it is useful to define the term
aging early in this dissertation. It is note worthy that no single definition of aging is
universally accepted. Aging was defined as a deleterious, progressive, intrinsic, and
universal process (Harman, 1981), which is a progressive accumulation of alteration as a
function of time associated with or responsible for the ever-increasing susceptibility to
age-related disease and death (Harman, 1981). Therefore, aging process is manifested in:
(a) progressive decreased in most, if not all, physiologic functions; (b) atrophy of most
organs; (c) increased susceptibility to infection, trauma and various immune
abnormalities; (d) increased susceptibility to malignancy; and (e) decreased capacity of
gas exchange during respiration.
2.1.1 Theories of Aging
Although the specific biologic basis of aging remains ambiguous, it is generally
agreed that aging phenotype can be explained in molecular level. Moreover, these
explanations should also consistently explain the life span differences between species
and the fact the non-dividing cells (e.g., neurons and myocytes) undergo a relatively
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uniform functional decline with age. Numerous theories have been proposed to
understand the phenomenon of aging. A credent theory of aging should able to (a)
explain how the loss of homeostasis occurs in aged individual organisms; (b) account for
the life-span variation among cohort genetic strains and species; (c) identify the crucial
factor(s) responsible for life-span extension by genetic mutation or experimental
regimens such as caloric restriction (CR); (d) demonstrate that variation of senescent
factors can manipulate the rate of aging (Sohal et al., 2002). It should be emphasized that
there is not a single theory can entirely explain the aging phenomenon. Current theories
of aging can be classified into stochastic, developmental, genome-based and free radicals
(Knight, 2000). The current theories of aging and their brief description are sumaized in
Table 2.1. However, in the past three decades, the free radical theory by Harman
(Harman, 1956) has gained relatively strong support. It was suggested that aging is due to
a combination of several theories, the free radical theory of aging presumably being the
most important, while other theories may play a definite role.
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Table 2.1 Theories of Aging
A. Stochastic
1. Somatic mutation
Surrounding insult, such as background radiation and endogenous mutagens cause
genetic loci alteration, thereby leading to critical functions failure and cell death.
2. Error catastrophe
Random errors during translation or transcription cause erroneous chromosomal proteins
that sequentially lead to abnormal protein synthesis and cell death.
3. Protein glycosylation
Nonenzymatic reactions between glucose and biomolecules, such as protein and DNA,
cause structural alterations and dysfunctions of these molecules, thereby cell death.
B. Developmental
1. Immune
A decline in ummunolgical function with increasing age cause older inducuduals more
susceptible to infectious disease.
2. Neuroendocrine
A decline in hyohthalamic-pituitary system cause the functional decline in the endocrine
target organs as founction of age.
C. Genome-based
1. Intrisic mutagenesis
Specific genetic constitutions regulate the fidelity of the genetic material and its
replication, thereby regulates the rate of mutation or errors, and thus the life span
2. Progammed
Genes carry specific instructions that control growth, maturation, decline and death.
D. Free radical
Producation of reactive free radical causes damages to biomacromolecules, thereby
leading to cellullar dysfunction and cell death.
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2.1.1.1 Free Radical Theory
The free radical theory aging of postulates that the free radical reactions with
biomolecules, such as proteins and lipid membranes, are responsible for the functional
deterioration related to aging (Harman, 1969). The free radical theory of aging has gain
significant support due to the following reasons: (a) it fulfill most of the requirement to
define the aging process; (b) it provides an excellent model for molecular and
mechanistic investigation; (c) it provides testable experimental approaches; and (d) it
provides the best molecular explanation for the interaction between aging and age-related
disease (Yu and Yang, 1996). This theory was later refined that mitochondria play a key
role in aging as the major source of oxidants and a target for their damages (Miquel et al.,
1980). It was proposed that there is a correlation between mitochondrial oxidant
production and longevity in mammalian species (Miquel et al., 1980). Since O2 is used by
aerobic organisms for energy, generation and leakage of free electrons from mitochondria
is inevitable. When oxygen is partially reduced by these electrons, free radicals are
formed to attack cell components. The free radicals can then form longer half-lives toxic
species that travel distant from where the free radicals were produced. These toxic
species and free radicals are collectively called reactive oxygen species (ROS) and
reactive nitrogen species (RNS). ROS and RNS have the capacity to modify proteins,
lipids and nucleic acids to develop or enhance age-related manifestations.
Several antioxidant defense mechanisms have evolved to protect cell components
from the attacks of ROS and RNS. The three main mechanisms in organisms include: (a)
scavenging ROS/RNS and their precursors; (b) binding catalytic metal ions needed for
ROS formation; and (c) generating and up-regulating endogenous antioxidant defenses.
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Two major groups of endogenous antioxidant are low molecular weight antioxidants
compounds, e.g., vitamin C and E, lipoic acid and ubiquinones, and antioxidant enzymes,
e.g., superoxide dismutases (SOD), superoxide reductases (SOR), catalase , glutathione
peroxidases (GPx), as well as many heat shocks proteins (Gilgun-Sherki et al., 2001).
Oxidative stress is described as the inbalance state that the production of ROS and RNS
exceed the capacity of these antioxidant defense systems.
2.1.2 Brain Aging
2.1.2.1 Neuronal Loss and Cell Growth
Declined brain volume and weight, enlarged ventricles, and narrowed gyri and
sulci are the most noticeable changes in aged human brain. Moreover, large neurons (>
90 μm) appear to atrophy. However, the total number of neurons, neuronal density, and
percentage of cell area in the cerebral cortex are unchanged with normal aging (Terry et
al., 1987) as number of small neurons (< 40μm) increased in aged brain. Progressive
increased in the number of atrophic neurons and glial cell are also demonstrated after 55
years of age (Terry et al., 1987). In contrast to cerebral cortex, progressive loss of
dopaminergic neurons in substantia nigra (CN) begin at 30 years of age, indicating that
aging clearly does not affect all brain region equally (Rogers and Bloom, 1985).
In aged rodents, approximately 20% of cell loss is observed in their CN, and less
than 20% of neuronal loss is observed their hippocampus (HP) (Morgan et al., 1987). The
specific subfield (e.g., CA1 and CA3) of HP which lose neurons during aging are
correlated to those that are selectively vulnerable to metabolic encephalopathies,
suggesting that certain neurons are more susceptible to aging and pathology.
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While certain brain regions show minor neuronal losses, others show major
neuronal loss. Despite the loss of neurons, the functional capacity of central nervous
system cricuts is well preserved. The neuronal loss triggers the surviving cells to sprount
and replace lost connection in the aged CNS. Consistent with this notion, reactive
synaptogenesis is observed in injured aged mice (Coleman and Flood, 1986). Moreover,
dendritic arbors continue to grow between middle and old aged in brain regions that show
neuronal loss (Cotman and Anderson, 1988). Therefore, compensatory mechanisms of
growth and remodeling may be part of the lifelong program to maintain and adapt brain
function.
2.1.2.2 Neurochemical Alteration
Although acetylcholine is a minor neurotransmitter in the CNS quantitatively, it
plays a significant role in intellectual activity, including memory. Despite no changes of
either choline or acetylcholine content, the in vivo and in vitro synthesis, release and
choline uptake are decreased in aged brain (Gibson et al., 1981). The number of
muscarinic receptor and the sensitivity of hippocampal pyramidal cell to acetylcholine
are also declined as a function of age (Gilgun-Sherki et al., 2001). Moreover, alteration in
the glycolytic enzymes causes decline in glycolysis, thereby decreasing the level of acetyl
coenzyme A, which is the key substrate for acetylcholine synthesis (Meier-Ruge et al.,
1984). These studies suggest that cholinergic transmission is diminished in aged brain,
although no direct electrophysiological evidence has been reported. It is possible that
various regulatory mechanisms compensate for loss of specific measures.
Pre- and postsynaptic dopamine metabolisms are selectively altered in aged brain.
Synthesis of dopamine is decreased with age in the nigrostriatal stem and in the nucleus
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accumbens (Giaquinto, 1988), and levels of dopamine and number of dopaminecontaining neurons are declined in advance age subjects (Morgan et al., 1987). Moreover,
the activity of the dompamine-degrading enzyme, monoamine oxidase, decreases as a
function of age in brain. The density of dompamine D2 receptors are also decreased both
in aged human and rodent. Another neurochemical, norepinephrine (NE), are synthesized
by dompamine-beta-hydroxylase (DBH) from dopamine. Therefore, many of the agerelated changes in dompamine are also found in NE. However, no alteration of DBH
activity is observed in striate nor in the substantia nigra (Morgan et al., 1987). However,
the NE level is decreased in the brain stem, hypothalamus and hippocampus (Morgan et
al., 1987).
Gamma-amminobytyric acid (GABA) is the most widely distributed
neurotransmitter in the CNS. The synthesis of GABA is decreased in in cerebellum,
substantia nigra and hippocampus (Giaquinto, 1988). GABA is synthesized from
glutamate, the neurotransmitter in most of the excitatory synapses and appears to be
involved in age-related functional alteration, such as motor behavior, cognition and
emotion. Glutamate level is decreased in cerebral cortex and hippocampus in aged
animals, although it may be mainly a consequence of alteration in metabolic activity
rather than glutamatergic neurotransmission (Segovia et al., 2001). Although, there is no
change in glutamate release during aging, reduced glutamate uptake and loss in glutamate
transporters in glutamatergic terminals are demonstrated in aged rats. Therefore, the lack
of changes in glutamate release may be due to compensatory alteration in glutamate
uptake. Moreover, decrease in the density of glutamatergic NMDA receptors is
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consistently reported in aged brain (Segovia et al., 2001), suggesting the glutamate
neurotransmission alteration in aged brain.
2.1.2.3 Calcium Ion Dysregulation
The regulation of Ca2+ and its compartmentalization is essential to synaptic
events, such as transmitter release, excitablility and second-messanger responses) . Ca2+
homeostatsis response differently to aging in different brain compartment, suggesting
age-related Ca2+ regulation is impaired in age brain (Gibson and Peterson, 1987). Only
1/10,000th of total neuronal Ca2+ is in cytosolic. This cytosolic Ca2+ is the physiological
active pool of Ca2+, thus dysregulation of the homeostasis of the
intracellular/extracellular in neuron could cause deleterious changes in neuronal function
by altering receptor mobility the coupling of receptors with enzymes involve in
phosphoinositide hydrolysis, the function of GTP-binding proteins, Ca2+ transport
systems, Ca2+ binding proteins, and Ca2+-activated protease (Gibson and Peterson, 1987).
For example, the Ca2+ activated protease, calpain, is present in high concentration in
selectively vulnerable neuron in aged brain (Baudry et al., 1986). Moreover, prolong Ca2+
dependent K+-mediated hyperpolarization after repetitive stimulation is demonstrated in
hippocampal brains slices from aged rats (Gibson and Peterson, 1987). These studies
suggest that free Ca2+ in hippocampal neurons is dysregulated in age brain. It was
suggests that the changes of Ca2+ homeostatic and Ca2+ signaling pathways are underlie
the development of these biological markers of aging (Foster and Kumar, 2002).
2.1.2.4 Energy Metabolism Impairment
Synthesis of adenosine triphosphate (ATP) by neuron and glia is critical to the
normal brain function. There are only slight declines in energy metabolism in the
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sensory-related areas of aged rats with few age-related neuropathological changes
(Cotman and Peterson, 1989). Moreover, positron emission tomography (PET) studies
show that cerebral metabolic rate and cerebral blood flow were reduced in aged brain
when elderly subjects with diseases were not excluded (Cotman and Peterson, 1989).
However, the brain oxidative metabolism does not change significantly with age in the
subjects that are cognitively intact and disease free (Duara et al., 1984). These studies
demonstrate that metabolic impairment in age brain is not an universal pheromone,
metabolism in aging can be preserved in healthy individuals.
2.1.2.5 Protein Abnormality
Protein abnormality in age brain was manifested by structure called neuritic or
senile plaques. These protein structures accumulate with age in the neuropil of frontal
cortex and hippocampus (Cotman and Peterson, 1989). These plaques (20-50 μm in
diameter) are involved in the enlarged axonal and dendritic processes that sprout and
dengerate. More over the degenerating neurites was surrounded by extracellular protein
aceous filaments called β-amyloid (Aβ). Senile plaques are present in brain of primates,
dogs and polar bears, but not rats.
Another abnormal protein inclusion is neurofibrillary tangles (NFT), which is
increased with advancing age. NFT are composed of primary microtubule-associated
protein tau (tau) and other insoluble proteins (Kosik et al., 1986). NFT are found in
normal aged brain, and the number of NFT increased during the ninth and tenth decades
of life.
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2.2 Supports for the Free Radical Theory in Brain Aging
2.2.1 Free Radical Production
Mitochondria are the most significant source of oxidants in cells because
approximately 1-2 % of electrons flow through the electron transport chain results in
generation of free raidcals (Calabrese et al., 2000a). Moreover, various toxins in the
environment can injure mitochondrial enzymes, leading to increased generation of free
radicals that play important major roles in aging (Ventura et al., 2002). It was reported
that the low abundant mitochondria in aged animals are enlarged with vacuolization,
cristae rupture and accumulation of paracrystalline inclusions [6]. Lacking many
endogenous antioxidant mechanisms, mitochondria depend on glutathione (GSH) to
remove H2O2 (Fernandez-Checa et al., 1998; Coll et al., 2003). Therefore, the role of
mitochondria in free radical formation is likely a major contributor to aging (Calabrese et
al., 2001). As a source of these toxic oxidants, mitochondria are also potential victims of
free radicals (Sastre et al., 2003), and mitochondrial decay is also a main contributor of
acceleration of aging (Atamna et al., 2002; Ames, 2003). Accumulation of mtDNA
mutations during life is a major cause of age-related disorders. The high mutagenic
propensity of mtDNA derives from its lack of introns and protective histones, which
limits nucleotide excision and recombination DNA repair mechanisms; and its location in
the inner mitochondrial membrane, which exposes mtDNA to an enriched free radical
milieu. mtDNA mutations increase as a function of age in brains and muscles. Agerelated increase in mtDNA deletion (common deletion) was found in elderly brain and in
PD (Ozawa et al., 1990). Common deletion removes a 5-kb region of mtDNA that
encodes for six essential polypeptides of the respiratory chain and five tRNAs. Relevant
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to mitochondrial bioenergetics is the diminishment of state 3/state 4 ratio in aged brains
(Barja, 1999). This ratio relates to the coupling efficiency between electron flux through
the electron transport chain and ATP production. An increase in state 4 would result in a
more reductive state of mitochondrial complexes and, consequently, to an increase in free
radical species production. Therefore, a decrease in the state 3/state 4 ratio during aging
indicates increase free radical production, which is associated with a significant decrease
in cardiolipin content in brain mitochondria (Ruggiero et al., 1992).
2.2.1.1 Reactive oxygen species (ROS)
The terms “free radicals” and “ROS” are commonly used synonymously.
However, it should be made clear that ROS refer to a number of chemically reactive
molecules derived from ground-state oxygen (O2) (Halliwell, 1996; Fridovich, 1999;
Halliwell, 1999a; Betteridge, 2000), while free radicals refer to the low molecular weight
molecules with at least one unpaired electron (Nordberg and Arner, 2001). ROS include
superoxide (O2·-), hydroxyl radical (HO·), hydrogen peroxide (H2O2), and hypochlorous
acid (HOCl); H2O2 is not a free radical, yet is still considered as ROS. ROS vary in their
reactivities and toxicities, two terms that are not necessary equal (for example, H2O2 is
less reactive, but more toxic than O2·- because of its ability to penetrate biological
membranes). Figure 2.1 summarizes the formations and metabolisms of ROS at the
intracellular level. We will individually discuss four major forms of ROS in terms of their
pathways and cellular effects.
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Figure 2.1
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2.2.1.1.1 Superoxide (O2·-)
Significant amounts of O2·- are produced by the reaction of O2 with a escaped
electron from the respiratory chain in mitochondria (Nordberg and Arner, 2001)
(Reaction 1):
O2 + e- Æ O2·-

(Reaction 1)

O2·- can also be produced endogenously by flavoenzymes such as xanthine
oxidase (Kuppusamy and Zweier, 1989), lipoxygenase, and cyclooxygenase (Kontos et
al., 1985; McIntyre et al., 1999). The NADPH-dependent oxidase complex in phagocytic
cells liberates large amounts of O2·- (Babior, 1999; Nauseef, 1999) during bacterial
infections to defend against intruding bacteria (Thomas et al., 1988). In non-phagocytic
cells, a similar NADPH-dependent oxidase complex is believed to involved in cell
signaling (Thannickal and Fanburg, 2000).
Since O2·- is an anion and a modestly reactive compound, it requires a specific
transport system acts to penetrate lipid membranes to produce further damage. O2·-, as
well as its damages, are usually enclosed in the compartments where this free radical
anion is produced; therefore, superoxide radical anion is considered to be less toxic
compared to HO· (Nordberg and Arner, 2001).
2.2.1.1.2 Hydrogen peroxide (H2O2)
In among other reactions, H2O2 is produced when cells try to detoxify O2·(Reaction 2) by Cu,Zn-superoxide dismutases (SOD) in cytosol, or Mn-SOD in
mitochondria (McCord and Fridovich, 1969; Yost and Fridovich, 1973; Fridovich, 1997).
2O2·- + 2H+ Æ 2H2O2 +O2
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(Reaction 2)

Besides serving as an intermediate of detoxifying pathway of O2·-, H2O2 is also proposed
to be an intracellular signaling molecule (Sundaresan et al., 1995; Chae et al., 1999a).
H2O2 can remodel the structure of (Choi et al., 2001) and activate a transcription factor,
which is responsible for initiating the transcription of a number of antioxidant genes, in
E. Coli (Aslund et al., 1999) and yeast (Carmel-Harel et al., 2001). H2O2 is removed by
antioxidant enzymes, such as catalase, gluthathione peroxidases, and peroxiredoxins,
once it was produced (Chae et al., 1999b; Chen et al., 1999; Guerra et al., 2000)
(Reaction 3):
2H2O2 Æ 2H2O + O2

(Reaction 3)

However, when the rate of H2O2 production exceeds the rate of Reaction 3, H2O2
accumulates and becomes toxic to cells because of its oxidative nature. Accumulation of
H2O2 can also lead to formation of HO· (Halliwell, 1987, 1999b) and HOCl (Winterbourn
et al., 2000) described below.
2.2.1.1.3 Hypochlorous acid (HOCl)
HOCl is formed by the enzymatic reaction of H+, Cl- and H2O2 catalzed by
myeloperoxidase (Rossi et al., 1985) (Reaction 4)
H+ + Cl- + H2O2 Æ HOCl + H2O

(Reaction 4)

Myeloperoxidase is expressed in the phagosomes of neutrophils (Winterbourn et
al., 2000) to produce HOCl as an antimicrobial agent for elimination of bacteria ingested
by the phagocyte. It was found that HOCl terminates the bacterial DNA replication by
destroying the DNA anchoring at the bacterial membrane (Rossi et al., 1985).
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2.2.1.1.4 Hydroxyl radical (HO·)
HO· can be produced spontaneously by either reaction of HOCl with O2·(Reaction 5), or metal ion-meidated catalytic reactions (Reaction 6 and 7) (Nordberg and
Arner, 2001):
HOCl + O2·- Æ O2 + HO· + Cl-

(Reaction 5)

HOCl + Fe2+ Æ HO· + Cl- + Fe3+

(Reaction 6)

HOCl + Cu+ Æ HO· + Cl- + Cu2+

(Reaction 7)

However, the steady-state concentration of HOCl is generally low due to its high
reactivity. Therefore, except in activated phagocytes, Reaction 5 seems unlikely to be a
significant source of HO· radicals (Mikkelsen and Wardman, 2003).
Formation of HO· from H2O2 through Fenton reactions (Reaction 8 and 9): is also
catalyzed by the metal ions (Fe2+ or Cu+) bound to proteins or other molecules
H2O2 + Fe2+ Æ HO· + OH- + Fe3+

(Reaction 8)

H2O2 + Cu+ Æ HO· + OH- + Cu2+

(Reaction 9)

Only small amount of metal ions are needed for Reaction 8 and 9 because the
metals ions are recycled by reacting with O2·- (Reaction 10 and 11):
O2·- + Fe3+ Æ O2 + Fe2+

(Reaction 10)

O2·- + Cu2+ Æ O2 + Cu+

(Reaction 11)

The net reaction that H2O2 reacts with O2·- to yield HO·, OH- and O2 is
collectively called the Haber-Weiss reaction (Reaction 12) (Nordberg and Arner, 2001):
H2O2 + O2·- Æ O2 + HO· + OH-

(Reaction 12)

It was proposed that the metal ions in the in vivo Haber-Weiss reaction are
released from ferritin (Harris et al., 1994) and the co-factor of different dehydrolases by
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reaction of O2·- (Fridovich, 1997). HO· is considered one of the most toxic free radicals
among other ROS because of its high reactivity, short half-life, and irreversible
modification of lipid, protein and DNA (Halliwell, 1987; Betteridge, 2000).
2.2.1.2 Reactive Nitrogen Species (RNS)
RNS refer to nitric oxide (NO) and molecules derived from NO, such as
peroxynitrite (-OONO), and nitrogen dioxide (NO2). Although RNS have different
reactivities from each other, their half-lives of RNS are generally longer than HO· and
O2·- (Balazy and Nigam, 2003). The pathways for formation and metabolism of RNS in
intracellular level are shown in Figure 2.2.
2.2.1.2.1 Nitric oxide (NO)
NO is synthesized enzymatically by NO synthase (NOS). Presently, there are
three distinct isoforms of NO synthases: neuronal (nNOS), inducible (iNOS), and
endothelial (eNOS). iNOS is different from the other isoforms because of its permanent
calmodulin binding and Ca2+-independent expression (Andrew and Mayer, 1999; Beck et
al., 1999; Bredt, 1999; Kroncke et al., 2000; Drew and Leeuwenburgh, 2002). By using
an electron from NADPH (C21H30N7O17P3), NOS catalytically oxidizes L-arginine
(C6H14N4O2) to form L-citrulline (C6H13N3O3) with NO as a by-product (Reaction 13)
(Andrew and Mayer, 1999; Beck et al., 1999; Bredt, 1999):

C6H14N4O2 + O2 + C21H27N7O17P3Æ C6H13N3O3 + NO + C21H26N7O17 P3+ + e(Reaction 13)
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NO has a long half-life (1-10s) when compared to that of O2·- (10-8s) and HO· (109

s) (Balazy and Nigam, 2003). Therefore, the reaction between NO and other free

radicals, such as O2·- and HO·, stabilizes these free radicals. As a result, it was proposed
that NO can function as a free radical scavenger; evidences showed that low dose of NO
can inhibit lipid peroxidation in cell membranes (Hogg and Kalyanaraman, 1998; Rubbo
et al., 2000).
In normal physiological concentration, NO serves as an intracellular messenger
for guanylate cyclase and protein kinase (Ignarro, 1990). However, the stability of NO
enables it to travel across cell membranes and even transmit the signals intercellularly.
When iNOS is induced by endotoxin, large amounts of NO are produced to control the
cellular function by redox reaction (Ignarro, 1990).
NO is removed by conjugation with glutathione. However, when glutathione
levels are depleted, such as in aging (Liu and Mori, 1993; Hussain et al., 1995), excessive
NO can nitrosylate protein, to cause dysfunction, or it can react with other reactive
molecules to form other RNS causing further damages to cells.
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Figure 2.2
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2.2.1.2.2Peroxynitrite (-OONO)
NO reacts with O2·-, it form –OONO which has a half-life of 0.9s (Reaction 14)
(Balazy and Nigam, 2003):
NO + O2·- Æ -OONO

(Reaction 14)

When the NO concentration is sufficiently high, such as in stimulated leukocytes,
the rate of reaction 14 is greater than 109 M-1s-1 (Balazy and Nigam, 2003). At this rate,
Reaction 14 can be faster than the dismutation of O2·- by SOD. Therefore, Reaction 14
competes with SOD for O2·- to form –OONO (Beckman and Koppenol, 1996). –OONO
can then undergo homolysis to form HO· to damage cells. Studies have revealed that –
OONO also play a role in age-associated oxidative stress (van der Loo et al., 2000; Imam
and Ali, 2001) by initiating fatty acids transformation through peroxidation, epoxidation
and nitration (Radi et al., 1991; Balazy, 1994; O'Donnell et al., 1999).
2.2.1.2.3 Nitrogen dioxide (NO2)
Increased production of –OONO leads to auto-homolysis into HO· and NO2 in the
acidic conditions provided by the cellular CO2 concentration (Meli et al., 2002) (Reaction
15):
-

OONO + H+ Æ HO· + NO2

(Reaction 15)

Although it was shown that decomposition of –OONO is the major source of NO2,
NO2 can also be produced through the direct oxidation by O2 (Balazy and Nigam, 2003)
(Reaction 16)
2NO + O2 Æ 2NO2

(Reaction 16)
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NO2 oxidatively modifies lipids (Singh et al., 1998; Goss et al., 1999; Jiang et al.,
1999), suggesting NO2 may also contribute to the initiation of oxidative damage in
tissues.
It should be noted that not all of ROS and RNS have been discussed above. Nor
have other reactions been described, such as rearrangement of –OONO forming NO3- and
carboxylation of –OONO forming ONOOCO2-, which also are important in ROS and
RNS formations. Recently, carbon monoxide (CO) has drawn attention because, like NO,
this gas binds to guanylate cyclase to activate cGMP (Verma et al., 1993; Maines, 1997).
Binding of CO to guanylate cyclase was abolished by a potent heme oxygenase inhibitor,
but not by NOS inhibitors (White and Marletta, 1992; Glaum and Miller, 1993). Heme
oxygenase (HO) is a CO synthetic enzyme with 60% homology to the carboxyl terminal
of NOS at the amino acid level (Foresti and Motterlini, 1999), suggesting CO plays a
similar role as NO in the signal transduction mechanism to regulate intercellular
communication (Graser et al., 1990). HO inhibition increases NO production in mouse
when macrophages are exposed to endotoxin (Wang and Wu, 2003), indicating that CO
plays a significant role of in regulating NO generation. On-going research is aimed to
understand the relation between CO and NO. Another important point to be noted is that
ROS and RNS are not necessarily harmful to normal cellular functions, such as defense
against infection and cellular signaling (Nordberg and Arner, 2001), but they are
essential. It is the excessive amounts of ROS and RNS that exceed the capacity of the
antioxidant defense system, creating an imbalanced oxidative system that causes damage
to cells.
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2.2.2 Antioxidant Defense
ROS and RNS have the capacity to modify proteins, lipids and nucleic acids to
develop or enhance the age-related manifestations. Fortunately, living organisms
developed several mechanisms to protect themselves from the attack of ROS and RNOS.
These antioxidant defense mechanisms include: (a) scavenging ROS/RNOS and their
precursors; (b) binding metal ions needed for catalyzed ROS; (c) generating and upregulating the endogenous antioxidant defenses. Two major groups of antioxidant
defense systems are low molecular weight antioxidant compounds, e.g vitamin C and E,
lipoic acid and ubiquinones, and anitoxidant enzymes, e.g. superoxide dismutases (SOD),
superoxide reductases (SOR), catalases , glutathione peroxidases (GPx) (Gilgun-Sherki et
al., 2001). When the production of ROS and RNOS exceed the capacity of the
antioxidant defenses systems, the new state is named oxidative stress.
Two of the major endogenous antioxidant defense systems are heat shock proteins
and glutathione. Reduced glutathione (GSH) is the most prevalent non-protein thiol in
animal cells. Its de novo and salvage synthesis maintain a reduced cellular environment.
The tripeptide of glutathione is a co-factor for many cytoplasmic enzymes and also acts
as an important post-translational modification in a number of cellular proteins. The
cysteine thiol acts as a nucleophile in both exogenous and endogenous reactions.
Consequently, ROS are frequently removed by GSH in both spontaneous and catalytic
reactions (Butterfield et al., 2002a; Butterfield et al., 2002e; Drake et al., 2002; Drake et
al., 2003; Poon et al., 2004a). Since ROS have defined roles in cell signaling events as
well as in human disease pathologies, an imbalance in expression of GSH and associated
enzymes has been implicated in a variety of pathological conditions (Butterfield et al.,

24

2002b; Calabrese et al., 2003a). GSH metabolism plays an important role in diseases such
as cancer, neurodegenerative diseases and aging (Droge, 2002).
Another antioxidant defense system is the heat shock response. In the CNS, heat
shock protein (HSP) synthesis is induced by the alterations in the intracellular redox
environment, exposure to heavy metals, amino acid analogs or cytotoxic drugs (Calabrese
et al., 2003b; Calabrese et al., 2003a). While prolonged exposure to conditions of extreme
stress is harmful, induction of HSP synthesis can result in increased stress tolerance and
cytoprotection against stress-induced molecular damage (Calabrese et al., 2002b). Hence,
the heat shock response contributes to establishing a cytoprotective state in a variety of
metabolic disturbances, such as age-related neurodegenerative disease and aging
(Motterlini et al., 2000; Calabrese et al., 2002a; Mayer, 2003). In aged animals,
oxidatively modified proteins lead to protein aggregation, cell damage, and decreased
function of organs. HSP, stress proteins or molecular chaperones play a role in protecting
cells from damage through defense against denaturation or renaturing the denatured
proteins. Therefore, alterations of the expression and activity of stress proteins are related
to protein denaturation with aging. The details of HSP and glutathione are discussed
below.
2.2.2.1 Heat Shock Proteins
Heat shock proteins serve as chaperones that bind to other proteins and regulate
their conformation, regulate the protein movement across membranes or through
organelles, or regulate the availability of a receptor or activity of an enzyme. In
mammalian cells the induction of the heat shock response requires the activation and
translocation to the nucleus of one or more heat shock transcription factors which control
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the expression of a specific set of genes encoding cytoprotective HSPs. In the nervous
system, HSPs are induced in a variety of pathological conditions, including cerebral
ischemia, neurodegenerative disorders, epilepsy and trauma. Expression of the gene
encoding HSPs has been found in various cell populations within the nervous system,
including neurons, glia and endothelial cells (Kelly and Yenari, 2002). HSPs consist of
both stress-inducible and constitutive family members. Some of the known HSPs include
ubiquitin, HSP10, HSP27, HSP32 (or HO-1), HSP47, HSP60, HSC70, HSP70 (or
HSP72), HSP90 and HSP100/105. Most of the proteins are named according to their
molecular weight.
The 70 kDa family of HSPs has been studied extensively. Included in this
family are HSC70 (heat shock cognate, the constitutive form), HSP70 (the inducible
form, also referred to as HSP72), GRP75 (a constitutively expressed glucose-regulated
protein found in the endoplasmic reticulum). After a variety of CNS insults, HSP70 is
synthesized at high levels and is present in the cytosol, nucleus and endoplasmic
reticulum. Denaturated proteins are proposed to stimulate the HSP70 synthesis.
Denaturated proteins activate heat shock factors (HSFs) by dissociating other HSPs that
are normally bound to HSF (Calabrese et al., 2001). Free HSFs are then phosphorylated
and form trimers to enter the nucleus. Once in the nucleus, they bind to heat shock
elements (HSE) within the promoters of different heat shock genes leading to
transcription and synthesis of HSPs. The synthesis of HSP70 is terminated when it
becomes the most abundant single protein in a cell. HSP70 binds to denaturated proteins
in an ATP-dependent manner. Recently, transgenic animals that overexpress the gene
encoding HSP70 demonstrated that overproduction of HSP70 were reported to lead to
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neuroprotection in several different models of CNS injury (Kelly et al., 2002). Mild heat
shock protects neurons against glutamate-mediated toxicity and protects astrocytes
against injury produced by lethal acidosis (Narasimhan et al., 1996). Transfection of
cultured astrocytes with HSP70 protects them from ischemia or glucose deprivation (Fink
et al., 1997). Cytokine-induced nitrosative stress is associated with an increased synthesis
of HSP70 stress proteins in astroglial cell cultures. Increased HSP70 protein expression
was also found after treatment of cells with the NO generating compound sodium
nitroprusside (SNP), suggesting HSP70 proteins possibly protect cells from RNS. The
molecular mechanisms regulating the NO-induced activation of heat-shock signal seems
to involve cellular oxidant/antioxidant balance, mainly represented by the glutathione
status and the antioxidant enzymes (Calabrese et al., 2000c; Calabrese et al., 2000b).
HSP 32 or heme oxygenase (HO) is the rate-limiting enzyme in the production of
bilirubin. There are three isoforms of heme oxygenase, HO-1 or inducible isoform, HO-2
or constitutive isoform and the recently discovered HO-3 (Schipper, 2000; Goldbaum and
Richter-Landsberg, 2001; Sahlas et al., 2002; Scapagnini et al., 2002). HO catalyzes the
multistep degradation of heme by consuming energy. HO catalyzes the α-specific
oxidative cleavage of the heme molecule to form biliverdin and carbon monoxide (CO).
The iron released by HO-1 is bound by ferritin, perhaps via a HO-1 chaperone function
(Nath et al., 2000). Similar to other antioxidant, increasing evidence suggests that the
HO-1 gene is redox regulated and contains in its promoter region the antioxidant
responsive element (ARE). Heme oxygenase-1 is rapidly upregulated by oxidative and
nitrosative stresses, as well as by glutathione depletion. All these findings have
introduced new perspectives in medicine and pharmacology, as molecules activating this

27

defense mechanism appear to be possible candidates for novel cytoprotective strategies
(Butterfield et al., 2002a).
Ubiquitin is one of the smallest HSPs. It is involved in targeting and chaperoning
of proteins degraded by proteasomes. HSP27 is synthesized mainly in astrocytes in
response to ischemic situations or to kainic acid administration. It chaperones
cytoskeletal proteins, such as intermediate filaments, actin or glial fibrillary acidic protein
following stress in astrocytes. HSP27 also protects cells against H2O2-induced necrosis
(Bechtold and Brown, 2003). HSP47 is synthesized mainly in microglia following
cerebral ischemia and subarachnoid hemorrhage (Valentim et al., 2003). HSP60, glucoseregulated protein 75 (GRP75) and HSP10 chaperone proteins within mitochondria.
GRP75 and GRP78, also called oxygen-regulated proteins, (ORPs) are produced by low
levels of oxygen and glucose to protect brain cells against ischemia and seizures in vivo
(Turner et al., 1999; Izaki et al., 2001).
2.2.2.2 Glutathione
Because mitochondria lack the enzymes needed to synthesize GSH, this tripeptide
must be transported into the mitochondria. The tri-peptide glutathione (γ-glutamylcyteinyl-glycine) is an endogenous antioxidant of great importance. Glutathione exists in
either a reduced (GSH) or oxidized (GSSG) form and participates in redox reactions
through the reversible oxidation of its active thiol. In addition, GSH acts as a coenzyme
of numerous enzymes involved in cell defense. In unstressed cells the majority (99 %) of
this redox regulator is in the reduced form, and its intracellular concentration is between
0.5 and 10 mM depending on the cell type (Butterfield et al., 2002a; Butterfield et al.,
2002e). Depletion of glutathione has been shown to occur in conditions of moderate or
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severe oxidative stress and has been associated with increased susceptibility to cell
damage (Calabrese et al., 2000c; Calabrese et al., 2000b; Calabrese et al., 2002b;
Calabrese et al., 2003b; Calabrese et al., 2003a; Poon et al., 2004a). Glutathione (GSH)
is required for the maintenance of the thiol redox status of the cell, protection against
oxidative damage, detoxification of endogenous and exogenous reactive species, storage
and transport of cysteine, protein and DNA synthesis, cell cycle regulation and cell
differentiation (Butterfield et al., 2002a). In addition, glutathione and glutathione-related
enzymes play a key role in protecting the cell against the effects of reactive oxygen
species. The key functional element of glutathione is the cysteinyl moiety, which
provides the reactive thiol group. Glutathione is the predominant defense against ROS,
which are reduced by GSH in the presence of GSH peroxidase. As a result, GSH is
oxidized to GSSG, which in turn is rapidly reduced back to GSH by GSSG reductase at
the expense of NADPH. The thiol-disulfide redox cycle also aids in maintaining reduced
protein and enzyme thiols. Without a process to reduce protein disulfides, vulnerable
cysteinyl residues of essential enzymes might remain oxidized, leading to changes in
catalytic activity. Glutathione also aids in the storage and transfer of cysteine as well.
Cysteine oxidizes rapidly into cystine which produce toxic oxygen radicals. To avoid
this toxicity, most of the nonprotein cysteine is stored in glutathione. In addition to
protection against ROS, glutathione is an excellent scavenger of lipid peroxidation
products such as HNE and acrolein, both of which have been found to bind proteins
inhibiting their activities (Pocernich et al., 2000; Pocernich et al., 2001). Glutathione also
reacts with saturated reactive carbon atoms (epoxides), unsaturated carbon atoms
(quinones, esters), and aromatic carbon atoms (aryl nitro compounds) to detoxify the
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nucleophilic attack from the electrophilic carbon on these compounds (Hammond et al.,
2001; Butterfield et al., 2002a). Glutathione also forms metal complexes via
nonenzymatic reactions to terminate Fenton reactions (Hammond et al., 2001; Butterfield
et al., 2002a; Butterfield et al., 2002e).
A complex GSH system in the brain has been connected with the oxidative stress
occurring in neurological diseases (Butterfield et al., 2002b; Drake et al., 2003; Poon et
al., 2004a). Recent data demonstrate that GSH has also important extracellular functions
in brain. Astrocytes appear to play a key role in the GSH metabolism of the brain, since
astroglial GSH export is essential for providing GSH precursors to neurons. Among the
different brain cell cultures studied in vitro, only astrocytes release substantial amounts of
GSH and GSSG during oxidative stress (Dringen and Hirrlinger, 2003).
Evidence suggests that there exists a direct relation between decreased glutathione
levels by oxidant stress and rapid up-regulation of HO-1 (mRNA and protein) in a variety
of cells of rat brains, human fibroblasts, endothelial cells and rat cardiomyocytes
(Calabrese et al., 2000a). In addition, increased production of NO and RNS can lead to
changes in intracellular glutathione. In astroglial cell cultures, stimulation of iNOS
decreases total glutathione, while raising GSSG, and this effect was abolished by pretreatment of glial cells with NOS inhibitors (Calabrese et al., 2000c). Moreover, elevation
of intracellular glutathione prior to exposure of endothelial cells to NO donors almost
completely abolishes activation of the heme oxygenase pathway, which suggests that
glutathione can antagonize the effect of RNS by inducing HO-1 (Calabrese et al., 2003b).
All these reports support the notion that the decline of antioxidant defense systems is as
important as the generation of ROS and RNS in damaged of the aged CNS.
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2.2.3 Oxidative stress and Brain Aging
As mention earlier, oxidative stress is the inbalance condition in which the
production of ROS and RNS exceed the capacity of these antioxidant defense systems.
The brain is more susceptible to oxidative stress for the following reasons: (a) high
content of peroxidizable unsaturated fatty acid, (b) high oxygen consumption per unit
weight, (c) high content of lipid peroxidation key ingredients: iron and ascorbate, and (d)
the scarcity of antioxidant defenses systems (Floyd, 1999). It is widely held that free
radicals induce oxidative stress increases in brain aging. The increased oxidative stress is
manifested by protein oxidation and lipid peroxidation.
2.2.3.1 Lipid Peroxidation
The mechanism of lipid peroxidation can be divided into three stages: initiation,
propagation, and termination. In initiation, since OH· is a very reactive ROS (Halliwell
and Gutteridge, 1992), it attacks the hydrogens from nearly any C-H bond to form H2O.
The electron-rich hydrogens at the CH2 group in the system -CH=CH-CH2-CH=CH- of
polyunsaturated fatty acids (PUFA) are even more vulnerable to the OH· attack due to the
electron donating double bonds (Frankel, 1984). The OH· irruptions, along with other
radicals (Spiteller, 2001), generate racemic peroxyl radicals which attack the hydrogens
from other PUFAs and begin a chain reaction (Frankel, 1984). These chain reactions are
collectively called propagation. The peroxyl radicals will then undergo the Esterbauer
dioxetane mechanism to from multiple aldehydes with varying lengths of carbons, such
as 4- hydroxyl-2-nenonal (HNE) (Esterbauer et al., 1991), and terminate the chain
reaction, thus the termination stage. The end products of lipid peroxidation are usually
more stable than the free radicals, serving as excellent markers for free radical irruptions.
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Although these aldehydes have lower activity than free radicals, their longer half-life
allows the, to be more neurotoxic.
2.2.3.1.1 Phospholipids Composition
One way to assess the lipid peroxidation is to use the compositional alterations of
brain phospholipids. PUFAs, such as arachidonic (AA, 20:4n-6), docosatetraenoic acid
(DCS, 22:4n-6) and decosohexaenic acid (DCH, 22:6n-6), are abundant in brains and
highly susceptible to free radical attack by the mechanism mentioned above. When
PUFAs act as substrates of lipid peroxidation and become oxidized, their lipid
peroxidation end-product fatty acids, e.g. palmitic acid (16:0), stearic acid (18:0), palmitc
acid (16:1n-7), oleic acid (18:1n-9) and godonic acid (20:1n-9), will process reduced
number of double bonds as well as different chemical and physical properties. Therefore,
the quantity of lipid peroxidation can be estimated by measuring the depletion of PUFAs,
or the ratio change between PUFAs and saturated/monounsaturated fatty acids. These
measurements can be done by simple extraction (Delsal, 1944) and separation of the fatty
acids by thin layer chromatography (TLC) (Vitiello and Zanetta, 1978; Hedegaard and
Jensen, 1981), gas chromatography (GC) (Lanza et al., 1980) or high-performance liquid
chromatography (HPLC) (Murphy et al., 1993) followed by Ultra Violet (UV) or mass
spectrometry for identification of the fatty acids.
It was ubiquitously reported that brain aging is accompanied by changes in the
overall membrane lipid composition (Schroeder et al., 1984; Lopez et al., 1995). The
most important changes involve a decreased level in PUFA (20:4n-6, 22:4n-6, 22:6n-3)
and an increase in monounsaturated fatty acids (18:1n-9 and 20:1n-9) in cerebral cortex
and cerebellum of aged rats (Giusto et al., 2002). Moreover, AA, along with n-6 and n-3
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fatty acids, were also reported to decrease in brains of aged rats with cognitive deficit
(Ulmann et al., 2001). This study suggested that low levels of AA might be related to the
cognitive deficit in rats as membrane AA concentration were showed to be correlated
with the log-term potentiation (LTP). LTP is a form of synaptic plasticity characterized
by persistent synaptic efficacious increases, which follow tetanic stimulation from an
afferent pathway to one of the hippocampal subfields (Lynch, 1998). The ability to
sustain LTP is usually used as a parameter of cognitive function. The changes in
phospholipid composition provide evidence that free-radical mediated lipid peroxidation
occurs in brains and such changes might also be responsible for the cognitive deficit we
observed in aged animals and humans.
2.2.3.1.2 Reactive aldehyde
HNE is an end product of linoeic acid (mainly, but not exclusively) peroxidation
(Esterbauer et al., 1991). Because of its extensive half-life, HNE is able to diffuse to sites
that are distant from that of its formation and cause further damage. HNE introduce
neurotoxicity and cause apoptosis in many ways. This major product of lipid peroxidation
can inhibit proliferation and cell cycle progression by the down regulation of D1, D2, and
A cyclin expression (Pizzimenti et al., 1999). It can also react with the bases in DNA and
lipid amino groups by Michael-addition (Uchida and Stadtman, 1992; Guichardant et al.,
1998) to alter the proper function of these biological molecules. The most damaging
effect of HNE comes from its ability to form covalent adduct of histidine, lysine and
cysteine residues in proteins to modify their activity. HNE deactivate aldose reductase
and glutathione peroxidase, which detoxify HNE (Del Corso et al., 1998) and catalyze the
reduction of H2O2 by glutathione (Boschi-Muller et al., 2000) respectively. HNE reduces
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Na+/K+ -ATPase activity (Siems et al., 1996). Reduction of these critical ion pumps
causes neurotoxicity in rat hippocampal neurons by disrupting the Ca2+ homeostasis
(Butterfield et al., 2002d) and impairing glucose transport (Mark et al., 1997).
Acrolein is the most reactive of the α,β-unsaturated aldehydes formed by lipid
peroxidation source that are not fully characterized as yet. (Uchida et al., 1998). Sharing
the chemical properties of HNE, acrolein introduces toxicity to primary hippocampal
culture (Lovell et al., 2001). This toxicity can due to the distortion of the transmembrane
and cytoskeletal proteins structures (Pocernich et al., 2001) as well as the inhibition of the
glucose and glutamate uptake (Lovell et al., 2000).
Since acrolein and HNE adducts are more stable than most free radicals, acroleinand HNE adducts, in particular acrolein- and HNE-modified proteins, provide a effective
marker for free radical mediated lipid peroxidation. It was also suggested that the proteinbound acrolein is a potential marker of oxidative stress in aging (Uchida et al., 1998).
Study showed that the amount of HNE-modified protein staining increased
logarithmically with age in human oculomotor neurons, but not melanized neurons
(Yoritaka et al., 1996). Additonally, the HNE-modified proteins, along with
neurofibrillary tangles, are also observed in the senile plaques in aged dogs (Papaioannou
et al., 2001).
Malondialdehyde (MDA) is the most abundant toxic aldehyde formed when
arachidonic aicd (AA) acts as the PUFA source for the lipid peroxidation (Basu and
Marnett, 1983; Michiels and Remacle, 1991; Esterbauer, 1993). MDA can catalytically
hydrolyze to formic acid or acetaldehydes by lysine or arginine (Nair, 1988). Similar to
HNE, MDA can react with amino acids in protein to from MDA adducts. Lysine,
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tryptophan and histidine react with MDA to form N-β-lysyl-ammino-acrolein (β-LAA)
(Nair et al., 1981; Slatter et al., 1998), whereas arginine reacts with MDA to form N-(2pyrimidyl)-l-ornithine (NPO) (King, 1966; Slatter et al., 1999). β-LAA can then further
react with another MDA molecule to form N-lysyl-4-methyl-2,6-dihydropyridine-3,5dicarbaldehyde (NLMDD) (Nair, 1988; Xu et al., 1998) which contains an aldehyde sidechain on the dihydropyridine ring responsible for reactions with lysine, to form a
reversible crosslink (Slatter et al., 1998). Although there is no evidence that such a
reaction occurs physiologically, it is possible that HNE, arolein etc can also react, in
place of the second MDA, with NLMD to form a reversible crosslink reaction. (Slatter et
al., 2000). MDA is also a highly reactive genotoxic compound that induces DNA damage
by reacting with nucleic acids to form adducts, thus disrupting base-pairing (Agarwal and
Draper, 1992). One of these adducts, deoxyguanosine-MDA (dG-MDA), is shown to
induce cell cycle arrests in human cell cultures (Ji et al., 1998).
MDA reacts with thiobarbituric acid (TBA) to produce fluorescent thiobarbituric
acid reacting substances (TBARS), commonly used to measure MDA levels (Yagi, 1982;
Yagi, 1994). However, TBA also reacts with other carbonyl-containing compounds.
Therefore,TBARS are generally considered a non-specific measurement of MDA. Such a
problem can be corrected through HPLC coupling with post column TBA derivatization.
This column will be able to specifically identify TBA-MDA complexes, thereby
providing a relevant assay in biological systems (Wong et al., 1987; Young and Trimble,
1991; Fukunaga et al., 1998). The cellular distribution of MDA can also be assessed
immunohistochemically (Slatter et al., 2000).
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In aged human brain, it was shown that the MDA was increased in inferior
temperal cortexes (Palinski et al., 1990), and in cytoplasm of neurons and astrocytes (Dei
et al., 2002) compared to the young controls. Through electron microscopic
immunohistochemistry, MDA was shown to form linear deposit. These deposits are caplike when associating with lipofuscin in neuron and vacuole-encircling when find in glia
in the CA4 region of human hippocampus (Dei et al., 2002). In a human aging canine
model, which naturally develops extensive diffused deposits of human-type Amyloid-β
(Aβ), MDA were increased in the prefrontal cortex of aged brains (Head et al., 2002).
Although there is no significant increase of MDA-modified protein observed in aged rat
brains (Mooradian et al., 1994), it was shown that the basal MDA level was significantly
raised (19%) in hippocampus of old rats (Cini and Moretti, 1995). Additionally, five dGMDA adducts were identified as the indigenous DNA (iDNA) adducts, which considered
a biomarker of aging brain (Cai et al., 1996) due to the increase of iDNA with age
(Randerath et al., 1989; Gupta et al., 1990; Randerath et al., 1990; Randerath et al.,
1993). The above studies suggest that the presence of free radical mediated MDA
production could induce further damage of the proteins or DNAs in brain. In Mooradian
study, the increased MDA-modified proteins were not observed. This could be due to the
fact that MDA-modified protein react with lipid peroxidation products to crosslink with
each other. Therefore, MDA-modified proteins could not be detected immunochemically.
2.2.3.2 Protein Oxidation
Protein oxidation is an exothermic event where peptides react with free radicals.
This reaction is mainly, though exclusively, mediated by the OH·, which is mostly
produced by the Fenton reaction through the decomposition of H2O2 in the presence of
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redox metals (Cu+ and Fe+) (Butterfield and Stadtman, 1997). Free radicals can attack
peptides at two locations: back bone and side-chain. In backbone modification, a free
radical attacks the hydrogen on the α-carbon to form a carbon-centered radical. In
presence of oxygen, this radical then further converts into a peroxyl radical (Butterfield
and Stadtman, 1997) which can attack other hydrogen of the same or differing peptides to
propagate the free radical oxidation in a similar fashion as the initial and propagation
stage of free radical mediated lipid peroxidation. Such oxidation can lead to protein
cross-linking and/or peptide bond cleavage. Four types of cleavage are reported: (a) αamidation which yields RCOCOOH and NH3; (b) diamide which yields RCOOH, CO2
and NH3; (c)glutamate oxidation which yields CH3COCOOH, HOOC-COOH and NH3;
and (d) proline oxidation which yields H2NCH2(CH2)2COOH and CO2 (Levine and
Stadtman, 2001). In side-chain modification, the free radicals attack the amino acid side
chains of a peptide. Although most amino acids side-chains are vulnerable to oxidative
modification, only some of these modifications are fully characterized: (a) histidine
modified to aspartic, aspargine or oxo-histidine; (b) tyrosine modified to 3,4dihyroxyphenlalaine and Tyr-Tyr cross-links; (c) phenylalanine modified to 2-,3-,4hydroyphenylalanine; (d) tryptophan modified to N-formylkynureine, kynurenine, 2-4-,5,and 6-hydroxyvaline; (e) valine modified to 3-hydroxyvaline; (f) leucine modified to 3and 4-hydoryleucine (g)lysine modified to 2-aminoadipic semialdehyde; (h) arginine
modified to gluamic semialdehyde; (i)proline modified to glutamic semialdehye ,
pyrogluamic acid, 2-pyroglutamic acid, 2-pyrrolidone, and 4-hydroxyproline; (j)glutamic
acid modified to 4-hydroyglutamic acid, and pyruvate α-ketoglutaric acid; (k) threonine
modified to 2-amino-3ketobutyric acid; (l) methioine modified to methionine sulfoxide,
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and methionine sulfone; (m) cysteine modified to disulfides such as Cys-S-S-Cys and
Cys-S-S-R (Stadtman, 1990, 1995). These oxidative modifications generally cause the
loss of catalytic or structural function in the affected protein and contribute serious
deleterious effects on cellular and organ functions (Levine and Stadtman, 2001). Free
radical modification of proteins may be responsible for the gradual alteration of
physiological function and accumulation of altered enzymes in aged brain. In a recent
review (Levine and Stadtman, 2001), evidences supporting this view are classified into
seven major areas: (a) in vitro free radical alteration of catalytic activities, thermal
stability and sensitivity to photolytic degradation is similar to aging; (b) inducing free
radicals to young animals in vivo can change the enzymes to aged-like forms; (c)
increasing the life-span of animals by factors or physiological condition can lead to
decreases of protein carbonyl levels , and vice-versa; (d) increased levels of oxidized
protein in frontal pole and occipital pole concur with the age-related loss of cognitive
function; (e) proteins from aged animals are more sensitive to oxidative damage,
compared to the proteins from young animals; (f) protein oxidation levels are correlated
to increased surface hydrophobicity of protein in aged animals; (g) protein carbonyl
levels increase exponentially with age in different animal species and tissues. The review
further proposed that free radical induced protein oxidation might be the cause of changes
in aging. Concisely, free radicals and free-radical-mediated protein modification is
essential to the brain aging process.
2.2.3.2.1 Protein Carbonyl level
Carbonyl level is probably the most commonly used method of assessing the
oxidative modification of proteins. Besides introducing carbonyl to proteins directly as
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previously described, free radicals can introduce carbonyl to protein through lipid
peroxidation end product such as HNE, arolein and MDA. Due to the resonance effect
between the double bonds, the α-carbon of these reactive aldehydes are highly
electrophobic and able to covalently bind to the electron-rich site of Cys, His and Lys by
Michael addition. Therefore, the increased carbonyl number is introduced to the proteins
as these aldehydes process at least one carbonyl group. Carbonyl contents of proteins are
generally indices by its 2,4-dinitrophenylhydrazone (DNP-) adduct formed by reacting
the proteins with 2,4-dinitrophenylhydrazine (DNPH) (Butterfield and Stadtman, 1997).
The DNP-adduct can be detected by UV-Vis, fluorescence spectroscopy, or
immunochemically. It should be noticed that the quantity of the protein carbonyl level
depends not only on its formation, but also the degradation of the oxidized protein.
Therefore, we can only conclude that increased carbonyl levels are due to increased freeradicals attack if the protein degradation system is normal.
It was found that protein carbonyl levels were increased in frontal and occipital
cortex (Smith et al., 1991) of aged humans, in the cortex of Brown-Norway rats
(Aksenova et al., 1998) and Mongolian gerbils (Dubey et al., 1995), in forebrain of
Wistar rats (Cakatay et al., 2001), and in brain homogenates of aged canine models (Head
et al., 2002). The carbonyl level increase of proteins at 65kDa was also reported to be in
the hippocampus of aged spatial learning-impaired rodents (Nicolle et al., 2001),
suggesting free radical induced protein carbonyl is involved in the dementia observed in
some elderly. Since the alkaline protease activity in rat brains did not decline with age
(Agarwal and Sohal, 1994), the carbonyl level increase reported by these studies are most
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likely due to the increased free radical assault rather than the decrease the oxidative
modified protein degradation.
2.2.3.2.2 Protein 3-Nitrotyrosine (3-NT) level
3-NTs were derived from the nitration of the ortho position on the tyrosine
nitration of proteins (Beckman and Koppenol, 1996). Such reaction is a form of protein
oxidation by definition (Butterfield and Lauderback, 2002). 3-NT can make the aromatic
moiety more hydrophilic, thereby altering the secondary and tertiary structures of a
protein. It can also sterically or electronically hinder the phosphorylation or
dephosphorylation on the para-OH group of Tyr, thus interfering with the cell signaling
(Butterfield and Kanski, 2001). Protein 3-NT levels can be detected immunochemically
or by HPLC, couple with MS/MS to avoid the electrochemical potential complications of
3-NT (Althaus et al., 2000).
Although protein 3-NT levels of brain homogenate were found to decrease in
aged Wistar rats (Cakatay et al., 2001), it was increased in the hippocampus and the
cerebral cortex of aged rats (Shin et al., 2002), the CSF of aged human (Tohgi et al.,
1999), and the subcortical white matter of aged monkeys (Sloane et al., 1999). Moreover,
the most prominent labeling of 3-NT was discovered in prukije cell layers and molecular
layers of cerebellar cortex, as well as in the surroundings of neuropil in cerebellar nuclei
of aged rats (Chung et al., 2002). These suggest that increases in protein 3-NT level is in
regionally specific fashion. Such specificity could be attributed to the level of nitric oxide
synthase, which produces NO to activate tyrosine nitration, in cells (Tohgi et al., 1999).
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2.2.3.2.3 Electron Paramagnetic Resonance (EPR)
Free radical mediated protein oxidation can also be indirectly assessed by EPR
spin-labels. 2,2,6,6-tetramethyl-4-maleimidopiperdin-oxyl (MAL-6) spin-labels can
covalently bond to SH groups on Cys. The W/S ratio is a parameter derived from the
relative spectral amplitude of the low-field weakly immobilized line to the stronglyimmobilized line. The amplitude of low field weakly immobilized line indicates the
relatively fast MAL-6 motion as MAL 6 is binding to a weakly-immobilized SH group
while the amplitude of low field strongly immobilized line indicates the relatively slow
MAL-6 motion as MAL 6 is binding to a strongly-immobilized SH group. Therefore, the
W/S ratio is lowered when protein crosslinkings increase, protein-protein interactions
increase, and segmental motions of spin labeled protein decrease. Since all these protein
alterations occur when free radicals induce oxidation to proteins, change in W/S ratio
indices the protein conformation change due to free radical irruption (Butterfield et al.,
1982).
It was found that W/S ratio is extremely precise when assessing the oxidative
conformational changes of proteins (Hall et al., 1995; Hall et al., 1997; Subramaniam et
al., 1998; Koppal et al., 1999). It was also found that the W/S ratio decrease when OH•
induce oxidation to rodents’ synaptosomes in vivo and in vitro (Hensley et al., 1994;
Pocernich et al., 2000). Such W/S ratio decrease is also observed in cortical
synaptosomes, erythrocyte membranes of rats (Hensley et al., 1995a), synaptosomes of
senescence accelerated mice (SAM) (Farr et al., 2003). This suggests that free-radical
induced protein oxidations and thus conformational alteration are significant events occur
during brain aging.
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2.2.3.2.4 Oxidative Stress Sensitive Enzyme Activity.
Oxidative deactivation of enzymes is another index of free radical oxidative
damage to proteins. As described above, the free radical induced oxidative modification
of protein usually results in structural and functional change in proteins. Decreased
activities of glutamine synthetase (GS), creatine kinase (CK), and tyrosine hydroxylase
(Floyd, 1990; Hensley et al., 1995b; Hensley et al., 1995c; Howard et al., 1996) by free
radical induced modification were observed. Since the activities of these enzymes,
particularly CK and GS, can be easily determined by their efficiency of end-products
productions, their activities serve as efficient indexes for oxidative modification of
proteins.
Studies shows that the activities of CK and GS were decreased in aged brown
Norway rats’ brains (Aksenova et al., 1998), and in aged human frontal and occipital
lopes (Smith et al., 1991). Since CK and GS activity is very sensitive to free radical
induced oxidative modification, the declined activity of CK and GS in aged animals
demonstrates direct evidence that free radical induced oxidative modification of proteins
are essential during the aging process. It should be noticed that the activities of many
enzymes are also altered during aging. These proteins include: (a) lipid metabolic
enzymes phospholipase D, phosphatease phosphohydrolase, diacylglycerol lipase,
phosphatidylserine synthase, and phosphatidylserine decarboxylase (Giusto et al., 2002);
(b) metabolic enzyme, α-ketoglutarated dehydrogenase complex, pyruvate kinase, NADsiocitrate dehydrogenase, NAD-malate dehydrogenase (Vitorica et al., 1981), enolase
(Deloulme et al., 1996) ,and lactate dehydrogenase (Mizuno and Ohta, 1986; Ferrante and
Amenta, 1987; Hrachovina and Mourek, 1990; Agrawal et al., 1996); (c) mitochondrial
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enzymes, citrate synthetase, and electron transport complex I – IV (Sandhu and Kaur,
2003); (d) ionic homeostatic and signaling proteins: Na+, K+-ATPase (Kocak et al.,
2002), and acetylcholine esterase (Gorini et al., 2002); (e) antioxidant enzymes,
superoxide dismutase, catalase, glutathione peroxidase, γ'-glutamylcysteine synthetase,
glutathione reductase; glutathione-s-transferase; and γ-glutamyl transpeptidase (Tsay et
al., 2000; Vohra et al., 2001; Sandhu and Kaur, 2002). Although the alteration of these
enzymes are most likely due to oxidative modification of the proteins, no direct
correlation is established between the oxidative modification of the proteins and their
activity decline.
2.3 Learning and Memory
The abnormal cellular components mentioned above manifest in CNS
dysfunction. Learning and memory deficit is one of the common symptoms of the CNS
dysfunction. The term “learning” is defined as the acquisition of an altered behavioral
response due to an environmental stimulus, and “memory” is defined as the process by
which the learned item is stored and retrieved (Sweatt, 2003a). Two types of memory are
defined depending on how long it persists: short term (minutes to hours) and long term
(days to years). It is generally accepted that memory results from changes in the
particular synaptic structure and/or function. Long-term memory has the general attribute
that it undergoes a period of consolidation that involves the formation or elimination of
specific synapses in the brain and the synthesis of new mRNAs and proteins. Since shortterm memory is too rapid to be attributed to such alterations, it was suggested that
changes in the release and function of neurotransmitters at particular synapses are the
basis of short-term memory (Lodish et al., 2000).
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2.3.1 Molecular Learning and Memory
The Hebbian theory is the current molecular basis of learning and memory.
Hebb’s hypothesis

propose that the coincident activation of pre- and postsynaptic

neurons lead to modifications of synaptic efficacy between the two cells, thereby creating
associative links between them. Memories are stored as alterations of these synaptic
alterations (Hebb, 1949). Current hypothesis concerning the neurochemical basis of
learning and memory based on three basic assumptions (Agranoff et al., 1999).
The first assumption is that the basic behavioral paradigms in learning and
memory studies are the conditioned response. For example, in Pavlov’s characterization
of condition experiment, when a food stimulus is presented to a dog, a strong salivatory
response is elicited. This salivation is referred as unconditioned response and the food
stimulus is referred to as unconditioned stimulus (Sweatt, 2003a). The dog could then be
trained to associate the food stimulus with the ringing of a bell where, over time, the bell
ring alone would cause a salivatory response similar to the food does. This bell-elicited
salivation was termed conditioned response, and the bell ring was termed the conditioned
stimulus (CS) (Sweatt, 2003a). In order for learning to occur, the conditioned stimulus
must precede the unconditioned stimulus.
The second assumption is that protein synthesis is required to from long-term, but
not short-term memory. The formation of long-term and short-term memory can be
distinguished by their susceptibility to protein synthesis inhibitors (Agranoff, 1980).
Since learning and short-term memory occur with in milliseconds and last for minutes to
hours, they are proposed to be mediated by post-translational modifications at the
synapse. However, since long-term memory require longer acquisition time and last life
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time. It is predicted to be mediated by process that (1) require protein synthesis, (2) is
neuronal genome dependent; and (3) require intraneuronal communication, such as
axonal transport (Agranoff et al., 1999).
The last assumption is that memory is stored in synaptic connections. The
development and environment stimulation increase the synaptic complexity, and such
synaptic alteration is depend on the genome regulates phenotypic expression generated in
the nucleus to response to the environment (Agranoff et al., 1999).
2.3.1.1. Long-Term Potentiation (LTP)
LTP is the most frequently studied as the cellular basis of learning and memory in
vertebrates. LTP is defined as a long-lasting (hours to weeks) increase of excitatory
postsynaptic potentials amplitude in synaptic efficacy as a result high-frequency
stimulation of afferent pathway (Villarreal et al., 2002). It is measured both as the
amplitude of excitatory postsynaptic potentials and as the magnitude of the postsynaptic
cell population spike (Villarreal et al., 2002).
LTP was first discovered by application of high frequency electrical stimulation
to enhance synaptic transmission in the rabbit (Bliss and Lomo, 1973). In this study, the a
brief period of stimulation can increase the strength of synaptic connections of neurons
and likelihood of the cells firing action potentials in response to a constant synaptic input
for hours (Bliss and Lomo, 1973). These phenomena were termed LTP (Bliss and Lomo,
1973). LTP is considered as an analog of memory since LTP is a long-lasting alteration in
neuronal function which is resulted from a brief period of stimulus (Sweatt, 2003b).
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Several other properties of LTP make it an good analog of mechanisms from
learning and memory. There properties are state-dependent, input specificity, and
associativity (Purves et al., 2001).
LTP is state-dependent since LTP only occurs when the postsynaptic cell reach
certain degree of depolarization with specific period of time (Sweatt, 2003b). For
example, the increased firing action potential is only possible if the postsynaptic
depolarization occurs within about 100 ms of presynaptic transmitter release. Since a
requirement for coincident activation of presynaptic and postsynaptic elements is
necessary to formation of memory according to Hebbian theory (Hebb, 1949), LTP forms
a theoretical framework of the synaptic changes underlying learning and memory.
LTP is also exhibits input specific. When LTP is induced by the stimulation of
one particular synapse, other synapses of the same neurons remain inactive. Therefore,
LTP is restricted to activated synapses rather than to all of the synapses on a given neuron
This properties of LTP is consistent with the memory formation in which only the
activated synapses are potentiated, leading to selectively enhance particular sets of inputs,
as is required for learning and memory (Purves et al., 2001).
Another important property of LTP is associativity, which is analog of the linkage
of one set of information with another in neuronal network. Since weak stimulation of a
synapse cannot trigger LTP by itself, a simultaneous input from a weak stimulation and a
strong stimulation of a neighboring synapse of the same neuron can trigger both synaptic
pathways to undergo LTP (Purves et al., 2001). This conjoint enhancement of synaptic
inputs is often considered as a neuronal analog of associative conditioning observed in
Pavlov’s conditioning experiment (Sweatt, 2003a).
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It should be noted that LTP does not equal to memory. Rather, it is an important
component of memory formation (Stevens, 1998). Moreover, LTP is a mechanism of
activity-dependent synaptic plasticity that is capable of detecting multiple conincidence
events. Such properties suggest that LTP contribute to memory consolidation, formation
of complicated association, sequentially serving as a short-term memory buffer for
assicative conditioning (Sweatt, 2003a).
2.3.1.2 Synaptic Remodeling
As mentioned in the previous section, environmental stimulates leads to the
shaping and tuning of neuronal connectivity during development, and this process,
termed synaptic remodeling, continues throughout the life-span of the organisms. Since
neuronal connectivity is a dynamic process, the remodeling of synaptic connectivity
occur in response to general environmental manipulations, sensory stimulation or
learning a specific new task and may even be associated with cyclic changes in the
physiological status of the organism (Agranoff et al., 1999).
The mechanisms that are known to be involved in the initiation and maintenance
of synaptic plasticity is base on Hebbian theory (Lamprecht and LeDoux, 2004). It is
generally believed that the calcium influx into postsynaptic neurons through excitatory
amino-acid receptors, specifically NMDA (N-methyl-D-aspartate) receptors, and possibly
L-type voltage-gated calcium channels (VGCCs), is the initial event of synaptic plasticity
(Magee and Johnston, 1997; Bauer et al., 2002).
Receptor mediated calcium influx is usually blocked by magnesium at resting
membrane potentials. However, when glutamate is released presynaptically, it binds and
activates NMDA receptors, thereby relieving the magnesium and allowing calcium enters
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the neuron at the synapse. Since activation of NMDA receptors by glutamate will only
occur when the postsynaptic cell membrane is depolarized, the NMDA receptor act as a
coincidence detector that only allows calcium influx when presynaptic activity and
postsynaptic activity coincide (Lamprecht and LeDoux, 2004). Calcium also influx into
postsynaptic membrane during depolarization through VGCCs (Magee and Johnston,
1995, 1997). VGCCs are opened by back-propagating action potential, an action potential
that initiated at the cell body and propagate back into the dendrites plasticity. The
opening of VGCCs amplify the excitatory postsynaptic potentials at the synapse that were
recently activated by glutamate receptors (Lamprecht and LeDoux, 2004), thereby
shaping the integration of synaptic activity and influencing the induction of synaptic. The
net result of calcium influx is the activation of signaling pathways. For example, calcium
influx causes phosphorylation of calcium/calmodulin-dependent protein kinases
(CaMKs) and protein kinase C (Tanaka and Nishizuka, 1994; Lisman et al., 2002), which
results in an increase in synaptic efficacy, and subsequently activation of gene
transcription and protein synthesis that can also lead to structural changes in synapses
(Poo, 2001; West et al., 2002). Moreover, elevation of calcium leads to rearrangement of
the cytoskeleton at the synapse by actin polymerization and cytoskeletal rearrangements.
These processes result in new synaptic structures (Matus, 2000). Since these structural
alterations occur too quickly to be accounted for by nuclear or even dendritic protein
synthesis, they are not considered as the result from protein synthesis. Therefore, such
changes might participate in both short-term and long-term memory (Lamprecht and
LeDoux, 2004).
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The rapid changes in the concentrations of calcium and other signaling molecules
take place in dendritic spines. Spines are specialized compartments on dendrites that
contain receptors, channels and signaling molecules that couple synaptic activity with
postsynaptic biochemistry (Sheng and Kim, 2002). Since the induction of synaptic
plasticity (LTP induction or memory formation) leads to changes in the number or shape
of spines (Weiler et al., 1995), modulation of the number of dendritic spines and their
morphology was proposed to associated with the excitatory synaptic transmission
alterations during learning (Nimchinsky et al., 2002). Alteration of spine number and
morphology depends on its specialized structure of cytoskeletal actin filament (Matus,
2000). Actin is present ubiquitously in spine to interact with the receptors, channels and
signaling molecules, and the reorganization and/or polymerization of actin alter spine
stability and contribute to structural plasticity of spines after LTP induction and learning
(Lamprecht and LeDoux, 2004). The orientation, kinetics of assembly and stability of
actin filaments are regulated by extracellular stimulation, such as NMDA receptor
activation (Matus, 2000), indicating that NMDA-dependent actin polymerization is
important for the consolidation of memory. Another glutamate receptor, AMPA (αamino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor, is found to stabilize
spine morphology (Fischer et al., 2000). Therefore, NMDA receptors is important in the
initial phase of spine motility, followed by a stabilization phase that is mediated by
AMPA receptors. Since AMPA receptor is activated spontaneously with NMDA receptor
during glutamate release in synapses, the alteration and stabilization of dendritic spine
also occurs simultaneously (Lamprecht and LeDoux, 2004). Moreover, AMPA receptor
levels increase after LTP induction or learning experiences, indicating that an increase in
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AMPA receptors in spines could contribute to spine stability and thereby memory
formation (Malinow, 2003).
Cytoskeleton-mediated alteration of spine and dendritic morphology is regulated
by Rho GTPases and their downstream effectors (Luo, 2002). The schematic diagram the
Rho

GTPases

mediate

extracellular

stimulation-induced

actin

cytoskeleton

rearrangements is summarized in Figure 2.3. Another roles of Rho GTPases played in
synaptic plasticity is to mediate the activity of adhesion molecules and to regulate cellular
interactions (Lamprecht and LeDoux, 2004). Adhesion molecules, such as integrins,
cadherins, neurexin and the immunoglobulin superfamily, are membrane-bound
molecules that interacts with proteins in the extracellular matrix and synaptic membranes
to adhere the membranes between the pre- and postsynaptic components (Lamprecht and
LeDoux, 2004). This adhesion is a dynamic process that involves morphological
alterations and modulation of connection between the pre and postsynaptic neurons, and
result in new contacts (Benson et al., 2000). Adhesion molecules can also mediate
signaling pathways to regulate the extracellular connectivity with intracellular events that
control spine morphology (Lamprecht and LeDoux, 2004). Therefore, adhesion
molecules play a critical role in neuronal connectivity and spin morphogy, as well as
stabilization of synaptic connectivity that leads to consolidation of memory (Lamprecht
and LeDoux, 2004).
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Figure 2.3
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The formation of memory involves learning and consolidation. During learning,
stimulation on specific synapses initiate molecular changes, and cellular alterations are
progressively stabilized during consolidation. The initiate molecular alterations caused by
learning are complex and require coordination within and between signalling pathways
that involved Rho ATPases (Luo, 2002), and the modulation and stabilization of neurons
after LTP induction or learning is controlled in part by actin dynamics, a process that is
initiated by NMDA receptor activation and stabilized by AMPA receptor activation. The
process of actin dynamic in neuron causes morphological changes in dendritic spin, and
leads to the formation and stabilization of new synaptic contact of the pre and
postsynaptic elements (Lamprecht and LeDoux, 2004). The formation of new neuronal
connections is regulated by adhesion molecules that are also affected by both the
cytoskeleton and glutamate receptors. The remodeling of the synapses results in modified
neuronal circuit which represent the memory stored in the brain, and synaptic plasticity
are mediated by molecular activity at the synapse during specific time windows after
learning (Lamprecht and LeDoux, 2004).
2.3.2 Learning and Memory in Aging
Learning and memory decline is a part of the aging process (Barnes, 1988). The
most noticeable cognitive decline in age human is the hippocampus-dependent forms of
memory deficits, which is manifested by the difficulty of learning and remembering of
new names, recent events and even spatial information (Sweatt, 2001). These types of
cognitive impairment can be recapitulated in aging rodent by assessing their cognitive
function by learning and retention paradigms. Therefore, the age-related cognitive
impairment in behavioral and cellular manifestations of learning and memory is well
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established in humans and other mammals (Sweatt, 2001). Moreover, LTP is diminished
in aged animals (Barnes et al., 2000). However, the mechanisms underlie the cognitive
impairment in aged animals and human are still not clear. Although the bases of such
decline remain unknown, oxidative stress is proposed to play a significant role in agerelated memory and synaptic plasticity dysfunction (Lynch, 1998). Moreover, the decline
of cognitive function in aging subjects can be more server due to numerous reasons, such
as stroke, vascular problems, psychiatric disorders, PD and AD. These conditions can
cause the cognitive impairment to be more pronounced in normal aging (Sweatt, 2001).
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CHAPTER THREE
Principles Behind Applied Methods
3.1 Bicinchoninic acid (BCA) Protein Assay
The BCA Protein Assay is based on formation of colometric BCA-Cu+ complex.
All proteins have the characteristic peptide bond and the commonly found amino acids
(Cys, Trp, Tyr). When reacted with copper sulfate (CuSO4) in alkaline solutions, Cu2+ are
reduced to Cu+ by the electron-rich peptide bond and amino acids (the biuret reaction).
Cu+ can then be complex with two BCA to from a soluble purple BCA-Cu+ complex
exhibits a strong absorbance at 562 nm (Figure 3.1). The absorbance of this complex is
nearly linear with increasing protein concentrations over a broad working range (0.02-2
μg/μl). The final color of the BCA protein assay continues to develop, therefore it is not
a true end-point measure. However, the rate of continued absorbance development is
sufficiently slow to allow large numbers of samples to be assayed together. The total
protein concentration generally are measured by using a common protein, such as bovine
serum albumin (BSA), as reference standards. A series of dilutions of known
concentration of BSA are prepared and assayed alongside the sample before the
concentration of each sample is determined based on the standard curve obtain from the
BSA standard.
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Figure 3.1
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3.2 Oxidative Parameters
3.2.1 Protein Carbonyls
The assay of carbonyl groups in proteins is a common way for detecting and
quantifying oxidative modification of proteins. As mentioned previously, protein
carbonyl is induced by reaction between ROS and proteins, thereby increasing protein
carbonyl level imply increased oxidative stress of the system under studies. Carbonyl
contents of proteins are generally indices by its 2,4-dinitrophenylhydrazone (DNP-)
adduct formed by reacting the proteins with 2,4-dinitrophenylhydrazine (DNPH) (Figure
3.2). The DNP-adduct can be detected by immunochemically. Generally, the protein
DNP-adducts are immobilized on a nitrocellulose membrane. The membrane are the
incubated with the primary antibody specific for DNP-adduct. The alkaline phosphatase
(AP) conjugated secondary antibody are then bind to the primary antibody at room
temperature.

The AP convert 5-Bromo-4-Chloro-3-Indolyl Phosphate/Nitroblue

Tetrazolium solution (BCIP/NIT) to produce a purple reaction product with the color
intensity correlated to the amount of DNP-adduct present. The intensity of the purple
color were analysis digitally by densimetric software to quantify the amount of the DNPadduct.
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Figure 3.2
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3.2.2 4-Hydroxynonenal (HNE)
HNE is an end product of linoeic acid (mainly, but not exclusively) peroxidation
(Esterbauer et al., 1991). HNE is a major product of lipid peroxidation and covently
modify amino groups of protein by Michael-addition (Uchida and Stadtman, 1992;
Guichardant et al., 1998) (Figure3.3). Therefore, increased HNE level indicating increasd
oxidative stress.Similar to the DNP-adduct, HNE adduct can then be detected
immunochemically by using primary and secondary antibody mentioned in the previous
section. However, increased protein HNE level not only indicating increased oxidative
modification of protein, but also imply that lipid are significantly peroxidized in cells.
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Figure. 3.3
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3.2.3 3-Nitrotyrosine (3-NT)
3-NTs were the direct products of ONOO- and tyrosine (Beckman and Koppenol,
1996), Nitration of the ortho position on the tyrosine nitration of proteins is a form of
protein oxidation by definition (Butterfield and Lauderback, 2002) (Fig 3.4). Protein 3NT levels are also detected immunochemically similarly to the quantitative detection of
protein HNE- and protein DNP-adducts previously described. It should be noted that NO,
precursor of ONOO-, is produced by NOS. Therefore, although increased protein 3-NT
level generally indicating increased oxidative stress, no change of 3-NT level could also
be interpreted as the absent of NOS activity.
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Figure 3.4
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3.2.4 Electron Paramagnetic Resonance (EPR) Spin Labeling
EPR is an accurate measure to provid information on molecular motion, orientation,
environmental polarity and conformational changes of proteins and membranes. EPR
measure the energy absorbed by unpaired electrons in the presence of a microwave
electromagnetic field. However, unpaired electrons are negligible in most biological
systems, stable paramagnetic spin labels are used to study biological systems by EPR.
2,2,6,6-tetramethyl-4-maleimidopiperidin-1oxyl (MAL-6, Fig 3.5) is a nitroxide free
radical contain an in the p orbital of the nitrogen.

In the absence of magnetic filed, this

unpaired electron that has electron spin quantum numbers of Ms = + ½ or – ½,
corresponding to the two possible spinning motions of the electron. However, when a
magnetic field is applied, the electron will align either parallel (Ms = + ½) or anti-parallel
(Ms = - ½) to the magnetic field (Figure 3.6) causing the change of energy of the electron
to MI = +1, MI = 0 and MI = -1. This change of the energy levels due to the applied
magnetic field is known as the Zeeman effect. Since the alignment of the electron change
the energy state, when a constant microwave frequency (about 9.5 GHz) are applied and
absorption of energy corresponding to three different levels are observed (Figure 3.6).
When MAL-6 covalently binds to cysteine sulfhydryl groups on synaptosomal proteins in
synaptosomes, a three line EPR spectrum are observed (Figure 3.7) (Butterfield et al.,
1982). Due to the folding of a protein, MAL-6 can bind to the surface or/and in the
pockets of proteins. When binding to the protein surface, MAL-6 is weakly immobilized.
In contrast, binding of protein pockets cause MAL-6 strongly immobilized (Butterfield et
al., 1982). These weakly (W) and strongly (S) immobilized components are shown in the
low field line (MI = +1) of the EPR spectrum of MAL-6 (Figure 3.7). The ratio of the
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weakly to strongly immobilized spectral amplitudes (the W/S ratio) is lowed by oxidative
stress mediated protein alteration, such as to crosslinkings increase, protein-protein
interactions increase, and segmental motions of spin labeled protein decrease. Since all
these protein alterations occur when free radicals induce oxidation to proteins, change in
W/S ratio indices the protein conformation change due to free radical irruption
(Butterfield et al., 1982). Therefore, decreased W/S ratio is an indirect assessment of
protein oxidation.
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Figure 3.5
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Figure 3.6
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Figure 3.7
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3.2.5 Thiobarbituric Acid Reactive Substances (TBARS)
Malondialdehyde (MDA) is the most abundant toxic aldehyde formed when
arachidonic aicd (AA) acts as the PUFA source for the lipid peroxidation (Basu and
Marnett, 1983; Michiels and Remacle, 1991; Esterbauer, 1993). Therefore, lipid
peroxidation can be assessed by determining the amount of MDA in the system. MDA
was first extracted by organic solvent, then reacts with thiobarbituric acid (TBA) to
produce fluorescent thiobarbituric acid reacting substances (TBARS) at 95oC (Fig 3.8).
However, TBA also reacts with other carbonyl-containing compounds. Therefore
TBARS are generally considered a non-specific measurement of MDA, results usually
required validation of HNE level to ensure lipid peroxidation.
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Figure 3.8
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3.3 Enzyme Assay
Oxidative modification of a protein alters its structure and function. Therefore,
one way to validate the oxidation of specific protein is measuring their enzyme activity.
Moreover, activities of some enzymes are particular sensitive to oxidative modification
due the nature of its activity site. Therefore, activities of CK and GS can also serve as
efficient indexes for oxidative modification of proteins.
3.3.1 Glutamine Synthase (GS)
The biosynthesis of glutamine is catalyzed by GS with the requirement of ATP.
Moreover, GS catalyze a γ-glutamyl transfer reaction in the presence of nucleotide (ATP
or ADP) and arsenate:
L-Glutamine + NH3OH ↔L-γ-glutamylhydroxamate + NH2
Therefore, the activity of GS can be determined by amount of γ-glutamylhydroxamate in
certain amount of time. γ-Glutamylhdroxamate gives a characteristic brown color with
absorbance at 535 nm on addition of ferric chloride, therefore measuring the change of
absorbace at 535 nm in specific amount of time is proportion to the activity of GS. The γglutamyl transfer activity of GS is about 10 times greater than synthase activity,
therefore, measuring the γ-glutamyl transfer activity is more sensitive mway to determine
the activity of GS.
3.3.2 Lactate Dehydrogenase
Lactate dehydrogenase (LDH) catalyzes the following reaction:
Pyruvate + NADH ↔ Lactate + NAD+
NADH has absorbance at 340 nm. Therefore, the activity of LDH can be determined
reaction velocity of a decrease in absorbance at 340 nm resulting from the oxidation of
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NADH. One unit causes the oxidation of one micromole of NADH per minute at 25°C
and pH 7.3 (Zewe and Fromm, 1965; Stambaugh and Post, 1966).
3.3.3 Enolase
In the presence of enolase, KCl and Mg2+ , D-glyceric acid 2-phosphate is
dehydrated to pyruvic acid phosphate. Pyruvic acid phosphate has a strong absorbance at
240nm. Therefore, the activity of enolase can be measured by the increase of absorbance
at 240nm in certain amount of time in the present of D-glyceric acid 2-phosphate, KCl
and Mg2+ (Wagner et al., 2000).
3.3.4 Creatine Kinase
CK reversibly catalyzes the transfer of a phosphate group from creatine phosphate
to ATP, which is then is used to produce glucose-6-phosphate and ADP from glucose by
hexokinase (HK). The glucose-6 phosphate is then oxidized by glucose-6 phosphate
dehydrogenase (G-6-PDH) with simultaneous reduction of the NADP to give NADPH
and 6-phosphogluconate. The reactions are listed as the following:
Creatine phosphate + ADP Î Creatine + ATP
ATP + d-glucose Î glucose-6-phosphate + ADP
Glucose-6-phosphate + NADP+ Î gluconate-6-phosphate + NADPH
The rate of increase of absorbance at 340 nm due to the formation of NADPH is
directly proportional to the activity of the CK in the sample.
3.4 Redox Proteomics
3.4.1 Overview
As mentioned in the previous sections, most protein oxidative modifications are
irreversible (lysine and arginine carbonylation, tyrosin nitration, tryptophan nitration,
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dityrosine formation, protein-protein cross-linking), some oxidative modifications are
reversible (glutathionylation, S-nitrosylation). These reduced forms of oxidized proteins
together with those non-oxidized proteins are considered in their reduced states, in
contrast to the oxidatively modified proteins in their oxidized states. This redox state of
the proteins contributes to the redox regulation of the cellular responses to oxidative
stress and antioxidant status in brains (recently reviewed in(Calabrese et al., 2003b; Poon
et al., 2004a)). Initial attempts to address the redox states of these specific oxidized
protein is by double immunopercipitation, in which oxidized proteins are first
immunopercipitated using an antibody, followed by a similar immunopercipitation step
with the antibody against the protein of interested (Lauderback et al., 2001). Although
this one-at-a-time method is commonly used and accepted, it is impractical and
unfeasible for the enormous brain proteome, a term was first defined in 1994 as the total
set of proteins expressed in a given cell at a given time (Dove, 1999).
The study of proteome, termed "proteomics", encompasses the separation,
identification, and qualitative, quantitative and functional characterization of the entire
protein profile of a given cell, tissue and/or organism. Not only the native proteins are
analyzed in proteomics, the profiling of isoforms, splice variants, mutants, and posttranslationally modified species, and the definition of protein-protein interactions are also
studied (Schoneich, 2003). Recent advances in proteomics allow the identification of a
large number of proteins as well as their redox states, hence referred to as redox
proteomics (Ghezzi and Bonetto, 2003; Dalle-Donne et al., 2005).
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3.4.2 Sample Preparation
The samples being analyzed are first derivatized by dinitrophenolhydrazine
(DNPH) to from DNP-adduction for carbonyl detection. If 3-nitrotyrosine levels or
protein levels are measured, no derivatization step is needed. The samples after
derivatization usually contain high concentration of ions since an acidic buffer is used to
optimize the reaction. The high level of ions in the buffer can cause variation of voltage
and current during isoelectric focusing (IEF), thereby preventing successful isoelectric
separation. This phenomenon usually manifested by horizontal smearing of the protein
spot (Figure 3.9).
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Figure 3.9
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This horizontal smearing problem is usually avoided by using trichloroacetic acid (TCA)
to precipitate the protein and using organic solvents to wash the pellet substantially.
Commercial spin ion-removal columns (Sigma and Pierce) are also available to remove
ion from samples prior to IEF.
3.4.3 Two-dimensional (2D) gel electrophoresis
2D gel electrophoresis can separate a mixture of proteins into single detectable
protein spots in most cases. The 2D separation of proteins is usually achieved by two
separation steps. In the first step, proteins are separated according to their isoelectric
point by IEF on an IEF gel, or strip. The resulting IEF strips are then treated with
dithiothreitol and iodacetamide to avoid cysteine-cysteine interaction, which will
decrease the resolution of the second step of separation. In the second step, proteins are
separated according to their molecular migration rate (similar to molecular weight in
most cases). Therefore, if cross-linking between the cysteine residues occurs, vertical
smearing will appear in the 2D gel since the molecular migration rate is shape-dependent
as well as molecular weight dependent (Fig 3.10).

74

Figure 3.10
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The resulting 2D map allows comparison within and between groups of samples for
statistical analysis (Tilleman et al., 2002). The ability to compare and match between
different samples on 2D electrophoresis is especially important in redox proteomics. This
is because in order to identify the oxidation state of a protein, the 2D gels are transferred
and developed by Western blotting. Therefore, the 2D map of the gels and the blots can
be matched to determine the unit of oxidative modification per unit of proteins (specific
carbonyl level or specific 3-NT level of a protein). The advantages of the 2D gel
electrophoresis are its consistency and high resolution. However, some drawbacks of this
technique are still present. The solubilization of membrane proteins is still the main
obstacle for 2D-electrophorsis, because the ionic detergents used for solubilization of
membrane proteins can interfere with the focusing process. Additionally, the mass range
and the detection limits also represent technical limitations of the method. However, our
laboratory and many others are trying to overcome these issues by using chaotropic
agents, subcelluar 2D gel electrophoresis, etc. High throughput proteomic techniques,
such as HPLC, are also available to separate proteins without 2D electrophoresis
(Soreghan et al., 2003). However, the application of these techniques in redox proteomics
is still at an embryonic stage, and more development in these techniques to obtain
quantitative data regarding the redox state of a protein will be beneficial to overcome the
limitation of 2D electrophoresis.
3.4.3 Image Analysis and Statistical Analysis
The 2D gels traditionally were visualized by classical detection methods,
including Coomassie blue and silver staining. However, these detection methods remain
problematic due to low sensitivity (for Commassie) or poor reproducibility and dynamic
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range (for silver). The recent development of fluorescent dyes, namely SYPRO™ Ruby,
overcame these problems with its sensitive (1-2ng) detection limits and linear dynamic
range over three orders of magnitude (Molloy and Witzmann, 2002). The result 2D map
images are then analyzed by specially programmed software.
Image analysis allows gel-to-gel comparison and generated a large amount of data
accumulated from multiple 2D gels. Therefore, special programmed softwares are
commercially available to manage these data. Some of these softwares were evaluated in
a recent survey (Righetti et al., 2004). These softwares enable investigator matching and
analysis of visualized protein spots among differential gels and blots. The principles of
measuring intensity values by 2-D analysis software were similar to those of
densitometric measurement. After completion of spot matching, the normalized intensity
of each protein spot from individual gels (or blots) is compared between groups using
statistical analysis. Although the softwares use raw-image-based alignment coupled with
neighbor matching spots to improve the spots matching steps by significantly reduced
analysis time, hands-on processing is still necessary for accuracy of the matching.
3.4.4 In-gel Digestion and Mass Spectrometry
The protein of interest is excised and treated with ammonium bicarbonate and
acetonitrile to provide optimal protease digestion in the gel. The excised spots are then
in-gel-digested with a protease (trypsin is commonly used) in an optimal buffer for its
activity. The digested peptides are then easily eluted from the gel to undergo mass
spectrometry analysis. In-gel-digestion not only reduces the mass of a protein into small
peptides ideal for mass spectrometry, it also forms a collection of proteolytically
sequence-specific peptides that enable the identification of the protein.
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Mass spectrometry has made a great impact on proteomics by facilitating the
rapid identification and characterization of thousands of protein. The traditional
ionization fragmentation of peptides, thus fail to provide accurate peptide mass.
However, development of two Nobel prize-winning ionization methods, MALDI (matrix
assisted laser desorption/ionixation) and ESI (electrospray ionization), enabled the
ionization of large biological macromolecules without fragmentation, thus enabling the
identification of proteins. However, both of these ionization processes are very sensitive
to charges, low concentration of salt is required for the peptide solution to be analyzed.
The peaks detected by mass spectrometer results in a mass spectrum represent the peptide
ions mass which can be used for protein identification.
3.4.4.1 MALDI-TOF
In MALDI, the peptide samples are mixed to an acidic matrix and condense on a
plate that is subjected to laser radiation. The peptides are incorporated into the crystal
lattice of the matrix during the condensation process. Various compound are used as the
matrices for laser absorption. One of the wildly used matrices for peptides is α-cyano-4hyroxy cinnamic acid because it provides high sensitivity and negligible matrix adduction
during the laser absorption (Beavis and Chait, 1989). When the high energy of laser is
applied to the matrix, the peptides along with the matrix particles were vaporized. In
order to ensure the sublimation of the matrix-peptides solid, high vacuum are generally
applied during this process. The positive ions of the peptides are formed in gas phrase
due the acidic nature of the matrix. The ions are then accelerated into the mass analyzer
(Fig 3.11). Since MALDI is a pulsed ionization technique, it is generally couple with
TOF (time-of-flight) mass analyzer.
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Fig 3.11
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3.4.4.2 ESI
In ESI, the peptide in the solution is sprayed at atmospheric pressure through an
outlet with a high potential difference between the outlet and the mass spectrometer. This
potential difference generates a repulsive coulombic force between the like charges on
the droplets to extend the solution to form a cone (Taylor cone) from the outlet, causeing
the solution to disperse into fine droplets (Taylor, 1964). The solvent continuously
evaporates while the charges of the droplets remain constant. Droplet fission occurs when
the coulombic repulsion exceed the surface tension of the droplets. This process
continues until nanometer sized droplets are produced to forms a single peptide ion for
the mass spectrometer (Fig 3.12) the charges on the sing;e peptide are sttistica;;y
distributed over the peptide’s potential charge site., thereby, multiply charged ions are
possible. This unique feature of ESI yields an effectively rduced mass/charge ratio from
peptides of interest. Therefore, ESI offer significant advantages for the analyis of
peptides with large molecular weight.
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Figure 3.12
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3.4.5 Bioinformatics and Identification
Since the peaks of the resulting mass spectrum represent the peptide ions mass of
the sample of interest, the peaks should be correlated to the mass of the peptides
produced by the protease from a larger protein (see Fig 3.13).
Databases are available for theoretical digests of all known proteins,; thus,
matching the peptide mass data obtained from samples interested to this theoretical
digested protein database can successfully identify the proteins. This process, known as
peptide mass fingerprinting, must accounts for several factors, such as molecular weight,
pI and the probability of a single peptide appears in the whole database, for the
identification of a protein. Many search engines can perform this matching process with
an output of a probability score for each theoretical digested protein indicating the
certainty of the identification. The threshold score, which indicates if the experimental
mass spectrum significantly matches the theorical digested protein spectrum, is calculated
by mathematical algorithms specific to each search engine and each experimental mass
spectrum. Although false identification is conceivable, it can be avoided by taking into
account the molecular weight and pI range on the 2D map in the identification. Moreover,
prior results suggest that the accuracy of protein identification by mass spectrometry is
equivalent to immunochemical identification (Castegna et al., 2002b).
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Figure 3.13
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CHAPTER FOUR
The Antioxidant α-Lipoic Acid Reverse Memory Impairment and Brain
Oxidative Stress in Aged SAMP8 mice
4.1 Introduction
4.1.1 SAMP8 model
The senescence-accelerated mouse (SAM) is a model of accelerated senescence
that was established through phenotypic selection from a common genetic pool of AKR/J
strain of mice (Takeda et al., 1981). In 1975, certain littermates of AKR/J mice were
noticed to become senile at an early age and had a shorter life span. Five of these litters
with early senescence were selected as the progenitors of the senescence-acceleratedprone mice (SAMP). Three litters with normal aging process were also selected as the
progenitors of senescence-accelerated-resistant mice (SAMR) (Takeda et al., 1981;
Miyamoto, 1997). Thereafter, selective inbreeding was applied based on the degree of
senescence, the lifespan, and the age-associated pathologic phenotypes (Hosokawa et al.,
1997). In 1981, the SAM model was established, including nine major SAMP substrains
and three major SAMR substrains, each of which exhibits characteristic disorders. The
characteristics of the SAMP substrains are summarized in Table 4.1. It should be noted
that other strains were also derived from these major substrains (Takeda, 1999).

84

Table 4.1: Summary of the characteristics of different
substrains of SAMP model
Strain

Characteristics

SAMP1

Senile amyloidosis, impaired immune system, impaired audiatory
system, retinal atrophy, hypertensive vascular disease, contracted
kidney, pulmonary hyperinflation

SAMP2

Senile amyloidosis, impaired immue system

SAMP3

Degenerative arthrosis

SAMP6

Senile osteoporosis

SAMP7

Senile amyloidosis, thymoma

SAMP8

Age-related learning and memory deficits, anxiety, impaired immune
system, age-dependent deposition of amyloid β-peptide

SAMP9

Age-related cataracts

SAMP 10

Brain atrophy, age-related learning and memory deficits, age-related
depression

SAMP11

Age-relating thickening of tunic media of thoracic aorta, senile
amyloidosis, contracted kidney.

SAMR1

Normal aging with non-thymic lymphoma, histiocytic sarcoma and
ovarian cysts.

SAMR4.

Normal aging with non-thymic lymphoma, histiocytic sarcoma, no
ovarian cysts.

SAMR5

Normal aging with colitis.
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Recently, SAMP8 mice have drawn attention in gerontological research of
dementia due to its characteristic learning and memory deficits at old age (Flood and
Morley, 1998). The life span of ARK/J mice is approximately 10 months. Depending on
the microbiological condition of housing, the life span of SAMP8 mice ranges from 10
months to 17 months. Such life span is shorter than that of SAMR1, which ranges from
19 months to 21 months (Flood and Morley, 1998). The unique characteristic of SAMP8
mice is that it has low incidence of other phenotypic aging alterations when its deficits in
learning and memory are developed (Flood and Morley, 1998). Therefore, it is a good
rodent model for cognitive impairment in age subjects. Moreover, in comparison with
aged SAMR1 mice, the aged SAMP8 mice show impairments in learning tasks, altered
emotion, abnormality of circadian rhythm (Miyamoto, 1997), and increased oxidative
stress (Butterfield et al., 1997a). When compared to young SAMP8, aged SAMP8 mice
also show clear age-related impairment in learning assessed by foot shock avoidance
(Flood and Morley, 1993), which correlates with oxidative stress parameters (Farr et al.,
2003). These findings are consistent with the free radical theory of aging that posits the
oxidative modification by reactive oxidative species (ROS) on biomolecules contribute to
the cellular dysfunction in aging (Harman, 1956).
Cross breeding of a CD-1 dame and a SAMP8 sire developed a series of paternal
backcross strains. Siblings from each backcross were then bred to establish strains with
different percentages of SAMP8 genes. It was demonstrated that the age-related learning
and memory impairment is correlated to the percentage of SAMP8 genes (Morley et al.,
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2002). Initial examination of the genetic profiles revealed that at least one genotype in
SAMP8 strain is different from that in the AKR/J strain (Takeda, 1999). Moreover, a
series of Southern hybridization analyses of DNA isolated from SAMP8 mice showed
that: (1) the SAMP8 genome is genetically distinguishable from that of other SAM mice;
(2) SAMP8 mice resemble other SAMP, but are clearly different from the parental
AKR/J strain; and (3) the level of murine leukemia virus in SAMP8 mice is increased
(Takeda, 1999).
One of the interesting genes that affects the learning and memory in SAMP8 mice
is the amyloid precursor protein (APP) (Kumar et al., 2000b). The function of APP is not
entirely understood; however, the internalization and endosomal processing of APP
produces neurotoxic Aβ (Perez et al., 1999), and recent studies suggest that rodent Aβ is
toxic (Boyd-Kimball et al., 2004). APP cDNA cloned from the hippocampus of 8month-old SAMP8 mouse shows high similarity to that of other species (Kumar et al.,
2001). At the amino acid level, the homology was 99.2% with other rodent APP
sequences. A single amino acid substitution of alanine instead of valine at position 300 of
APP was unique to SAMP8. However, familial AD mutations were not observed in
SAMP8 cDNA, suggesting that the learning and memory deficits of SAMP8 maybe
different from that in familial AD (Kumar et al., 2001). Moreover, the age-related
increase of APP mRNA affects the learning and memory in SAMP8 mice (Morley et al.,
2000). Such cognitive deficits are significantly improved when the expression of APP is
down-regulated by using an antisense oligonucleotide specific to APP mRNA in aged
SAMP8 mice (Kumar et al., 2000b; Kumar et al., 2001). Therefore, these studies indicate
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that the abnormal processing of APP may contribute to the increased oxidative stress and
cognitive deficits in aged SAMP8 mice.
Further identification of genes that are specifically expressed in the hippocampus
of SAMP8 was performed to understand the molecular basis of the pathological changes
and cognitive deficits of SAMP8 (Wei et al., 1999b).

The mRNAs of eukaryotic

translation initiation factor 2B subunit 1 (EIF-2B) like gene and phospholipase D like
gene are only expressed in SAMP8 mice but not in SAMR1, suggesting these genes are
relevant to the dysfunction of the central nervous system (CNS) of SAMP8 mice (Wei et
al., 1999b).
Other analyses of neurotrophic genes revealed that the expression of hippocampal
glial cell line-derived neurotrophic factor (GDNF) mRNA in SAMP8 is less than that in
SAMR1 (Miyazaki et al., 2003), and neurotrophin–3 (NT-3) and nerve growth factor
(NGF) mRNA levels in the midbrain, hippocampus and forebrain of SAMP8 mice are
also lower than those in SAMR1 at early stages (Kaisho et al., 1994). These studies
suggest that low neurotrophic gene expression in young SAMP8 may contribute to their
hippocampal dysfunction.
Comparing the levels of Alzheimer’s disease (AD)-related genes in the
hippocampus and cerebral cortex of SAMP8 mice to those of the SAMR1 by reverse
transcription polymerase chain reaction (RT-PCR) showed that levels of apohyprotein E
(apoE) and mineralocorticoid receptor (MR) mRNAs of SAMP8 were decreased, while
bcl-2 alpha and presenilin-2 (PS-2) mRNA levels were significantly increased (Wei et al.,
1999a). These studies suggest that the abnormal expression of these AD-related genes
contribute to the age-related deterioration of learning and memory in SAMP8.
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A

microarray study of mRNA in SAMP8 hippocampus also showed that genes associated
with the stress response and antioxidant systems are strongly affected during age-related
cognitive impairment (Kumar et al., 2000a). The genes identified in this study were
V(D)J recombination activating protein (RAG-1), ubiquitin-like protein, T-complex
proteins a and b subunits, T-complex protein 1 delta, episilon, gamma, eta, theta, zeta
subunit, heme oxygenase 1, endoplasmin precursor, calnexin precursor, phospholipase Calpha, JNK stress-activated protein kinase, mitogen-activated protein kinase (MAPK) p38
, MAPK kinase 4, JNK activating kinase, RhoB, peroxisome proliferator activated
receptor beta, cytochrome P450 IIB9, cytochrome P450 IIIA, quinone oxidoreductase,
and microsomal UDP-glucuronosyltransferase 1-1 precursor (Kumar et al., 2000a). Since
the translational products of these affected genes are involved in signaling, chaperone
function and antioxidant systems, this study suggests that abnormalities of the signal
transduction, protein folding and antioxidant system may contribute to the cognitive
decline in aged SAMP8 mice.
In addition to genes that are involved in neuroprotection, signal transduction,
protein folding and degradation, other altered gene expression in SAMP8 mice are related
to involved in energy metabolism, immune response, the cytoskeleton and transport.
Decreased Δ 9-desaturase mRNA with age in SAMP8 mice could contribute to altered
membrane fluidity and signaling pathways in synapses (Kumar et al., 1999) The mRNAs
of bullous pemphigoid antigen like gene is only present in SAMR1, while the mRNAs of
glycogen debranching enzyme isoform like gene is only expressed in SAMP8 mice,
suggesting these genes are relevant to the dysfunction of the CNS of SAMP8 mice (Wei
et al., 1999b). Comparing the levels of AD-related genes in the hippocampus and cerebral
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cortex of SAMP8 mice to that of the SAMR1 by RT-PCR showed that levels of apoE and
glucocorticoid receptor-alpha (GR alpha) mRNAs of SAMP8 were decreased, while tau
mRNA levels were significantly increased (Wei et al., 1999a). Moreover, the ubiquitous
kinesin heavy chain gene is altered in SAMP8 mice brain. Since all of these genes are
involved in energy metabolism, immune response, cytoskeleton and transport, the
alteration of these genes may affect these process and lead to neuronal damage in SAMP8
mice brain.
The alterations of gene expression described in the studies cited above can be
functionally

classified

into

neuroprotection,

signal

transduction,

protein

folding/degradation, the cytoskeleton, transport, and immune response (Table 4.2). These
changes in gene levels are consistent with the pathological and neurochemical findings in
SAMP8 mice (Nomura et al., 1996). All of these processes are reportedly involved in
age-related cognitive decline (Lal and Forster, 1988; Butterfield and Stadtman, 1997;
Wilson et al., 2002; Poon et al., 2004a, b). Moreover, the abnormal APP and Aβ
metabolism in SAMP8 mice brain suggest that the learning and memory deficits in
SAMP8 could have some similarities to those in AD. These findings support the view
that SAMP8 mouse is useful for the investigation of the mechanism of age-related
learning and memory deficits (Nomura et al., 1996).
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Table 2: Altered genes in SAMP8 mice brain
Gene

Expression
Function of gene products #
changes *

Reference

Neuroprotection
APP

↑

apoE

↓

heme oxygenase 1

↓

cytochrome P450 IIB9

↓

cytochrome P450 IIIA

↑

A cell surface protease inhibitor
that reduces copper; proteolytic
peptides (Aβ) are found in amyloid
deposits.
An lipoprotein that binds low
density
lipoprotein
receptor
(LDLR), involved in clearance of
circulating cholesterol, allele 4
linked to Alzheimer disease.
An enzyme that cleaves the heme
ring at the alpha methylene bridge
to form biliverdin and carbon
monoxide, involved in oxidative
stress response; altered expression
of human version is associated
with AD and Parkinson disease
(PD).
A cytochrome P450 enzyme that is
induced by phenobarbital and
regulated by sex hormones in a
sex-dependent,
organ-dependent
fashion
A major drug metabolizing enzyme
that oxidizes the Ca2+ channel
inhibior nifedipine, involved in
benzopyrene, steroid, retinoid, and
toxin metabolism.
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(Kumar et
al.,
2000b)
(Wei et
al., 1999a)

(Kumar et
al., 2000a)

(Kumar et
al., 2000a)

(Kumar et
al., 2000a)

4.1.2 Lipoic Acid
α-Lipoic acid (LA), a coenzyme involved in production of ATP in mitochondria,
is a potent antioxidant (Packer et al., 1997a; Packer et al., 1997b). The antioxidant
properties are proposed due to its its ability to (a) act as a scavenger of reactive oxygen
species (ROS); (b) chelate metals; and (c) to recycle endogenous antioxidants . LA can
scavenge singlet oxygen, H2O2, OH•, NO and ONOO-, and the reduced form of LA,
dihyrolipoic acid, can further scavenge O2• and peroxyl radical (Kagan et al., 1992). LA
can also chelate several divalent cations, e.g. Mn2+, Cu2+, Zn2+, Cd2+, Pb2+. Therefore, LA
can inhibit ascorbate-induced production of H2O2 by Cu+ (44). LA can act to recycle
endogenous antioxidants, e.g. GSH (Ou et al., 1995) and vitamin C (Sen et al., 1997),
which regenerates vitamin E. GSH, vitamin C and vitamin E all protect brain from
oxidative stress (Drake et al., 2002; Butterfield and Pocernich, 2003). It was shown that
LA can improve memory in aged female NMR1 mice (Kidd, 1999) and reverse partial
brain mitochondrial decay, RNA/DNA oxidation and memory loss in old rats (Liu et al.,
2002). AD patients with LA treatment for approximately 1 year resulted in mild cognitive
improvements (Hager et al., 2001).
Our lab demonstrated a higher oxidative stress insult present in SAMP8 mouse
brain compared to SAMR1 mouse. If oxidative stress is involved in the learning and
memory in aged SAMP8 mice, aged SAMP8 mice should have higher oxidative stress
than young SAMP8 mice, correlating to their learning and memory decline as a function
of aged. In addition, this study examined the ability of LA to protect SAMP8 mouse
against the behavior deficits and oxidative stress of accelerated aging.
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4.2 Experimental Procedures
4.2.1 Subjects
Experimentally naive, 4- and 12-month-old male SAMP8 mice were obtained
from the breeding colony at St. Louis University. The colony is derived from siblings
generously provided by Dr Takeda of (Kyoto University, Japan), and has been
maintained as an inbred strain for 12 years under clean-room procedures (i.e. use of
sterile gloves in handling mice, sterilized cages and bedding, restricted access to breeding
area), and housed in microisolator HEPA filter units (Allentown Caging, PA, USA). The
colony routinely undergoes serological testing for viral and bacterial contamination and
has remained free of pathogens for over 5 years. Mice are housed in rooms with a 12 : 12
light/dark cycle (lights on at 06.00 h) at 20-22°C with water and food (Richmond
Laboratory Rodent Diet 5001) available ad libitum. All experiments were conducted after
institutional approval of the animal use subcommittee, which subscribes to the NIH
Guide for Care and Use of Laboratory Animals.
4.2.2 LA Administration
LA were obtained from Jarrow Formulas, Inc. (Los Angeles, CA, USA), and
dissolved in saline at pH 7.0. LA (100 mg/kg), or saline were administered
subcutaneously once daily for 4 weeks at 1 PM. At the end of week one, animals were
tested in the T-maze footshock avoidance paradigm. The following day, activity was
tested in an open field and a 1-week habituation to milk was begun. At the end of the 1week habituation, mice were trained in the lever press. Behavioral measures and training
were conducted between 07.30 and 11.30 h.
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4.2.3 T-maze Footshock Avoidance
The T-mase training was performed by Dr. Susan Farr at St. Louis University.
Training procedures for the T-maze footshock avoidance apparatus have been described
(Farr et al., 1999; Farr et al., 2000). The maze consisted of a black plastic start alley with
a start box at one end and two goal boxes at the other. A stainless steel rod floor ran
throughout the maze. The start box was separated from the start alley by a plastic
guillotine door that prevented the mouse from moving down the alley until the training
started.
A training trial began when a mouse was placed into the start box. The guillotine
door was raised and the buzzer was sounded simultaneously; 5 s later, footshock was
applied. The goal box the mouse first entered on the first trial was designated as
'incorrect'. Footshock was continued until the mouse entered the other goal box, which on
all subsequent trials was designated 'correct' for the particular mouse. At the end of each
trial, the mouse was removed from the goal box and returned to its home cage. A new
trial began by placing the mouse back in the start box, sounding the buzzer, and raising
the guillotine door. Footshock was applied 5 s later if the mouse did not leave the start
box or failed to enter the correct goal box.
Training used an intertrial interval of 45 s and a door-bell type buzzer at 65 dB as
the conditioned stimulus warning of onset of foot shock at 0.40 mA (Coulbourn
Instruments scrambled grid floor shocker model E13-08). Mice were trained until they
made one avoidance.
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4.2.4 Sample Preparation
SAMP8 brains samples were flash frozen in liquid nitrogen in St. Louis and sent
to Lexington on ice overnight. The samples were homogenized in 0.32M sucrose
isolation buffer (2mM EDTA, 2mM EGTA, 20mM HEPES, 20μ.g/mL Trysin inhibitor, 4
μg/mL Leupeptin, 4 μg/mL pepstatin, 5 μg/mL aprotinin) by sonication and the protein
concentration was determined by the BCA method.
4.2.5 Carbonyl Level
Protein carbonyl levels of proteins were determined immuchemically as adducts
of 2,4-dinitrophenylhydrazine (32). 5μL of the samples were treated with equal volume of
12% SDS. Samples were then derivatized with 10 μL of 20 mM 2,4-DNPH for 20
minutes. The reaction was stopped by addition of neutralizing reagent (7.5 μL of 2M
Tris/ 30% glycerol buffer, pH = 8.0). Levels of protein carbonyls were measured by using
the slot-blot technique with 250 ng of protein loaded per slot. The 2,4-dinitrophenyl
hydrazone (DNP) adduct of the carbonyls is detected on the nitrocellulose paper using a
primary rabbit antibody (Intergen) specific for DNP-protein adducts (1:100) and then a
secondary goat anti-rabbit IgG (Sigma) antibody. The resultant stain was developed by
application of Sigma-Fast (BCIP/NBT) tablets, and the line densities were quantified by
Scion-Image software package.
4.2.6 TBARS
The concentration of TBARS in brain tissue was determined according the
method of Ohkawa et al. (33). 50 mL of 10% w/v of ice cold TCA was added into 0.25
mL of 4mg/mL tissue homogenate. The samples were spun in an Eppendorf centrifuge
tube for 5 min at 3,000 g. The supernatant was collected (0.5 ml) and treated with TBA
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reagent (20 mM TBA in 50% v/v glacial acetic acid). The samples were then heated at
100°C for 1 hr. After the cooling period, butanol was added, and the organic layer was
removed and redistributed to a black microtiter plate (Corning Inc, Acton, MA). End
point fluorescence was measured at λex = 515 nm and λem = 585 nm.
4.2.7 W/S Ratio
4.2.7.1 Synaptosome Isolation.
Synaptosomes were purified as described (26, 34, 35). The crude homogenate was
removed and respun at 20,000 × g at 4°C for 10 min. The resulting pellet was
resuspended in the 0.32M sucrose isolation buffer and layered on a discontinuous sucrose
gradient (10 ml of 1.18 M sucrose, pH 8.5/ 10 ml of 1.0 M sucrose, pH 7.4/ 10 ml of 0.85
M sucrose, pH 7.4, each containing 2 mM EDTA/2 mM EGTA/10 mM Hepes). The
samples were then spun at 82,500 × g at 4°C for 60 min in a Beckman swinging-bucket
rotor. Synaptosomes were removed from the 1.18/1.0 M sucrose interface and
resuspended in 20 ml of lysing buffer (10 mM Hepes/2 mM EDTA/2 mM EGTA, pH
7.4). The samples were then centrifuged at 32,000 × g at 4°C for 10 min. The pellet was
removed and resuspended in PBS buffer and spun down two more times. After the third
wash, the protein concentration was determined by the BCA method
4.2.7.2 Spin Labeling
Spin labeling of synaptosomal membrane proteins was performed as described
(26, 36). Isolated synaptosomes were suspended in lysing buffer for 30 minutes. Lysed
synaptosomal membranes were labeled with the protein-specific spin label MAL-6. After
incubation for 18 hr at 4°C with 20 µg MAL-6/mg protein, samples were washed six
times in lysing buffer to remove excess spin label. The pellet was then resuspended in
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approximately 400 μl lysing buffer and allowed to come to room temperature. EPR
spectra were acquired on a Bruker model EMX EPR spectrometer (Bruker, Billerica, MA)
operating at an incident microwave power of 18 mW, a modulation amplitude of 0.4 G, a
time constant of 1.28 msec, and a conversion time of 10 msec.
4.2.8 Statistics
The data of oxidative parameter measurements were analyzed by Student's t tests.
Result of T-maze avoidance was analyzed with one-way analysis of variance (ANOVA)
and a two-way analysis of variance. A value of p < 0.05 was considered statistically
significant.
4.3 Results
4.3.1 T-maze Footshock Avoidance
The acquisition decline as a function of age in SAMP8 mice. However,
administration of LA improved acquisition as tested in the T-maze footshock avoidance
paradigm. The

ANOVA

for the trials to first avoidance measure indicated a significant

effect (F 2,27 = 34.31, p < 0.001). Statistical analysis revealed 12-month-old SAMP8 mice
that had received LA took significantly fewer trials to reach criterion than the 12-monthold SAMP8 mice which received saline. The group of mice administered LA did not
significantly differ from the 4-month-old SAMP8 mice administered saline. The

ANOVA

for latencies to escape shock on the first trial did not indicate a significant difference.
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Figure 4.1
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4.3.2 Protein Carbonyl level
To determine whether the protein carbonyl levels of cortical synaptosomal
membranes were increased in the 12 month SAMP8 mouse relative to those from 4
month SAMP8 mouse, the 2,4-dinitrophenylhydrazone adducts were measured
immunochemically. The results suggest that the protein carbonyl levels of brain proteins
in 12 month SAMP8 were significantly greater than those of 4 month SAMP8 by 29%
(Fig. 4.2 ; P < 0.01). However, if 12-month-old and 4-month-old SAMP8 mice were
treated with LA, the protein carbonyl level of 12 month SAMP8 mice only increase 17%
with no significant difference (Fig. 4.2).
4.3.3 W/S Ratio
Consistent with result of protein carbonyl levels, the W/S ratio is decreased
significantly in synaptosomal membrane proteins of 12-month SAMP8 mice compared
with that of 4-month SAMP8 mice (Fig 4.3; p < 0.001). There is no significant difference
between this parameter in brain membranes from 4-month and 12-month old SAMP8
mice with prior in-vivo LA treatment (Fig. 4.3)
4.3.4 TBARS
Additional oxidative stress markers were decreased in 12-month old SAMP8
mice. Increased TBARS levels were observed in brain from 12-month-old SAMP8 mice
compared to 4-month-old SAMP8 mice (Fig. 4.4 p < 0.05). This result suggested that
increased lipid peroxidation in 12-month-old SAMP8 mice compared with that of 4month-old SAMP8 mice. (Fig. 4.4 p < 0.05). Again, there is no significant difference in
brain lipid peroxidation as indicated by TBARS between the 4-month and 12-month
SAMP8 mice if they were treated previously in vivo with LA.
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Figure 4.2
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Figure 4.3
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Figure 4.4
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4.4 Discussion
By comparing oxidative stress indices: protein carbonyl level, W/S ratio
and TBARS, it has been well established that brain from SAMP8 mice has more
oxidative stress than normal aging mice model (ddY and SAMR1) . Consistent with the
multiple evidence of other laboratories (Yagi et al., 1988; Miyamoto, 1997; Morley et al.,
2000), the results from the present study show that the brains of 12-month-old SAMP8
mice suffer from higher oxidative insult than 4-month SAMP8 mice . This suggests that
either antioxidant defense of SAMP8 mice is weakened or endogenous oxidative stress
was strengthened by accelerated aging.
Consistent with oxidative stress, impairment of learning was reported for SAMP8
mice at 12 months of age. Previously, 4-month and 12-month old SAMP8 mice were
trained to learn a specific sequence of left-right or black-white responses to obtain milk
reinforcement. All of the 12-month-old SAMP8 mice failed to learn the task, whereas
about 60% of the 4-month-old SAMP8 mice learned the task (Flood and Morley, 1998).
Also, impairment of memory retention for passive avoidance training was detected in 8
month SAMP8 (Yagi et al., 1988). Morely, Flood and coworkers reported that there is
significant difference of accumulation of APP in the hippocampal area between 8-monthold SAMP8 mice and 12-month-old SAMP8 mice, and plaque formation occurs only well
after development of cognitive deficits in SAMPP8 mice (Kumar et al., 2000b).
Increased APP leads to Aβ accumulation and oxidative damage to brain tissue
(Butterfield, 1997, 2002; Butterfield et al., 2002d). The current study indicates that
oxidative stress is closely related to learning ability and memory retention in SAMP8
mice. Lesion studies in other animals have shown that spatial learning is dependent on
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the integrity of the septohippocampal pathway (O'Keefe, 1978). It is possible that free
radicals react with enzymes, receptors or/and neurotransmitters (Norepinephrine,
dopamine etc.) in the pathway and therefore destroy their proper functions. As the result,
the functioning of the whole septohippocampal pathway was decreased as Reddy et. al.
hypothesized (Reddy et al., 1998). Further studies will be needed to prove this
hypothesis.
Ames and coworkers have shown that LA is able to partially reverse memory loss
in normal aging rats by delaying mitochondrial dysfunction and RNA/DNA oxidation
(Liu et al., 2002). Mitochondrial dysfunction is accompanied by a leakage of O2• and
H2O2. That LA is readily taken up into mitochondria where it acts as a cofactor in
oxidative decarboxylation of α-keto acids has led to the view that LA maybe a useful
therapeutic agent in disease which are characterized by mitochondria dysfunction or
oxidative stress (Packer et al., 1997a; Packer et al., 1997b). The present result showed
that LA is also a good therapeutic for accelerated aging. The results of present study
show that if 12-month-old SAMP8 mice are treated with LA, there is no significant
between age groups in oxidative stress parameters and T-maze footshock avoidance test.
After 12-month-old SAMP8 mice were treated with LA, the learning is
improved as shown by T-maze footshock avoidance test, perhaps because of the
improved antioxidant defense by LA. LA possibly protects the septohippocampal
pathway by reducing the oxidation of dopamine and norepinephrine (Biewenga et al.,
1997) which are activated by training of the animals (Flood and Morley, 1998). LA acts
not only by increasing the concentration of dopamine and norepinephrine, but also by the
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scavenging action that stops the toxic end products of dopamine and norpinephphrine
oxidation, H2O2 and O2• (Packer et al., 1997b). LA should protect other enzymes and
receptors in the septohippocampal pathway from oxidative damage as well because of its
antioxidant ability.
We conclude that increased oxidative stress observed in 12-month-old SAMP8
mouse brain when compared to 4-month-old SAMP8 mice is contributed to the memory
and learning deficits in aged SAMP8 mice. This is probably due to the oxidative damage
to the septohippocampal pathway. LA was able to reverse these changes. Therefore, LA
may be an efficient treatment or supplement for age related cognitive impairment.

105

CHAPTER FIVE
Quantitative Proteomics Analysis of Specific Protein Expression and
Oxidative Modification in Aged Senescence-Accelerated-Prone 8 Mice Brain
5.1 Introduction
In the last chapter, we showed that 12-month-old SAMP8 mice have higher
protein oxidation, and lipid peroxidation compared with 4-month-old SAMP8 (Farr et al.,
2003). In order to investigate the relations among age-related oxidative stress on proteins,
physiological alterations and impairments in learning and memory, we used proteomics
to identify brain proteins that are expressed differently and oxidatively modified with
aging in SAMP8 mice brain.
5.2 Experimental Procedures
5.2.1 Rodent Subjects
Rodent subjects used are the same as described in section 4.2.1
5.2.2 Sample Preparation
The whole brains of SAMP8 mice were flash frozen in liquid nitrogen in the
laboratory of Geriatric Research Education and Clinical Center (GRECC), VA Medical
Center, St. Louis and sent to the Chemistry Department, University of Kentucky,
Lexington on dry ice overnight. The whole brain samples were homogenized in a lysis
buffer (10 mM HEPES, 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4 and
0.5 mg/mL leupeptin, 0.7µg/mL pepstatin, 0.5 µg/mL trypsin inhibitor, and 40 µg/mL
PMSF). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The
supernatant was extracted to determine the concentration by the BCA method (Pierce,
IL).
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5.2.3 Two-dimensional electrophoresis
Samples of brain proteins were prepared according to the procedure of Levine et
al. (Levine et al., 1994). 200μg of protein were incubated with 4 volumes of 2N HCl at
room temperature (25°C) for 20min. Proteins were then precipitated by addition of icecold 100% trichloroacetic acid (TCA) to obtain a final concentration of 15% TCA final.
Samples are placed on ice for 10 min to let protein precipitate. Precipitates were
centrifuged at 15,800 g for 2 min. This process removed ions that affect the voltage
during the isoelectric focusing. The pellets were washed with 1mL of 1:1 (v/v)
ethanol/ethyl acetate solution. After centrifugation and washing with ethanol/ethyl acetate
solution three times, the samples were dissolved in 25 μL of 8 M urea (Bio-Rad, CA). The
samples then were mixed with 185μL of rehydration buffer (8 M urea, 20mM
dithiothreitol, 2.0% (w/v) CHAPS, 0.2% Biolytes, 2 M thiourea and bromophenol blue).
In first-dimension electrophoresis, 200 µL of sample solution were applied to a
ReadyStrip™ IPG strip (Bio-Rad, CA). The strips were soaked in the sample solution for
1 hour to ensure uptake of the proteins. The strip was then actively rehydrated in the
protean IEF cell (Bio-Rad) for 16 hours at 50V. The isoelectric focusing was performed
at 300V for 2 hours linearly; 500V for 2 hr linearly; 1000V for 2 hr linearly, 8000V for 8
hr linearly and 8000V for 10 hr rapidly. All the processes above were carried out at 22oC.
The strip was stored in –80oC until the second dimension electrophoresis was performed.
For the second dimension, IPG® Strips pH 3-10 were equilibrated for 10 min in
50 mM Tris-HCl (pH 6.8) containing 6M urea, 1% (w/v) sodium dodecyl sulfate (SDS),
30% (v/v) glycerol, and 0.5% dithiothreitol, and then re-equilibrated for 15min in the
same buffer containing 4.5% iodacetamide in place of dithiothreitol. 8-16% Linear
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gradient precast criterion Tris-HCl gels (Bio-Rad, CA) were used to perform second
dimension electrophoresis. Precision ProteinTM Standards (Bio-Rad, CA) were run along
with the sample at 200V for 65 min.
The gel was incubated in fixing solution (7% acetic acid, 40% methanol) for 20
min after the second dimension electrophoresis. Approximately, 60 mL of Bio-Safe
Coomassie blue were used to stain the gel for 2 hours. The gels were destained in
deionized water overnight.
5.2.4 Western Blotting
200μg of protein were incubated with 4 volumes of 20 mM DNPH at room
temperature (25°C) for 20min. The gels were prepared in the same manner as for 2Delectrophoresis. After the second dimension, the proteins from gels were transferred to
nitrocellulose papers (Bio-Rad) using the Transblot-Blot® SD semi-Dry Transfer Cell
(Bio-Rad) at 15V for 4 hrs. The 2,4-dinitrophenyl hydrazone (DNP) adduct of the
carbonyls of the proteins was detected on the nitrocellulose paper using a primary rabbit
antibody (Chemicon, CA) specific for DNP-protein adducts (1:100), and then a
secondary goat anti-rabbit IgG (Sigma, MO) antibody was applied. The resultant stain
was developed by application of Sigma-Fast (BCIP/NBT) tablets.
5.2.5 Image Analysis
The gels and nitrocellulose papers were scanned and saved in TIFF format using
Scanjet 3300C (Hewlett Packard, CA). Investigator HT analyzer (Genomic Solutions
Inc., MI) was used for matching and analysis of visualized protein spots among
differential gels and oxyblots. The principles of measuring intensity values by 2-D
analysis software were similar to those of densitometric measurement. Average mode of
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background subtraction was used to normalize intensity value, which represents the
amount of protein (total protein on gel and oxidized protein on oxyblot) per spot. After
completion of spot matching, the normalized intensity of each protein spot from
individual gels (or oxyblots) was compared between groups using statistical analysis.
5.2.6 Trypsin Digestion
Samples were prepared using techniques described by Jensen (Jensen et al.,
1999), modified by (Thongboonkerd et al., 2002). The protein spots were excised with a
clean blade and transferred into clean microcentrifuge tubes. The protein spots were then
washed with 0.1M ammonium bicarbonate (NH4HCO3) at room temperature for 15 min.
Acetonitrile was added to the gel pieces and incubated at room temperature for 15 min.
The solvent was removed, and the gel pieces were dried in a flow hood. The protein spots
were incubated with 20 µl of 20 mM DTT in 0.1M NH4HCO3 at 56°C for 45min. The
DTT solution was then removed and replaced with 20µl of 55mM iodoacetamide in 0.1M
NH4HCO3. The solution was incubated at room temperature in the dark for 30min. The
iodoacetamide was removed and replaced with 0.2ml of 50mM NH4HCO3 and incubated
at room temperature for 15 min. 200μL of acetonitrile was added. After 15min
incubation, the solvent was removed, and the gel spots were dried in a flow hood for 30
min. The gel pieces were rehydrated with 20 ng/µl modified trypsin (Promega, Madison,
WI) in 50 mM NH4HCO3 with the minimal volume to cover the gel pieces. The gel pieces
were chopped into smaller pieces and incubated at 37°C overnight in a shaking incubator.
5.2.7 Mass Spectrometry
All mass spectra reported in this study were acquired from the University of
Kentucky Mass Spectrometry Facility (UKMSF). LC/MS/MS spectra were acquired on a

109

Finnigan LCQ 'Classic' quadrupole ion trap mass spectrometer (Finnigan). Separations
were performed with an HP 1100 HPLC modified with a custom splitter to deliver
4µL/min to a custom C18 capillary column (300µm id x15cm, packed in-house with
Macrophere 300 5µm C18 (Alltech Associates). Gradient separations consisted of 2 min
isocratic at 95% water: 5% acetonitrile (both phases contain 0.1% formic acid), the
organic phase was increased to 20% acetonitrile over 8min, then increased to 90%
acetonitrile over 25min, held at 90% acetonitrile for 8min, then increased to 95% in
2min, and finally returned to initial conditions in 10min (total acquisition time 45 min
with a 10-min recycle time). Tandem mass spectra were acquired in a data dependent
manner. Three microscans were averaged to generate the data-dependent full scan
spectrum. The most intense ion was subjected to tandem mass spectrometry and three
microscans were averaged to produce the MS/MS spectrum. Masses subjected to the
MS/MS scan were placed on an exclusion list for 2min. The tandem spectra obtained
were searched against the NCBI protein databases using the MASCOT search engine (
http://www.matrixscience.com). For the MS/MS spectra, the peptides were also assumed
to be monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine
residues. A 0.8-Da MS/MS mass tolerance was used for searching.
5.2.8 Statistics
The data of protein levels and protein specific carbonyl levels of 6 animals per
group (young and old SAMP8 mice) were analyzed by Student's t tests. A value of p <
0.05 was considered statistically significant. Only the proteins that are considered
significantly different by Student’s t-test are reported.
5.3 Results
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5.3.1 Protein expression level
Proteomics was used to study oxidized proteins in AD (Castegna et al., 2002b;
Castegna et al., 2002a; Castegna et al., 2003). The specific carbonyl levels were obtained
by dividing the carbonyl level of a protein spot on the nitrocellulose membrane by the
protein level of its corresponding protein spot on the gel. Such numbers give the carbonyl
level per unit of protein. We found that in comparison to 4-month-old SAMP8 mice, 12month-old SAMP8 mice brain have five proteins that are expressed significantly
differently and five proteins that have significantly higher specific carbonyl levels. All
the mass spectra of the peptides were matched to the mass spectra in NCBI protein
databases. The identified proteins are listed in Table 5.1. The probability-based Mowse
score is assigned for each spectrum to indicate the probability that the match between the
database and the spectra is a random event. Scores greater than 66 were considered
significant. Thus, if a match has a score higher than 66, the probability of the match being
a random event is lower than 0.05. All protein identifications agree with the expected
MrW and pI range based on their positions on the gel.
Fig. 5.1 shows a gel for 2D-electrophoresis after Coomassie Blue staining. The
proteins that were expressed differently in SAMP8 brains are summarized in Table 5.2.
The expression of neurofilament triplet L protein (NF-L), lactate dehydrogenase 2 (LDH2) and heat shock protein 86 (HSP86), α-spectrin are significantly decreased, whereas the
expression of triosephosphate isomerase (TPI) was significantly increased in brain
from12-month-old SAMP8 mice.
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Figure 5.1
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5.3.2 Specific Protein Carbonyl Level.
Fig. 5.2 shows an example of a Western blot for detection of the level of protein
carbonyl. The summary of the specific protein carbonyl levels is given in Table 5.3. The
specific protein carbonyl levels of LDH-2, dihydropyrimidinase-like protein 2 (DRP-2),
α-spectrin and creatine kinase (CK) are significantly increased in the brain of 12-monthold SAMP8. The specific carbonyl level of α-enolase was showed a trend toward being
higher in 12-month-old SAMP8 with P-value lower than 0.07.
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Figure 5.2
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5.4 Discussion
Proteomics were used to identify oxidized and nitrated protein in Alziemer’s
disease (AD) brain (Castegna et al., 2002b; Castegna et al., 2002a; Castegna et al., 2003).
α-enolase, CK, and DRP-2 were reported to be more oxidized, and α-enolase and TPI
were significantly nitrated in AD brain when compared to age-matched controls
(Castegna et al., 2002b; Castegna et al., 2002a; Castegna et al., 2003). Our current study
shows that the specific protein carbonyl levels of LDH-2, α-enolase, α-spectrin and
DRP-2 were significantly decreased, and the protein expression level of TPI, LDH-2, NFL, α-spectrin and HSP86 are significantly changed, in 12-month-old SAMP8 brains.
α-enolase is a subunit of enolase, the other subunits are β- and γ-enolase. αenolase is present in embryonic development and switches to γ or β, concurring with
terminal differentiation of the muscle or neuron (Giallongo et al., 1990). A mutation by
inserting splice-trap vectors into the first intron disrupts the α-enolase gene results in
early embryonic lethality (Couldrey et al., 1998). Two of the subunits form active enolase
isoforms (αα, ββ, γγ, αβ and αβ), which interconverts 2-phosphoglycerate and
phoenolpyruvate. Since αγ abd γγ isoforms are predominate in the brain, they are called
neuron-specific enolase (NSE) (Keller et al., 1994). NSE has been well used as a
neuronal marker for structural damage (el-Mallakh et al., 1992) and neuronal metabolic
properties (Trapp et al., 1981; Marangos and Schmechel, 1987; Hamre et al., 1989).
Expression and high activity of NSE were detected in rat oligodendroglial cells at a
certain stage of differentiation. However, when the culture was treated with basic
fibroblast growth factor to stimulate the proliferation and block the differentiation of the
oligodendrocyte precursor cell, the activity of NSE decreased (Deloulme et al., 1996). It
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was also reported that the expression of NSE coincides with the onset of synaptic
connections (Maxwell et al., 1982; Whitehead et al., 1982; Hedgecock et al., 1985).
These studies show that enolase is not only involved in metabolism, but also in cell
differentiation and normal growth in brains. In primary human fetal mixed brain cell
cultures, the NSE level decreases correlated to the treatment of Aβ(1-40) (Hayes et al.,
2002). Although the level of NSE is not significantly alter in aged brain (Kato et al.,
1990) and in AD brain (Kato et al., 1991), α-enolase specific carbonyl level and protein
level (Schonberger et al., 2001; Castegna et al., 2002a) are increased in AD brain when
comparing to age-matched control, suggesting that the loss of activity by oxidative
modification of α-enolase is compensated by the increased protein level. It was shown
that the decline of enolase activity results in abnormal growth and reduced metabolism in
brain (Tholey et al., 1982). Our current study show that the specific carbonyl level of αenolase is significantly increase while protein level of α-enolase is not, indicating the
activity of α-enolase is reduced in SAMP8 brain.
LDH-2 is a subunit of lactate dehydrogenase (LDH). The five isoenzymes of
tetrameric LDH are found in various proportions of different somatic tissues in the
combination of the A and B subunit in mammals (Sakai et al., 1987). LDH is also a
glycolytic protein that catalyzes the reversible NAD-dependent interconversion of
pyruvate to L-lactate. A single mutation in LDH-2 lower the activity of LDH (Maekawa
et al., 1993; Sudo et al., 1994) suggesting LDH-2 subunit is critical to LDH activity. LDH
release is a common indicator of damage to plasma membrane integrity. LDH activity is
significantly increased in neuron and glial cell cultures from the brains of chick embryos
(Tholey et al., 1982) and rat brains during postnatal development (Bilger and Nehlig,
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1991) between 3 and 6 days, suggesting that LDH is important in the energy metabolism
of the brain and differentiation process in the brain, and lactate appears to be the only
oxidizible energy substrate available to support neuronal recovery (Schurr et al., 1997a,
b). Although the activity of LDH shows no significant difference in AD compared to
matched-age controls (Chandrasekaran et al., 1994), many studies show that LDH
activity in rat brains declined with age increased (Mizuno and Ohta, 1986; Ferrante and
Amenta, 1987; Hrachovina and Mourek, 1990; Agrawal et al., 1996). Total LDH activity
in the brains of aged rats that rose under chronic hypoxia is also diminished (Lai et al.,
2003) Since aging and chronic hypoxia are highly associated with oxidative stress, the
above studies suggest that the observed LDH activity loss may due to the oxidative
modification of the enzyme, and our current study shows direct evidence that LDH-2 is
significantly modified by oxidative insult in aged SAMP8 brains.
TPI catalyzes the reversible interconversion of glyceraldehyde 3-phosphate and
dihydroxyacetone phosphate during glycolysis. A case study in 1982 reported that a 12year-old girl who had chronic nonspherocytic hemolytic aemia, due to TPI deficiency
eventually developed cerebellar dysfunction and spasticity with hyperreflexia (Clay et al.,
1982). Also, inhibition of TPI by α-monochlorohydrin causes decreased neuronal ATP
production followed by progressive neuronal death (Sheline and Choi, 1998). Therefore
if TPI are oxidized or nitrated in AD (Castegna et al., 2003), lower activity of TPI should
be observed. However, activity of TPI is not altered in neither AD patients (Meier-Ruge
et al., 1984) nor demented patients (Iwangoff et al., 1980). Our current study provide a
possible explanation: since the level of TPI in aged SAMP8 brain significantly increase,
the “non-specific” carbonyl level must also increase to maintain a similar (94%) specific
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carbonyl level between the 4-month old and 12-month-old SAMP8, indicating that
although more TPI are inactivated by oxidative modification, there are also more TPI
proteins available to catalysis the reaction. Therefore, no net decrease in activity is
observed. Consistent with this explanation, the TPI level was reported to increase when
inducing oxidative stress by hypoxia to tissue (Lushchak et al., 1998) suggesting cells
upregulate TPI to compensate its loss of activity by oxidative modification.
CK, which is highly sensitive to oxidation, is found in cytoplasm and
mitochondria of cells to catalyze the reversible transfer of high energy phosphoryl
between the ATP and creatine phosphate (Schlegel et al., 1990; Wallimann et al., 1992;
Wyss et al., 1992; Kaldis et al., 1994). At least other three isoenzymes of CK have been
described. It is proposed that three CK genes exist (Eppenberger et al., 1967; Sobel et al.,
1972; Roberts, 1980) to encode the three protein subunits, designated M(muscle), B
(brain), and mitochondrial (Mi). These subunits form three dimeric cytosolic (MM, BB
and MB) and distinct mitochondrial isoenzymes (Mi-CKs). In AD brains, the expression
of CK-BB was decreased compared to the age-matched controls (David et al., 1998). It
was also well established that oxidative modification of CK-BB decrease its activity in
aging, AD and other neurodegenareative disease brain (Aksenova et al., 1998; Aksenova
et al., 1999a; Yatin et al., 1999b; Aksenov et al., 2000; Castegna et al., 2002b). Our
current study, consistent with many others, shows that CK in aged SAMP8 brain is
oxidized significantly, and therefore affect its activity to produce ATP.
It was reported that the reduced glucose metabolism in aged SAMP8 (Shimano,
1998). Our current study indicated the reduced ATP production possibly due to loss of
activity of specific glycolytic enzymes and CK by oxidative modification. Since 20% of
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ATP in brain is produced from glycolysis, loss of activity of glycolytic enzymes by
oxidative modification will significantly decrease the energy availability to neurons and
synaptic elements for defending oxidative stress. Another abnormal observation in aged
SAMP8 brain is the 14.6% acetylcholine concentration decrease in hippocampus
(Ikegami et al., 1992). Choline is derived from serine, an endogenous product from
glycolysis. The loss of activity of glycolytic enzymes and CK by oxidative modification
could reduce the production of substrates, glycerate-3-phosphate, to generate serine
endogenously, therefore lowered the concentration of choline for acetylcholine synthesis.
Our current suggests that oxidative modification of CK and glycolytic enzyme may be
responsible for the alteration of matabolism and neurochemicals reported in SAMP8.
DRP-2 is one of the four members of the dihydropyrimidinase-related protein
family (DRP-1, -2,-3 and –4), which are originally identified in human by their homology
to dihydropyrimidinase (Hamajima et al., 1996; Wang and Strittmatter, 1996; Kato et al.,
1998). Other non-human counterparts of the human DRPs are chicken collapsing
response mediator protein (CRMP-62) (Goshima et al., 1995), rat turned on after division
(TOAD)-64 (Minturn et al., 1995) and mouse unc-33-like phosphoprotein (Ulip). Based
on the comparison of the amino acid sequences, these genes were classified into 4
groups; DRP-1/CRMP-1/Ulip3, DRP-2/CRMP2/TOAD-64/Ulip2, DRP-3/CRMP-4/Ulip1
and DRP-4/CRMP-3 (Byk et al., 1996; Hamajima et al., 1996). The amino acid
sequences of DRP proteins show 64-79% identical to each other. The DRP family is
involved in axonal outgrowth and pathfinding through transmission and modulation of
extracellular signals. (Goshima et al., 1995; Minturn et al., 1995; Byk et al., 1996). One
of the identified extracellular signals is mediated by the proteins of the collapsing-
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semaphorin family in collaboration with their receptor, neuropilion (He and TessierLavigne, 1997; Kolodkin et al., 1997). Collapsin contribute to axonal pathfinding by
inducing growth cone (the tip of a growing axon responding to guidance cues) collapse
which repel the outgrowing axon (Luo et al., 1993). It was reported that CRMP-2 can
induce growth cone collapse (Goshima et al., 1995; Wang and Strittmatter, 1996) by
Rho-kinase phosphorylation (Arimura et al., 2000), and binding to tubulin heterodimers
and bundled microtubule as carriers to promote microtubules assembly and dynamics (Gu
and Ihara, 2000; Fukata et al., 2002). Also, neuropilion is expressed coordinately to
CRMP-2/DRP-2 axonal injury (Pasterkamp et al., 1998). Many neurodegenerative
diseases are associated with DRP-2 mutation in the unc-33 gene, a C. elegans homologue
of DRP-2, results in uncoordinated movements and abnormal swelling of axonal endings
with premature termination. (Pasterkamp et al., 1998). Yoshida et al suggested that
incorporation of DRP2 in the neurofilbrilary tangles decrease cytosolic DRP-2 and leads
to abnormal neuritic and axonal growth, thus accelerating the neurotic degeneration in
AD (Yoshida et al., 1998). Decreased expression of DRP-2 protein were observed in AD,
adult Down’s Syndrome (DS) (Lubec et al., 1999), fetal DS (Weitzdoerfer et al., 2001),
schizophrenia, and affective disorders (Johnston-Wilson et al., 2000). The deranged
DRP-2 mRNA level and the increased specific carbonyl level of DRP2 were indicated in
DS (Lubec et al., 1999) and AD (Castegna et al., 2002a), repectively. These studies
suggested that the DRP-2 activity loss, due to either reduced expression or oxidative
modification, disturbs neural development and plasticity in the CNS, resulting in mental
retardation and impairment in learning and memory. Consistent will others, our studys
show that the oxidative modification of DRP2 is significantly increased in the 12-month-
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old SAMP8 brain suggesting that the oxidative modification of DRP2 play an important
role in memory and learning deficit observed in aged SAMP8.
Neurofilaments (NFs) are axonal proteins that give axons their structure and
define axonal diameter (Hoffman et al., 1987; Brady, 1993). NFs are composed of three
subunits of light (NF-L), medium (NF-M) and heavy (NF-H), which assemble to from
long filmarcolmolecular filament in 6:2:1 ratio. NF-L is able to assemble homogously
while the other subunits cannot assemble competently without NF-L (Cohlberg et al.,
1995). All three subunits contain an α-helic rod domain, an amino-terminal head domain
and a carboxyl-terminal tail domain (Lee and Cleveland, 1996). The rod domains wrap
around each other to form a superhelix (Lupas, 1996). These structures combine to form
protofilaments through head-to-tail domain binding. Two protofilaments wrap around
each other to form protofibrils, and four protofibrils are combined to form the
characteristic 10-nm diameter NFs. Since the natures of NFs are dynamic, the individual
neurofilament proteins are turned over or exchanged within NFs in the axon (Okabe et
al., 1993; Takeda et al., 1994). The mechanism regulating the filament assembly is
believed to involve the phosphorylation of Ser-55 in the head domain (Gibb et al., 1996).
The modification of the NFs structure will result in the destabilization of the interactions
between the neurofilament proteins. Such destabilization is particularly dreadful to motor
neurons because motor neurons, which possess elongated axonal length and high axonal
constitution, contain more neurofilaments than other neurons (Crow et al., 1997). It was
shown that both of the transgenic mice expressing point mutation in NF-L, and mice
oversexpressing either NF-L or NF-H, display accumulations of disarrayed filaments in
motorneuronal perikarya and proximal axons, thus developed motor neuron disease (Cote
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et al., 1993; Lee et al., 1993; Xu et al., 1993). Oxidation and nitration of neurofilament
proteins will transform the α-helix to β-sheet and random coil (Gelinas et al., 2000), and
these oxidized proteins will then be degraded by protease (Grune et al., 1996; Davies,
2001; Inai and Nishikimi, 2002; Grune et al., 2003). Consequently, the oxidative
modification could be responsible for the NFs abnormalities observed in several
oxidative-stress-related neurodegenerative disease. It was shown that there was a
decrement in the transcription rate and mRNA level of NF-L in aged male Fischer 344 rat
brains (Krekoski et al., 1996). Consistent with this result, the expression NF-L in SAMP8
brains is significantly decreased in aged SAMP8 brain, suggesting the decreased level of
NF-L in brain caused the increased axonal dystrophy in the gracile nucleus observed in
aged SAMP8 mice (Kawamata et al., 1998).
The spectrins is a family of widely distributed filamentous proteins. α-spectrin, a
component of the membrane-associated cytoskeleton, form a supporting and organized
scaffold for intracellular cohesion with the association of actins (Leto et al., 1988).
mRNA level of α-spectrin increase gradually during the first postnatal days and reach
plateau between second and third week of life following by decreased globally during the
young adulthoods in rat (Gelot et al., 1994). This suggests that α-spectrin is important
during central nervous system (CNS) development and normal function. The breakdown
products of α-spectrin from calcium-activated proteolysis are commonly used as markers
of apoptosis (Vanderklish and Bahr, 2000). It was reported that Aβ can also induced
these α-spectrin breakdown products in cultured rat cortical neurons by activating
capases (Harada and Sugimoto, 1999). Similar increases of α-spectrin breakdown
products were also observed in some regions of aged Balb/c mice brain (Bahr et al.,
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1991), indicating the level of α-spectrin decrease as function of age in mice brain (Bahr
et al., 1994). Consistent of these studies, our results show decreased level of α-spectrin in
aged SAMP8, as well as increased specific carbonyl level, suggest that the proteolytic
mechanism in apoptosis involve oxidative modification and degradation of α-spectrin.
Loss of α-spectrin by oxidation or degradation disrupts the cytoskeleton and the structure
of cells in brain affecting intercellular and intracellular communications, consequently
causes the learning and memory deficits in SAMP8
DRP-2, α-spectrin, NF-L are involved in signaling, intracellular trafficking and
maintaining structure of dendrites and axons in neurons. Increased oxidation or reduced
expression of these proteins may account for the neuronal atropy and loss in posterior
cholinergic column, reduction of dendritic spines of hippocampal pyramidal neurons, and
increased axonal dystrophy in the gracile nucleus observed in aged SAMP8 (Kawamata
et al., 1998). These physiological alterations may further disrupt the communications
between neurons therefore causing learning and memory impairments in SAMP8.
Heat shock protein referred to a group of proteins that their syntheses are induced
when cells in culture respond to heat and chemical stress (Welch, 1992). The most
hightly expressed heat shock protein in unstressed cells is the 90k-Da heat shock protein
(HSP 90) (Perdew et al., 1993). While most studies examine HSP90 as a single protein,
there are two separate structural genes, HSP86 and HSP84 in mouse (Moore et al., 1989;
Moore et al., 1990), or HSP89α and HSP89β in human cells (Rebbe et al., 1989). The
sequences of HSP90-related proteins are highly conserved among vertebates (Perdew et
al., 1993). Although HSP84 and HSP86 are highly conserved, examination of the level of
expression of HSP86/HSP84 in murine tissues revealed that HSP86 is expressed in brain,
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testis, and placenta while HSP84 is highly expressed in liver, thymus, kidney, etc. (Lee,
1990). It was shown that HSP90 has the ability to bind to actin (Koyasu et al., 1986) in a
Ca2+- calmodulin-dependent manner (Nishida et al., 1986; Koyasu et al., 1989) and
interact with many receptors and kinases (Brugge, 1986; Ziemiecki et al., 1986). These
studies suggest that HSP90 play a critical role in cell signaling for calcium homeostatic,
apoptosis etc. cell cycle processes. HSP90 also involves in protecting protease activity
from oxidative modification (Conconi et al., 1996; Conconi and Friguet, 1997),
indicating HSP90 possess antioxidant activity. It was also shown that hepatic HSP90
(HSP84) level was decreased in liver of aged rats (Nardai et al., 2002). Consistent with
this study, we show that level of HSP86 was decreased in aged SAMP8 brain suggesting
that the weakened antioxidant defense in aged SAMP8 may contribute to the increased
oxidative modification of proteins, which consequently leads to the neurochemicals
changes and learning and memory deficit observed in SAMP8 brains
In previous chapter, we demonstrated that protein oxidation is increased in
SAMP8 mice brain. In our current study, we have identified the proteins that are
oxidatively modified, as well as differently expressed, in SAMP8 brain as result of
increased oxidative stress. These proteins are critical to metabolism, structure,
communications and antioxidant defense of the brain. The losses of the activities of these
proteins by oxidative modification, or decreased levels, maybe contribute to the abnormal
metabolism (Shimano, 1998) and neurochemicals changes (Nardai et al., 2002), thus
learning and memory deficits observed in aged SAMP8. Base on our result, individual
purification or assay of these proteins will be needed to investigate their inactivation by
oxidative modification. However, this study provides evidence that the oxidative-stress-
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induced

learning and memory impairment involved specific protein oxidation and

changes of expression. Identifying these proteins can provide valuable information on
potential therapeutic targets for future studies.
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CHAPTER SIX
Metabolic Enzymes Impairment in Aged SAMP8 Mice: Implications of Energy
Metabolism in Cognitive Function
6.1 Introduction
We deomstrated that increased oxidative stress in aged SAMP8 mice brain is
manifested by increased protein oxidation (Howard et al., 1996; Butterfield et al., 2001a;
Farr et al., 2003). However, protein oxidation is not a random event, but rather is
associated with increased oxidative modification of particular proteins (Castegna et al.,
2002b; Castegna et al., 2002a; Poon et al., 2004d; Perluigi et al., 2005; Poon et al.,
2005b; Poon et al., 2005c). Using redox proteomics, we identified the brain proteins that
are oxidatively modified in aged SAMP8 mice when compared to that in young SAMP8
mice in the pervious chapter. These proteins are α-enolase, lactate dehydrogenase 2,
dihydropyrimidinase-like protein 2, α-spectrin and creatine kinase (CK). Since oxidative
modification of proteins alters their confirmation and activity (Hensley et al., 1994;
Lauderback et al., 2001; Sultana and Butterfield, 2004; Poon et al., 2005c), we
hypothesize that oxidative modification of α-enolase, lactate dehydrogenase, and CK
alters their functions in aged SAMP8 mice brain. In order to investigate this hypothesis,
we determine the activity of enolase (ENO), lactate dehydrogenase (LDH) and CK in
aged SAMP8 mice brain relative to that in young SAMP8 mice brain.
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6.2 Experimental Procedures

6.2.1 Rodent subjects
The rodents subjects used is previously describled in Section 4.2.1
6.2.2Sample preparation
The sample preparation is the same is previously describled in Section 5.2.2
6.2.3 Ex-vivo protein oxidation
4-month-old brain homogenates of SAMP8 mice were oxidized ex vivo by
incubating with 30 mM FeSO4 and 10 mM H2O2 for 30 min at room temperature. The
enzyme activities in ex-vivo oxidized young brain homogenates were determined with
the young and old brain homogenates.
6.2.4 Enzyme Activities Assay
LDH enzymatic activity was determined by the method previously described
(Zewe and Fromm, 1965; Poon et al., 2005c). Briefly, the assay for the enzyme activity
of LDH was performed in 100 μL Tris buffer (0.2M Tris.HCl, 30mM sodium pyruvate,
6.6mM NADH, pH 7.3). The reaction was initiated by adding 5 µL of the samples
(2mg/mL). LDH activity was measured as the reduction of NADH to NAD+. A decrease
in absorbance at 340 nm was recorded as change in A340 min-1 by using a PowerWaveX®
microtiter plated UV-VIS spectrophotometer (Bio-Tek Instruments, Winooki, VT).
Enolase activity assay was performed as described previously (Wagner et al.,
2000; Poon et al., 2005c) with modification. Enolase was added to 100 μL of assay
mixture (20 mM Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-
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glycerate) in a UV-transparent microtiter plate (Corning, MA). The enzymatic activity
was determined by the change of absorption at A240 for 5 min.
The activity of CK is determined by a Stanbio CK-NAC kit (Stanbio, Boern, TX).
Briefly, 95 μL of CK reagent ( 2 mM ADP, 5 mM AMP, 10 mM
diadenosinepentaphosphate, 2 mM NAD, 3000 U/mL hexokinase, 3000 U/mL glucose-6
phosphate dehydrogenase, 20mM N-acetylcysteine, 20mM D-glucose, 10 mM Mg2+, 2
mM EDTA) is mixed with 5 µL of the samples (2mg/mL). LDH activity was measured as
the reduction of NAD+ to NADH. The change in absorbance at 340 nm was recorded in
A340 min-1 by using a PowerWaveX® microtiter plated UV-VIS spectrophotometer (BioTek Instruments, Winooki, VT).
6.2.5 Statistics
The data of oxidative parameter measurements were analyzed by Student's t tests.
6.3 Results
The activity of ENO decreased approximately 50% in aged SAMP8 mice brain
when compared to that in young SAMP8 mice brain. Ex vivo oxidation of young SAMP8
brain homogenate mimicked such activity decline (Figure 6.1), indicating oxidative
modification contribute its function decline.
Similarly, LDH activity is significantly decreased 15% in aged SAMP8 mice
brain, and the similar activity decline was detected in the young SAMP8 mice brain
homogenate which is oxidized by Fe/H2O2 (Figure 6.2).
Although there was only 5% decrease in the activity of CK in aged SAMP8 mice
brain, it is statistically significant when compare to that in young SAMP8 mice brain.
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Moreover, such activity decline was mimicked by oxidation of young SAMP8 mice brain
homogenate ex vivo (Figure 6.3).

Figure 6.1
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Figure 6.2
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Figure 6.3
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6.4 Discussion
Previous chapter indicates that α-enolase, lactate dehydrogenase 2 and CK are
oxidatively modified in aged SAMP8 mice brain when compared to that in young
SAMP8 mice brain (Poon et al., 2004d). Our current study should that the oxidative
modification of these enzymes leads to their functional decline.
ENO interconvert 2-phosphoglycerate to phosphoenolpyruvate in glycolysis, and
a decline of enolase activity results in abnormal growth and reduced metabolism in brain
(Tholey et al., 1982). LDH is a glycolytic protein that catalyzes the reversible NADdependent interconversion of pyruvate to lactate, and production of lactate also serves as
intercellular energy transfer from astrocytes to neurons for ATP production (Deitmer,
2001). CK is a highly oxidative sensitive protein that is located in cytoplasm and
mitochondria of cell. CK catalyzes the transfer of high energy phosphoryl between ATP
and creatine phosphate. It was also well established that oxidative modification of CK
decreased its activity with aging, AD and other neurodegenerative disease brain (Hensley
et al., 1995c; Aksenova et al., 1998; Aksenova et al., 1999b; Yatin et al., 1999a; Aksenov
et al., 2001; Castegna et al., 2002b).
The striking feature of these proteins is that they are all involved in the ATP
production in neuron. Therefore, oxidative inactivation of these proteins may contribute
to the lowered glucose metabolism and ATP production in the brain of SAMP8 mice
(Shimano, 1998), leading to impairment of ATP-dependent process in neuron, such as
cell potential maintenance, signal transduction and protein synthesis. Since these
processes are critical to learning and memory (Lamprecht and LeDoux, 2004), oxidative
inactivation of ENO, LDH and CK may play a significant role in the cognitive decline in
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aged SAMP8 mice. Consistent with this notion, glucose metabolism, an important
process to maintain intact cognitive function (Messier and Gagnon, 1996), is impaired in
SAMP8 mice (Rossignol et al., 2000).
Our current study demonstrated that oxidative modification of ENO, LDH and
CK contribute to their activities decline in aged SAMP8 mice brain indeed. These
oxidative inhibitions may contribute to the decreased ATP production, thereby leading to
learning and memory deficits in aged SAMP8 mice.
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CHAPTER SEVEN
Proteomic Analysis of Specific Brain Proteins in Aged SAMP8 Mice Treated with αLipoic Acid: Implications for Aging and Age-related Neurodegenerative Disorders
7.1 Introduction
Aging and age-related neurodegenerative disorders are becoming more important
as the mean age of the United States' population increases. Ongoing research is being
pursued for development of therapeutics for oxidative stress related neurodegenerative
diseases, among which are those that scavenge free radicals by antioxidants. α-Lipoic
acid (LA), a coenzyme involved in production of ATP in mitochondria, is a potent
antioxidant (Packer et al., 1997a; Packer et al., 1997b; Liu et al., 2002). Increased protein
oxidation and lipid peroxidation were demonstrated in 12-month-old SAMP8 mouse
brains when compared to 4-month-old SAMP8 and the same age SAMR1 mice
(Butterfield et al., 1997a; Farr et al., 2003), and oxidative inhibition of specific proteins
in aged SAMP8 mice may lead to learning and memory deficits in aged SAMP8 mice.
The increases in protein oxidation and lipid peroxidation seen in aged SAMP8 mouse
brains were reversed by injecting the mice with LA as shown in Chapter three (Farr et al.,
2003). We rationalized that LA improves the learning and memory in SAMP8 mouse by
reducing oxidation and changing the expression of specific proteins in SAMP8 mice
brain. To test this hypothesis, we used proteomics to identify the proteins that are
expressed differently and/or the proteins that are less oxidized in the 12-month-old
SAMP8 mouse brain treated with LA.
7.2 Experimental Procedures
7.2.1 Rodent Subjects
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Rodent subjects used are the same as Section 4.2.1
7.2.2. Drug Administration
LA administration is the same as Section 4.2.2
7.2.3 Sample Preparation
Sample preparation is the same as Section 5.2.2
7.2.4 Two-dimensional electrophoresis
2D electrophoresis is the same as Section 5.2.3
7.2.5 Western Blotting
Western blotting is the same as Section 5.2.4
7.2.6 Image Analysis
Image analysis is the same as Section 5.2.5
7.2.7 Trypsin digestion
Trypsin digestion is the same as Section 5.2.6
7.2.8 Mass Spectrometry
Mass spectrometry is the same as Section 5.2.7
7.2.9 Statistics
Statistical analysis is the same as Section 5.2.8
7.3 Results
7.3.1 Protein expression levels
We used a proteomics parallel approach to investigate the effect of LA treatment
in aged SAMP8 mice. Fifty-six proteins were screened. We found that expression of
three proteins were significantly increased and that the specific carbonyl levels of three
proteins were significantly decreased in aged 12-month-old SAMP8 mouse brains when
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compared to that in 12-month-old SAMP8 mice not treated with LA (n=6 in each group).
All the mass spectra of the identified proteins were matched to the mass spectra in NCBI
protein databases. All identified proteins (Table 7.1) appeared in the expected MrW and
pI range on the gels.
Fig. 7.1 shows the 2D-electrophoresis gels after Coomassie blue staining. The
levels of the proteins that are expressed differently are summarized in Table 7.2. We
report here that the expressions of brain resident neurofilament triplet L protein (NF-L),
α-enolase, and ubiquous mitochondrial creatine kinase (uMiCK) are significantly
increased in aged SAMP8 mice injected with LA compared to aged, non-treated SAMP8
mice.
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Table 7.1: Summary of proteins identified by mass spectrometry
Identified Protein

# Peptide
GI accession
matches
#
Identified

% Coverage
matched
peptides

gi|6678674 14

41

Lactate dehydrogenase 2

Probability
Mowse
of a
Score
random hit

5.87,

(LDH 2)
α-enolase

pI, MrW

632

2x10-62

947

2x10-95

776

2.5x10-78

245

3.2x10-25

922

6.3x10-100

36.6
6.69,
gi|12963491 17

47
47.1
6.16,

dihydropyrimidinase-like 2
gi|1351260 14

35

gi|6753428 8

14

62.16

(DRP-2)
ubiquous mitochondrial
8.65,
creatine kinase

47.7
(uMiCK)
Neurofilament L

4.40,
gi|417355

18

37

(NF-L)

61.5

Mowse scores greater than 62 are considered significant (p<0.05).
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Table 7.2: Proteins expressed differently when 12-month old SAMP8
mice are treated with LA compared to non-treated 12-month old SAMP8
mice
Identified Proteins

Neurofilament triplet L protein
(NF-L)

α-enolase

Protein levels of 12-month-old
SAMP8 injected with LAa (n =6)

p-value

625±58%

p < 0.005

143±47%

p < 0.05

183±28%

p < 0.05

ubiquous Mitochondrial
creatine kinase
(uMiCK)

a

Percent of the level found in brain from 12-month old, no-treated SAMP8 mice
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Figure 7.1
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7.3.2 Specific Protein carbonyl levels
Fig. 7.2 shows the resultant nitrocellulose membranes for protein carbonyl
detection. The summary of the proteins that have significantly increased specific carbonyl
levels is given in Table 7.3. We show that the specific protein carbonyl levels of lactate
dehyrogenase 2 (LDH-2), dihydropyrimidinase-like protein 2(DRP-2), and α-enolase are
significantly decreased in the brains of aged SAMP8 mice treated with LA.
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Table 7.3: Proteins that have specific carbonyl level decreased by LA
Specific protein carbonyl
Identified Proteins

levels of 12-month-old
SAMP8 injected with LA

p-value

(n=6)
Lactate dehyrogenase 2

11.5±10.2%

P < 0.01

16.4±16.4%

p < 0.05

0.17±0.17%

P = 0.05

(LDH-2)

Dihydropyrimidinase-like 2 (DRP-2)

α-enolase

a

Percent of the level found in brain from 12-month old, no-treated SAMP8 mice

145

Figure 7.2

146

7.4 Discussion
LA is able to partially reverse memory loss in normal aging rats by delaying
mitochondrial dysfunction and RNA/DNA oxidation (Liu et al., 2002). In SAMP8 mice,
LA treatment markedly improved learning and memory of even older rodents (Farr et al.,
2003). Mitochondrial dysfunction is accompanied by a leakage of O2· and H2O2. Since
LA is readily taken up into mitochondria, it is suggested that LA may be a useful
therapeutic agent in diseases that are characterized by mitochondria dysfunction or
oxidative stress (Packer et al., 1997a; Packer et al., 1997b; Lynch, 2001). We report here
that in brains from aged SAMP8 mice treated with LA, the specific carbonyl levels of
LDH-2, DRP-2, and α-enolase are significantly decreased and the expression levels of
the α-enolase, NF-L, and uMiCK, are increased in comparison to aged SAMP8 mice not
treated with LA.
α-Enolase and DRP-2 is known to be more oxidized in AD (Castegna et al.,
2002b; Castegna et al., 2002a; Castegna et al., 2003). Our previous study showed that the
specific carbonyl levels of α-enolase, DRP-2, LDH-2, creatine kinase (CK), and αspectrin are increased in aged SAMP8 brains. We report here that injecting LA can
decrease the specific carbonyl levels of α-enolase, DRP-2, and LDH-2 and can increase
the protein levels of uMiCK, α-enolase, and LDH-2 in aged SAMP8 mice brains. These
alterations of proteins may be responsible for the improvement of learning and memory
in LA-injected SAMP8.
DRP-2 is involved in axonal outgrowth and path finding through transmission and
modulation of intracellular signals. (Goshima et al., 1995; Minturn et al., 1995; Byk et
al., 1996). DRP-2 can induce growth cone collapse (Goshima et al., 1995; Wang and
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Strittmatter, 1996). Decreased expression or increased oxidation of DRP-2 in AD
(Castegna et al., 2002a), adult DS (Lubec et al., 1999), fetal DS (Weitzdoerfer et al.,
2001), schizophrenia and affective disorders suggest that the DRP-2 activity is decreased
in these disorders. An increased specific carbonyl level of DRP-2 is also observed in aged
SAMP8 brains (Poon et al., 2004d), suggesting the oxidative deactivation of DRP-2 may
be responsible for the impairment of learning and memory in aged SAMP8. We show
here that the oxidative modification of DRP2 is significantly reduced by treating the aged
SAMP8 mice with LA, possibly resulting in restoration of DRP-2 activity, and thus, the
normal neurogenesis of axons.
α-Enolase, a subunit of enolase, is also found oxidized in aged SAMP8 mouse
brains (Poon et al., 2004d). Enolase is not only involved in metabolism, but also in cell
differentiation and normal brain growth. Although the levels of neuronal specific enolase
(NSE) are not significantly altered in aged brains (Kato et al., 1990) and in AD brains
(Kato et al., 1991), the specific carbonyl level and protein level of α-enolase are
increased in AD (Schonberger et al., 2001; Castegna et al., 2002a), suggesting the
reduced enolase activity caused by oxidation is compensated for by its increased
expression. The decline of enolase activity results in abnormal growth and reduced
metabolism in brains (Tholey et al., 1982), therefore oxidation of α-enolase observed in
aged SAMP8 brains (Poon et al., 2004d) may be responsible for the reduced ATP
production (Shimano, 1998) and acetylcholine concentration (Ikegami et al., 1992) seen
in the brains of aged SAMP8 mice. Our current study shows that injecting the SAMP8
mice with LA is able to reduce the oxidative modification and increase the protein level
of α-enolase, suggesting the possibility that the activity of α-enolase may be restored.
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Therefore, the reduced glucose metabolism and neurochemical alterations in SAMP8
mouse brains (Ikegami et al., 1992; Shimano) are possibly reversed by the LA injections
as well.
LDH-B is a subunit of lactate dehydrogenase (LDH), which catalyzes the
reversible NAD-dependent interconversion of pyruvate to L-lactate. This may be an
important step for neuroprotection as lactate is considered the only oxidizible energy
substrate available to support neuronal recovery (Schurr et al., 1997a, b). Although the
activity of LDH shows no significant alteration in AD (Chandrasekaran et al., 1994),
many studies showed that LDH activity in rat brains declined in advanced age (Mizuno
and Ohta, 1986; Ferrante and Amenta, 1987; Hrachovina and Mourek, 1990), suggesting
the LDH activity loss may be caused by the oxidative modification of the enzyme.
Oxidation and depleted levels of LDH were observed in aged SAMP8 mouse brain,
suggesting LDH activity is also impaired in aged SAMP8 brain (Poon et al., 2004d). Our
current study shows that the carbonyl level of LDH decreases when SAMP8 mice are
injected with LA, suggesting that treatment of LA can possibly restore the ability of LDH
to produce lactate in aged SAMP8. Therefore, recovered LDH activity can possibly
facilitate neuronal recovery, and thus improvement in learning and memory, in aged
SAMP8 mice.
uMiCK, one of the isoenzymes of creatine kinase (CK), is considered as the
counterpart of cytoplasmic brain-type creatine kinase (CK-BB) in brain (Kanemitsu et al.,
2000). uMi-CK is responsible for the transfer of a high energy phosphoryl group (Pi)
from mitochondria to the cytosolic carrier and creatine (Payne and Strauss, 1994). In
neurons, a coordinated pattern in expression of CKBB and uMiCK was demonstrated
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(Friedman and Roberts, 1994), suggesting metabolic energy was transferred via a creatine
phosphate energy shuttle between cytosol and mitochondria. Recently, it was proposed
that uMiCK couples with CK to regulate ATP concentration in cerebral gray matter
(Kekelidze et al., 2001). Moreover, the mitochondrial synthesis of creatine phosphate is
restricted to uMiCK expressing neurons, suggesting uMiCK protects neurons from
energy shortage during periods of increased energy demands (Boero et al., 2003). It was
suggested that the increased oxidation of CKBB could be the cause of the decreased
production of ATP observed in aged SAMP8 mice brains (Shimano, 1998). Increasing
uMiCK expression by LA injection conceivably can compensate for the decreased ATP
synthesis due to the loss of CKBB activity in aged SAMP8 brains. This would result in
restoration of ATP production for antioxidant defensive systems in neurons and synaptic
elements.
Neurofilament-L is an subunit of neurofilaments (NFs), which give axons their
structure and diameter (Hoffman et al., 1987; Brady, 1993). Depletion of NF-L level in
AD, DS, and ALS brains (Bergeron et al., 1994; Bajo et al., 2001) indicates that the
normal NF-L expression is critical to central nervous system (CNS) functions. It was
suggested that the decreased NF-L expression in SAMP8 brains causes the increased
axonal dystrophy in the gracile nucleus. We report here that treating SAMP8 mice with
LA can raise the level of NF-L in aged SAMP8 brains and possibly decrease the axonal
dystrophy in the gracile nucleus, which consequently improves the learning and memory
in aged SAMP8.
Chapter four showed that LA reverses learning and memory impairment by
decreasing protein oxidation and lipid peroxidation of SAMP8 mice brains (Farr et al.,
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2003). We now identify the specific proteins (DRP-2, α-enolase, LDH, CK, and NF-L)
that are protected by LA injection. LA is a disulfide compound that is found naturally in
mitochondria as a coenzyme for pyruvate dehydrogenase (PDH) and α-ketoglutarate
dehydrogenase (KGD). Therefore, LA protection in aged SAMP8 mouse brains is
possibly owed to its free radical scavenging ability and its accessibility to mitochondria.
Since LDH and enolase are involved in the oxidoreduction-phoshphorylation stage of
glycolytic pathways, they locate near the mitochondria for substrate accessibility and
become the immediate targets for free radicals produced by mitochondria. Since LA has
easy access to mitochondria, LA can scavenge the free radicals produced by
mitochondria, or may even reduce the oxidation on the LDH and α-enolase. As a result, a
significant decrease of specific carbonyl levels in α-enolase and LDH-2 are observed in
SAMP8 brains. The increased level of α-enolase is possibly in response to the recovered
activity of LDH, which, in turn, is caused by a reduction of oxidative damage following
LA treatment. Demand for pyruvate is increased as the restored LDH activity speeds up
the conversion of pyruvates to lactate. In order to meet this demand, enolase levels are
increased to produce sufficient phosphophenol pyruvate (PEP) for pyruvate production.
The standard free energy of conversation from 2-phospho-D-glycerate to PEP is -14.8
kcal-mol-1. This suggests that increasing the level of the catalytic enolase, which
mediates this high-energy and rate limiting reaction, is the most efficient way to control
the substrate concentration for its downstream reactions. Increased uMiCK is possibly
controlled by similar mechanisms. Since a Pi is eliminated from PEP to form pyruvate,
extra creatine kinase activity will be needed to transfer Pi to creatine. Therefore, the level
of uMiCK is increased to reduce the Pi level in SAMP8 mice brain. This indicates that
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LA can rescue the energy depletion and neurochemical changes observed in aged SAMP8
mouse brains (Ikegami et al., 1992; Shimano, 1998) by improving the function of the
glycolytic pathway and increasing NADPH production.
γ-Enolase, encoded by a single gene as α-enolase, is associated with DRP-2 in
the complex of NADH-dichlorophenol-indophenol (DCIP) reductase (Bulliard et al.,
1997). DCIP reductase, one of the trans-plasma-membrane oxidoreductases (PMOs), is
involved in redox control of receptor function through the receptor-mediated signaltransduction pathway (Fuhrmann et al., 1989; Toole-Simms et al., 1991). More
importantly, it is involved in control of cell growth and development in response to
external oxidative stress or anti-oxidants (Bulliard et al., 1997). Therefore, the restored
enolase activity may trigger the decrease in the carbonyl level of DRP-2 in the DCIP
reductase complex, which in turn signals within the cells that the oxidative stress is
relieved by the LA treatment. The cells, consequently, increase NF-L production to
restore the normal structure of the neuron for recovery. However, more experiments are
needed to investigate the putative relationship between enolase and DRP-2, as well as
their roles in the signaling of DCIP reductase complex and oxidative stress.
Although no direct evidence is provided in the current study that injection of LA
can reverse neurochemical changes, increased ATP production, and improve learning and
memory in aged SAMP8 mice, we suggest here that the improvement of learning and
memory in LA treated SAMP8 mice is associated with the reduced specific carbonyl
levels and increased the protein levels of specific proteins. The latter are involved in
metabolism (LDH-2, α-enolase, uMiCK), cell signaling (DRP-2), and axonal structure
(NF-L) in cells. The possibly improved glycolytic pathway induced by reduction of
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enzyme oxidation may provide sufficient energy for neuronal recovery from oxidative
stress that may be consequently responsible for the improvement of learning and memory
in aged SAMP8 mice treated with LA. Therefore, improvement in energy metabolism
may lead to, at least partially, neuronal recovery, such as a restored cytoskeletal network
and enhancement of interneuronal communication in aged SAMP8 mice. However,
further studies will be needed to investigate the relation among enolase, DRP-2, and NFL in the recovery of neuronal function (Farr et al., 2003). Here, we used proteomics to
gain insight of the mechanism of cognitive improvement by LA injection in SAMP8
mice.
Our current study suggests that the improved learning and memory observed in
LA injected SAMP8 is associated with the restoration to the normal condition of oxidized
DRP-2, α-enolase, LDH, uMiCK, and NF-L in aged SAMP8 mouse brains.
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CHAPTER EIGHT
Antisense Oligonucleotides Directed at the Aβ Region of APP Decreases
Brain Oxidative Markers in Aged Senescence Accelerated Mice
8.1 Introduction
In previous chapters, we showed oxidative stress in brain play significant
role in the learning and memory deficits, and reducing oxidative stress by LA can reduce
oxidative stress and improve cognitive functions in aged SAMP8 mice. Therefore, using
an alternative strategy to reduce oxidative stress should also improve learning and
memory. One way to reduce oxidative stress is by reducing the production of neurotoxic
agent, such as amyloid β-peptide (Aβ)
Aβ is the major constituent of the senile plaques, a pathological hallmark of
Alzheimer’s disease (AD). It is generally accepted that Aβ(1-42) plays a central role in
the pathophysiology of AD (Selkoe, 1996). Our laboratory, along with others, suggested
that Aβ neurotoxicity is mediated through its ability to produce free-radical oxidative
stress (Butterfield et al., 1994; Varadarajan et al., 2000; Butterfield et al., 2001b;
Butterfield et al., 2002c; Butterfield and Kanski, 2002; Butterfield and Lauderback,
2002). The methionine residue at position 35 (Met-35) is important in this process
(Butterfield and Kanski, 2002). Other mechanisms by which Aβ can induce neurotoxicity
include binding to the nicotinic acetylcholine receptor (Wang et al., 2000), forming
calcium and potassium channels in cell membranes (Arispe et al., 1993; Etcheberrigaray
et al., 1994; Engstrom et al., 1995), decreasing glucose transport across brain endothelial
cells (Blanc et al., 1997), and actuating the release of chemokines (Fiala et al., 1998) and
cytokines(Akama and Van Eldik, 2000).
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When Aβ is given exogenously, it causes deficits in learning and memory in
animals (Flood et al., 1991, 1994; Cleary et al., 1995; Sisodia and Gallagher, 1998;
Tanaka et al., 1998; Yamada et al., 1998; Chen and Fernandez, 1999). Such learning and
memory impairments are also present when Aβ is overly expressed in transgenic models
(Hsiao et al., 1996) and the SAMP8 mouse (Flood and Morley, 1992, 1993; Flood et al.,
1993; Flood et al., 1995; Nomura et al., 1996; Flood and Morley, 1998; Farr et al., 2003).
It has, therefore, been proposed that reducing the levels of Aβ could slow or even
prevent cognitive impairment observed in AD or age-related dementia (McMahon et al.,
2002). Such reductions can be achieved by site-directed antisense oligonucleotide
therapy. This type of oligonucleotide is designed to bind to a complementary sequence
(referred to as the "target sequence") in a selected mRNA, inhibiting gene expression at
the translational level. As a consequence, the protein product coded by that particular
mRNA is not produced (Gewirtz et al., 1998). Since antisense oligonucleotides are
intended to inactivate specific RNA nucleotide sequences rather than three-dimensional
protein structures as antibodies do, they offer the advantage of discriminating among
closely related gene products (Seidman et al., 1999). Therefore, site-directed antisense
oligonucleotide therapy offers significant advantages for the specific reduction of Aβ
production.
As mentioned in previous chapters, SAMP8 mice produce increased amounts of
APP and Aβ in brain similar to those moieties observed in AD. Unlike transgenic mice
that have 5-14 times the normal amount of Aβ in their brains, the Aβ of SAMP8 mice had
only a 100% increase from 4 month to 12 months (Kumar et al., 2001). Such an increase
is much closer to the estimated 50% increase in Aβ seen in AD (Rosenberg, 2000) than is
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observed in transgenic mouse models. The APP and APP mRNA of SAMP8 mice also
increase significantly as the mice age from 4 months to 12 months (Morley et al., 2000;
Kumar et al., 2001). Hence, SAMP8 mice serve as a useful model in the study of agerelated cognitive impairment.
It is possible to decrease the Aβ production in the brain by giving an
intracerebroventricular

injection

of

a

42

mer

phosphorothiolated

antisense

oligonucleotide (AO) directed at the Aβ region of the APP gene. Injection of AO twice or
more has been shown to improve acquisition and retention in a footshock avoidance
paradigm (Kumar et al., 2000b). Although many in vitro studies show the benefits of
reducing APP level by antisense RNA (LeBlanc et al., 1992), antisense ribozoymes
(Denman et al., 1993; Denman et al., 1994; Denman and Phillips, 1998), or AOs
(Majocha et al., 1994; Allinquant et al., 1995; Coulson et al., 1997), little is known about
the relation between the reduced Aβ level and oxidative stress. Therefore, in this current
study, we hypothesized that the cognitive improvement resulting from AO treatment of
SAMP8 mice is caused by a decrease in Aβ-induced free radical insults. To test this
hypothesis, we compared the protein oxidation and lipid peroxidation markers in brain
from 4-month-old SAMP8 mice treated with saline (4m), 12-month-old SAMP8 mice
treated with random AO (12mR), and 12-month-old SAMP8 mice treated with the 42mer
AO directed at the Aβ region of the APP gene (12mA).
8.2 Experimental Procedures
8.2.1 Rodent Subjects
Rodent subjects used are the same as Section 4.2.1
8.2.2 Antisense oligonucleotides (AO) and its permeability to cell membrane
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We designed phosphorothiolated antisense oligonucleotides (AO) directed at
positions 17 to 30 of the Aβ region of the APP gene (Midland Certified Reagent
Company, Midland, TX). The sequences of the designated AO and of a random AO used
as a control are given in Table 8.1. These AOs were previously used to reverse the
learning and memory deficit observed in aged SAMP8 mouse (Kumar et al., 2000b).
Hippocampal neuronal cultures were prepared from 18-day old Sprague-Dawley
rat fetuses as described previously (Drake et al., 2003). Incorporation of AO into neurons
was observed using fluorescien conjugated-AO. Briefly, neuronal cells were incubated
with 5'-FITC-AO for 2 hr at 37oC followed by washing with PBS (3 times) to remove the
excess of 5'-FITC-AO and the cells were examined under a confocal fluorescence
microscope equipped with an argon laser (λex 485 nm, λem 530 nm).
8.2.3 Antisense Administration
Mice were anesthetized in a stereotactic instrument with methoxyflurane. Three
injections of vehicle or AO were given to the mice by intracerebroventricular (ICV)
injection at 2 weeks intervals. All substances (65ng) were injected in a 2 μL volume by
drilling a hole through the skull over the third ventricle (-0.5 relative to Bregma; 0.5 mm
right of central suture). The scalp wound was closed and the mice were returned to their
cages.
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Table 8.1: the antisense and control random phosphorothiolated
oligonucleotides used for inhibition of APP translation
AO
AO
inhibiting
APP
translation
Random
AO

Sequence
GGCGCCTTTGTTCGAACCCACATCTTCAAAAGAACACCAG

GATCACGTACACATCGACACCAGTCGCCATGACTGAGCTT
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8.2.4 Sample Preparation
Mice are scarified two weeks after the last injection. SAMP8 mouse brains were
flash frozen in liquid nitrogen in St. Louis and flown to Lexington on ice overnight. The
samples were homogenized in PBS with protease inhibitors (2mM EDTA, 2mM EGTA,
20mM HEPES, 20μ.g/mL Trypsin inhibitor, 4 μg/mL leupeptin, 4 μg/mL pepstatin, 5
μg/mL aprotinin) by sonication. Protein concentration was determined by the BCA Assay
method.
8.2.5 Immunochemistry
12.5 μL of the samples was treated with an equal volume Laemmli buffer
(0.125M Trizma base, 4%SDS, 20% glycerol) for 20 minutes. 12.5% linear Gradient
Precast criterion Tris-HCl gels (Bio-Rad) were used to perform the separation of the
proteins. Precision ProteinTM Standards (Bio-Rad) were run along with the sample at
200V for 45 min. The proteins from gels were transferred to a nitrocellulose paper (BioRad) using the Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 8V for 45
minutes. Aβ level was detected on the nitrocellulose paper using a primary mouse
antibody (a generous gift from Dr. Ralph N. Martins) specific for Aβ (1:50) and then a
secondary anti-mouse IgG (AnaSpec) antibody. The resultant stain was developed by
application of Sigma-Fast (BCIP/NBT) tablets.
Levels of 3-nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) and protein carbonyls
were determined immunochemically. Protein carbonyl levels were determined as
described in Section 4.2.5. HNE and 3-NT levels were determined in the same manner.
5μL of the samples was treated with an equal volume of 12% SDS. Samples were then
further denatured with 10 μL of Laemmli buffer (0.125M Trizma base, 4%SDS, 20%
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glycerol) for 20 minutes. Levels of 3-NT and HNE were measured by using the slot-blot
technique: 500 ng of protein per slot for protein 3-NT levels and 250 ng of protein per
slot for HNE levels. The HNE levels were detected on the nitrocellulose paper using a
primary rabbit antibody (Alpha Diagnostics) specific for HNE-modified protein (1:8000).
The 3-NT levels were detected by primary rabbit antibody (Chemicon) specific for 3-NT
(1:100). The same secondary goat anti-rabbit IgG (Sigma) antibody was then used. The
resultant stain was developed by application of Sigma-Fast (BCIP/NBT) tablets; and the
line densities were quantified by Scion-Image software package
8.2.6 TBARS
TBARS is determined as Section 4.2.6
8.2.7 Glutamine Synthetase (GS) assay
Fresh, non-frozen-brains, shipped on ice overnight from St. Louis to Lexington,
were homogenized in a 0.32M sucrose isolation buffer (2mM EDTA, 2mM EGTA,
20mM HEPES, 20μg/mL Trysin inhibitor, 4 μg/mL Leupeptin, 4 μg/mL pepstatin, 5
μg/mL aprotinin). The samples were then centrifuged at 20,000 × g at 4°C for 10 min.
Supernatants that contain GS and other cytosolic proteins were extracted. The protein
concentration was determined by the BCA method and normalized to 0.4mg/mL by
addition of the 0.32M sucrose solution. GS activity was determined by the method of
Rowe et al. (Rowe et al., 1970; Meister, 1985) as modified by Miller et al. (Miller et al.,
1978). The absorbance was recorded at 505nm in a microtiter plate reader (
PowerWaveX®, Bio-Tek Instruments).
8.2.7 Statistics
Statistical Analysis applied is the same as Section 4.2.8
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8.3 Results
8.3.1 Accessibility to cells and effects on Aβ levels of AO
8.3.1.1 Accessibility of AO in Cell Cultures
The AO approach previously was used to reverse the learning and memory
deficits of aged SAMP8 mice (Kumar et al., 2000b), consistent with the notion that the
AO penetrated nucleuses in vivo. To model this result, we used neuronal cultures. Fig.
8.1A shows bright-field microscopy of living neurons (arrows) and Fig. 8.1B shows the
fluorescence intensity of AO inside the neurons, indicating that the AOs successfully
cross the cell membrane and remain in the neurons after washes. Approximately 8% of
the neurons successfully took up the AO.
8.3.1.2 Effect of AO on Aβ levels in SAMP 8 mice brain
Fig. 8.2A shows the Western blot of Aβ levels in 12mR and 12mA brain
homogenate. The Aβ level in the 12mA SAMP8 mice brain is decreased by 40% due to
the effect of AO (p<0.05), while the Aβ level in brain from SAMP8 mice treated with
12mR was equal to that of untreated 12-month-old SAMP8 mice. Slot blot analysis of
levels of Aβ in brains of 4-month-old SAMP8 mice reveals that Aβ levels are equivalent
to those of 12-month-old treated with AO, i.e., AO treatment of aged SAMP8 mice lower
Aβ levels in brain to those of young mice (Fig. 8.2B).
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Figure 8.1
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Figure 8.2
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8.3.2. Protein oxidation
8.3.2.1 Glutamine synthetase (GS) Assay
GS is an oxidatively-sensitive enzyme (Butterfield et al., 1997a), whose activity is
decreased in AD brain (Hensley et al., 1995c), probably a result of specific oxidation
(Castegna et al., 2002b; Butterfield and Pocernich, 2003). Fig 8.3 shows that the activity
of GS in 12mR mice brains was decreased to 85.7±3.1% compared to the 4m mice brains
(p<0.01). Antisense directed against the Aβ region of APP partially reversed this
decrease (p < 0.05, with the activity of GS restored to 94.3±1.9% of the mean GS activity
from 4m brains. This value was statistically identical to that between the 4m old brain
(p>0.2).
8.3.2.2 Protein Carbonyl level
Protein carbonyls are an index of protein oxidation (Butterfield and Stadtman,
1997) and are increased in AD brain (Hensley et al., 1995c; Butterfield et al., 2001b;
Butterfield and Lauderback, 2002). Consistent with the GS assay results, Fig. 8.4 shows
that the brain protein carbonyl levels were increased in 12mR mouse brains compared to
those in brains from 4m mice (p < 0.05). However, by decreasing the production of Aβ
by antisense against APP, the brain protein carbonyl levels of 12-month old SAMP8 mice
were significantly decreased to 89.6±4.5% (p<0.01), and found to be insignificantly
different to those in brain from 4m old mice (p>0.05).
8.3.2.3 3-Nitrotyrosine (3NT)
Fig. 8.5 shows that the 3-NT levels of 12mR SAMP8 brain protein were significantly
increased compared to those in brain from 4m old mice (118±3.4%, p<0.001). However,
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after injection of the antisense against APP, the 3-NT levels were significantly decreased
to 99.6±2.7% (p<0.005), a level similar to that of brain from 4m mice (p>0.8).
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Figure 8.3
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Figure 8.4
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Figure 8.5
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8.3.3 Lipid Peroxidation
8.3.3.1 HNE
HNE is a reactive product of lipid peroxidation (Butterfield and Stadtman, 1997)
that is elevated in AD brain (Markesbery and Lovell, 1998; Lauderback et al., 2001;
Butterfield et al., 2002c)}. Fig. 8.6 shows that in the 12mR SAMP8 mice brain, the
protein-bound HNE levels were 114±0.8% of the level found in 4-month-old mice, a
statistically significant increase (p<0.00005). However, the HNE levels for brain protein
from 12-month-old mice was decreased significantly to 106±1.9% by the AO injection
(p<0.005), a value only slightly elevated from that in 4m mice brain (p=0.04).
8.3.3.2 TBARS
Consistent with the increase in HNE levels, Fig. 8.7 shows that TBARS levels in
12mR were increased to 108.6±3.0% of that found in 4 month old mice, a statistically
significant increase (p<0.05). However, with the injection of AO, the TBARS levels were
significantly decreased to 96.7±3.5% (p<0.05), a level that was not significantly different
that in 4m mice brain (p>0.4).
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Figure 8.6
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Figure 8.7
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8.4 DISCUSSION
It was reported that AO is able to cross blood brain barrier (BBB) and led reduce
to mRNA levels of APP in aged SAMP8 mice brains(Banks et al., 2001). We report here
that AOs successfully cross cell membranes and enter neurons (Figures 1, 2). Others
reported that cells in culture can take up antisense oligonucleotides against APP (Adlerz
et al., 2003), and neuronal cells in culture appear to internalize AOs relatively efficiently
(Larsen et al., 1999). Consistent with these other studies, we show here that small amount
of neurons are able to internalize AOs. The low amount neuronal uptake of AOs were
possibly due to the short incubation time (2hr). Nonetheless, AOs shown to enter the
cells. Although no direct evidence here shows that AO binds to APP mRNA, mRNA
level and APP level reduction were previously reported (Kumar et al., 2000b), which in
turn reduced Aβ production. Others reported that AO against APP can reduce Aβ
production in rats (McMahon et al., 2002). Consistent with this result, we find that AOs
reduced Aβ level by 39% in SAMP8 mice brains. This indicates that the AO is able to
cross the BBB (Banks et al., 2001) and enter neurons, then reduce the mRNA and protein
levels of APP (Kumar et al., 2000b), consequently reducing the level of Aβ (Figure 2).
Consistent with previous findings (Butterfield et al., 2001a; Farr et al., 2003), our
current results show that the 12mR SAMP8 mice have increased brain lipid peroxidation
and protein oxidation compared to those in brain from 4m SAMP8 mice. Therefore, the
random AO treatments had no protective effect on lipid peroxidation or protein oxidation
observed in aged SAMP8 mice brain. Our findings also show that brain lipid peroxidation
and protein oxidation of 12-month-old SAMP8 mice can, indeed, be reduced by injection
of AO and lower levels of Aβ.
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Lipid peroxidation is an important mechanism of neurodegeneration in AD brains.
TBARS and protein-bound HNE levels, commonly used as lipid peroxidation markers
(Butterfield and Stadtman, 1997), are significantly elevated in AD brains (Subbarao et al.,
1990; Balazs and Leon, 1994; Palmer and Burns, 1994; Lovell et al., 1995; Sayre et al.,
1997; Marcus et al., 1998; Markesbery and Lovell, 1998; Butterfield et al., 2001b;
Butterfield and Lauderback, 2002). HNE is able to diffuse to sites distant from that of its
formation because of its comparatively long half-life (Butterfield and Stadtman, 1997).
HNE elevation has been described in multiple brain regions and in ventricular
cerebrospinal fluid (CSF) in AD (Markesbery and Lovell, 1998). Aβ leads to HNE
formation (Mark et al., 1997); and this alkenal can alter the conformation of membrane
proteins (Subramaniam et al., 1997). It is, therefore, a reasonable hypothesis that
reducing the production of Aβ should decrease lipid peroxidation. Unlike other
antioxidant studies which decrease lipid peroxidation by blocking the Aβ-associated
radical insult (Butterfield et al., 1994; Avdulov et al., 1997; Gridley et al., 1997; Mark et
al., 1997; Bruce-Keller et al., 1998; Daniels et al., 1998; Mark et al., 1999; Yatin et al.,
2000; Butterfield et al., 2002d), our current study shows that Aβ-mediated lipid
peroxidation can be reduced by decreasing the production of Aβ through AO injection
into brain.
Protein oxidation is another important factor in aging and age-related
neurodegenerative disorders (Stadtman, 1992; Hensley et al., 1995c; Butterfield et al.,
1997a; Butterfield and Stadtman, 1997; Butterfield and Lauderback, 2002; Butterfield et
al., 2003; Farr et al., 2003). Protein carbonyls, 3-NT levels, and GS assay are commonly
used as markers of brain protein oxidation(Butterfield and Stadtman, 1997). A significant
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increase in protein carbonyls was reported in AD brains (Hensley et al., 1995c; Lyras et
al., 1997; Aksenov et al., 2001; Castegna et al., 2002b; Castegna et al., 2002a; Butterfield
and Pocernich, 2003). 3-NT is formed by oxidation of tyrosine by peroxynitrite. 3-NT
levels were significantly increased in the hippocampus and cortical regions of AD as well
as CSF (Hensley et al., 1998; Tohgi et al., 1999; Castegna et al., 2003). Other studies
have demonstrated that oxidative processes often result in decreased activity of key
enzymes (Floyd, 1990; Hensley et al., 1995c; Howard et al., 1996; Aksenova et al.,
1998). AD is characterized by the loss of GS activity (Hensley et al., 1995c), which can
also be caused by Aβ (Aksenov et al., 1996; Aksenov et al., 1997; Butterfield et al.,
1997b). Antioxidants can inhibit brain protein oxidation induced by Aβ (Harris et al.,
1995; Butterfield et al., 1999a; Varadarajan et al., 1999; Yatin et al., 1999a; Yatin et al.,
1999c; Varadarajan et al., 2000; Yatin et al., 2000; Butterfield et al., 2001b; Butterfield
and Kanski, 2001; Yatin et al., 2001), and here we show that Aβ mediated protein
oxidation also can be inhibited by injections of AO to reduce Aβ production.
Our laboratory has proposed a model for neurodegeneration in AD brains based
on free radical oxidative stress associated with Aβ (1-42) (Varadarajan et al., 2000;
Butterfield et al., 2002c; Butterfield and Lauderback, 2002). This model predicts that
chemistry associated with the single methionine residue of Aβ(1-42) [Met-35] would
induce lipid peroxidation and protein oxidation in neuronal membranes. The role of Met35 as a mediator of the toxicity of Aβ is most likely to involve an oxidative event at the
sulfur atom (Yatin et al., 1999b; Kanski et al., 2002a; Kanski et al., 2002b). However, the
event that initiates the oxidation of Met-35 is not yet clear. It could involve one or more
of the several reactive oxygen species present in biological systems (Varadarajan et al.,
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2001) or redox metal ions (Curtain et al., 2001; Barnham et al., 2003). Since the structure
of Aβ from position 28 to position 42 is helical (Coles et al., 1998; Shao et al., 1999), the
backbone oxygen atom of Ile-31 is within a van der Waals distance of the sulfur atom of
Met-35. Such an interaction could increase the susceptibility for oxidation of the sulfur
atoms of Met-35 in Aβ, leading to sulfuramyl free radicals (Varadarajan et al., 2001;
Kanski et al., 2002a). APP in SAMP8 mice has 89.2% homology to the human protein.
The amino sequence of Aβ in SAMP8 mice is highly similar to that of humans with the
exception of glycine replacing arginine at position 5, phenylalanine instead of tyrosine at
position 10, and arginine instead of histidine at position 13 (Kumar et al., 2001). The
critical Met-35 and Ile-31 remain present in Aβ of SAMP8 mice. Therefore, it is
reasonable that the 12mR mouse brains suffer higher oxidative stress than the 4m mouse
brains. In the case of 12m mouse brains, APP expression was decreased by AO
treatments (Kumar et al., 2000b). Thus, there is less Aβ present in brain to induce
oxidative insults. The current study suggests that decreased Aβ production contributed to
the decreased protein oxidation and lipid peroxidation in 12m mouse brains. Reduction of
protein oxidation and lipid peroxidation conceivably could alleviate the mitochondrial
dysfunction, redox metal imbalance, advanced glycation end-products, and excitotoxicity
that interact with, and are exacerbated by, Aβ (Butterfield et al., 2001b). Thus, this
approach, which improves the learning and memory impairment observed in 12m old
SAMP8 mice (Kumar et al., 2000b), points to the importance of Aβ in oxidative stress in
this mouse strain, and presumably in AD patients as well.
In previous chapters, we have shown that oxidative stress is closely related to
learning ability and memory retention in SAMP8 mice (Farr et al., 2003). It was also
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demonstrated that using AO against the Aβ region of APP to lower Aβ production could
improve learning and memory in SAMP8 mice (Kumar et al., 2000b). In the current
study, we extended the previous research and investigated the role of Aβ in oxidative
stress associated with learning and memory impairment. Lesion studies in other animals
have shown that spatial learning is dependent on the integrity of the septohippocampal
pathway (O'Keefe, 1978; Farr et al., 2000). Although Aβ may not directly inhibit cellular
function, Aβ-mediated oxidative stress in the form of lipid peroxidation may do so
(Butterfield et al., 2001b; Butterfield et al., 2002c). It is possible that Aβ–mediated free
radicals, possibly through the effects of the lipid peroxidation product HNE and acrolein,
react with enzymes, receptors, and neurotransmitters (such as norepinephrine or
dopamine), thereby disrupting the function of the septohippocampal pathway. As a result,
the functioning of the whole septohippocampal pathway would be decreased.
Pharmacological studies have shown that the memory defects in SAMP8 mice are
dependent on the septohippocampal pathway (Flood et al., 1998).
Therefore, injecting AO directed to the Aβ region of APP in 12 month old
SAMP8 mice can alleviate the Aβ-mediated oxidative stress, improving the learning
ability and memory retention, as reported by (Kumar et al., 2000b) and (Banks et al.,
2001). This study further indicate that the important role of oxidative stress in learning
and memory deficit in aged SAMP8 mice.
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CHAPTER NINE
Proteomic Identification of Less Oxidized Brain Proteins in Aged Senescence
Accelerated Mice Following Administration of Antisense Oligonucleotide Directed
at the Aβ Region of Amyloid Precursor Protein
9.1 Introduction
Senile plaques, neurofribillary tangles (NFTs) and synapse loss are three
pathological features of Alzheimer’s disease (AD) (Braak and Braak, 1990; Delacourte et
al., 2002). Senile plaques contain extracellular deposits of amyloid-β peptides (Aβ) in
star-shaped masses of amyloid fibrils, and NFTs are composed of the microtubuleassociated protein tau (Brion et al., 1985; Grundke-Iqbal et al., 1986; Kosik et al., 1986;
Nukina and Ihara, 1986; Wood et al., 1986). There is growing evidence that the formation
of NFTs in AD is one of the neuronal responses to the accumulation of Aβ and Aβassociated stress (Selkoe, 2001). Aβ is released from cells under entirely normal cellular
conditions (Haass et al., 1992; Seubert et al., 1992; Busciglio et al., 1993; Sherrington et
al., 1995) during the internalization and endosomal processing of APP (Koo and
Squazzo, 1994; Perez et al., 1999). However, accumulation of Aβ can induce
neurotoxicity by binding to the nicotinic acetylcholine receptor (Wang et al., 2000),
forming calcium and potassium channels in cell membranes (Arispe et al., 1993;
Etcheberrigaray et al., 1994; Engstrom et al., 1995), decreasing glucose transport across
brain endothelial cells (Blanc et al., 1997), and actuating the release of chemokines (Fiala
et al., 1998) and cytokines(Akama and Van Eldik, 2000). Moreover, Aβ can induce
oxidative damage directly to cells through its ability to produce free-radicals (Butterfield
et al., 1994; Varadarajan et al., 2000; Butterfield et al., 2001b; Butterfield et al., 2002c;
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Butterfield and Kanski, 2002; Butterfield and Lauderback, 2002). Aβ-mediated oxidative
stress also includes the production of O2.-

through the stimulation of NADPH oxidase

(Hurst and Barrette, 1989); the production of H2O2 through copper or iron reduction; and
the production of nitric oxide (NO) production in macrophages in a microglial cell line
(Meda et al., 1995). These Aβ mediated reactive oxygen species (ROS) can further
oxidatively modify proteins, lipids and DNA to enact damages in cells.
When Aβ is administrated exogenously, it causes deficits in learning and memory
in animals (Flood et al., 1991, 1994; Cleary et al., 1995; Sisodia and Gallagher, 1998;
Tanaka et al., 1998; Yamada et al., 1998; Chen and Fernandez, 1999). Such learning and
memory impairments are also observed in overexpressed Aβ transgenic models (Hsiao et
al., 1996) and the senescence accelerated mice prone 8 (SAMP8) mice (Flood and
Morley, 1992, 1993; Flood et al., 1993; Flood et al., 1995; Nomura et al., 1996; Flood
and Morley, 1998; Farr et al., 2003). Aged SAMP8 mice show impaired age-dependent
defects of learning and memory (Flood and Morley, 1993), along with Aβ-like-protein
immunoreactive granular structures in their central nervous system (CNS) (Takemura et
al., 1993). Brains of SAMP8 mice also show spheroidal axonal dystrophy in dorsal
column nuclei, small neurons in gracile nucleus, and some well-defined or swollen axons
(Kawamata et al., 1998). Age-related shrinkages of the cholinergic neurons of the
laterodorsal tegmental nucleus are observed in aged SAMP8 mice brains (Kawamata et
al., 1998), indicating abnormal axonal transport, synaptic terminal remodeling, and/or
actin polymerization/depolymerization occur in SAMP8 mice brains.
In last chapter, we showed that decreasing the production of Aβ by giving an
intracerebroventricular injection of a 42 mer phosphorothiolated AO directed at the Aβ
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region of the APP gene can reduce lipid peroxidation, protein oxidation (Poon et al.,
2004c) and improve cognitive deficits (Kumar et al., 2000b) in aged SAMP8 mice. In
order to investigate how Aβ level reduction improves learning and memory performance
of SAMP8 mice through reduction of oxidative stress in brains, we used proteomics to
identify the proteins that are less oxidized, as well as the proteins that are expressed
differently, in 12-month-old SAMP8 mice brains treated with AO against the Aβ region
of APP (12mA) compared to brain from age-controlled SAMP8 mice treated with
random AO (12mR)., an AO that show no protective effect against protein oxidation.
9.2 Experimental Procedures
9.2.1 Rodent Subjects
The rodent subjects used is described in 4.2.1
9.2.2 Antisense administration
The antisense administration was prveously described in Section 8.2.3
9.2.3 Sample Preparation
Sample preparation is the same as Section 5.2.2
9.2.4 Two-dimensional electrophoresis
2D electrophoresis is similar to Section 5.2.3 with minor modification. After 2D
electrophoresis separation, The gel was incubated in fixing solution (7% acetic acid, 40%
methanol) for 20 min after the second dimension electrophoresis. Approximately, 60 mL
of Sypro Ruby stain (Bio-Rad, Hercules, CA) were used to stain the gel for 2 hours. The
gels were destained in deionized water overnight.
9.2.5 Western Blotting
Western blotting is the same as Section 5.2.4
9.2.6 Image Analysis
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Image analysis performed was similar to Section 5.2.5 with minor modification,
The gels and nitrocellulose papers were scanned and saved in TIF format using Strom
860 Scan (Molecular Dynamics, Sunnyvale, CA) and Scanjet 3300C (Hewlett Packard)
respectively. PDQuest 2D analysis software (Bio-Rad, Hercules, CA) was used for
matching and analysis of visualized protein spots among differential gels and oxyblots.
Average mode of background subtraction was used to normalize intensity value, which
represents the amount of protein (total protein on gel and oxidized protein on oxyblot per
spot). After completion of spot matching, the normalized intensity of each protein spot
from individual gels (or oxyblots) was compared between the aged SAMP8 mice (n=7)
and the aged SAMP8 mice treated with AO (n=7) using Student’s t test statistical
analysis.

9.2.7 Trypsin digestion
Trypsin digestion is the same as Section 5.2.6
9.2.8 Mass Spectrometry
Mass spectrometry was similar to Section 5.2.7 with minor modification.
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10
mg/mL in 0.1% TFA:ACN, 1:1, v/v). The mixture (1 μL) was deposited onto a fast
evaporation nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and
analyzed with a TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in
reflectron mode. The mass axis was adjusted with trypsin autohydrolysis peaks (m/z
2239.14, 2211.10, or 842.51) as lock masses.
9.2.9 Statistics
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Statistical analysis is the same as Section 5.2.8
9.3 Results
The specific carbonyl level, obtained by dividing the carbonyl level of a protein
spot on the nitrocellulose membrane by the protein level of its corresponding protein spot
on the gel, indicates the carbonyl level per unit of protein. 144 proteins on 2D gels and
2D Western blots are matched between 12mR SAMP8 and 12mA SAMP8. In
comparison to 12mR SAMP8 mice, 12mA SAMP8 mice brains have two proteins that are
expressed differently in terms of protein levels, and three proteins that have significantly
lower specific carbonyl levels. The identified proteins are listed in Table 9.1. All the
mass spectra (not shown) of the peptides were matched to the mass spectra in MSDB
protein databases with reported probability-based Mowse score. All protein
identifications agree with the expected MrW and pI range based on their positions on the
gels.
9.3.1 Protein expression levels
Fig. 9.1 shows the representative gel of the whole brain homogenate from 12mR
and 12mA-treated SAMP8 mice. The proteins that were expressed differently in SAMP8
brains are summarized in Table 9.2. The expression level of α-ATP synthase (Atp5a1)
was significantly decreased, whereas the expression of profilin 2 (Pro-2) was
significantly increased in brain from12-month-old SAMP8 mice treated with AO.
9.3.2 Specific Protein carbonyl level
Fig. 9.2 shows the representative Western blots of 12mR and 12mA SAMP8 mice
brains. The summary of the specific protein carbonyl levels is given in Table 9.3. The
specific protein carbonyl levels of aldoase 3(Aldo3), coronin 1a (Coro1a) and
peroxiredoxin 2 (Prdx2) were significantly decreased in the brain of 12mA SAMP8.
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Table 9.1: Summary of proteins identified by mass spectrometry
Databse
# Peptide
accession matches
code
Identified
PRO2_MO
6
USE

% Coverage
matched
peptides

pI, MrW

Mowse
Score

38

6.78, 14.9

68

gi|6680748 14

26

9.22, 59.7

123

Aldo3 protein

gi|13435924 8

25

6.47, 39.3

87

Peroxiredoxin 2

Q9CWJ4

34

5.70, 21.8

74

16

6.05, 51.0

94

Identified Protein
Profilin 2
ATP synthase alpha
subunit, isoform 1

7

Coronin, actin binding
gi|31418362 10
protein 1A

Mowse scores greater than 62 are considered significant (p<0.05).
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Table 9.2: Proteins expressed differently when 12-month old SAMP8
mice are injected with AO compared to non-treated 12-month old
SAMP8 mice
Identified Proteins

Protein levels of 12-month-old
SAMP8 injected with AOa

p-value

alpha-ATP synthase

54.5±11.2

< 0.05

profilin 2

139± 7.8

< 0.05

a

Percent of the level found in brain from 12mR-treated SAMP8 mice
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Table 9.3: Proteins that have specific carbonyl level decreased by AO
Specific protein carbonyl
Identified Proteins

levels of 12-month-old

p-value

SAMP8 injected with AO
Aldo 3

9.4±0.3

<0.000001

Coronin1A

46.4± 16.3

< 0.005

Peroxiredoxin 2

26.8±12

< 0.005

a

Percent of the level found in brain from 12mR-treated SAMP8 mice
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Figure 9.1
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Figure 9.2

186

Figure 9.3
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9.4 Discussion
We showed that AO was successfully internalized by neurons and reduced the
level of Aβ, thus reducing Aβ-mediated protein oxidation and lipid peroxidation in 12mA
SAMP8 mice brains in the last chapeter (Poon et al., 2004c). Here we show that the
specific carbonyl levels of Aldo3, Coro2 and Prdx2 in the 12mA SAMP8 mice brains are
significantly decreased when compared to those in the 12mR SAMP8 mice. We also find
that the protein levels of Pro-2 and Atp5a1 in brains of 12mA SAMP8 mice are
significantly altered when compared to 12mR SAMP8 mice brains. In our previous study,
we found that the specific carbonyl level of Aldo3, Coro1a and Prdx2 were increased
(486%, 599% and 223% respectively) in 12-month-old SAMP8 mice brains when
comparing to that in the 4-month-old SAMP8 mice brains (chapter 3). However, these
increases of the specific carbonyl levels are not statistically significant, thus were not
reported in the previous study (Poon et al., 2005b).
Coro1a is an actin binding proteins (de Hostos et al., 1991) which promotes rapid
actin polymerization by reducing the lag phase of actin polymerization. Coro1a level in
fetal Down’s syndrome (DS) brain is reduced, indicating that it plays role in migration of
cells and /or neuronal outgrowth (Weitzdoerfer et al., 2002). Therefore, oxidative
inactivation of Coro1a might contribute to the neuronal shrinkage observed in SAMP8
mice brains, thus leading to learning and memory impairment similar to DS patients.
Here, we show that the specific carbonyl level of Coro1a was reduced with the treatment
of AO to reduce Aβ level in SAMP8 mice brains, suggesting the oxidative inactivation of
Coro1a was possibly recovered. Thus the normal neuronal outgrowth dynamic and
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neuronal functions presumably were reestablished by the AO treatment in SAMP8 mice
brains.
Aldo3 is a brain specific glycolytic enzyme. Reduced activity of Aldo3 was
reported in aged rats, suggesting oxidative modification may be responsible for Aldo3
activity decline in aged animals (Leong et al., 1981). Moreover, Aldo3 interacts with
dihydropyrimidinase-like 2 (DRP-2) in the complex of NADH-dichorophen-indophenol
(DCIP) reductase to response to the external oxidative stress and/or antioxidants (Bulliard
et al., 1997). Here, we show that specific carbonyl level of Aldo3 was significantly
reduced in 12mA SAMP8 mice by i.c.v. injection of AO when compared to that in 12mR
mice brains, which should partially restore the impaired metabolic pathway, increase
ATP production for antioxidant defensive systems and synaptic elements in neurons of
SAMP8 mice brains.
Prdx2 is an antioxidant enzyme that is exclusively expressed in neurons. (Sarafian
et al., 1999). Since Prdx2 modulates intracellular H2O2 production and H2O2 mediated
apoptosis (Kim et al., 2000), it is possible that Prdx2 is responsible for the elimination of
Aβ-mediated H2O2 production in neurons. The increased expression of Prdx2 in AD,
Down’s syndrome and PD (Kim et al., 2001; Krapfenbauer et al., 2003) is likely to be in
response to the increased oxidative stress and/or its activity loss due to oxidative
modification. Therefore, reducing Aβ level in SAMP8 mice brain by i.c.v. injection of
AO can reduce the H2O2 production and therefore reduce the specific carbonyl level of
Prdx2, suggesting more active Prdx2 are available in neurons to strengthen its antioxidant
system. This may result in improving the biological function of neurons in aged SAMP8
mice, and contribute to the improvement in learning and memory.
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Pro-2, expressed in neuronal cells, is an isoform of the profilin family. Profilin
binds to monomeric actin to prevent the abnormal polymerization of action into
filaments. Pro-2 also promotes actin polymerization (Pollard and Borisy, 2003). The
expression of profilin is regulated by oxidative stress instead of protein kinase C
(Clarkson et al., 2002), and down regulation of profilin is also observed in oxidativestressed conditions, i.e. hypoxia (Vorum et al., 2004). Profilin is reported as a
glutathionylated protein in oxidatively stressed cell lines (Fratelli et al., 2002; Fratelli et
al., 2003), suggesting that glutathionylation might be a common mechanism for the
global regulation of profilin functions. Our current study shows that the Pro-2 expression
is increased in the brain of SAMP8 mice treated with AO, indicating that the neuronal
outgrowth dynamic by actin is restored, which in turn possibly secures neuronal junction
and improves learning and memory in SAMP8 mice.
Atp5a1 is a member of the F1 synthase enzymatic complex that binds ADP,
phosphate and ATP for the synthesis of ATP during oxidative phosphorylation. Atp5a1 is
inner mitochondrial membrane protein. However, localization and accumulation of
Atp5a1 in cytosol are demonstrated in the degenerated neurons of AD patients (Sergeant
et al., 2003) and level of Atp5a1 are post-transcriptionally increased as a function of age
in the cerebral cortex of rats (Nicoletti et al., 1995; Nicoletti et al., 1998), suggesting that
the oxidative modification of Atp5a1 causes it to accumulate in cytosol, thereby
mediating mitochondrial dysfunction. Moreover, cytosolic Atp5a1 binds to the plasmin
precursor, plasmininogen, which directly decreases the level of the Aβ degrading protein,
plasmin (Tucker et al., 2000). Therefore, decreased level of Atp5a1 causes decreased
plasmininogen and increased plasmin, thereby enhancing the Aβ reduction effect of AO.
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Our current study shows the cytosolic Atp5a1 level is decreased by AO injections,
suggesting less ATP synthases are released by mitochondria. This could restore the
oxidative phosphorylation for ATP production and increase the level of plasmin for
further reduction of Aβ level. Consistent with this notion, Aβ levels are decreased
dramatically by 40% in brain from AO treated SAMP8 mice (Poon et al., 2004c).
Examination of the functional interacteome by interaction explorer ™ Pathway
Module indicating that all the protein altered by AO treatment directly or indirectly
interacts with actin through the interaction of NFκB or the antioxidant systems. Actin
polymerization/depolymerization plays an important role in synaptic plasticity and
memory consolidation (Fischer et al., 1998; Matus, 2000; Lamprecht and LeDoux, 2004),
and disruption of the actin polymerization results in growth cone collapse (Meberg and
Bamburg, 2000). Synapse loss is one of the neuropathological features in the brains of
patients with AD (Bertoni-Freddari et al., 1992; Brown et al., 1998), and neuronal
shrinkage in SAMP8 brain is also observed (Kawamata et al., 1998), suggesting actin
polymerization in AD brains as well as SAMP8 mice brain are disrupted. The disruption
of actin polymerization is possibly due to accumulation of Aβ through activating p38
mitogen-activated protein kinase and increasing intracellular calcium level (Furukawa
and Mattson, 1995; Song et al., 2002). Since these processes are both associated with
oxidative stress (reviewed in (Floyd, 1999; Annunziato et al., 2003; Torres and Forman,
2003)). Therefore, our study showed that decreased Aβ level can reduce Aβ-mediated
oxidative stress by improving the antioxidant. Aβ reduction potentially also decreased the
inflammation brought about by NFκB. These changes sequentially improve the action
polymerization, thereby cognitive improvement. Moreover, our study show that the
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changes of antioxidant system, NFκB and action dynamics are brought about by
alteration of specific carbonyl level or expression of Aldo3, Prdx2, Coro2, Pro2 and
Atp5a1 in aged SAMP8 mice brains. Consistent with others (Furukawa and Mattson,
1995; Song et al., 2002), our study suggests that agents that can improve the dynamics of
actin polymerization may be beneficial for AD.
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CAHPTER TEN
Quantitative Proteomics Analysis of Specific Protein Expression and Oxidative
Modification in Aged Mice Brain – Insight into the Mechanism of Compensation of
Activity Lost by Oxidative Modification
10.1 Introduction
Oxidative stress is one of the most important mediators in the progressive decline
of cellular function during aging. In the brain, free radical-mediated oxidative stress plays
a critical role in the age-related decline of cellular function as a result of the oxidation of
nucleic acids, lipids, and proteins, which alters the structure and function of these
macromolecules (Beckman and Ames, 1998; Poon et al., 2004b). A number of studies
indicate a strong role for increases in protein oxidation as a primary cause of cellular
dysfunction observed during aging as well as in age-related neurodegenerative diseases
(Stadtman, 1992; Butterfield and Stadtman, 1997; Butterfield and Lauderback, 2002).
The brain is susceptible to oxidative stress because of its high content of
peroxidizable unsaturated fatty acids, high oxygen consumption per unit weight, high
levels of free radical-inducing iron/ascorbate, and relatively low levels of antioxidant
defense systems (Floyd, 1999; Poon et al., 2004a, b). In most cases, the oxidation of
proteins, including those involved in biosynthesis, energy production, cytoskeletal
dynamics, and signal transduction, leads to their dysfunction (Butterfield and Stadtman,
1997). Although protein oxidation contributes to this functional decline, not all proteins
are oxidized: many enzymes preserve their activity during aging, suggesting that specific
proteins are targets of oxidative modification during aging and in age-related
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neurodegenerative disorders (Stadtman, 1992; Butterfield et al., 2003; Keller et al., 2004;
Poon et al., 2004d).
In the previous studies, we investigated the role of oxidative stress in brain aging
using SAMP8 mice, an accelerated aging model with cognitive decline. In order to fully
understand the mechanism of age-related cognitive decline, we hypothesis that the
oxidized protein profiles in the brain of normal aging mice model is different from that in
SAMP8 mice. To investigate our hypotheis, we have used proteomics to compare protein
expression levels and the oxidation of specific proteins, as assessed by elevated protein
carbonyl levels, in the brains of old vs. young C C57BL/6 mice mice (a commonly used
normal aging mice model), and to identify the differentially expressed and oxidized
proteins.
10.2 Experimental Procedures
10.2.1. Rodent Subjects
A total of ten C57BL/6 male mice were obtained from Harlan, USA; five, from
the National Institute on Aging Aged Rodent Colonies, were 80 weeks old (the “old”
cohort), and five were 6 weeks old (the “young” cohort). It should be noted that at 6
weeks of age, mice are sexually mature, so “young adult” could be equally used to
describe these mice. All 10 mice were maintained in an animal facility at the Department
of Laboratory Animal Research on a 12 hr light:dark cycle in Bioclean units with sterilefiltered air and provided food and water ad libitum. All protocols were implemented in
accordance with NIH guidelines and approved by the University of Kentucky
Institutional Animal Care and Use Committee. The body weights of the old mice ranged
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from 32 to 35 g and of the young mice from 19 to 24 g. Following euthanasia with CO2,
the brain was removed quickly, weighed and snap frozen in liquid N2 prior to analysis.
10.2.2 Sample Preparation
Sample preparation is the same as Section 5.2.2
10.2.4 Two-dimensional electrophoresis
2D electrophoresis is the same as Section 5.2.3
10.2.5 Western Blotting
Western blotting is the same as Section 5.2.4
10.2.6 Image Analysis
Image analysis is the same as Section 5.2.5
10.2.7 Trypsin digestion
Trypsin digestion is the same as Section 5.2.6
10.2.8 Mass Spectrometry
Mass spectrometry is the same as Section 5.2.7
10.2.9 Immunochemical Detection of Lactate Dehydrogenase (LDH2), Glutamine
Synthase (GS) and Dynamin-1 (DNM1)
The levels of lactate dehydrogenase 2 (LDH2) and glutamine synthase (GS) were
measured by the Slot Blot® technique described previously (Poon et al., 2004c). Briefly,
1 μg of protein was loaded into the slots. The proteins were detected on nitrocellulose
paper using a primary rabbit anti-LDH antibody (1:100, Chemicon, Temecula, CA) or
mouse anti-GS antibody (1:1000, Chemicon,) followed by an alkaline phosphataseconjugated secondary anti-rabbit or anti-mouse IgG antibody (Sigma, St. Louis, MO),
respectively. Antibody binding was visualized by application of 5-bromo-4-chloro-3-
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indolyl

phosphate/nitro

blue

tetrazolium

(BCIP/NBT;Sigma-Fast)

followed

by

densitometric measurement using the Scion-Image software package (Scion, Frederick,
MD).
For quantification of dynamin-1 (DNM1) levels, 50 μg of protein from five
individual mice in the young and old cohorts (total of ten) were resolved by SDS-PAGE
and transferred onto nitrocellulose paper. DNM1 was detected by a mouse anti-DNM1
primary antibody (Chemicon) and an alkaline phosphatase-conjugated anti-mouse IgG
secondary antibody (Sigma). The bands were developed by BCIP/NBT and quantified by
densitometric measurement as described above.
10.2.10 Enzyme Activity Assay
Lactate dehydrogenase activity was determined by the method previously
described (Stambaugh and Post, 1966). Briefly, the assay was performed in 100 μL Tris
buffer (0.2M Tris.HCl, 30mM sodium pyruvate, 6.6mM NADH, pH 7.3). The reaction
was initiated by adding 5 µL of the brain protein samples (2mg/mL). Lactate
dehydrogenase activity was measured as the reduction of NADH to NAD+. A decrease in
absorbance at 340 nm was recorded as the change in A340 min-1 by using a PowerWaveX®
microtiter plate reader spectrophotometer (Bio-Tek Instruments, Winooki, VT). GS
activity was determined by the method of Rowe et al. (Rowe et al., 1970) as modified by
Miller et al. [29]. The absorbance was recorded at 505 nm as described above.
10.2.11 Immunochemical Detection of Total Protein Carbonyl Level, β-Actin
(ACTB) CarbonylLevel and Neurofilament 66 (NF-66) Carbonyl Level.
Slot blots and Western blots were used to detect the level of total protein
oxidation in the brains of young and old mice as previously described (Poon et al.,
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2004c). Briefly, total protein in the homogenates from the brains of the five young and
five old mice was derivatized by 10mM DNPH. For slot blot detection of carbonyl levels,
250 ng of 2,4-dinitrophenyl hydrazone (DNP)-protein adducts were loaded into each slot.
For Western blot carbonyl detection, 30 μg of DNP-protein adducts from each animal
were resolved on SDS-PAGE gels. The technique for the immunochemical detection of
the DNP-protein adducts was the same for both methods and was described previously
(Poon et al., 2004c). The quantification of the DNP-protein adducts determined by slot
blots was as described above. The quantification of the DNP-protein adducts resolved by
Western blotting was by densitometric measurement of the immunoreactivity in the entire
lane on the nitrocellulose paper.
The method used for the detection of β-actin (ACTB) carbonyl levels was similar
to that for total protein carbonyl level detection described above. The quantification of
the DNP-actin adduct was by densitometric measurement of the bands at 40 kDa where
actin is predominately present.
Neurofilament 66 (NF-66) was derivatized by DNPH for carbonyl detection as
described above. The carbonyl levels of NF-66 were detected by Western blot after
immunoprecipitation (IP). IP was performed as described previously (Lauderback et al.,
2001). A mouse anti-NF-66 antibody (5 µL, Chemicon) was added directly to the brain
homogenate, and the mixture was incubated on a rotary mixer overnight at 4°C. The NF66/antibody complexes were precipitated with protein G-conjugated agarose beads.
Protein G beads were added in 50 µL aliquots from a stock of 300 mg/mL in PBS and
mixed on a rotary mixer for 1 hour at room temperature. Beads were then centrifuged and
washed with the washing buffer (pH 8, 50mM Tris HCl, 150 mM NaCl, 0.1% Tween 20)
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three times. The NF-66 proteins from each animal were resolved by SDS-PAGE and
transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA). The method used for
the detection and quantification of NF-66 carbonyl levels was similar to that for total
protein carbonyl level detection described above.
10.2.12 Statistics
Statistical analysis is the same as Section 5.2.8

10.3 Results
To assess whether there were any changes in the proteomic profile in the brains of
aging mice, we first assayed the differential expression of proteins in the brains of young
and old mice. We found that the expression level of 7 proteins was significantly altered (4
proteins showed increased expression and 3 protein showed decreased expression); and
the specific carbonyl levels of 4 proteins are significantly increased in the old mice.
Comparing the densitometric intensities of individual spots on the gels, we
determined that 4 proteins were expressed at significantly higher levels, and 3 proteins
were expressed at significantly lower levels in the brains of the old compared to young
mice. Fig. 10.1 shows representative gels from the brains of a young and old mouse after
2D-electrophoresis. To identify the differentially expressed proteins, the mass spectra of
the peptides were matched to the mass spectra in NCBI protein databases. The four
proteins that were up-regulated in the brains of the old mice were identified with Moswe
scores > 62; they were dihydropyrimidinase-like 2 (DRP2), α-enolase (ENO1), dynamin1 (DNM1), and lactate dehydrogenase 2 (LDH2). An example of the mass spectrum for
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LDH2, which was significantly up-regulated in the brains of old mice, is shown in Fig.
10.2A (top), and the results of the database search are shown in Fig. 10.2A (bottom). The
parameters for the identification of these proteins by mass spectrometry are summarized
in Table 10.1; all protein identifications agreed with the expected MrW and pI range
based on their positions on the gels. The quantitative details of their relative expression
levels in old vs. young mice are summarized in Table 10.2. None of the down-regulated
proteins were identified with a Mowse score > 62.
We then investigated total protein oxidation levels and the oxidation of specific
proteins in the brains of the old vs. young mice. The total level of oxidized proteins as
determined by slot blots and Western blots was significantly higher (by approximately
30-40%) in the brains of the old vs. young mice (Fig. 10.3).

Comparing the

densitometric intensities of individual spots on the oxyblots, we determined that four
proteins had significantly higher specific carbonyl levels in the brains of old mice
compared to young. Fig. 10.4 shows representative oxyblots from the brains of a young
and an old mouse. The significantly oxidized proteins were identified by matching their
mass spectra to those in the NCBI protein databases as described above. The four
oxidized proteins were identified; they are β-actin (ACTB), glutamine synthase (GS),
neurofilament 66 (NF-66), and an unnamed protein. An example of the mass spectrum
for GS is shown in Fig. 10.2B (top), and the results of the database search for GS are
shown in Fig. 10.2B (bottom). The parameters for the identification of the oxidized
proteins by mass spectrometry are summarized in Table 10.3; these protein identifications
agreed with the expected MrW and pI range based on their positions on the blots. The
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quantitative details of their relative specific carbonyl levels in old vs. young mice are
summarized in Table 10.4.
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Table 10.1. Mass spectrometry identification of proteins up-regulated in the brains
of old vs. young mice
Protein

# Peptide
GI accession
matches
#
Identified

% Coverage
matched
peptides

pI, MrW

Mowse
Score*

gi|40254595 14

35

6.16, 62.16

776

gi|19353272 17

47

6.37, 47.5

166

gi|21961254 22

24

7.61, 98.1

155

gi|28386162 13

40

5.87, 36.6

120

dihydropyrimidinase-like 2
(DRP2)
α-enolase
(ENO1)
dynamin-1
( DNM1)
lactate dehydrogenase 2
(LDH2)
* Mowse scores greater than 62 are considered significant.
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Table 10.2. Identified proteins up-regulated in the brains of old vs. young mice

Protein

DRP2

Young

Old

(A.U. ± SEM)

(A.U. ± SEM)

(n = 5)

(n = 5)

545 ± 175

1327 ± 221

2.4

0.024

1761 ± 202

2589 ± 259

1.5

0.036

740 ± 142

1135 ± 92

1.5

0.048

1489 ± 372

3770 ± 286

2.5

0.0012

Fold increase in
old

p-value

ENO1

DNM1

LDH2
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Table 10.3. Mass spectrometry identification of oxidized proteins in the brains of old vs. young
mice
% Coverage
Protein

GI accession # Peptide
matches
#
Identified

Mowse
matched

pI, MrW

Score*

peptides
β-actin
gi|49868

13

49

5.78, 39.4

121

gi|15929291 11

26

6.64, 42.8,

93

gi|609535

37

5.49, 55.5

71

12

N/A

66

(ACTB)
glutamine synthase
(GS)
neurofilament 66
18

(NF-66)
unnamed protein

gi|38089221 9

* Mowse scores greater than 62 are considered significant.

203

Table 10.4. Identified proteins oxidized in the brains of old vs. young
mice

Protein

ACTB

GS

Young

Old

Fold increase

(A.U. ± SEM)

(A.U. ± SEM)

in old

1.25 ± 0.20

3.03 ± 0.68

3.4

0.035

2.4 ± 0.56

12.0 ± 2.89

5.2

0.011

0.70 ± 0.21

3.52 ± 1.18

7.2

0.046

0.59 ± 0.196

31.7 ± 13.3

68

0.048

p-value

NF-66

unnamed protein
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Figure 10.1
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Figure 10.2
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Figure 10.3
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Figure 10.4
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We hypothesized that oxidative modification of specific enzymes would decrease
their activity but that the activity of enzymes whose expression level was up-regulated
would not necessarily be changed. To test this, we measured the activities of GS, which
was oxidized in the brains of the old mice, and lactate dehydrogenase, the LDH2 subunit
of which was expressed at a higher level in the brains of the old mice. First, using
immunochemical analysis (Fig. 10.5A), we validated the proteomic results that indicated
that the level of expression of GS was unchanged and that of LDH2 was up-regulated by
about 20%. In support of our hypothesis, Fig 10.5B shows that the activity of GS in the
brains of old mice was significantly lower (by about 20%) than in the brains of young
mice. In contrast, lactate dehydrogenase activity in the brains of old mice showed no
significant difference relative to that in the brains of the young mice. Because the
expression level of LDH2 increased, this suggests that there is a relatively lower activity
per unit of lactate dehydrogenase enzymatic activity in the brains of the old mice.
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Figure 10.5
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We validated our proteomics results for 3 additional proteins. With
immunochemical detection, we demonstrated that the level of expression of DNM1 in the
brains of old mice was significantly increased by 57% (Fig 10.6), which is in close
agreement with the results of the proteomics analysis (Table 10.2). We also measured the
carbonyl levels of NF-66 and ACTB by IP (NF-66) and Western blotting. Consistent with
the proteomics results, the carbonyl levels of ACTB (Fig. 10.7) and NF-66 (Fig. 10.8)
were significantly increased by about 40% and 50%, respectively, in the brains of the old
mice as compared to young. The increased carbonyl level of ACTB and NF-66 in the
brains of old mice was more robust when detected by proteomics method. The
differences in the magnitude of fold changes of carbonyl levels between the two
techniques is likely due to the fact that proteomics measures the carbonyl level per unit of
protein while Western blotting measures the carbonyl level of total protein. Clearly, both
techniques show that ACTB and NF-66 are significantly oxidatively modified in the
brains of old mice, thus validating the proteomics results.
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Figure 10.6
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Figure 10.7
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Figure 10.8
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10.4 Discussion
Our aim in this study was to identify differentially expressed and oxidized
proteins in the normally aging murine brain. Using the proteomics approach previously
utilized in our laboratories (Castegna et al., 2002b; Castegna et al., 2002a; Poon et al.,
2004d; Poon et al., 2005b; Poon et al., 2005a), we determined that the expression levels
of DRP2, ENO1, DNM1 and LDH2 were significantly increased in the brains of old mice
when compared to the brains of young mice. Additionally, the expression levels of 3
proteins were significantly decreased, but these proteins could not be identified because
their mass spectra did not match any in the databases with a significant Mowse score.
Further, we show that the total level of protein oxidation increased in the brains of old
mice when compared to young, and that the specific carbonyl levels of ACTB, GS, NF66 and an unnamed protein were significantly increased in the brains of old mice.
Selected results were validated using immunochemistry. Additionally, we demonstrated
that for GS, which was oxidized but not expressed at significantly different levels in the
brains of old vs. young mice, oxidation reduced enzyme activity; in contrast, for LDH,
whose expression level was up-regulated in the brains of old mice, enzyme activity was
unchanged.
DRP2, one of the four proteins whose expression was up-regulated in the brains
of old vs. young mice, is a member of the dihydropyrimidinase-related protein family.
These proteins are involved in axonal outgrowth and path-finding through the
transmission and modulation of extracellular signals. It was reported that DRP2 induced
growth cone collapse by Rho-kinase phosphorylation (Arimura et al., 2000) and by
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binding to tubulin (Fukata et al., 2002). Decreased expression of DRP2 has been
observed in AD, Down syndrome (Lubec et al., 1999), schizophrenia, and affective
disorders (Johnston-Wilson et al., 2000), and DRP2 is oxidized in brains from AD
patients (Castegna et al., 2002a). The increased expression of DRP2 in brains from old
vs. young animals may indicate that neuronal sprouting is being positively regulated as a
compensatory response to neuronal dysfunction in the aged brain.
Another of the up-regulated proteins, ENO1, is the α-subunit of enolase; the αγ
isoform is a neuron-specific enolase. We recently reported that ENO1 is up-regulated in
the olfactory bulbs (OBs) of old mice as well (Poon et al., 2005b). Enolase is a cytosolic
enzyme involved in metabolism, cell differentiation, and normal growth; a decline of
enolase activity results in abnormal growth and reduced metabolism in brains (Tholey et
al., 1982). Increased ENO1 oxidation in the brains of AD patients suggests that the loss
of activity by oxidative modification of ENO1 may lead to neurodegeneration (Castegna
et al., 2002a; Poon et al., 2004d), emphasizing the importance of this glycolytic enzyme
in brain metabolism. The increased levels of ENO1 in the brains of old mice may indicate
a compensatory response to decreased activity in other metabolic and mitochondrial
pathways in the brains of old mice and a protective response against neurodegeneration.
Our proteomics analysis, validated with immunochemistry, demonstrated that
DNM1 increased in abundance in the brains of old vs. young mice. Among its functions,
DNM1 is known to inhibit phosphatidylinositol 3-kinase (PI3K), a survival signaling
molecule that acts via its effector, Akt (Harrison-Findik et al., 2001). Thus, through its
inhibition of PI3K, DNM1 up-regulation may cause increased cell death in the brains of
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old mice. Alternatively, the formation of complexes between DNM1 and the actinbinding protein profilin at sites of synaptic vesicle recycling has been well-characterized
(Witke et al., 1998); the significant decrease in DNM1 mRNA and protein levels in AD
brains was interpreted to reflect its role in synaptic vesicle endocytosis. (Yao et al.,
2003). We recently reported that DNM1 protein is less abundant in the OBs of old vs.
young mice (Poon et al., 2005b); however, because the OB is a site of on-going synaptic
remodeling, DNM1 may be constitutively expressed at high levels, and its downregulation may reflect this regional specialization. Thus, the increased expression of
DNM1 in the brains of old mice may indicate increased synaptic vesicle recycling
associated with increased synaptic plasticity as a compensatory response to age-related
synaptic loss such as that proposed to occur in neurodegenerative diseases (Hashimoto
and Masliah, 2003).
LDH2, which was also up-regulated in the brains of old mice, is a subunit of the
enzyme

lactate

dehydrogenase

that

catalyzes

the

reversible

NAD-dependent

interconversion of pyruvate and lactate. In astrocytes, lactate dehydrogenase favors the
formation of lactate over that of pyruvate; the lactate is secreted by astrocytes, taken up
by neurons, and converted to pyruvate, which enters the Kreb’s cycle for ATP production
(Deitmer, 2001). Lactate appears to be the main energetic compound delivered by
astrocytes and is the only oxidizable energy substrate available to support neuronal
recovery in the CNS (Sahlas et al., 2002). The increased expression of LDH2 in the
brains of old mice may compensate for metabolic down-regulation in other enzyme
systems to provide sufficient lactate and ATP for cellular processes and neuronal
survival.
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The proteins that were identified as being up-regulated in the brains of old mice in
this study have also been shown to be oxidized in the brains of SAMs with cognitive
deficit and in the brains of patients with neurodegenerative diseases and in models
thereof (Castegna et al., 2002b; Castegna et al., 2002a; Butterfield et al., 2003; Castegna
et al., 2003; Poon et al., 2004d). Taken together, one can speculate that the up-regulation
of these proteins may play critical roles in the cognitive stability of aged mice without
cognitive deficit. Results from our laboratory, as well as others, have demonstrated that
total protein oxidation in the brain increases as a function of age (Butterfield and
Stadtman, 1997).

Our laboratory has previously used this proteomics approach to

identify oxidized proteins in the brains of senescence-accelerated mice and humans in
order to gain insights into the mechanism of accelerated aging and age-related
neurodegenerative diseases (Castegna et al., 2002b; Castegna et al., 2002a; Poon et al.,
2004d).
ACTB, which was oxidized in the brains of old vs. young mice, is a component of
the

cytoskeletal

network

responsible for cell structure and motility. Actin

polymerization/depolymerization plays an important role in synaptic plasticity in
dendritic spines (Fischer et al., 1998; Matus, 2000), and disruption of actin
polymerization results in growth cone collapse (Meberg and Bamburg, 2000). Decreased
levels of actin in cultured neurons as a function of increasing age indicates that the
oxidation of actin may accelerate its degradation (Aksenova et al., 1999a). Such an effect
is also observed in the brains of patients with Alzheimer’s disease (AD) (Aksenov et al.,
2001). The oxidative modification of ACTB in the brains of old mice may affect actin
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filament architecture and lead to disarrangement of the cytoskeleton, thus increasing the
susceptibility of neurons to age-related neurodegenerative diseases.
It is well documented that GS activity declines as a function of age (Aksenova et
al., 1998; Farr et al., 2003). The decline in enzyme activity is caused by the alteration of
protein structure induced by oxidative modification (Butterfield and Stadtman, 1997;
Butterfield et al., 1999b; Castegna et al., 2002b). GS catalyzes the rapid amidation of
glutamate to form the non-neurotoxic amino acid, glutamine. This reaction maintains the
optimal level of glutamate and ammonia in neurons and modulates excitotoxicity. The
results presented here confirm and extend earlier studies showing that GS is specifically
oxidized and its activity reduced in the brains of old mice, suggesting that the glutamateglutamine cycle in these aged brains may be impaired (reviewed in (Butterfield and
Stadtman, 1997)). Such an impairment would contribute to the cellular functional decline
in aging brain. Because both GS and ACTB are also oxidized in AD brains (Aksenov et
al., 2001; Castegna et al., 2002b), the specific oxidation of these proteins may be
involved

in

the

increased

susceptibility of aged individuals to age-related

neurodegenerative diseases.
NF-66 (α-internexin), which was oxidized in the brains of old vs. young mice, is
an intermediate filament protein that contributes to cytoskeletal organization,
neurogenesis and neuronal architecture in the brain. Oxidation or nitration of
neurofilament (NF) proteins transform the α-helix secondary structure to β-sheet and
random coil conformations, destabilizing the interactions between the NF proteins and
resulting in axonal damage (Crow et al., 1997). Binding of NF-66 by viral proteins results
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in neurological disorders, indicating that NF-66 is critical to the proper functioning of the
CNS (Reddy et al., 1998).
A novel unnamed protein was also oxidized in the brains of old mice. Further
experiments will be needed to identify this protein and determine it how its oxidation
may impact brain function.
In this study, we have shown that there is an altered proteomic profile in the
brains of old mice, and we identified the proteins that were differentially expressed or
oxidized in the brains of old vs. young mice. Our results are consistent with the free
radical theory of aging, which proposes that increased protein oxidation occurs as a
function of age, and that the oxidation of proteins causes cellular functional decline, thus
increasing the susceptibility of aging brains to neurodegeneration. Interestingly, several
of the oxidized proteins in the brains of old mice are the same as those that have been
identified in the brains of SAMP8 mice. Our results also support the possibility that the
expression levels of certain proteins may increase as a compensatory response to
oxidative stress. This compensation would allow for the maintenance of proper molecular
functions in aging brains and protection against neurodegeneration. This report is our
initial study of age-related changes in brains of mice, and as such, forms a framework for
future studies, including the testing of potential novel therapeutic molecules that may
modulate the effects of oxidative stress in brain aging.
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CHAPTER ELEVEN
Redox Proteomics Identification and Interacteome of Oxidatively Modified
Hippocampal Proteins in Mild Cogntive Impairment: Involvement of Energy
Metabolsim, Neuroplasticity, and Cell Cycle Events Initation in Development of
Alzheimer’s Disease From Mild Cogitive Impairment
11.1 Introduction
In previous chapters, we have example the role of oxidative stress and protein
oxidation in aged brain and brain of age-related cognitve impairment of rodent subjects.
In this chapter, we will investigate the role of protein oxidation in age-related cognitive
imparment of human subjects.
Mild cognitive impairment (MCI) is generally referred to the transitional zone
between normal cognitive function and clinically probable Alzheimer’s disease (AD)
(Winblad et al., 2004). Most subjects with MCI eventually develop AD, suggesting MCI
is one of the earliest phrases in the AD development (Flicker et al., 1991; Almkvist et al.,
1998; Morris et al., 2001; Luis et al., 2003). Although a variety of criteria for defining
MCI are used, they are essentially common that, (a) MCI was referred as the measurable
cognitive deficits of non-demented persons, and (b) MCI represent a clinical syndrome
that does not fulfill a diagnosis of dementia, but leads to a high risk of progressing to a
dementia disorder (Winblad et al., 2004). When persons are diagnosed with MCI, some
of them can progress to AD and other dementia types, but some are stable or even
recover (Winblad et al., 2004). Moreover, neuroimaging studies by magnetic resonance
imaging (MRI) demonstrate the atrophy of the hippocampus or entorhinal cortex in MCI

221

patients, indicating the relationships with transition of normal aging to MCI, then later to
clinical (de Leon et al., 2004).
Oxidative stress plays a significant role in AD (Markesbery, 1997; Markesbery
and Carney, 1999; Giasson et al., 2002; Zhu et al., 2004). Manifested by elevated levels
of nucleic acid oxidation, protein oxidation and lipid peroxidation, the oxidative damages
are the most severe in AD hippocampus, a brain region that is responsible for the
cognitive dysfunction (Butterfield and Kanski, 2001; Butterfield and Lauderback, 2002).
Although the role of oxidative stress play in AD development is undeniable, it remains
unclear that whether oxidative stress is a primary event or an epiphenomenon of the AD
development. The highest level of oxidative damages are correlated to the brains region
that exhibit the most neuronal denegation in AD (Markesbery, 1997; Markesbery and
Carney, 1999; Butterfield and Kanski, 2001; Butterfield and Lauderback, 2002; Giasson
et al., 2002; Zhu et al., 2004). Moreover, oxidative stress mediating entities per se induce
neuronal death in vitro; and protein oxidation and lipid peroxidation in the superior and
middle temoral gyri (SMTG) of MCI patients are increased (Keller et al., 2005). All of
these studies indicate that oxidative stress is indeed a primary event to the development
of AD.
In order to gain insight of the primary role of oxidative stress in the development
of AD from MCI, we used redox proteomics to identify the proteins that are oxidatively
modified in the hippocampus of MIC, a condition that often precedes AD. We found that
α-enolase (ENO1), glutamine synthetase (GLUL), pyruvate kinase M2 (PKM2) and
peptidyl-prolyl cis/trans isomerase 1 ( PIN1) are significantly oxidized in the hippocampi
of MCI subjects when compared to that in control.
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11.2 Experimental procedures
11.2.1 Human Subjects
The normal control subjects in this study were four females and two males, and
the average age was 82 ± 2.6 years. The amnestic MCI patients were four females and
two males and the average age was 88 ± 1.5 years (Table 1). All subjects came from our
longitudinally followed normal control group that has annual neuropsychological testing
and neurological and physical examinations every two years. Control subjects had: a) no
cognitive complaints; b) normal cognitive test scores, especially objective memory test
scores; c) intact ADLs; and d) normal neurologic examinations. Amnestic MCI patients
met the criteria described by Petersen (Petersen, R.C.,(ed) Mild Cognitive Impairment,
Aging to Alzheimer's Disease, Oxford University Press: New York 2003) which included:
a) a memory complaint corroborated by an informant, b) objective memory test
impairment (age and education adjusted), c) general normal global intellectual function,
d) intact ADLs, e) Clinical Dementia Rating score of 0.0 to 0.5, f) no dementia, and g) a
clinical evaluation that revealed no other cause for memory decline.
11.2 2 Neuropathology
Hippocampal specimens were taken immediately at the time of autopsy and
immersed in liquid nitrogen. Immediately adjacent specimens were for immersed in
formalin for histological and immunohistochemical evaluation. Sections also were taken
from the middle frontal gyrus (Broadmann area 9), superior and middle temporal gyri
(areas 21/22), inferior parietal lobule (areas 39/40), medial occipital lobe (areas 17/18),
anterior cingulate gyrus (area 24), posterior cingulate gyrus (area 23), hippocampus,
entorhinal cortex, amygdala, basal ganglia, thalamus, midbrain, pons, medulla, and
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cerebellum. Sections were stained with H & E, the modified Bielschowsky method, and
neocortical and medial temporal lobe structures were immunostained with 10D-5 (for
beta amyloid peptide) and alpha-synuclein using standard methods.

Neurofibrillary tangles (NFT), diffuse plaques, and neuritic plaques (NP) were
counted in the five most involved fields using Bielschowsky-stained sections of middle
frontal gyrus, middle temporal gyrus, inferior parietal lobule, and the posterior cingulate
gyrus. Similar counts were performed with Gallyas stained sections of hippocampal CA1
and subiculum, amygdala, and entorhinal cortex. The details of the findings of 10 MCI
cases (6 of the present series) are given in Markesbery et al. (Arch Neurol 2005, In Press)

Control subjects had Braak stage scores of II or less and only modest numbers of
diffuse and NP. In essence, in MCI patients NP were significantly elevated in all four
neocortical areas and the amygdala compared to controls.

There was a significant

increase in NFT in amygdala, entorhinal cortex, and hippocampal CA1 and subiculum
compared to controls. None of the MCI or control subjects had Lewy bodies. Two of the
MCI patients had tiny microscopic infarcts – one had five microinfarcts and another had
one. One patient had a single lacunar infarct. All of these were quite small and had no
role in the patient’s symptoms.
11.2.3 Sample Preparation
The hippocampal samples prepared as described in Section 5.2.2
11.2.4 Total Protein Carbonyl level
The protein carbonyl level is measured as described in Section 4.2.5
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11.2.5 Two-dimensional electrophoresis
2D electrophoresis is the same as Section 9.2.4
11.2.6 Western Blotting
Western blotting is the same as Section 9.2.5
11.2.7 Image Analysis
Image analysis is the same as Section 9.2.6
11.2.8 Trypsin digestion
Trypsin digestion is the same as Section 5.2.6
11.2.9 Mass Spectrometry
Mass spectrometry is the same as Section 9.2.8
11.2.10 Immunopercipitation
The antibodies against ENO1, GLUL, PKM2 and PIN1 are commercially
available. The anti-ENO1 antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA) is raised
against a peptide mapping near the C-termius of human ENO1. The anti-PKM2 antibody
(Abgent, San Diego, CA) is generated from rabbits immunized with a synthetic peptide
selected within amino acid 100-200 of human PKM2. The anti-PIN1 antibody is raised
against amino acid 41-163 of human PIN1. The anti-GLUL antibody is generated in
mice with purified GLUL from sheep brain, but reactivity against human is previously
reported (Hensley et al., 1995c). The Immunopercipitation was performed as described
previously (Lauderback et al., 2001). The antibodies were added directly to the
hippocampal homogenate, and the mixture was incubated on a rotary mixer overnight at
4°C. The antigen/antibody complexes were precipitated with protein A-conjugated
agarose beads if the antibodies were raised in rabbit; or protein G-conjuated agarose
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beads are used if the antibodies were raised in goat or mouse. Agarose beads were added
in 50 µL aliquots from a stock of 300 mg/mL in PBS and mixed on a rotary mixer for 1
hour at room temperature. Beads were then centrifuged and washed with the washing
buffer (pH 8, 50mM Tris HCl, 150 mM NaCl, 0.1% Tween 20) three times. The ENO1,
GLUL, PKM2 and PIN1 from each subjects (12 total) were resolved by SDS-PAGE and
transferred

to

a

nitrocellulose

membrane
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(Bio-Rad,

Hercules,

CA).

11.2.11 Post-Western Blot Immunochemical Detection of Protein Carbonyl Level
The carbonyl levels of ENO1, GLUL, PKM2 and PIN1 were detected by PostWestern blot derivatization after immunoprecipitation (Conrad et al., 2000). Following
the electroblotting procedure, the nitrocellulose membranes were equilibrated in 20%
methanol for 5 minutes. Membranes were then incubated in 2N HCl for 5 minutes. The
membranes were next incubated in 0.5mM DNPH solution exactly 5 minutes. The
membranes were washed three times in 2N HCl and five times in 50% methanol (5
minutes each wash). After post-Western blot derivatization, the immunochemical
detection and quantification of carbonyl levels of GLUL, PKM2 and PIN1 were similar
to that for total protein carbonyl level detection described above.
11.2.12 Enzyme Activities
Enolase activity assay was performed as described previously (Wagner et al.,
2000) with modification. Enolase was added to 100 μL of assay mixture (20 mM
Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-glycerate) in a
UV-transparent microtiter plate (Corning, MA). The enzymatic activity was determined
by the change of absorption at A240 for 5 min.
Glutamine synthetase was determined by the method of Rowe et al. (Rowe et al.,
1970) as modified by Miller et al. (Miller et al., 1978). The absorbance was recorded at
505 nm as described above.
Pyruvate kinase activity is determined according to Mildvan et al. (Mildvan and
Cohn, 1965). Briefly, 95 μL of assay mixture ( 1.66mM of ADP, 0.22 mM NADH, 0.1
mM of phosphpehoalpyruvate and 5 units lactate dehydrogenase) is added to 5 μL of the
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hippocampal protein (2μg/μL). The enzymatic activity was determined by the change of
absorption at A340 for 15 min.
Peptidyl-prolyl cis/trans isomerase activity was measured by a protocol from
Kullertz et. al. (Kullertz et al., 1998). Typically, the 100 μl assay mixture consisted of 97
μl of HEPES buffer (32mM, pH 7.8), 1μL (25mg/ml) Suc-AEPF-pNA (Bachem,
Switzerland) and 1μL (60mg/ml) of chymotrysin solution (St Louis, MO). , The reaction
was started by addition of 2 μl of brain homogenate (2 mg/mL) to the assay mixture, and
the absorbance of p-nitroaniline was followed at 395nm for 10 min.
11.2.13 Protein Interacteome
The functional protein interacteome was obtained by using Interaction Explorer™
Software PathwayAssist™ software package (Stratagene, La Jolla, CA). PathwayAssist
is a software for functional interaction analysis. It allows for the identification and
visualization of pathways, gene regulation networks and protein interaction maps
(Donninger et al., 2004). The proteins are first imported as the gene symbols as a set of
data. This data set is then searched against ResNet, a database contain over 500,000
biological interactions built by applying the MedScan text-mining algorithms to all
PubMed abstracts. These interactions are then visualized by building interaction networks
with shortest-path algorithms. This process can graphically identify all known interaction
among the proteins. The information of the function of these proteins and their relevance
to diseases are then obtained by using the

BIOBASE's Proteome BioKnowledge Library form

Incyte Corporation (Incyte, Wilmington, DE) (Hodges et al., 2002).
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11.2.14 Statistics
The statistical anaylsis applied was the same as Section 4.2.8
11.3 Results
In order to determine if protein oxidation occurs in the hippocampi of MCI
subjects, the total protein carbonyl level of hippocampi of MCI is compared with that of
control subjects. The average age and post mortem interval (PMI) of the control and MCI
subjects were not statistically different (Figure 11.1). However, the mean brain weight of
MCI subjects were significant lower (10%) than those of the controls (Figure 11.1).
Moreover, the Braak stage of MCI subjects range between 1 and 2 while the MCI subject
range between 3 and 5 (Table 11.1). This is consistent with the previous findings that
cognitive impairment is associated with lower brain weight and more severe
neurofibrillary pathology (Riley et al., 2005). Therefore, these control subjects are agematched and sex-matched (4 females and 2 male) to the MCI subjects (Table 11.1).
When compared to control, hippocampus of MCI show increased protein carbonyl
level (Figure 11.2). By using redox proteomics, the oxidized proteins were separated and
identified. Figure 11.3 shows the representative 2D gels of the hippocampi of control and
MCI subjects. The corresponding 2D Western blots of the hippocampi of control and
MCI are shown in Figure 11.4. Comparing the densitometric intensities of individual
spots, we determined that four proteins were oxidatively modified in the hippocampi of
MCI subjects when compared to that of the controls, indicated by the increased carbonyl
level of these proteins (Table 11.2). The fold changes of the carbonyl level of these
proteins are shown in Figure 11.5.
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Figure 11.1
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Figure 11.2
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Figure 11.3
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Figure 11.4
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Figure 11.5
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Table 11.1: Profile of subjects used in this study

Female
Male
Female
Female
Female
Male

Brain
Weight
(g)
1300
1400
1150
1110
1315
1240

3.75
4
1.75
4
2
1.75

1
1
1
2
1
2

Female
Female
Male
Male
Female
Female

1155
1050
1200
1170
1080
1075

5
2.75
3.5
2.25
2.25
3

3
3
4
3
5
3

Age
(years)

Gender

Control 1
Control 2
Control 3
Control 4
Control 5
Control 6

86
74
86
90
76
79

MCI 1
MCI 2
MCI 3
MCI 4
MCI 5
MCI 6

91
93
87
87
88
82
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The four oxidized proteins were identified by mass spectrometry; they are ENO1,
GLUL, PKM2 and PIN1. The mass spectra of these proteins used for identification were
shown in Figure 11.6A, and the database search for these proteins results in a single
identification (Figure 11.6B). The parameters for the identification of the oxidized
proteins by mass spectrometry are summarized in Table 11.3; these protein identifications
agreed with the expected MrW and pI range based on their positions on the 2D gels.
To validate the proteomics results, we used traditional immunochemistry to detect
the oxidized protein in MCI subjects. Consistent with the proteomics results, the carbonyl
levels of ENO1, GLUL, PKM2 and PIN1 were significantly increased by about 35%,
40%, 30% and 50%, respectively, in the hippocampi of the MCI subjects as compared to
that of controls (Figure 11.7). The increased carbonyl levels of ENO1, GLUL, PKM2 and
PIN1 in the hippocampi of MCI subjects were more robust when detected by proteomics
method. The differences in the magnitude of fold changes of carbonyl levels between the
two techniques is likely due to the fact that proteomics measures the carbonyl level per
unit of protein while Western blotting measures the carbonyl level of total protein.
Clearly, both techniques showed that ENO1, GLUL, PKM2 and PIN1 are oxidatively
modified in the hippocampi of MCI subjects, thus validating our current proteomics
results.
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Figure 11.6
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Figure 11.7
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The oxidized proteins are not only oxidatively modified, but also oxidatively
inhibited, showing by the decreased activity of ENO1 (48%), GLUL (23%), PKM2
(26%) and PIN1 (11%) in hippocampi of MCI subjects when compared to controls
(Figure 11.8). These results is consistent with the notion that oxidative modification of
proteins generally leads to its inactivation (Butterfield and Stadtman, 1997; Aksenova et
al., 1998; Babior, 1999; Sultana and Butterfield, 2004; Poon et al., 2005c).
Using Pathway explorer ™ to exam the functional interaction of ENO1, GLUL,
PKM2 and PIN1 (Figure 11.9), we found that these proteins are important to energy
metabolism,

synaptic

plasticity

and

mitogenesis/proliferation.

Moreover,

they

functionally interact with SRC, hypoxia-inducible factor 1, plasminogen (PLG), MYC,
tissue plasminogen activator (PLAT) and BCL2L1. The information of the function of
these proteins and their relevance to diseases are stated on Figure 11.9.
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Figure 11.8

242

Figure 11.9
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11.4 Disscussion
Since early AD involved hippocampal dysfunction (Barnes, 1988) and MCI
precede AD (Winblad et al., 2004), investigation of oxidative stress in hippocampi of
MCI subjects can determine if oxidative stress is a primary event or an epiphenomenon
in the development of AD. The current study had demonstrated that the protein oxidation
is significant increased in the hippocampi of MCI subjects when compared to that of ageand sex- matched controls (Figure 11.2), suggesting that protein oxidation is important to
the development of AD. This result is consistent with the previous study suggested that
oxidative stress is increased in the SMTG of MCI subjects (Keller et al., 2005). It was
well established that protein oxidation is not a random event, but rather is associated with
increased oxidative modification of particular proteins (Castegna et al., 2002b; Castegna
et al., 2002a; Poon et al., 2004d; Perluigi et al., 2005; Poon et al., 2005b; Poon et al.,
2005c). Therefore, we further investigate the specific proteins that are oxidatively
modified in hippocampi of the MCI subjects by using redox proteomics. The proteins that
are significantly oxidized in the hippocampi of MCI subjects are ENO1, GLUL, PKM2
and PIN1 (Table 11.2). Moreover, these oxidized proteins show activity decline in the
hippomcapi of MCI subjects (Figure 11.8).
ENO1 is a subunit of enolase, which interconvert 2-phosphoglycerate to
phosphoenolpyruvate. It was shown that a decline of enolase activity results in abnormal
growth and reduced metabolism in brain (Tholey et al., 1982). PKM2 is also a glycolytic
enzyme that converts phosphoenolpyruvate to pyruvate with phosphorylation of ADP to
ATP. Therefore, the oxidative inactivation of ENO1 and PKM2 in the hippocampi of the
MCI subjects could conceivably result in the reduced ATP production and alter the ATP-
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dependent process, such as signal transduction, and cell potential maintenance, thereby
leading to neuronal dysfunction.
It is well documented that GLUL activity declines in AD (Hensley et al., 1995c;
Aksenov et al., 1996; Howard et al., 1996; Butterfield et al., 1997b). GLUL catalyzes the
rapid amination of glutamate to form the non-neurotoxic amino acid, glutamine. This
reaction maintains the optimal level of glutamate and ammonia in neurons and modulates
excitotoxicity, and glutamate receptors is important to neuroplasticity (Lamprecht and
LeDoux, 2004). Therefore, oxidative inactivation of GLUL suggests the glutamateglutamine cycle in hippocampi of MCI subject was impaired, which may contribute to the
glutamate dysregulation, and impairment neuroplasticity during the development of AD
(Lee et al., 2002).
PIN1 is a chaperone enzyme that reversibly alters the conformation of proteins
from cis to trans between a given amino acid and a proline (Schutkowski et al., 1998).
PIN1 recognizes phosphorylated Ser-Pro and phosphorylated Thr-Pro motifs in proteins,
and thereby, binds to many cell cycle regulating proteins and tau protein. PIN1 is
colocalized with phosphorylated tau and also shows an inverse relationship to the
expression of tau in AD brains (Holzer et al., 2002; Kurt et al., 2003; Ramakrishnan et
al., 2003). Moreover, PIN1 is oxidatively inhibited in AD brain (Sultana et al., 2005), and
is able to restore the function of tau protein in AD (Lu et al., 1999). Therefore, our
current study show that oxidative inactivation of PIN1 in the hippocampi of MCI subjects
could be one of the initial events that trigger tangle formation, oxidative damage as well
as cell cycle events in AD brains.
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Examination of the interacteome of ENO1, GLUL, PKM2 and PIN1 indicates that
they functionally interact with SRC, PLG, MYC, PLAT BCL2L1 (Figure 9). ENO1,
PKM2 and GLUL are involved in energy metabolism since they are interacting with
glucose during glycolysis and glutamine metabolism. Therefore, alteration of this
proteins could eventually lead to impaired brain energy metabolism, a common feature
that is shared by both AD and MCI subjects (Messier and Gagnon, 1996; Cao et al.,
2003). ENO1, PIN1, GLUL and BCL2L1 are involved in mitogenesis, proliferation and
apotosis. Therefore, the alteration of these proteins in our study support the notion that
cell cycle events initiate the apoptosis in neuronal cells (Herrup et al., 2004). Moreover,
ENO1, PKM2, SRC, MYC, and hypoxia-inducible factor 1 are involved in RNA
elongation and MAP kinase pathway. These processes are important to signal
transduction and protein synthesis, two essential process of neuroplasticity and memory
formation (Lamprecht and LeDoux, 2004). Therefore, our current study suggests that
alteration of these proteins may contribute to the cognitive impairment in MCI subject.
Two other proteins that interact with ENO1, GLUL, PKM2 and PIN1 are PLG and
PLAT. PLAT converts inactive PLG to plasmin that degrade amyloid β (Aβ), the major
component of senile plaque (Tucker et al., 2000). Since PLG and PLAT interact with the
protein identified in this study, one can speculate that the oxidative modification of these
proteins in the hippocampi of MCI subjects may initiate the Aβ accumulation, thereby
leading to the development of AD.
Compared the oxidized protein profiles of MCI subjects to that of AD, we see
ENO1, GLUL and PIN1 overlap in two of these oxidized protein profiles (Figure 11.10).
This suggests that oxidative inactivation of ENO1, GLUL and PIN1 alter the cellular
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processes

these

proteins

are

involved,

such

as

energy

metabolism,

mitogenesis/proliferation and neuroplasticity. Impaired brain energy metabolism is
reported in both MCI and AD subjects (Messier and Gagnon, 1996; Cao et al., 2003);
mitogenesis mediated cell cycle events in MCI subjects precede the neuronal death in AD
(Yang et al., 2003); and decline of neuroplasiticity is suggested to correlated with the
development of AD from MCI (Ikonomovic et al., 2003). Therefore, our current study
not only demonstrate that protein oxidation play a significant role in the development of
AD from MCI, but also indicates that the oxidative inactivation of ENO1, GLUL, PKM2
and PIN1 is involved in the progression of AD from MCI, possible through impaired
energy metabolism, triggering abnormal cell cycle events and neuroplasticity decline.
Therefore, this study provides a framework for future studies for the development of AD
from MCI at molecular level.
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Figure 11.10
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CHAPTER TWELVE
Conclusions and Future Studies
12.1 Conclusions
In this desertation, we have demonstrated that increased oxidative stress in brain
play a significant role in age-related cognitive impairment in SAMP8 mice. Moreover,
such increased oxidative stress leads to specific protein oxidation in the brain of cognitive
impaired subject, thereby leading to cognitive function impairment in SAMP8 mice.
These proteins are lactate dehydrogenase 2 (LDH-2), dihydropyrimidinase-like 2(DRP2), α-spectrin and creatine kinase (CK). Moreover, the altered expression of
neurofilament triplet L protein (NF-L), lactate dehydrogenase (LDH-2), heat shock
protein 86 (HSP86), α-spectrin, and triosephosphate isomerase (TPI) may also contribute
to the cognitive sfunctions in aged SAMP8 mice.
Additionally, LA injection and reduce Aβ level using AO against APP reduces
oxidative stress in aged SAMP8 mice brain, thereby improve their learning and memory.
This desertation demonstrated that the improve learning and memory in aged SAMP8
treated with LA are possibly due to the reduced oxidation of LDH-2, DRP-2, and αenolase and/or altearted expression of NF-L, α-enolase, and ubiquitous mitochondrial
creatine kinase. Morover, the expression level of α-ATP synthase (Atp5a1) abd profilin
2 (Pro-2) was significantly altered in brains of aged SAMP8 mice treated with AO
against APP. The oxidative modification of aldoase 3 (Aldo3), coronin 1a (Coro1a) and
peroxiredoxin 2 (Prdx2) are also significantly decreased. These studies in this desertation
indicate that the functional alterations of these proteins may leads to impaired
metabolism, decline antioxidant system, and damaged synaptic communication.
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Ultimately, impairment of these processes lead to neuronal damages and cognitive
decline.
This desertation also show that the expression levels of dihydropyrimidinase-like
2 (DRP2), α-enolase (ENO1), dynamin-1 (DNM1), and lactate dehydrogenase 2 (LDH2)
were significantly increased in the normally aged brains, and the oxidation of β-actin
(ACTB), glutamine synthase (GS), and neurofilament 66 (NF-66) were significantly
increased. Several of the up-regulated and oxidized proteins in the brains of normal aging
mice identified are known to be oxidized in neurodegenerative diseases as well,
suggesting that the expression levels of certain proteins may increase as a compensatory
response to oxidative stress. This compensation would allow for the maintenance of
proper molecular functions in aging brains and protection against neurodegeneration.
In the hippomcapus of human subjects with MCI, protein oxidation is increased
and these oxidized proteins are α-enolase (ENO1), glutamine synthetase (GLUL),
pyruvate kinase M2 (PKM2) and peptidyl-prolyl cis/trans isomerase 1 ( PIN1) when
compared to age-matched and sex matched controls. This is consistent of the hypothesis
of this desertation that increased oxidative stress leads to specific protein oxidation in the
brain of cognitive impaired subject, thereby leading to cognitive function impairment.
Moreover, the oxidative inactivation of ENO1, GLUL, PKM2 and PIN1 is the primary
event, not epiphonomone, of the progression of AD from MCI.
12.2 Future Studies
Based on the results of this desertation, the following experiments maybe
explored to furter understand the role of oxidative stress in aging and age-related:
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1. Other forms of oxidative modification of proteins, such as HNE and 3-NT, should
also be investigated in the brains of age-related cognitive decline subjects.
2. Mass spectrometry can reveal the amino acids that are oxidatively modified. This
information can indicate the structural changes of the oxidized proteins.
3. Ex vivo oxidative stress in neuronal culture or synaptosome, using proteomics to
exam the proteins with increased expression. Also, since glutatione is one of the
system to determine the oxidative stress response, indentified the glutationated
proteins can gain insight into the compensatory response.
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Appendix A
Mitochondrial associated metabolic proteins are selectively oxidized in A30P αsynuclein transgenic Mice - a model of familial Parkinson's disease
A1. Introduction
Parkinson’s disease (PD) is the second most common neurodegenerative disorder,
approximately 1% of the population by age 65 is affected with PD (Eriksen et al., 2003).
Loss of dopaminergic neurons in the substantia nigra compacta results in clinical
symptoms of PD, such as bradykinesia, resting tremor, cogwheel rigidity, and postural
instability. Although the majority of PD is sporadic, approximately 10% of PD are
familial cases (Giasson and Lee, 2003). Mutations in α-synuclein, parkin, DJ-1 and
PINK1 are all linked to early onset familial PD (Dawson and Dawson, 2003). In the case
of α-synuclein, 4 different mutations have been identified in kindreds associated with
familial PD: A53T, A30P, E46A and genomic duplication (Polymeropoulos et al., 1997;
Kruger et al., 1998).
Oxidative damage is a prominent pathological change in PD brains (Yoritaka et
al., 1996; Alam et al., 1997; Floor and Wetzel, 1998). Free radicals produced by
autoxidation of dopamine, semiquinone formation, decreasd of antioxidant system,
increased iron level, and polymerization of protein are all thought to contribute to the
oxidative stress, although other stresses might also contribute to the oxidative stress
associated with PD (Adams et al., 1972; Tse et al., 1976; Graham, 1978; Spina and
Cohen, 1988; Youdim et al., 1989; Ostrerova-Golts et al., 2000). Toxicity associated with
this reaction is exacerbated by over-expression of wild type or mutant α-synuclein
(Jenner, 2003). All of these factors might contribute to the oxidative changes observed in
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brains of subjects with PD. Increasing evidence suggests that oxidative stress in PD
might also be linked to mitochondrial dysfunction, excitotoxicity, and the toxic effects of
nitric oxide, all of which are believed to be associated with cell death in PD brains (Alam
et al., 1997; Floor and Wetzel, 1998). Although the relationships of oxidative stress to PD
are still unknown, basal protein oxidation is high in the substantia nigra of PD patients,
and the levels of reactive carbonyls are increased in PD brains (Goedert, 2001).
Together, these data suggest that oxidative stress contributes significantly to the
pathophysiology of PD.
Wild-type α-synucleins can bind to lipid membranes, inhibit enzymes such as
phospholipase D2, protein kinase C and the dopamine transporter (Reviewed in (Kohno
et al., 2004) as well as induce brain-derived neurotrophic factor (BDNF). The A53T and
A30P mutant forms of α-synucleins do not induce BDNF (Ostrerova et al., 1999; Souza
et al., 2000). α-Synuclein shares physical and functional homology with chaperone
protein 14-3-3 and has chaperone functions (Lee et al., 2001). Taken together,these
studies suggest that α-synuclein is neuroprotective. However, the effects of α-synuclein
depend on the experimental conditions. α-Synuclein has a strong tendency to aggregate,
and most studies suggest that the accumulation of aggregated α-synuclein is toxic.
Expression of mutant α-synuclein cells produces increased levels of 8-hydroxyguanine,
protein carbonyls, lipid peroxidation and 3-nitrotyrosine, and markedly accelerated cell
death in response to oxidative insult (Li et al., 2001b, 2002). These studies suggest that
accelerated aggregation of mutant α-synucleins stimulates oxidative stress by loss of
protective effect of the soluble α-synuclein (Kahle et al., 2000; Neumann et al., 2002). In
order to gain insight into the mechanism(s) by which loss of antioxidant ability caused by
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overexpression of A30P mutant α-synuclein leads to cell death, we used proteomics to
identify the brain proteins that are significantly oxidatively modified in symptomatic
mice with overexpression of a A30P mutation in α-synuclein compared to the brain
proteins from the non-transgenic mice.
A2 Experimental procedures
Animals
The animals used in this study were previously described. (Sahara et al., 2002).
The mice develop symptoms between 6-14 months. The symptoms begin with a tremor
and progress to an end-stage phenotype characterized by muscular rigidity, postural
instability and ultimately paralysis. Mice that progressed to end stage symptoms were
sacrificed by cervical dislocation and their brains hemi-sectioned. Non-transgenic
control mice were C57Bl/6 mice, and were also sacrificed at the same time as the
symptomatic transgenic mice.
Sample Preparation
Brain tissue extraction was performed as previously described by Sahara et al. (Poon et
al., 2004e) with minor modifications. Left hemi-brains were weighed and homogenized
in 3 volumes of TBS (TBS, pH 7.4, 1 mM EDTA, 5mM sodium pyrophosphate, 30 mM
glycerol 2-phosphate, 30 mM sodium fluoride, 1 mM EDTA) containing a protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Protein content was determined via
the BCA method.
Two-dimensional gel electrophoresis
Samples of the proteins in the whole brains were prepared as previously described
(Poon et al., 2004e). Briefly, 200μg of protein were applied to a pH 3-10 ReadyStrip™
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IPG strip (Bio-Rad, Hercules, CA) for isoelectric focusing. The focused IEF strip was
stored at –80oC until second dimension electrophoresis was performed.
For second dimension electrophoresis, Linear Gradient (8-16%) Precast criterion
Tris-HCl gels (Bio-Rad) were used to separate proteins according to their molecular
weight (MrW). Precision ProteinTM Standards (Bio-Rad) were run along with the
samples.
After electrophoresis, the gel was incubated in fixing solution for 20 min. Sypro
Ruby stain was used to stain the gel for 2 hours. The gels were placed in deionized water
overnight for destaining.
Western Blotting
Western blotting for 2D gels was performed as previously described (Poon et al.,
2004e). 200μg of the brain protein were incubated with 2,4-dinitrophenyl hydrazine
(DNPH) at room temperature (25°C) for 20 min. The gels were prepared in the same
manner as for 2D-electrophoresis. The proteins from the second dimension
electrophoresis gels were transferred onto nitrocellulose paper (Bio-Rad) using a
Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2 hrs. The 2,4dinitrophenylhydrazone (DNP) adducts of the carbonyls of the brain proteins were
detected immunochemically.
Image Analysis
The gels and nitrocellulose blots were scanned and saved in TIF format using a
Storm 860 Scanner (Molecular Dynamics) and Scanjet 3300C (Hewlett Packard),
respectively. PDQuest (Bio-Rad) was used for matching and analysis of visualized
protein spots among differential gels and oxyblots.

256

Statistics
The data of specific carbonyl level (intensity of carbonyl level divided by the
intensity of protein level of an individual spot) of 6 animals per groups (6 in control
group and 6 in A30P group) were analyzed by Student's t test. A value of p < 0.05 was
considered statistically significant. Only the proteins that are considered significantly
different by Student’s t-test were selected for identification.
Trypsin digestion
Samples were digested using the techniques previously described (Poon et al.,
2004e). Briefly, the selected protein spots were excised. The gel pieces were digested
with 20 ng/µl modified trypsin (Promega, WI) in 25 mM NH4HCO3 with the minimal
volume to cover the gel pieces. The gel pieces were chopped into smaller pieces and
incubated at 37°C overnight in a shaking incubator.
Mass Spectrometry
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10
mg/mL in 0.1% TFA:ACN, 1:1, v/v). The mixture (1 μL) was deposited onto a fast
evaporation nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and
analyzed with a TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in
reflectron mode. The mass axis was adjusted with trypsin autohydrolysis peaks (m/z
2239.14, 2211.10, or 842.51) as lock masses. The MALDI spectra used for protein
identification from tryptic fragments were searched against the NCBI protein databases
using the MASCOT search engine (http://www.matrixscience.com). Peptide mass
fingerprinting used the assumption that peptides are monoisotopic, oxidized at
methionine residues and carbamidomethylated at cysteine residues (Zewe and Fromm,
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1965; Stambaugh and Post, 1966). Up to 1 missed trypsin cleavage was allowed. Mass
tolerance of 150 ppm was the window of error allowed for matching the peptide mass
values.
Enzyme Activity assay
Lactate dehydrogenase (LDH) enzymatic activity was determined by the method
previously described (Poon et al., 2005). Briefly, the assay for the enzyme activity of
LDH was performed in 100 μL Tris buffer (0.2M Tris.HCl, 30mM sodium pyruvate,
6.6mM NADH, pH 7.3). The reaction was initiated by adding 5 µL of the samples
(2mg/mL). LDH activity was measured as the reduction of NADH to NAD+. A decrease
in absorbance at 340 nm was recorded as change in A340 min-1 by using a PowerWaveX®
microtiter plated UV-VIS spectrophotometer (Bio-Tek Instruments, Winooki, VT).
Enolase activity assay was performed as described previously (Wagner et al.,
2000) with modification. Enolase was added to 100 μL of assay mixture (20 mM
Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-glycerate) in a UVtransparent microtiter plate (Corning, MA). The enzymatic activity was determined by the
change of absorption at A240 for 5 min.
Carbonic anhydrase activity is measured according to Anderson (Andersson et al.,
1972) with modification. Briefly, a CO2 saturated Tris buffer (pH 8.3, 0.2M Tis-HCl,
phenol red), decrease absorbance at 560nm is record upon addition of 5μL of the
2mg/mL samples. The maximum changes of absorbance are recorded.
A3 Results
We used a parallel approach to investigate the effect of an A30P α-synuclein
mutation on specific protein oxidation. Fig. A1 shows representative 2D-electrophoresis
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gels of brains homogenates from symptomatic A30P α-synuclein transgenic mice (A30P)
and non-transgenic mice after Sypro Ruby staining. Fig. A2 shows representative 2D
western blots of the brains of symptomatic non-transgenic mouse and symptomatic
A30P-α-synuclein transgenic mice. The specific carbonyl levels indicate the carbonyl
level per unit mass of protein (Table A1).
In comparison to wild-type mice, three proteins in the brains of A30P α-synuclein
transgenic mice were found to have significantly higher specific carbonyl levels. Only the
specific carbonyl level of proteins that are different statistically were identified and
reported here. These proteins were identified as carbonic anhydrase 2 (Car2), alphaenolase (Eno1) and lactate dehydrogenase 2 (Ldh2). Prior results suggest that the
accuracy of protein identification by mass spectrometry is equivalent to immunochemical
identification (Conway et al., 1998; Narhi et al., 1999; Li et al., 2001b, 2002). The
specific carbonyl levels of these proteins are summarized in Table A1. The summary of
the mass spectrometry results for the proteins is listed in Table A2.
Oxidative modification of brain proteins leads to loss of their activity (Hensley et
al., 1995a; Butterfield et al., 1997; Lauderback et al., 2001). To determine if these
proteomic identified oxidatively modified brains proteins in the A30P α-synuclein mouse
were dysfunctional, their enzymatic activities were analyzed. The activities of these
enzymes in the A30P α-synuclein transgenic mice were significantly decreased when
compared to the brain proteins from non-transgenic control (Fig A3).

259

Table A1: Specific carbonyl level of oxidized proteins in A30P-α synuclein mice

Proteomics Identified Protein

Wild-type Mice
(A.U.± S.E.M.)
(n=6)

A30P-α synuclein

Carbonic anhydrase 2 (Car2)

0.92±0.19

2.22±0.59

< 0.05

alpha-enolase (Eno1)

0.51±0.09

0.93±0.17

< 0.05

0.29±0.18

1.73±0.63

< 0.05

Transgenic Mice
(n = 6)

p value

Lactate dehydrogenase 2
(Ldh2)
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Table A2: Summary of proteins identified by mass spectrometry
# Peptides % Coverage

Probability
pI, MrW Mowse

Identified Protein

gi accession # matched of matched

of a random
(kD)

Score

peptides

identification

Carbonic anhydrase 2
gi|33243954

9

30

6.52, 29.1

75

3.16 x 10-8

alpha-enolase (Eno1) gi|13637776

23

61

6.37, 47.4

208

1.58 x 10-21

11

36

5.7, 36.8

103

5.0 x 10-11

(Car2)

lactate dehydrogenase
gi|6678674
2 (Ldh2)
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Figure A1
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Figure A2
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Figure A3
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A4 Discussion
A30P mutation accelerates synuclein aggregation (Lee et al., 2001),. Cell in
which mutant α-synuclein is overexpressed have increased vulnerability to oxidative
insult (Lee et al., 2001). Taken together, these result suggest α-synuclein aggregation
mediated oxidative stress is increased in the mutant (Neumann et al., 2002). Consistent
with this notion, the aggregation of α-synuclein occurs in parallel with symptoms in
A30P α-synuclein transgenic mice (Kahle et al., 2001; Giasson et al., 2002). Also,
transgenic mice over-expressing α-synuclein develop an age dependent-accumulation of
α-synuclein in neurons of the brain stem (Chesler and Kaila, 1992; Deitmer and Rose,
1996; Tong and Chesler, 1999), suggesting the α-synuclein aggregation associated
oxidative stress is involved in the pathology in the A30P α-synuclein transgenic mice.
Car2 is a Zn2+ metallo-enzyme that catalyzes reversible hydration of carbon
dioxide (CO2) to bicarbonate (HCO3-). Glia use this process to govern the pH shift
associated with normal neuroactivity (Heck et al., 1994; Shah et al., 2000). Since the
extracellular pH shift affects normal and pathological brain functions, dysfunction of
Car2 usually results in neuronal abnormalities. BLAST alignments of Car2 with proteins
from M. musculus shows high (68%) similarity in amino acid level to the mitochondrial
counterpart carbonic anhydrase 5a (Car5a) and 5b (Car5b). One can speculate that they
may couple or interact with each other to function in metabolic process, cellular
transport, gluconeogenesis and mitochondrial metabolism (Bittar et al., 1996). Our study
shows that Car2 is significantly oxidized in A30P α-synuclein mice and its activity is
significantly decreased, suggesting its inactivation may lead to loss of the buffering
system in brains with resulting in aggregation of synuclein and neurodegeneration.
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Ldh2 is a subunit of lactate dehydrogenase (LDH). LDH is a glycolytic protein
that catalyzes the reversible NAD-dependent interconversion of pyruvate to lactate. LDH
isoform 5 (LDH-5) in astrocytes favors the formation of lactate (Brooks et al., 1999).
Also, LDH-5 is more abundant in mitochondria than elsewhere in cells (Kasischke et al.,
2004), indicating that lactate is the predominant monocarboxylate oxidized by
mitochondria for intracellular lactate transport (Giege et al., 2003). Here we show that
Ldh2 is significantly modified and inactivated by oxidative insults in A30P α-synuclein
transgenic mice brains, suggesting oxidative inactivation of LDH may contribute to
mitochondrial dysfunction in PD patients.
Eno1 is a subunit of enolase that interconverts 2-phosphoglycerate and
phosphoenolpyruvate during glycolysis. The loss of the mitochondrial constituent (αketoglutarate dehydrogenase complex, KGDHC)-enriched cells is proportional to the
total loss of immunoreactivity to neuronal specific enolase (NSE), indicating that enolase
not only is involved in metabolism, but also in cell differentiation, normal growth and
mitochondrial function. Moreover, enolase and other glycolytic enzymes were identified
in an intermembrane space/outer mitochondrial membrane fraction (Schapira et al., 1998;
Schapira, 2001; Sherer et al., 2002), suggesting glycolytic enzymes are associated with
proper mitochondrial function. We show here that the specific carbonyl level of Eno1 is
significantly increased and its activity is decreased in brains from A30P α-synuclein
transgenic mice compared to that of non-transgenic mice, suggesting this oxidative
inactivation may alter normal glycolysis and mitochondrial function in brains and
contribute to the alteration of energy metabolism in PD.
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The striking feature of Ldh2, Eno1 (possibly Car2) is that they are all associated
with mitochondrial function. Oxidative inactivation of Car2 can cause the accumulation
of CO2 and pH shift in neurons, which possibly leads to alteration of mitochondria
potential and mitochondrial deficits. Increasing data implicate mitochondrial decrements
and oxidation in PD (Ferrante et al., 1999; Pennathur et al., 1999; Sherer et al., 2003a;
Sherer et al., 2003b). Also, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and
rotenone target the mitochondria with increased oxidative modification of proteins and αsynuclein aggregation (Canet-Aviles et al., 2004; Palacino et al., 2004; Valente et al.,
2004). Moreover, DJ-1, PINK1 and parkin all appear to modulate mitochondrial function
(Bouyer et al., 1984; Mizuno et al., 1989; Parker et al., 1989; Shoffner et al., 1991;
Benecke et al., 1993; Marey-Semper et al., 1993; Zeevalk et al., 1995; Zeevalk et al.,
1997). The observation that each of the brain protein is involved in oxidative stress in
A30P synuclein mice and each is associated with mitochondria is consistent with the
mitochondrial hypothesis for PD and implicates mitochondrial pathology in toxicity
associated with aggregated synuclein.
Since impairment of energy production and mitochondrial dysfunction leads to
neurodegeneration reminiscent of PD both in in vitro and in vivo studies, our current
study suggests that the oxidative stress mediated impaired energy metabolism and
mitochondrial dysfunction may be responsible, at least partially, for the
neurodegeneration in the brains of A30P α-synuclein transgenic mice. Furthermore, this
oxidative stress mediated impaired energy metabolism and mitochondrial dysfunction is
brought about through the oxidative inactivation of Eno1, Ldh2 and Car2. We conclude,
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therefore, that the mitochondria dysfunction and impaired metabolism in familial PD may
be associated with the oxidative inactivation of Eno1, Ldh2 and Car2.
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Appendix B
Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1
transgenic mice-a model of familial amyotrophic lateral sclerosis
B1 Introduction:
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron degenerative disease
characterized by the loss of neuronal function in motor cortex, brainstem and spinal cord.
ALS typically presents at middle age and progress rapidly. Life expectancy of victims of
ALS usually are 3 -5 years after diagnosis (Cudkowicz et al., 1997; Orrell, 2000).
Inherited ALS accounts for 10-15% of cases, and among all of the familial ALS (FALS)
patients, 20-30% of them are caused by gain of-function mutations in Cu,Zn-superoxide
dismutase (SOD1) (Deng et al., 1993; Rosen et al., 1993). SOD1 catalyzes the
disproportionation of superoxide anion radical (O2•-) to hydrogen peroxide and oxygen.
Over 100 different missense substitutions in the 153-amino-acid SOD1 (mSOD) have
been described in individuals and kindreds affected by SOD1-linked FALS
(www.alsod.org, 2000-2002). One of the most common mutations of SOD1 is the
substitution of glycine by alanine at residue 93 (G93A) (Orrell, 2000).
Two principal of hypotheses have been proposed to explain the toxic gain of
function of mutant SOD (mSOD) (Liochev and Fridovich, 2003). One is that mSOD can
directly promote reactive oxygen species (ROS) and reactive nitrogen species (RNS)
generation (Beckman et al., 1993; Lyons et al., 1996; Wiedau-Pazos et al., 1996; Yim et
al., 1996; Crow et al., 1997; Yim et al., 1997). Evidence supporting this hypothesis
showed that mSODs enhance oxidative activity by acting as peroxidases (Wiedau-Pazos
et al., 1996; Yim et al., 1996; Valentine, 2002), superoxide reductases (Liochev and
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Fridovich, 2000) or producing O2- to form peroxynitrite (ONOO-) (Estevez et al., 1999;
Beckman et al., 2001). The second hypothesis is that mSODs are prone to aggregation
due to their instability or association with other proteins (Durham et al., 1997; Cleveland
and Liu, 2000; Julien, 2001; Okado-Matsumoto and Fridovich, 2002). These aggregates
facilitate toxicity (Bruijn et al., 1998; Johnston et al., 2000) and deplete the mSODassociated proteins and thus perturb the normal functions of cells (Liochev and Fridovich,
2003). The proteinaceous inclusion found in tissues from ALS patient (Shibata et al.,
1994; Matsumoto et al., 1996; Shibata et al., 1996) and mSOD transgenic mice (Bruijn et
al., 1997; Bruijn et al., 1998) reportedly are rich in mSOD1, ubiquitin and neurofilament
proteins. It is noteworthy that the hypotheses of oxidative stress and protein aggregation
are not mutually exclusive (Butterfield and Kanski, 2002), although the roles of oxidative
stress and aggregation in ALS are highly controversial (recently reviewed in (Cleveland
and Liu, 2000; Cleveland and Rothstein, 2001; Bruijn et al., 2004)).
Increased oxidative modification of macromolecules was demonstrated in
neuronal tissues of SOD1-related FALS patients and transgenic mice (Ferrante et al.,
1997; Andrus et al., 1998; Hall et al., 1998). Enhanced susceptibility of exogenous
oxidative stress in mSOD1 cell cultures was also observed in in-vitro studies (Mena et al.,
1997; Aguirre et al., 1998; Gabbianelli et al., 1999). Exogenous oxidative stress can even
inhibit the rapid degradation of mSOD (Oeda et al., 2001). These studies are consistent
with the notion that oxidative stress plays an important role in ALS development. G93ASOD1 transgenic mice show significant increased protein carbonyl levels in their spinal
cord from 2 months to 4 months (Andrus et al., 1998) and eventually develop motor
neuron disease and die within 5-6 months (Gurney et al., 1994). G93A-SOD1 catalyzes
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the oxidation of a model substrate by H2O2 at a higher rate (Wiedau-Pazos et al., 1996)
and has a higher capacity to generate free radicals (Yim et al., 1996) when compared to
wild –type SOD1. Also, elevation of imflammation-related genes (i.e., induced nitric
oxide synthase; proinflammatory cytokines, etc.) occurred at 11 weeks of age in the
presymptomatic stage prior to motor neuron death in G93A-SOD1 transgenic mice,
suggesting that neuroimflammation-mediated oxidative stress is also present in G93ASOD1 mice (Hensley et al., 2003). Therefore, the expression of G93A-SOD1 is believed
to elevate the generation of oxygen radicals in vulnerable tissue, such as spinal cord (Gu
and Ihara, 2000), creating oxidative stress that may be responsible for the ALS-like
syndrome observed in the G93A-SOD1 mice. One of the oxidatively modified proteins in
G93A-SOD1 transgenic mice is SOD1 (Andrus et al., 1998), indicating that oxidization
of SOD1 is likely important to the development of the this model of ALS. However,
other oxidatively modified proteins were not identified. Recent quantitative proteomic
studies enabled the identification of oxidized protein in Alzheimer’s disease (AD)
patients and models thereof (Butterfield et al., 2003; Butterfield and Castegna, 2003;
Butterfield, 2004) and provided important insights of the role of protein oxidation in AD.
In order to better understand the role of oxidative modification of proteins in ALS, we
employed quantitative redox proteomic analysis to identify the specific oxidized proteins
in the spinal cord of G93A-SOD1 mice.
B2 Experimental procedures
Animals
Transgenic mice expressing the human SOD1 gene with a G93A mutation strain
B6SJL/TgN (SOD1-G93A)-2Gur) (Gurney et al., 1994) were purchased from the Jackson
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Laboratory (Bar Harbor, ME, USA) and maintained as hemizygotes by mating transgenic
males with B6/SJLF1 females as previously described (Hensley et al., 2002).
All studies of live animals were authorized and overseen by the Institutional
Animal Care and Use Committee (IACUC) of the Oklahoma Medical Research
Foundation, and conducted by trained and certified technical and veterinarian staff. Every
effort was made to avoid unnecessary discomfort to the experimental animals.
Sample Preparation
Whole frozen mouse spinal cords (n=6) were homogenized in 10 mM sodium
acetate buffer pH 7.2 containing 0.1% triton X-100 and mammalian protease inhibitor
cocktail (Sigma Chemical, St Louis, MO, USA).
Two-dimensional (2D) gel electrophoresis
Samples of spinal cord proteins were prepared according to the procedure
previously described (Poon et al., 2004e). Briefly, 300μg of protein were incubated with
4 volumes of 2N HCl at room temperature (25°C) for 20min. Proteins were then
precipitated by addition of ice-cold 100% trichloroacetic acid (TCA) to obtain a final
concentration of 15% TCA. The samples were then mixed with 185μL of rehydration
buffer (8 M urea, 20mM dithiothreitol, 2.0% (w/v) CHAPS, 0.2% Biolytes, 2 M thiourea
and bromophenol blue).
In first-dimension electrophoresis, 200 µL of sample solution were applied to a
ReadyStrip™ IPG strip (Bio-Rad). The strip was then actively rehydrated in protean IEF
cell (Bio-Rad) for 16 hours at 50V. The focused IEF strip was stored at –80oC until
second dimension electrophoresis was performed. For second dimension electrophoresis,
thawed IPG® Strips pH 3-10 were equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8)
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containing 6M urea, 1% (w/v) sodium dodecyl sulfate (SDS), 30% (v/v) glycerol, and
0.5% dithiothreitol, and then re-equilibrated for 15 min in the same buffer containing
4.5% iodacetamide in place of dithiothreitol. Linear Gradient (8-16%) Precast Criterion
Tris-HCl gels (Bio-Rad) were used to perform second dimension electrophoresis.
Precision ProteinTM Standards (Bio-Rad) were run along with the sample at 200V for 65
min. The protein level on the 2D gels were detected by Bio-Safe Coomassie blue (BiRad).
Western Blotting
As previously described (Poon et al., 2004e), 300μg of protein were incubated
with 2,4-dinitrophenyl hydrazine (DNPH). The 2D gels were prepared in the same
manner as 2D-electrophoresis. The proteins from the 2D gels were then transferred to
nitrocellulose paper (Bio-Rad) and detected immunochemically.
Image Analysis
The gels and nitrocellulose blots were scanned and saved in TIF format using a
Scanjet 3300C (Hewlett Packard). Investigator HT analyzer (Genomic Solutions Inc.,
Ann Arbor, MI) was used for matching and analysis of visualized protein spots among
differential gels and oxyblots. The average mode of background subtraction was used to
normalize intensity values, which represents the amount of protein (total protein on gel
and oxidized protein on oxyblot) per spot. After completion of spot matching, the
normalized intensity of each protein spot from individual gels (or oxyblots) was
compared between groups using ANOVA.
Trypsin digestion
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Samples were prepared using the techniques described previously (Poon et al.,
2004e). The selected protein spots were excised with a clean blade and transferred into
clean microcentrifuge tubes. After being washed by ammonium bicarbonate (NH4HCO3)
and acetonitrile, the protein spots were dithiothreitol and iodoacetamide separately. Then
the gels pieces were washed by NH4HCO3 and acetonitrile again before rehydration with
modified trypsin (Promega, Madison, WI). The gel pieces were chopped into smaller
pieces and incubated at 37°C overnight in shaking incubator.
Mass Spectrometry
Mass spectra reported in this study were acquired from both the University of
Kentucky Mass Spectrometry Facility (UKMSF) and Department of Pharmacology in
University of Louisville School of Medicine and VAMC. A Bruker Autoflex MALDI
TOF (matrix assisted laser desorption ionization-time of flight) mass spectrometer
(Bruker Daltonic, Billerica, MA) in UKMSF or a TOF Spec 2E (Micromass, UK)
MALDI-TOF mass spectrometer in University of Louisville operated in the reflectron
mode were used to generate peptide mass fingerprints. Peptides resulting from in-gel
digestion with trypsin were analyzed on a 384 position, 600 μm AnchorChipTM Target
(Bruker Daltonics, Bremen, Germany) and prepared according to AnchorChip
recommendations (AnchorChip Technology, Rev. 2, Bruker Daltonics, Bremen,
Germany). Briefly, 1 μL of digestate was mixed with 1 μL of alpha-cyano-4hydoxycinnamic acid (0.3 mg/mL in ethanol:acetone, 2:1 ratio) directly on the target and
allowed to dry at room temperature. The sample spot was washed with 1 μL of a 1% TFA
solution for approximately 60 seconds. The TFA droplet was gently blown off the
sample spot with compressed air. The resulting diffuse sample spot was recrystallized
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(refocused) using 1 μL of a solution of ethanol: acetone:0.1 % TFA (6:3:1 ratio).
Reported spectra are a summation of 100 laser shots. External calibration of the mass
axis was used for acquisition and internal calibration using either trypsin autolysis ions or
matrix clusters was applied post acquisition for accurate mass determination.
The MALDI spectra used for protein identification from tryptic fragments were
searched against the NCBI protein databases using the MASCOT search engine
(http://www.matrixscience.com). Peptide mass fingerprinting used the assumption that
peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at
cysteine residues. Up to 1 missed trypsin cleavage was allowed. Mass tolerance of 150
ppm was the window of error allowed for matching the peptide mass values.
Ubiquitin carboxyl terminal hydrolase L1 (UCH-L1) Assay
The activities of UCH-L1 in the spinal cord were measured by determining the
rate of conversion of ubiquitin-C-terminal 7-amido-4-methylcoumarin (Ub-AMC)
(Calbichem) to ubiquitin and free AMC (Dang et al., 1998). In this assay, 39 μL of buffer
(50mM Hepes, pH 7.0, 10mM DTT, and 0.1 mg/ml ovalbumin) are mixed with 10μL of
2mg/mL spinal cord homogenates of six individual transgenic animals and six individual
control animals for 1 hour. Then 10 μL of 200 nM Ub-AMC was added to the enzyme
solution, and cleavage of AMC from Ub-AMC was monitored by λex 355nm and λem
460nm using a SpectrMAX Gemini XS fluorescence microtiter plate reader. UCH-L1
activities of each individual were assayed by the change of λem 460nm over time. The
average UCH-L1 activities of six transgenic animals were compared to those of six
control animals using Student’s t test.
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Immunoprecipitation
Immunoprecipitation was performed essentially as described previously
(Lauderback et al., 2001). A rabbit anti-αB-crystallin antibody (5 µL) (Chemicon) was
added directly to the spinal cord homogenate. Antibody/lysate solutions were incubated
on a rotary mixer overnight at 4°C. The αB-crystallin/antibody complexes were
precipitated with protein A-conjugated agarose beads. Protein A beads were added in
50 µL aliquots from a stock of 300 mg/mL in PBS and mixed on a rotary mixer for1 hour
room temperature. Beads were then centrifuged and 2D electrophoresis was performed on
the supernatant.

B3 Results
We used a parallel approach to investigate the effect of G93A-SOD1 on protein
oxidation. The specific carbonyl levels were obtained by dividing the carbonyl level of a
protein spot on the nitrocellulose membrane by the protein level of its corresponding
protein spot on the gel. Such numbers give the carbonyl level per unit of protein. We
found that in comparison to non-transgenic mice, four proteins in the spinal cords of
G93A-SOD1 transgenic mice have significantly higher specific carbonyl levels than
those spots for non-transgenic littermate controls. These proteins are identified as SOD1,
translationally control tumor protein (TCTP), ubiquitin carboxyl terminal hydrolase L1
(UCH-L1) and, αB-crystallin. The specific carbonyl levels of the proteins that are
significantly different are summarized in Table B1.The summary of the mass
spectrometry results for the proteins are listed in Table B2.
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Fig. B1 shows representative 2D-electrophoresis gels of G93A-SOD1 transgenic
mice (A) and non-transgenic mice (B) after Coomassie blue staining. Fig.2 shows the
representative 2D western blots of the spinal cord of a G93A-SOD1 transgenic mouse
(A) and a non-transgenic mouse (B). We report here that the specific carbonyl levels of
human SOD1, TCTP, UCH-L1 and, possibly αB-crystallin are significantly increased in
the spinal cord of G93A-SOD1 transgenic mice when compared to that of non-transgenic
mice. Spots closed to human SOD1 are modified SOD1, possibly phosphorylated SOD1.
However, these modifications cannot be resolved by MALDI mass spectrometry.
Although our mass spectra do not significantly match the mass spectra of αBcrystallin, the molecular weight and pI value of αB-crystallin agree with the location of
the gel spots on the 2D gel map. In order to assure the identification of αB-crystallin, we
identify the protein spot immunochemically. The spot was absent in the 2D gels upon
immunoprecipitation (Fig. B3). Therefore, the protein identification of αB-crystallin is
assured.
In order to confirm that oxidative modification inactived protein activity, we
compared the activity of UCH-L1 in the G93A-SOD1 transgenic mice to that in the
control mice. Consistent with our prior studies that demonstrate loss of activity of
oxidatively modified proteins (Hensley et al., 1995a; Lauderback et al., 2001; Sultana and
Butterfield, 2004), UCH-L1 activity is significantly decreased (29%) in the G93A-SOD1
transgenic mice when compared to that of non-transgenic control (Fig B4).
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Table B1: Increased Specific carbonyl level of oxidized proteins in G93A-SOD1 mice (n=6)

Proteomics Identified Protein

Non-Transgenic Mice
(A.U..± S.D.)
(n=7)

G93A-SOD1 Transgenic
Mice
(A.U.± S.D.)
(n = 7)

F
Fcrit = 4.7

p value

Transcriptionally control
tumor protein 1 (TCTP)

15.1±10.1

30.6±14.1

5.6

< 0.05

Cu,Zn-Superoxide Dismutase
(SOD1)

Not Detected

2.88±1.78

18.2

< 0.005 *

Ubiquitin carboxyl-terminal
hydrolase isozyme L1
(UCH-L1)

0.74±0.23

2.31±1.27

10.3

< 0.0001

Alpha B crystallin

Not Detected

20.1±8.4

39.7

< 0.0001 *

* Since specific carbonyl level are not detected in non-transgenic mice, a value of 0
was used to calculate the p value.
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Table B2: Summary of proteins identified by mass spectrometry
# Peptides
Identified Protein

%

gi accession # matched Coverag

pI, MrW

Mowse

Probability

(kD)

Score

of a random

e

identification

Transcriptionally
5

28

4.76, 19.5

79

1.25 x 10-8

gi|2982081

8

42

5.73, 16.1

85

3.16 x 10-9

gi|18203410

8

39

5.29, 24.6

86

2.5 x 10-9

gi|6753530

5

26

7.05, 20.1

60

Not significant

control tumor protein gi|6678437
1 (TCTP)
Cu,Zn-Superoxide
Dismutase (SOD1)
Ubiquitin carboxylterminal hydrolase
isozyme L1 (UCH-L1)
Alpha B crystallin
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Figure B1
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Figure B2
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Figure B3
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Figure B4
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B4 Discussion
The G93A-SOD1 transgenic mouse is frequently used as an animal model of
human FALS due to the neuropatholgical similarity of this mouse model to the human
disease (Zang and Cheema, 2002; Azari et al., 2003). Moreover, this mouse model can
provide insight into the mechanisms of the neurotoxicity by mutant SOD in vivo. It is
well established that mutant SOD1 enhances oxidative activity by acting as a peroxidases
(Wiedau-Pazos et al., 1996; Yim et al., 1996; Valentine, 2002) or a superoxide reductases
(Liochev and Fridovich, 2000). Protein carbonyl levels in the spinal cord of 3-4 month
old G93A-SOD1 transgenic mice show a 557% increase when compared to nontransgenic animals at same age (Andrus et al., 1998). Such protein oxidation in spinal
cord of G93A-SOD1 transgenic mice followed an alteration of cytokine expression
(Hensley et al., 2002). In the current study, we identified the proteins that demonstrate
increased carbonyl levels when compared to those of the non-transgenic mice as SOD1,
TCTP, UCH-L1 and αB-crystallin.
SOD1 previously was identified as one of the oxidatively modified proteins in
G93A-SOD1 transgenic mice spinal cord immunochemically (Andrus et al., 1998). Here,
we used a parallel proteomics approach to confirm that the specific carbonyl level of
SOD1 is increased in the spinal cords of G93A-SOD1 transgenic mice. Although G93ASOD1 shows identical dismutation activity as wild-type SOD1, the activity of SOD1 in
FALS patients with mutations decreased 50% in motor cortex, parietal cortex, and
cerebellum (Browne et al., 1998). Moreover, free radicals production in the G93A-SOD1
transgenic animals is induced by SOD1 mutation (Andrus et al., 1998), alteration of
tumor necrosis factor α (TNFα), and TNFα-modulating cytokines (Hensley et al., 2002;
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Hensley et al., 2003). Although the issue whether oxidative stress plays an early role in
ALS remains unknown, our current study is consistent with the notion that oxidative
modification of SOD1 plays a role in the neurotoxicity of mutant SOD1 in the disease.
Another oxidatively modified protein in G93A-SOD1 transgenic mice identified
by proteomics was TCTP. TCTP processes calcium-binding activity (reviewed in
(Bommer et al., 2002)) and has a tubulin binding region (Kim et al., 2000).
Overexpression of TCTP stabilizes microtubules and alters cell morphology (Gachet et
al., 1999). Other molecular interactions of TCTP include self-interaction (Yoon et al.,
2000) and the interaction with myeloid cell leukemia 1 protein (MCL1) (Zhang et al.,
2002). TCTP levels are highly regulated in response to various stress conditions and
extracellular signals, including growth signal (Bommer et al., 2002), cytokines (Nielsen
et al., 1998; Teshima et al., 1998), starvation (Bonnet et al., 2000; Bommer et al., 2002),
heat shock, heavy metals, calcium stress (Xu et al., 1999) and pro-apototic/cytotoxic
signals (Sinha et al., 2000; Oikawa et al., 2002). Along with the structural similarity to
chaperones (Thaw et al., 2001) and characterization as an anti-apoptotic protein (Li et al.,
2001a), these observations suggest that TCTP may exert a cytoprotective function for
cells. The current study showed that TCTP was oxidatively modified in the spinal cord of
G93A-SOD1 mice, suggesting that the putative cytoprotective function and the calcium
binding affinity of TCTP are impaired in G93A-SOD1 mice since oxidative modification
alters the structure and function of proteins (Hensley et al., 1994; Hensley et al., 1995a;
Subramaniam et al., 1997; Lauderback et al., 2001; Sultana and Butterfield, 2004).
Consistent with this notion, free cytosolic calcium was increased in lymphocytes from
ALS patients (Curti et al., 1996), suggesting that oxidative modification of TCTP may
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also play an important role in neurotoxicity of G93A-SOD1, and thus neurodegeneration
in the spinal cords of G93A-SOD1 transgenic mice.
UCH-L1 belongs to a family of ubiquitin carboxyl-terminal hydrolases (UCHs)
that play important roles in the ubiquitin-proteolytic pathway (Kon et al., 1999). The
ubiquitin-proteasome system is a major pathway for selective protein degradation
(Hershko and Ciechanover, 1992). Ubiquitinated proteins form polyubiquitin chains that
are eventually degraded by the 26S proteasome (Hershko and Ciechanover, 1998). UCHLs then recycle ubiquitin from ubiquitinated protein complexes or polyubiquitin chains
by cleaving the amide linkage next to the C-terminal glycine of ubiquitin (Hershko and
Ciechanover, 1992). Loss of UCH-L1 function causes neuroaxonal dystrophy (Yamazaki
et al., 1988; Mukoyama et al., 1989; Saigoh et al., 1999) significant protein oxidization
(Castegna et al., 2004), and accumulation of synuclein protein in gracile axonal
dystrophy (GAD) mice (Wang et al., 2002). Similarly, decreased UCH-L1 activity by
mutation also enhances protein aggregation in E. Coli (Leroy et al., 1998). Therefore,
base on the prior literature, oxidative inactivation of UCH-L1 presented in the current
study possibly contributes to both the protein aggregation and oxidative stress observed
in G93A-SOD1 transgenic mice and ALS patients. Consistent with this notion and
consistent with our finding (Fig 4), that UCH-L1 activity is decreased In G93A-SOD1
mice spinal cord, the inclusions of human ALS and mSOD1 (including G93A) mice are
excessively ubiquitinated (Migheli et al., 1990; Leigh et al., 1991; Mather et al., 1993;
Watanabe et al., 2001).
αB-crystallin belongs to the small heat shock protein (sHSP) class of the heat
shock protein (HSP) family. HSPs are cellular constituents synthesized by living
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organisms under stress conditions as well as normal conditions. The major function of
sHSP is to stabilize other proteins under stress condition, while the high molecular weight
HSPs normally play roles in protein folding during biosynthesis (Ganea, 2001; Poon et
al., 2004a). Incorporation of αB-crystallin into red cell ghosts protects ATPase against
oxidative stress (Derham et al., 2003), and overexpression of αB-crystallin protects cells
against apoptosis and necrosis during myocardial ischemia and reperfusion (Ray et al.,
2001) by acting as a chaperone (Wang and Spector, 1995). Therefore, one can speculate
that αB-crystallin contributes to the neuroprotection when the cells are under oxidative
stress. Moreover, α-crystallins were recruited to aggregates when cells were treated with
proteasome inhibitor (Ito et al., 2003), and the degradation of αB-crystallin, along with
ubiquitin conjugation, was decreased in bovine lens epithelial cells when αB-crystallin
are oxidized (Huang et al., 1995). Therefore, these studies suggest that oxidized αBcrystallin has a higher tendency toward aggregation than degradation. Therefore,
oxidative modification of αB-crystallin observed in our current study may impair
neuronal protection and increase aggregation of αB-crystallin in cells. Consistent with
this notion, inclusions in ALS patients contain αB-crystallin, along with metallothionin,
glutamine synthetase, and tubulin immunoreactivities (Kato et al., 1997).
The remarkable feature of the oxidatively modified proteins (except for TCTP) in
G93A-SOD1 transgenic mice is that they are involved in the formation of inclusion in
ALS patients or ALS models. Ubiquitin protein epitopes and αB-crystallin are found in
fibrillar neuronal inclusions in cortex of sporadic ALS patients (Migheli et al., 1990;
Leigh et al., 1991; Mather et al., 1993; Arima et al., 1998). Aberrant accumulation of
mutant SOD1 is demonstrated in C. elegan expressing human mutant SOD1 (Oeda et al.,
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2001). Based on our current observations, the increased oxidatively-modification of
SOD1, UCH-L1 and αB-crystallin plays significant roles in the protein aggregation in the
spinal cords of G93A-SOD1 transgenic mice. Our current study provide insights into the
mechanism of G93A-SOD1 neurotoxicity in vivo which involves oxidative modification
of a Ca2+ regulating protein (TCTP) and proteins involved in inclusion formation (SOD1,
UCH-L1 and αB-crystallin), suggesting a potential relationship between protein
oxidation, protein aggregation and Ca2+ regulation in ALS. Moreover, one can speculate
that the oxidative modification of these proteins impairs protein stability (αB-crystallin),
Ca2+ binding (TCTP), protein degradation (UCH-L1) and antioxidant capacity (SOD1). It
should be noted that other oxidative modifications could also play a role in the
pathogenesis of ALS involving other proteins (Perluigi et al., 2005). Moreover, since
only symptomatic mice were compared to the non-transgenic mice in this study, it is
possible that the oxidative modification of the proteins described is related to the
consequence of the degenerative process. Therefore, future studies will address whether
similar changes are observed in presymptomatic G93A-SOD1 mutant mice.
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Appendix C
Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1
transgenic mice--a model of familial amyotrophic lateral sclerosis
C1 Introduction
Degeneration of cortical and spinal motor neurons is the typical feature of
amyotrophic lateral sclerosis (ALS) (Carri et al., 2003), a progressive, fatal disease
occurring both sporadically (sALS) and as a familial disorder (fALS) accounting for
about 10% of patient. fALS is caused by dominantly inherited mutations in the SOD1
gene encoding Cu/Zn superoxide dismutase (Rosen et al., 1993). fALS cases are
indistinguishable from sALS on the basis of clinical and pathological criteria (Hand and
Rouleau, 2002), suggesting that the SOD1-mutant animal model provide insight into
similar and converging pathogenic mechanisms shared by both sporadic and familial
forms.
Over 100 SOD1 mutations (Andersen, 2000) have been identified in fALS
patients. Most of the individual mutations result from substitution of one single amino
acid, such as SOD1G85R, SOD1G37R and SOD1G93A, which were intensely characterized in
transgenic mouse models of ALS (Gurney et al., 1994; Ripps et al., 1995; Wong et al.,
1995; Bruijn and Cleveland, 1996). It is well established that SOD1-mediated toxicity in
ALS is due to a “gain” of toxic properties that are independent of the levels of SOD1
activity (Gurney, 1997).
However, the mechanism of fALS caused by mutant SOD1 (mSOD1) is currently
unknown. Two hypotheses have been proposed to explain the toxicity of ALS mutant
SOD1 proteins. The oligomerization hypothesis states that mSOD1 proteins are or
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become misfolded and consequently oligomerize to form intracellular aggregates
(Cleveland and Rothstein, 2001; Valentine, 2002) which diminish the availability of
essential proteins for normal cellular function. The oxidative damage hypothesis proposes
that toxicity is caused by aberrant chemistry of the active Cu/Zn sites of the misfolded
enzyme (Beckman et al., 1994). The mSODs exhibit enhanced oxidative stress by acting
as a peroxidase (Valentine, 2002), superoxide reductase (Liochev and Fridovich, 2000) or
by producing O2¯ (Estevez et al., 1999). Indeed, autooxidation of mutant SOD1 proteins
increases the frequency of protein misfolding (Rakhit et al., 2002). Elevated levels of
reactive free radicals and the formation of insoluble protein complexes of mutant SOD1
protein have been detected in spinal cords of the G93A transgenic mice prior to motor
neuron degeneration (Liu et al., 1998; Liu et al., 1999). It is tempting to assume that these
two phenomena are linked, since oxidative damage to the SOD1 was demonstrated in the
G93A-SOD1 transgenic mice (Andrus et al., 1998; Hensley et al., 2002; Poon et al.,
2004c). Moreover, the oxidative damage hypothesis is further supported by considerable
evidences of increased ROS-mediated oxidative stress, such as malondialdehyde, 4hydroxyl-2-nonenal (HNE), oxidized proteins, DNA and membrane phospholipids, in
sporadic and fALS (Valentine, 2002).
Lipid peroxidation is a result of oxidative stress in living cells. Since the central
nervous system is enriched with polyunsaturated fatty acids, it is particularly vulnerable
lipid peroxidation. Lipid peroxidation end product, HNE, is an unsaturated aldehyde that
can modify proteins by Michael addition to form covalent adducts with cysteine, lysine,
or histidine (Esterbauer et al., 1991). HNE-modification initiates conformational and
structural changes of proteins and results in neuronal death (Subramaniam et al., 1998;
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Malecki et al., 2000). HNE level and HNE-modified proteins are increased in the spinal
cord and ventral horn motor neurons of ALS patients indicating that HNE play a critical
role motor neuron degeneration in ALS (Simpson et al., 2004). In order to gain insight of
roles of HNE-modified protein in the neurodegenerative in fALS, we used a proteomic
approach to identify the significantly HNE-modified proteins in the spinal cord of G93ASOD1 transgenic mice when compared to non-transgenic mice.
C2 Experimental Procedures
These experiments are conducted by collaboration with Dr. Marzia Perluigi
Animals
Transgenic mice expressing human SOD1 gene with a G93A mutation (strain
B6SJL/TgN (SOD1-G93A)-2Gur) (Gurney et al., 1994) were purchased from the Jackson
Laboratory (Bar Harbor, ME, USA) and maintained as hemizygotes by mating transgenic
males with B6/SJL F1 hybrid females. Non-transgenic littermates were used as the
primary control group. From four months of age G93A transgenic mice showed signs of
hindlimb weakness and rapidly developed a paralysis resembling fALS both clinically
and pathologically (Gurney et al., 1994); they eventually died meanly 11 days after
paralysis. Behavioral tests were carried out between postnatal days 100 and 110 to
evaluate advanced motor dysfunction. All the studies on isolated cord were performed on
tissue isolated from 120 days-old animals and were performed according to the guidelines
on the ethical use of animals overseen by the Institutional Animal Care and Use
Committee (IACUC) of the Oklahoma Medical Research Foundation.
Sample Preparation
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The spinal cords were rapidly removed from the mice (n=5), dissected on a bed of
ice, immediately frozen in liquid nitrogen, and stored at –80 °C until time of analysis.
Spinal cords were suspended in 10 mM HEPES containing 137 mM NaCl, 4.6 mM KCl,
1.1 mM KH2PO4 and proteinase inhibitors: leupeptin (0.5 mg/mL), pepstatin (0.7 μg/mL),
type IIS soybean trypsin inhibitor (0.5 μg/mL) and PMSF ( 40 μg/mL). Homogenates
were sonicated 20sec three times and then centrifuged at 14,000 g for 15 min to remove
debris. Protein concentration in the supernatant was assayed by BCA method (Pierce,
Rockford, IL, USA).
Two-dimensional gel electrophoresis

Samples of spinal cord proteins were prepared according to the procedure of
Levine et al. (Levine et al., 1994). 200μg of protein were precipitated by addition of icecold 100% trichloroacetic acid (TCA) to obtain a final concentration of 15% TCA.
Samples were placed on ice for 10 min to allow precipitation of proteins. Precipitates
were centrifuged at 15,800 g for 2 min. The pellets were washed with 0.5mL of 1:1 (v/v)
ethanol/ethyl acetate solution. After centrifugation and washing with ethanol/ethyl acetate
solution three times, the samples were dissolved in 25 μL of 8

M

urea (Bio-Rad). The

samples were then mixed with 185μL of rehydration buffer (8M urea, 20mM
dithiothreitol, 2.0% (w/v) CHAPS, 0.2% Biolytes, 2 M thiourea and bromophenol blue).
For the first-dimension electrophoresis, 200 µL of sample solution were applied
to a ReadyStrip™ IPG strip (Bio-Rad). The strips were soaked in the sample solution for
1 hour to allow uptake of the proteins. The strip was then actively rehydrated in protean
IEF cell (Bio-Rad) for 16 hours at 50V. The isoelectric focusing was performed at 300V
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for 2 hours linearly; 500V for 2 hr linearly; 1000V for 2 hr linearly, 8000V for 8 hr
linearly and 8000V for 10 hr rapidly. All the processes above were carried out at 22oC.
The focused IEF strip was stored at –80oC until second dimension electrophoresis was
performed.
For second dimension electrophoresis, thawed IPG® Strips pH 3-10 were
equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) containing 6M urea, 1% (w/v)
sodium dodecyl sulfate (SDS), 30% (v/v) glycerol, and 0.5% dithiothreitol, and then reequilibrated for 15 min in the same buffer containing 4.5% iodacetamide in place of
dithiothreitol. Linear Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad) were
used to perform second dimension electrophoresis. Precision ProteinTM Standards (BioRad) were run along with the sample at 200V for 65 min.
After electrophoresis, the gels were incubated in fixing solution (7% acetic acid,
10% methanol) for 20 min. Approximately 40 mL of SYPRO Ruby Gel Stain (Bio-Rad)
were used to stain the gels for 2 hours, on a gently continuous rocker. The gels were
placed in deionized water overnight for destaining.
Western Blotting
The same amount of protein samples (200μg) was used for 2D-immunoblotting
analysis and the electrophoresis was carried out in the same way as described above. The
proteins from the second dimension electrophoresis gels were transferred to nitrocellulose
(Bio-Rad) using a Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2
hrs. HNE-protein adducts were detected on the nitrocellulose paper using a primary
rabbit antibody (Intergen) specific for HNE-bound protein (1:100), followed by a
secondary goat anti-rabbit IgG (Sigma, St Louis, MO, USA) antibody. The resultant stain
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was developed using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium
(BCIP/NBT) solution (SigmaFast tablets; Sigma).
Image Analysis
The gels (5 for each group, G93A-SOD1 transgenic mice and non transgenic
mice) and nitrocellulose blots (n=10) were scanned and saved in TIF format using a
Scanjet 3300C (Hewlett Packard). PDQuest 2-D Analysis Software (Bio-Rad, Inc.) was
used for matching and analysis of visualized protein spots among differential gels and
membranes to compare protein and HNE immunoreactivity content between G93ASOD1 transgenic and non-transgenic mice. This sophisticated software offers powerful
comparative analysis and is specifically designed to analyze many gels or blots at once.
Powerful automatching algorithms quickly and accurately match gels or blots and
sophisticated statistical analysis tools allow to identify experimentally significant spots.
The principles of measuring intensity values by 2-D analysis software were similar to
those of densitometric measurement. The average mode of background subtraction was
used to normalize intensity values, which represents the amount of protein (total protein
on gel and HNE-bound protein on the membrane) per spot. After completion of spot
matching, the normalized intensity of each protein spot from individual gels (or
membranes) was compared between groups using statistical analysis. Statistical
significance was assessed by a two-tailed Student`s t-test. P values < 0.05 were
considered significant for comparison between control (non transgenic mice) and
experimental data (G93A-SOD1 transgenic mice).
Trypsin digestion
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In-gel digestion on selected gel spots was performed according to
(Thongboonkerd et al., 2002). The selected protein spots were excised with a clean blade
and transferred into clean microcentrifuge tubes. The protein spots were then washed
with 0.1M ammonium bicarbonate (NH4HCO3) at room temperature for 15 min.
Acetonitrile was added to the gel pieces and incubated at room temperature for 15 min.
The solvent was removed, and the gel pieces were dried in a flow hood. The protein spots
were incubated with 20 µl of 20 mM DTT in 0.1M NH4HCO3 at 56°C for 45min. The
DTT solution was then removed and replaced with 20µL of 55mM iodoacetamide in
0.1M NH4HCO3. The solution was incubated at room temperature in the dark for 30min.
The iodoacetamide was removed and replaced with 0.2mL of 50mM NH4HCO3 and
incubated at room temperature for 15 min. 200μL of acetonitrile was added. After a 15min incubation, the solvent was removed, and the gel spots were dried in a flow hood for
30 min. The gel pieces were rehydrated with 20 ng/µl methylated trypsin (Promega,
Madison, WI) in 50 mM NH4HCO3 with the minimal volume to cover the gel pieces. The
gel pieces were chopped into smaller pieces and incubated at 37°C overnight in shaking
incubator.
Mass Spectrometry
All mass spectra reported in this study were acquired at the Department of
Pharmacology in the University of Louisville School of Medicine and VAMC. A Spec 2E
MALDI TOF (matrix assisted laser desorption ionization-time of flight) mass
spectrometer operated in the reflectron mode was used to generate peptide mass
fingerprints. Peptides resulting from in-gel digestion with trypsin were analyzed on a 384
position, 600 μm AnchorChipTM Target (Bruker Daltonics, Bremen, Germany) and
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prepared according to AnchorChip recommendations (AnchorChip Technology, Rev. 2,
Bruker Daltonics, Bremen, Germany). Briefly, 1 μL of digest was mixed with 1 μL of
alpha-cyano-4-hydoxycinnamic acid (0.3 mg/mL in ethanol:acetone, 2:1 ratio) directly on
the target and allowed to dry at room temperature. The sample spot was washed with 1
μL of a 1% TFA solution for approximately 60 seconds. The TFA droplet was gently
blown off the sample spot with compressed air. The resulting diffuse sample spot was
recrystallized (refocused) using 1 μL of a solution of ethanol: acetone:0.1 % TFA (6:3:1
ratio). Reported spectra are a summation of 100 laser shots. External calibration of the
mass axis was used for acquisition and internal calibration using either trypsin autolysis
ions or matrix clusters was applied post acquisition for accurate mass determination.
The MALDI spectra used for protein identification from tryptic fragments were
searched against the NCBI protein databases using the MASCOT search engine
(http://www.matrixscience.com). Peptide mass fingerprinting used the assumption that
peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at
cysteine residues. Up to 1 missed trypsin cleavage was allowed. Mass tolerance of 150
ppm was the window of error allowed for matching the peptide mass values. Probability
based MOWSE scores were estimated by comparison of search results against estimated
random match population and were reported as –10 *LOG10(p), where p is the absolute
probability. MOWSE score greater than 61 were considered significant (p<0.05). All the
protein identifications were in the expected size range based on position in the gel.
Enzyme Activity assay
Enolase activity assay was performed as described previously (Wagner et al.,
2000) with modification. Enolase was added to 100 μL of assay mixture (20 mM
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Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-glycerate) in a
UV-transparent microtiter plate (Corning, MA). The enzymatic activity was determined
by the change of absorption at A240 for 5 min.
C3 Results
Two-dimensional (2D) electrophoresis offers an efficient tool to screen for
abundant protein changes in different disease states as well as differences in metabolic
pathways. Western blot and subsequent immunochemical detection of HNE allowed
identification of HNE-modified proteins in the spinal cord tissue of transgenic G93ASOD1 mice in comparison to non-transgenic mice. We used a parallel approach to
quantify the protein levels by SYPRO Ruby staining and the extent of HNE-binding by
immunoistochemistry (Figs C1, C2). SYPRO Ruby fluorescent stain achieves a linear
and sensitive staining of gel slabs and immunoblotting with HNE antibody allows
specific detection of HNE-adducts in the spinal cord tissue of G93A-SOD1 transgenic
mice. We measured the specific HNE-bound levels by dividing HNE level of a protein
spot on blotted membrane by the protein level of its corresponding protein spot on the
gel. Fig. C1 shows the representative 2D-electrophoresis gels of G93A-SOD1 transgenic
mice (bottom) and non-transgenic mice (top) after SYPRO Ruby staining. Fig. C2 shows
the representative 2D western blots of the spinal cord of a G93A-SOD1 transgenic mouse
(bottom) and a non-transgenic mouse (top). The HNE-modified proteins identified in this
study were dihydropyrimidinase related protein 2 (DRP-2), heat shock protein 70
(Hsp70) and possibly α-enolase. HNE-bound protein levels of the three identified
proteins in G93A-SOD1 mice compared to non-transgenic mice are summarized in Table
C1. The increase of HNE immunoreactivity in G93A-SOD1 vs non-transgenic mice was
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not significant for α-enolase but the molecular weight and the pI value of the identified
protein match the location of the spot on the 2D gel map (Table C2). Others previously
reported that HNE-modified proteins are increased in the spinal fluid, in the spinal cord
and ventral horn motor neurons of ALS patients compared with control patients (Simpson
et al., 2004), but there are few evidences indicating which individual proteins are
specifically affected by HNE modification. In the present study, we show the
identification of three proteins (DRP-2, Hsp70 and α-enolase) significantly modified by
HNE in the spinal cord tissue of G93A-SOD1 mice. One example of mass spectra
corresponding to tryptic digest of one of the identified protein is shown in Fig. C3. Also,
we found that activity of the HNE-modified enzyme, enolase, is significantly decreased
(39%) in the spinal cords of the G93A-SOD1 transgenic mice when compared to that in
non-transgenic mice.
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Table C1: HNE-bound protein levels in G93A-SOD1 mice

Identified Protein

Non-Transgenic Mice G93A-SOD1 Transgenic Mice
(A.U. ± S.E.M)
(n = 5)
(A.U. ± S.E.M)

p value

Dihydropyrimidinase related
protein (DRP-2)
Hsp70
α-enolase

1.16 ± 0.55

3.46 ± 1.52

1.15 ± 0.25
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283.48 ± 98.5

< 0.02

30.6 ± 7.02

< 0.005

10.7 ± 4.12

< 0.049

Table C2: Summary of proteins identified by mass spectrometry
#
Identified Protein

gi accession
#

%

Peptides Coverage

pI, MrW (kD)

matched matched

Mowse
Score *

Dihydropyrimidinase
gi|13242237

18

36

5.95, 62.6

152

Hsp70

gi|40254595

26

51

5.37, 71.1

192

α-enolase

gi|12963491

6

13

6.37, 47.7

41

related protein 2
(DRP-2)

•

MOWSE score greater than 61 are considered significant statistically.
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Figure C1
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Figure C2
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Figure C3
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Figure C4
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C4 Discussion
The role of ROS-mediated oxidative stress in ALS has been proposed by many
laboratories and supported by the evidence that typical oxidation products such as
malondialdehyde, HNE, oxidized proteins, oxidized DNA and membrane phospholipid
peroxidation are elevated both in sporadic and fALS spinal cord (review by (Valentine,
2002)). HNE is a reactive and cytotoxic by-product of ω-polyinsaturated fatty acids
peroxidation. HNE can rapidly diffuse from the lipid bilayers to modify extracellular or
intracellular membrane proteins which are necessary for normal cellular function. HNE is
implicated in several neurodegenerative disease, including ALS (Simpson et al., 2004).
In the present study, we have identified the proteins that were significantly modified by
HNE in the spinal cord tissue of a model of fALS, G93A-SOD1 transgenic mice, in
comparison to that of the non-transgenic mice. We found that increased amounts of HNE
are significantly covalently bound to dihydropyrimidinase related protein 2 (DRP-2), to
the heat shock protein 70 (Hsp70) and possibly to α-enolase.
DRP-2 is a member of the DRP gene family involved in axonal outgrowth and
pathfinding through the transmission and modulation of extracellular signals(Goshima et
al., 1995; Minturn et al., 1995). Immunoreactivity of human DRP-2 was shown in the
neurofibrillary tangles of Alzheimer`s Disease (AD) human brain, suggesting that DRP-2
is involved in the neuritic degeneration in AD (Yoshida et al., 1998). Proteomic data
obtained in our laboratory showed significantly increased specific protein carbonyls level
of DRP-2 in AD brain (Castegna et al., 2002a), suggesting that DRP-2 is also essential in
repairing and maintaining the plasticity of neuronal connection in aged brains.
Dysfunction of the DRP-2 repairing activity in brain indicate that depletion of DRP-2
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may result in neuronal abnormalities, thus accelerating the neuritic degeneration in many
neurodegenerative disorders. Our finding, that the increased oxidative modification of
DRP-2 in G93A-SOD1 transgenic mice when compared to non-transgenic mice,
establishes a potential link between oxidation-mediated loss in protein function and
neuritic regeneration and plasticity.
It has been reported that mSOD1 is aggregated with heat shock proteins 70 and 40
(Hsp70 and Hsp40) and alpha-crystallin in transfected cells (Shinder et al., 2001). The
Hsp 70 is a chaperone that helps newly synthesized proteins to be folded and transported
across the membrane (Calabrese et al., 2003). Besides the constitutive expression of
Hsp70 in the mammalian cells, the protein is induced by a variety of stimuli including
heat, cytotoxic drugs, imbalance in the cellular redox state, ionizing radiation, heavy
metals, disease states and injuries (Rossner et al., 2003). Pathologically, human SOD1
immunoreactive inclusions in spinal cord of patient and of transgenic mice are frequently
stained with antibody against heat-shock cognate Hsc70 (Watanabe et al., 2001).
Moreover, overexpression of Hsp70 leads to reduction of protein aggregates and
enhanced viability of G93A-SOD1 overexpressed motor neurons (Bruening et al., 1999).
A recent study reported a potential anti-ALS drug candidate acting as a coinducer of Hsp
family (Kieran et al., 2004), suggesting Hsp70 plays a role in the folding of SOD1 and
prevents aggregate formation. Here, we propose that diminished degradation of mSOD1
is possibly due to inactivation of Hsp70, which once cross-linked to HNE is not able to
facilitate mSOD1 degradation by the proteasome. Our data suggest that mechanisms
regulating Hsp70 chaperone activity could play a crucial role in the pathophysiology of
motor neurons disease, in particular in the context of mutations of SOD1.
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In this study, we observed a trend toward increased levels of HNE-bound αenolase. Enolase is a glycolytic enzyme that catalyzes the dehydration of 2-phospho-Dglycerate to form phosphoenolpyruvate. α-enolase was identified as a specifically
oxidized protein in AD brains (Castegna et al., 2002b). Inactivation of this glycolytic
enzyme, as a result of oxidative modification, might contribute to an impairment of
glycolysis and leads to decrease in production of ATP for normal cellular function.
Levels of glucose in cerebral cortex synaptic terminals were markedly decreased in
mSOD1 mice when compared to non-transgenic mice (Guo et al., 2000b). Consistent
with the notion that HNE-modification of glucose transport protein (GLUT-3) impairs
activity of glucose transport and metabolism (Derave et al., 1999), our findings indicate
that the HNE binds and inactivate α-enolase, thus contributes to energy metabolism
disruption in motor neuron.
There is evidence for increased membrane lipid peroxidation in association with
degenerating neurons in AD, Parkinson’s disease, traumatic CNS injury and stroke, and
in animal and cell culture model of such disorders (Butterfield, 2002; Butterfield et al.,
2002; Pocernich and Butterfield, 2003; Zarkovic, 2003; Mattson, 2004). HNE levels and
HNE-modified proteins are consistently elevated in the spinal cord motor neurons of ALS
patients. In the current study, we identified the proteins that are significantly modified by
HNE in the spinal cord of G93A-SOD1 transgenic mice when compared to that of nontransgenic mice. The evidences of protein and DNA oxidation, and membrane lipid
peroxidation, together with elevated levels of ROS (Liu et al., 1999) in mSOD1 mice,
support the hypothesis that free radical-triggered oxidation of major cell components is a
pathway for motor neuron damage in fALS. Protein oxidation is one of the most
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important causes of brain protein damage and dysfunction (Berlett and Stadtman, 1997;
Butterfield and Lauderback, 2002) and decreased activity of oxidized enzymes might
contribute to the impairment of the metabolic pathway and cell abnormalities. The results
presented in this report show the oxidative modification of three key enzymes in cellular
metabolism: DRP-2 (neuronal development and repair), Hsp70 (stress response) and
possibly α-enolase (energy metabolism). With potential relevance to ALS, our data
demonstrate that oxidative stress in the form of lipid peroxidation is implicated as a
pivotal event in the motor neuron degeneration processes.
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Appendix D
Proteomics Analyses of Specific Protein Oxidation and Protein Expression in Aged
Rat Brain and Its Modulation by L-Acetylcarnitine: Insights into the Mechanisms
of Action of This Proposed Therapeutic Agent for CNS Disorders Associated with
Oxidative Stress
D1 Introduction
Impaired function of the central nervous system (CNS) in aged animals is
associated with increased susceptibility to the development of many neurodegenerative
diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic
lateral sclerosis (ALS). Age-related brain functional deterioration is consistent with the
free radical theory of aging, postulating that free radical reactions with biomolecules,
such as proteins and lipids leads to cognitive decline and neurodegeneration (Harman,
1969). This theory was later refined to include the concept that mitochondria play a key
role in aging, acting as the major source and target of oxidants (Miquel et al., 1980).
Mitochondrial dysfunction plays a significant role in this increased oxidative damage,
since damaged mitochondrial enzymes in aged brains lead to increased generation of free
radicals (Ventura et al., 2002). However, mitochondria are also a target of increased
oxidative stress in aged brains (Sastre et al., 2003), causing mitochondrial decay in a
reinforcing cycle that contributes to accelerated aging (Atamna et al., 2002; Ames, 2003).
Such increased oxidative stress and mitochondrial dysfunction cause oxidation of
proteins, thereby leading to their dysfunction in most cases (Agarwal and Sohal, 1994;
Agrawal et al., 1996; Butterfield et al., 1997; Aksenova et al., 1998; Sohal et al., 2002;
Butterfield, 2004). However, oxidation of proteins during aging and age-related
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neurodegenerative disorders is specific (Stadtman, 1992; Agarwal and Sohal, 1994;
Agrawal et al., 1996; Butterfield and Stadtman, 1997; Stadtman, 2001; Castegna et al.,
2002b; Castegna et al., 2002a; Castegna et al., 2003; Keller et al., 2004; Poon et al.,
2004e).
L-Acetylcarnitine (LAC; γ-trimethyl-β-acetylbutrobetaine) is the acetyl ester of
carnitine, which facilitates the transport of fatty acids and other moieties across the
membranes of mitochondria, thereby participating in the production of energy and
mitochondrial function within the brain (Thal et al., 2000). LAC levels are reduced in
aged brains, and chronic administration of LAC to aged rats improves age-related
cognitive impairment (Castorina and Ferraris, 1994). LAC-mediated modulation of
cognitive impairment in aged animals is reported to be due to its similar structure as
acetylcholine, thereby promote synthesis and release of acetylcholine (Castorina and
Ferraris, 1994). However, other mechanisms also likely play a role. For example, LAC
elevates levels of neurotrophins, which are key factors in the mediation of neural
plasticity and are required for memory consolidation (McDaniel et al., 2003). LAC can
also reduce brain oxidative stress by decreasing mitochondria decay (Liu et al., 2002).
Although it is well established that administration of LAC can decrease protein oxidation
in aged brains (Liu et al., 2002; Sharman et al., 2002; Yasui et al., 2002; Liu et al., 2004),
it is not clear which specific proteins are reduced in oxidative damage in the brains of
aged rats treated with LAC. In order to gain insight into the protective mechanism of
LAC in aged brains relevant to protein oxidation, we used a parallel proteomics approach
to identify the proteins that are oxidized in aged brains and those proteins that are have
reduced oxidative damage in aged brains in aged rats treated with LAC.
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D2 Experimental Procedures
Animals
All animal protocols were approved by the University of Catania Laboratory
Animal Care Advisory Committee. Wistar rats purchased from Harlan (Udine, Italy) were
maintained in a temperature and humidity-controlled room with a 12-h light:dark cycle.
Rats were fed ad libitum a certified diet prepared according to the recommendations of
the AIN. Young animals are between 6-12 months old and Old animals are 28 months
old. The old animlas was divided into two sub groups: one receiving the control diet and
the other supplemented, from the 24th month up to 28th month (4 months), with
acetylcarnitine (LAC), given orally dissolved in drinking water. The calculated intake of
LAC to this sub group of rats was 150 mg/kg/day. This group of animals was then
sacrificed at 28 months of age. After sacrifice, brains were quickly removed and
dissected into the cerebral cortex, hippocampus, septal area and striatum according to a
standardized procedure, in a cold anatomical chamber and following a protocol that
allows a maximum of 50 sec time-variability for each sample across animals. Substantia
nigra was dissected from the deepest part of the interpeduncolar fossa.

Sample Preparation and Methods Employed
Brain samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM NaCl,
4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4) containing protease inhibitors leupeptin
(0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5 µg/mL), and

PMSF (40

µg/mL). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The
supernatant was extracted to determine the protein concentration by the BCA method
(Pierce, IL).
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Immunochemistry
Levels of 3-nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) and protein carbonyls
were determined immunochemically as previously described (Poon et al., 2004d). Protein
carbonyl levels were determined as adducts of 2,4-dinitrophenylhydrazine (DNPH)
(Stadtman, 1992; Aksenov et al., 1997). The 2,4-dinitrophenyl hydrazone (DNP) adduct
of the carbonyls is detected on nitrocellulose membranes using a primary rabbit antibody
(Intergen)(1:1000) specific for DNP-protein adducts. HNE and 3-NT levels were
determined in the same manner. The HNE levels were detected using a primary rabbit
antibody (Alpha Diagnostics) specific for HNE-modified protein (1:8000) and the 3-NT
levels were detected by primary rabbit antibody (Chemicon) specific for 3-NT (1:100).
The same secondary goat anti-rabbit IgG (Sigma) antibody was used in all applications.
The resultant stain was developed by application of Sigma-Fast [5-Bromo-4-chloro-3indolyl phosphate dipotassium/nitrotetrazolium
blue chloride (BCIP/NBT)] tablets; and the line densities were quantified using ScionImage software.
Two-dimensional gel electrophoresis
Samples of the proteins in the hypocampus or cortex were prepared as previously
described (Poon et al., 2004e). Briefly, 200μg of protein were applied to a pH 3-10
ReadyStrip™ IPG strip (Bio-Rad, Hercules, CA) for isoelectric focusing, and Linear
Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad) were used to separate
proteins according to their molecular weight (MrW). Sypro Ruby stain was used to stain
the gel for 2 hours, following which the gels were placed in deionized water overnight for
destaining.
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Western Blotting
Western blotting for 2D gels was performed as previously described (Poon et al.,
2004e). 200μg of the brain protein were incubated with 10mM DNPH solution (2N HCl)
at room temperature (25°C) for 20 min. The gels were prepared in the same manner as for
2D-electrophoresis. The proteins from the second dimension electrophoresis gels were
transferred onto nitrocellulose paper (Bio-Rad) using a Transblot-Blot® SD semi-Dry
Transfer Cell (Bio-Rad) at 15V for 2 h. The adducts of the carbonyls of the brain proteins
were detected immunochemically.
Image Analysis
The gels and nitrocellulose blots were scanned and saved in TIF format using a
Storm 860 Scanner (Molecular Dynamics) and Scanjet 3300C (Hewlett Packard),
respectively. PDQuest (Bio-Rad) was the software used for matching and analysis of
visualized protein spots among differential gels and oxyblots. After completion of spot
matching, the normalized intensity of each protein spot from individual gels (or oxyblots)
was compared between groups using statistical analysis.
Trypsin digestion
Samples were digested using the techniques previously described (Poon et al.,
2004e). Briefly, the selected protein spots were excised and washed with ammonium
bicarbonate (NH4HCO3), then acetonitrile at room temperature. The gel pieces were
digested with 20 ng/µl modified trypsin (Promega, Madison, WI) and incubated at 37°C
overnight in a shaking incubator.
Mass Spectrometry
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Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10
mg/mL in 0.1% TFA:ACN, 1:1, v/v). The mixture (1 μL) was deposited onto a fast
evaporation nitrocellulose matrix surface and analyzed with a TofSpec 2E (Micromass,
UK) matrix-assisted laser desorption ionization-time of flight (MALDI-TOF)mass
spectrometer in reflectron mode. The mass axis was adjusted with trypsin autohydrolysis
peaks (m/z 2239.14, 2211.10, or 842.51) as lock masses. The MALDI spectra used for
protein identification from tryptic fragments were searched against the NCBI protein
databases using the MASCOT search engine (http://www.matrixscience.com).
Statistics
The data were analyzed by two-tailed Student's t tests. A value of p < 0.05 was
considered statistically significant. Only the proteins in hippocampus and cortex of old
rats that were significantly different from those of young brains or from old rats treated
with LAC assessed by the Student’s t-test were selected for identification.

D3 Results
In order to identify the brain regions that show age-associated protein oxidation
and the reversal of such protein oxidation by LAC treatment, we measured the bulk
protein 3-NT, HNE and carbonyl levels of cortex (CX), substantia nigra (SN), septum
pellucidum (SP), striatum (ST), hippocampus (HP) and cerebellum (CB). We observed
that protein oxidation increased generally in most brain regions of aged rats. However,
only certain brain regions of the aged rats show statistically significant increased
oxidative modification of proteins, and administration of LAC reduced such ageassociated protein oxidation. Old rats show significant increases in protein carbonyl
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levels in CX, SN, SP, ST, and HP compared to that of young rats (Fig. D1).
Administration of LAC reduced the carbonyl level of all of these regions except ST (Fig.
D1). Similar to the findings in Alzheimer’s disease (AD) (Hensley et al., 1995b), no
change in protein oxidation was brain aging was found in CB.
With regard to protein-bound HNE levels, significantly increased values are
observed in CX, SP and HP of old rats, while administration of LAC reduced the HNE
levels in all of these regions (Fig. D2). We also demonstrated a significant increase of
protein 3-NT levels in SN and HP of aged rats, which is reduced by administration of
LAC (Fig. D3).
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Figure D1
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Figure D2
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Figure D3
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To begin to gain insight into which oxidatively modified proteins are implicated
in brain aging relevant to age-related learning and memory deficits, we performed a
redox proteomics analysis (Butterfield, 2004) on the HP and CX, brain regions in which
all indices of oxidative modification are elevated in brain aging (Fig D1-D3) and brain
regions that are involved in learning and memory. The specific carbonyl levels of three
proteins, hemoglobin (HMG), cofilin 1 (COF 1) and β-actin (ACT), are significantly
increased in HP of aged rats (Table D1). All of the specific carbonyl levels of these
proteins are reduced by LAC administration in old rats brains although the reduction of
HMG and ACT are not statistically significant (Table D1). Figure D4 shows these
proteins on the representative 2D western blots of the hippocampus for young rats, old
rats and old rats treated with LAC. Moreover, expression levels of five proteins were
significantly altered in the HP of old rats. Protein levels of mitochondrial aconitase (ACO
2), inositol monophosphatase (IMP), and α-enolase (ENO1) are significantly increased in
HP of old rats, while the expression level of creatine kinase B chain (CK-B), and tubulin
alpha-1 chain (TUB 1) were decreased (Table D2). Although LAC administration
reversed all these alterations to a level that is similar to that of young rats’ HP, only the
reduction of IMP level is statistically significant. Figure D5 shows these proteins on the
representative 2D electrophoresis gels of the hippocampus of young rats, old rats and old
rats treated with LAC.
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Table D1: Altered Protein Specific Carbonyl Level in Aged Rat Hippocampus a

Protein

6m c

2004

Hemoglobin
(HMG)

100±48

8569±4334 2959±2492 P=0.06

P =0.15

2206

Cofilin 1
(COF 1)

100±48

8053±4250

76±27

P < 0.05

P < 0.05

7505

Actin
(ACT)

100±93

1173±380

320±184

P< 0.05

P = 0.7

a

28m c

p value: p value:
28m +LACc young Old vs old +
vs old
LAC

SSP #b

n =4; b SSP # is assigned by the PDQuest imaging software ; c result expressed as
mean ± S.E.M.
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Table D2: Altered Protein Levels in Aged Rat Hippocampus a
SSP #b

3802

4201

Protein
Mitochondrial
aconitase
(ACO 2)
Inositol
monophosphatase
(IMP)

6m c

28m c

28m
+LAC c

p value: p value:
young vs Old vs old
old
+ LAC

100±14

162±21

134±14

p < 0.05

P =0.4

100±19

149±12

240±19

p < 0.05

P < 0.05

5603

α-enolase
(ENO1)

100±12

175±15

159±12

P < 0.01

P= 0.6

6602

Creatine kinase, B
chain
(CK-B)

100±15

32±12

89±27

P < 0.05

P= 0.8

7703

tubulin alpha-1 chain
(TUB 1)

100±18

34±19

45±33

P < 0.05

P =0.9

a

n =4; b SSP # is assigned by the PDQuest imaging software; c result expressed as
mean ± S.E.M.
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Figure D4
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Figure D5
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In the CX of old rats, the specific carbonyl levels of eight proteins were increased.
These proteins are heat shock cognate protein 70 (HSC 70), glyoxylase 1 ( GOL 1), βactin (ACT), 3-mercaptopyruvate sulfurtransferase (MPST), peroxiredoxin 1 (PDX),
phosphoribosyl pyrophosphate synthetase 1 (PPRPS1), and fumarase (FUM) (Table D3).
LAC administration reduced the specific carbonyl levels of all these protein in the CX of
old rats though such changes did not reach statistical significance. Fig. D6 indicates these
proteins on representative 2D western blots of the CX of young rats, old rats and old rats
treated with LAC. Expression levels of F-actin capping protein beta subunit (CAPZ) and
Rab GDP dissociation inhibitor β (GDI 2) were decreased in the CX of old rats, although
these changes were not statistically significant. In contrast, ubiquitin (UBQ) is increased
in CX of old rats when compared to that of young rats. Administration of LAC alters the
levels of each of these CX proteins in aged rats to the levels that are close to those in
young (Table D4). Fig D7 indicates these proteins on representative 2D electrophoresis
gels of the CX of young rats and old rats and old rats treated with LAC.
In order to determine if any of the changes observed in CX and HP, which do
slow increased oxidative damage in brain aging, might be artifactual, similar proteomics
analysis was performed in aged CB, which did not show any elevated oxidative stress
indices in brain aging. Consistent with the idea that our proteomics results reflect reality,
all of the alterations mentioned in HP and CX were not observed in the cerebellum.
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Table D3: Protein Specific Carbonyl Level in Aged Rat Cortex a

SSP
#b

1712

Protein

6m c

28m c

Heat shock cognate protein 70
100±98 547±52
(HSC 70)

p value:
p value:
Old vs
28m +LAC c young
old +
vs old
LAC
223±132

p<0.05 p=0.08

2212

glyoxylase 1
( GOL 1)

100±73 457±38

288±113

p<0.05 p=0.23

2502

beta-actin
(ACT)

100±72 454±38

176±127

p<0.05 p=0.10

4407

3-mercaptopyruvate
sulfurtransferase
(MPST)

100±13 151±13

185±127

p<0.05 p=0.80

6203

peroxiredoxin 1
(PDX)

100±71 450±37

401±15

p<0.05 p=0.29

phosphoribosyl pyrophosphate
6401
synthetase 1
100±72 454±38
(PPRPS1)

402±15

p<0.05 p=0.26

285±116

p<0.05 p=0.20

6606
a

Fumarase
(FUM)

100±73 457±38

n =3; b SSP # is assigned by the PDQuest imaging software; c result expressed as
mean ± S.E.M.
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Table D4: Altered Protein Level in Aged Rat Cortex a

28m c

28m
+LAC c

p value:
p value:
Old vs
young
old +
vs old
LAC

100±21

42±9

75±7

p=0.06 p<0.05

Rab GTP dissociation
inhibitor β
(GDI-2)

100±34

72±5

29±8

p=0.47 p<0.05

Ubiquitin
(UBQ)

100±12

141±19

41±25

p=0.15 p<0.05

SSP
#b

Protein

6m c

4303

F-actin capping protein
beta subunit
(CapZ)

5211

7002

a

n =3;

b

SSP # is assigned by the PDQuest imaging software; c result expressed as

mean ± S.E.M.
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Figure D6

327

Figure D7
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The identification of the proteins was performed by matching the obtained mass
spectrum to the spectrum in the NCBI database. The Mowse score indicates the
probability of the match being a random event (i.e., high Mowse score indicates the
match is unlikely to be a random event). Prior results suggest that the accuracy of protein
identification by mass spectrometry is equivalent to immunochemical identification
(Castegna et al., 2002b). The data base characteristics and protein properties of proteins
identified by mass spectrometry in hippocampus (Table D5) and cortex (Table D6) are
summarized.
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Table D5: Summary of Hippocampal Proteins in Aged Brain Identified by Mass Spectrometry

MW

no. of
Mowse
peptide
Probability b
Score a
Matched

DB accession

Protein ID

gi|37748075

Hemoglobin
(HMG)

154.9 8.45

48

10

113

5.01 X 10-12

gi|34865596

Cofilin
(COF)

22.2 9.37

35

6

69

1.26 X 10-07

gi|6671509

Actin beta
(ACT)

42.1 5.29

26

9

86

2.51 X 10-09

gi|38541404

Mitochondrial aconitase
(ACO 2)

86.1 7.87

27

19

205

3.16 X 10-21

gi|44888968

Inositol monophosphatase
(IMP)

30.8 5.17

40

7

72

6.31 X 10-08

gi|22096350

α-enolase
(ENO1)

47.5 5.84

41

12

93

5.01 X 10-10

gi|125296

Creatine kinase, B chain
(CK-B)

43.0 5.33

40

12

136

2.51 X 10-14

A24903

tubulin alpha-1 chain
(TUB)

50.8 4.94

41

12

85

3.16 X 10-09

a

pI

%
coverage

Mowse score greater than 57 indicating the probability of the false identification of
the protein is less than 0.05, p<0.05 ; b Probability that the reported identification of
the proteins is a random event.
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Table D6: Summary of Cortical Proteins in Aged Brain Identified by Mass Spectrometry
no. of
%
Mowse
MW pI
peptide
Probability b
coverage
Score a
matched

DB accession

Protein ID

gi|13242237

Heat shock cognate
protein 70
(HSC 70)

71 5.37

20

12

64

3.98 X 10 -07

gi|46485429

glyoxylase 1
(GOL 1)

21 5.12

37

9

83

5.01 X 10 -09

gi|71620

β-actin
(ACT)

42.1 5.29

24

7

92

6.31 X 10 -10

F-actin capping
protein beta subunit
(Cap Z)
3-mercaptopyruvate
sulfurtransferase
(MPST)
Rab GDP dissociation
inhibitor beta
(GDI)

31 5.69

22

6

68

1.58 X 10 -07

33.2 5.88

24

8

90

1.00 X 10 -09

51.2 5.66

15

6

69

1.26 X 10 -07

gi|16923958

peroxiredoxin 1
(PDX)

22.3 8.27

23

6

92

6.31 X 10 -10

gi|10946854

phosphoribosyl
pyrophosphate
synthetase 1

35.3 6.51

26

7

68

1.58 X 10 -07

gi|227665

Fumarase
FUM

54.7 9.13

26

10

87

2.00 X 10 -09

gi|38373984

Ubiquitin
(UBQ)

11.4 5.43

65

9

118

1.58 X 10 -12

gi|4826659

gi|20304123

gi|1707891

a

Mowse score greater than 57 indicating the probability of the false identification of
the protein is less than 0.05, p<0.05 ; b Probability that the reported identification of
the proteins is a random event.

331

D4 Discussion
It this study, we demonstrated that oxidative modification of proteins (indicated
by elevated protein carbonyl, 3-NT, and HNE-binding levels) is generally increased in all
brain regions of old rats when compared to those of young control rats, except
cerebellum. Moreover, most of these age-related oxidative stress indices can be reduced
by in vivo administration of LAC. Others reported that LAC improves memory and
learning deficits, reduces oxidative stress and enhances impaired plasticity of the central
nervous system (CNS) in aged animals (Laschi et al., 1990; Hagen et al., 1998b; Yasui et
al., 2002; McDaniel et al., 2003; Liu et al., 2004; Lombardo et al., 2004). Among the
brain regions, HP shows dramatic increases in protein carbonyl, HNE and 3-NT levels in
old rats, and such oxidative parameters were reduced by administration of LAC. Similar
results are observed in the CX except for 3-NT levels. Since HP and CX are involved in
learning and memory and showed significant alterations in oxidative parameters in our
current study, we used a parallel proteomic analysis to identify the proteins that were
increased in specific carbonyl levels as well as those with altered expression in these
brain regions in old rats when compared to those in young rats. Moreover, we used the
same technique to identify the proteins that have decreased specific carbonyl levels or
altered expression levels in HP and CX of old rats treated with LAC when compared to
those in old rats without LAC treatment. We found that the proteins that are oxidized or
altered in expression as a function of age can be classified into three principal categories
by their function: antioxidant, mitochondria function, and plasticity (Fig. D8A). The
alteration in specific carbonyl level and expression level of certain proteins by the
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administration of LAC in the HP and CX of old rats are summarized in Fig D8B referring
to these three categories.
Hippocampal proteins altered in oxidation level and expression level
Besides being involved in oxygen transport between the lung and tissues, HMG
also participates in other cellular functions, such as: modulation of erythrocyte
metabolism; an onset of erythrocyte senescence by HMG oxidation; enzymatic activities
and interactions with drugs; and sources of physiologically active catabolites (Giardina et
al., 1995). Moreover, HMG can chelate nitric oxide to reduce oxidative stress (Mason et
al., 1999). Upon oxidation, neuroglobin, a heme protein similar to HMG, acts as a
guanine nucleotide dissociation inhibitor (GDI) by inhibiting the rate of exchange of
GDP for GTP (Wakasugi et al., 2003), thus leading to protection against apoptosis
(Schwindinger and Robishaw, 2001). Therefore, the increased specific carbonyl level of
HMG observed in brain-aging possibly leads to functional alteration of HMG and, thus,
potentially to apoptosis in aged brains. However, such increased carbonyl level of HMG
was decreased by treatment by LAC, consistent with the concept that LAC can reduce
oxidative stress by diminution of the carbonyl level of HMG in brain aging, thus likely
restoring HMG function and protecting neurons from apoptosis.
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Figure D8
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COF1 is a putative actin binding protein involved in the regulation of actin
polymerization and depolymerization. COF1 is accumulated in the nucleus of senescent
fibroblast cells (Kwak et al., 2004), suggesting that COF1 is altered as a function of age.
Since actin polymerization and depolymerization are significant processes that are
involved in neuronal plasticity and memory consolidation (Lamprecht and LeDoux,
2004), increased oxidative modification of brain COF1 in old rats observed in our study
may explain the increased susceptibility of age-related decline of cognition in aged
animals. Our study shows that LAC treatment can decrease the oxidative modification of
COF1;, therefore, one can speculate that LAC enhances the neuroprotective effect of
COF1and promotes COF1-mediated ability to maintain neuronal plasticity.
ACT is a part of the cytoskeletal network responsible for cell structure and
motility as well as synaptic plasticity in dendritic spines (Fischer et al., 1998; Matus,
2000). Oxidative modification of ACT in the muscles of aged rats (Goto et al., 1999) and
decreased levels of actin in aged cultured neurons indicate that the oxidation of ACT may
accelerate its degradation as a function of age (Aksenova et al., 1999a). Consistent with
this notion, we showed that ACT is oxidatively modified in the HP of old rats. The
oxidative modification of ACT may lead to its structural alteration, thereby affecting
actin filament architecture and leading to severe disarrangement of the cytoskeleton in
aged brain. Moreover, structural alteration of ACT can impair neuronal plasticity, thus
increasing the susceptibility of aged brains to age-related cognitive decline. However, in
vivo LAC treatment decreases the oxidative modification of ACT, suggesting LAC
protects aged HP by maintaining neuronal plasticity.
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ACO2 is a mitochondrial matrix enzyme involved in the Kreb’s cycle. Selective
oxidation during aging (Yan et al., 1997; Das et al., 2001) and oxidative inactivation of
ACO2 by peroxynitrite leads to mitochondrial dysfunction (Radi et al., 2002). Also,
stress-mediated induction of ACO2 (Rzymkiewicz et al., 2000) suggests that increased
expression of ACO2 is a compensatory response to its oxidative inactivation . Consistent
with this notion, our current study show that protein level of ACO2 is increased in HP of
old rats. However, LAC treatment reduces the increased expression level of ACO2 in
aged brains, suggesting LAC modulates oxidative stress and may restore the normal
mitochondrial functions.
IMP plays a significant role in the intracellular inositol level control by
dephosphorylating inositol monophosphate to produce inositol (Atack, 1996), which can
then be used to produce phosphatidyl inositol (PI) to activate the PI signal transduction
pathway (Atack and Schapiro, 2002). IMP activity is decreased in aged mice brains
when compared to adult mice brains (Patishi et al., 1996). Decreased IMP activity could
be brought about by the modification of the oxidation-sensitive thiol residues in IMP
(Knowles et al., 1992). Moreover, increased activity of IMP in the cerebral spinal fluid
as a function of age suggests that active IMP is lost from the brains (Atack and Schapiro,
2002). Taken together, the increased protein level of IMP in aged HP in the current study
is possibly a compensatory response to its loss of activity, consistent with a possible
altered function in brain aging. LAC increased IMP expression even further in brain
aging, consistent with a potential restoration of the PI signal transduction pathway in
aged rat brain.
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ENO1 is the α subunit of enolase, the other subunits being β- and γ-enolase. αγ
and γγ isoforms are called neuron-specific enolases (NSE) (Keller et al., 1994).
Decreased enolase activity results in reduced metabolism in brains (Tholey et al., 1982).
Also, the loss of the mitochondrial resident (α-ketoglutarate dehydrogenase complex,
KGDHC)-enriched cells is proportional to the total loss of immunoreactivity to NSE,
suggesting that enolase is not only involved in metabolism, but also in mitochondrial
function (Ko et al., 2001). Additionally, the increased ENO1 specific carbonyl level in
aged senescent-accelerated mice brains (Poon et al., 2004e) suggests oxidative
inactivation of ENO1 as a function of age. Here, we show that the protein level of ENO1
is significantly increased in HP of aged rats, suggesting the possibility that the increased
level is a compensatory response to the loss of activity of enolase in brain aging.
CK, which is highly sensitive to oxidation, is found in cytoplasm and
mitochondria of cells to catalyze the reversible transfer of high energy phosphoryl
between the ATP and creatine phosphate (Schlegel et al., 1990; Wallimann et al., 1992;
Wyss et al., 1992; Kaldis et al., 1994). Three protein subunits of CK are designated M
(muscle), B (brain), and Mi (mitochondrial), which form three dimeric cytosolic (MM,
BB and MB) and distinct mitochondrial isoenzymes (Mi-CKs). It is also well established
that oxidative inactivation of CK-B occurs in aging, AD and other neurodegenerative
diseases (Hensley et al., 1995b; Aksenova et al., 1998; Aksenova et al., 1999b; Yatin et
al., 1999; Aksenov et al., 2001; Castegna et al., 2002b). Moreover, the decreased
expression of CK-B indicates that oxidative modification of this protein accelerates its
degradation (David et al., 1998). Consistent with this notion, our study shows that levels
of CK in aged rat brain is reduced significantly, and therefore likely affects its activity to
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produce ATP. However, such reduction in CK expression was reversed by LAC
treatment, suggesting LAC treatment can improve mitochondrial function, and therefore,
ATP production in the HP of aged rats.
TUB 1 is a structural protein that polymerizes to form microtubules of the
cytoskeleton. TUB1 also interacts with metabotropic glutamate receptor 7, which
mediates a variety of responses to glutamate in brains (Saugstad et al., 2002). Therefore,
alterations of TUB 1 not only change the cytoskeleton and intercellular trafficking, but
also changes the intercellular glutamate level control, thereby affecting interneuronal
signaling and potentially promotes excitotoxicity. Consistent with the notion that level of
TUB 1 is significantly decreased as a function of age (Nishibayashi et al., 1994), our
current study shows that the level of TUB 1 was decreased in aged rat HP, suggesting
that the alteration of tubulin contributes to alteration of the cytoskeleton and glutamate
dysregulation in aged brains.

Cortical proteins altered in oxidation level and expression level
CapZ is a subunit of an actin-binding protein that binds to the barbed end of actin
filaments. CapZ regulates actin polymerization dynamics by attaching the actin filaments
to the Z-line of myofibrils. CapZ also interacts with 5-hydroxytryptamine type 2C (5HT2C) receptors, which modulate a large variety of behavioral and physiological
processes (Becamel et al., 2002). Since actin polymerization dynamics contribute to
memory consolidation (Lamprecht and LeDoux, 2004), one can speculate that CapZ
contributes to the receptor-mediated molecular learning and memory consolidation
process. Here, we show that the CapZ expression is decreased as a function of age,
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suggesting an impaired actin polymerization process, with possibly impaired learning and
memory in aged subjects. Moreover, we showed that the decreased level of Cap Z in CX
of old rats can be elevated by treatment of LAC, suggesting that LAC can improve the
actin polymerization process, thus improving learning and memory in aged brains.
Guanosine diphosphate (GDP) dissociation inhibitor 2 (GDI 2) regulates the
GDP/GTP exchange reaction of Rab proteins involved in vesicle transport. This process
is critical to the release of synaptic vesicles in synapses. Therefore, GDI 2 may play a
regulatory role in plasticity of neurotransmission (Ishizaki et al., 2000). Moreover, GDI 2
is oxidatively modified in aged muscle (Kanski et al., 2003). Although no significant
alteration was found in the aged brains in our current study, we found that LAC treatment
can significantly reduce the level of GDI 2, suggesting that LAC regulates the plasticity
of neurotransmission by altering the level of GDI 2.
UBQ is a polyubiquitin protein precursor that marks cellular proteins for
degradation. UBQ is up-regulated by stress and proteasome inhibition (Noga and
Hayashi, 1996). Increased UBQ deposits are observed in dystrophic neurites of both
normal aging and AD brains (Migheli et al., 1992). Moreover, increased expression of
UBQ in aged monkey brains suggest that UBQ up-regulation is a response to age-related
oxidative stress (Schultz et al., 2001). Consistent with this notion, we found that mean
protein expression of UBQ is increased by 41 % in cortex of aged rats, although
statistical significance was not reached. However, following LAC treatment, a
statistically significant diminution of UBQ levels were found, suggesting both that the
level of UBQ had been raised in brain aging and that LAC treatment modulates the
oxidative stress in the CX of old rats.
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Age-related oxidative stress induces heat shock proteins (HSP) in aged brains.
HSP are molecular chaperones that mediate folding and assembly of other proteins (Poon
et al., 2004a). HSP-70 protects neurons against apoptosis by inhibiting the activation of
the caspase cascade (Mosser et al., 1997). HSC 70, the constitutive isoforms of HSP 70,
is recruited by the cell as a primary defense against stress conditions. HSC 70 is involved
in the degradation of misfolded proteins by binding to a particular peptide region and
labeling it for proteolysis (Kouchi et al., 1999). Therefore, it was suggested that HSC 70
may be involved in the structural maintenance of proteins by coupling with the
proteasome (Kouchi et al., 1999). Alteration of HSC 70 and HSP 70 in aged brains is
well established (reviewed in (Calabrese et al., 2003)). Moreover, the diminished activity
of HSC 70 in aging was suggested to be compensated by increased expression (Cuervo
and Dice, 2000). The decreased activity is believed to be brought about by oxidative
modification of HSC 70 (Castegna et al., 2002a). Consistent with this idea, the current
study suggests that HSC 70 was oxidatively modified in the CX of old rats when
compared to that in young rats (p<0.05). This result is consistent with the notion that
oxidative inactivation of HSC 70 in aged brains may cause impaired protein degradation
and lead to accumulation of aggregated proteins, thereby increasing susceptibility to agerelated cognitive decline. LAC treatment reduces the mean specific carbonyl level of
HSC 70, albeit not at a statistically significant level, potentially protecting brains from
age-related cognitive decline.
GOL 1 exhibits lactoylglutathione lyase activity that detoxifies toxic compounds.
Some of these toxic compounds are produced by the action of reactive oxygen species
(ROS) on biological molecules (Amicarelli et al., 1999). Hypoxia-induced oxidative
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stress impairs the activity of GOL 1 (Amicarelli et al., 1999), while antioxidant treatment
can enhance the activity of GOL 1 as well as reducing oxidative stress parameters
(Nagaraj et al., 2002), indicating oxidative modification could inactivate GOL 1.
Together, one can speculate that oxidative inactivation of GOL 1 is due to the age-related
oxidative stress. Consistent with this notion, the current study demonstrated increased
oxidative modification of GOL 1 in brain aging, suggesting the detoxification of toxic
species in aged CX is impaired. This would lead to accumulation of toxic species and
potentially neuronal death. Although not statistically significant, LAC treatment reduced
the oxidative modification of GOL 1, putatively improving its activity and reducing the
level of toxic species in aged brains.
MPST catalyzes the transfer of a sulfur ion from mercaptopyruvate to
mercaptoethanol. This reaction is especially important in regulation of the glutathione
level (Wrobel et al., 2000). The involvement of MPST in antioxidant metabolism is
manifested by its increased expression response to oxidative stress (Williams et al.,
2003). Our study shows that MPST is oxidatively modified and possibly inactivated in
aged CX, suggesting decreased antioxidant metabolism in aged CX. Consistent with this
notion, the glutathione level is also decreased in aged brains (Liu and Mori, 1993). Lower
levels of glutathione, possibly due in part to oxidative inactivation of MPST, not only
leads to loss of a reducing cellular component, but also could affecting expression and
activity of protective enzymes.
PDX is an oxidative stress-inducible antioxidant protein with peroxidase and
heme-binding activities. PDX is also involved in heme metabolism (Iwahara et al., 1995).
This enzyme is essential to cellular antioxidant defense (Neumann et al., 2003) and
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serves as a redox-regulating molecule against oxidative stress in aging (Yoshida et al.,
2003). Our proteomics analysis demonstrated increased oxidative modification of PDX in
CX of old mice, suggesting that redox regulation and antioxidant defense in aged rat CX
is possibly impaired by PDX oxidative inactivation, thus protecting aged brains from
oxidative damage and subsequent cognitive decline.
PRPPS1 produces phosphoribosyl pyrophosphate that is required for de novo
purine and pyrimdine biosynthesis. Mutations in PRPPS1 cause neurological impairment
(Roessler et al., 1993), indicating the activity of PRPPS1 is important to the proper
function of the CNS. Here, we show that oxidative modification of PRPPS1 in brain
aging could possibly inactive this enzyme and decrease the availability of phosphoribosyl
pyrophosphate, which is both a substrate and activator of the de novo and salvage
pathways of purine and pyrimidine synthesis (Kunjara et al., 1993). Therefore, oxidative
modification of PRPPS1 may be related to impaired RNA and protein synthesis necessary
for neuroplasticity observed in aged rats (Finch and Morgan, 1990; Rattan, 1996).
FUM catalyzes the hydration of fumarate to L-malate in the Kerb’s cycle. Severe
neurological impairment caused by FUM deficiency suggests that FUM is essential for
the integrity of the CNS (Coughlin et al., 1998). FUM contains an iron-sulfur cluster
active site that is sensitive to oxidative modification (Pan and Imlay, 2001). Therefore,
the oxidative modification of FUM shown in our proteomics study may inactivate the
enzyme and cause decreased ATP production, thus impairing the CNS functions in aged
brains. The addition of exogenous thioredoxin to FUM in mitochondria displays a
protective effect against oxidative stress (Ejima et al., 1999). Similarly, using LAC
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treatment can reduce oxidative stress and the oxidative modification of FUM, though not
statistically significant, thereby potentially improving cortical functions.
Summary of findings
The proteins identified in our study are involved in three impaired processes in
aged brains: antioxidant, mitochondria function and plasticity (Fig E8). Impaired
antioxidant capacity increases oxidative stress and cellular dysfunction (reviewed (Poon
et al., 2004a, b)). Mitochondrial dysfunction mediates increased oxidative stress and
apoptosis cascades as well as impaired energy metabolism (Cottrell and Turnbull, 2000).
Impaired plasticity leads to age-related learning and memory deficits (Castorina and
Ferraris, 1994). All of these processes contribute to the functional decline of the CNS in
aged subjects (Rattan, 1996; Cottrell and Turnbull, 2000; Foster and Kumar, 2002).
Treatment by LAC can improve the decline of these functions. Evidence shows that
oxidative stress is reduced and antioxidant levels are increased in aged brains treated with
LAC (Paradies et al., 1999; Sharman et al., 2002). Furthermore, improvement of
mitochondrial dysfunction by LAC is well established and recently reviewed (Hagen et
al., 1998b; Hagen et al., 1998a). Moreover, LAC improves neuronal plasticity, thus
ameliorating learning and memory deficits in aged brains (Castorina and Ferraris, 1994;
Liu et al., 2002; Yasui et al., 2002). Therefore, our results support the point of view that
treatment of LAC reduces oxidative stress by improving antioxidant defense and
mitochondrial function in the CNS, thereby improving the neuroplasticity and learning
and memory deficits in aged subjects. Moreover, we pinpoint that the improved
antioxidant, mitochondrial function and plasticity by LAC treatment in aged brain is, at
least partially, due to the alteration of the oxidation or the expression of ACT, COF,

343

CapZ, GDI, PRPP1, TUB, HMG, UBQ, HSC70, GOL 1, MPST, PRDX, MPST, ACO2,
IMP, ENO 1,CK, FUM. To our knowledge, this is the first study to identify specific
protein targets in HP and CX in brain aging and those proteins that are positively affected
by LAC in brain aging. Our results provide a valuable insight into the mechanism of agerelated protein oxidation and the effect of LAC on oxidative stress reduction and
functional improvements in the HP and CX of aged brains. We posit that LAC should be
considered as a potential therapeutic contributor for the treatment of cognitive decline in
aging and age-related neurodegenerative disorders.
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Appendix E
Proteomics Analysis provides Insight into Caloric Restriction Mediated Oxidation
and Expression of Brain Proteins Associated with Age-Related Impaired Cellular
Processes: Mitochondrial dysfunction, Glutamate Dysregulation and Impaired
Protein Synthesis
E1 Introduction
Age-related impairment of functionality of the central nervous system (CNS) is
associated with increased susceptibility to the development of many neurodegenerative
diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic
lateral sclerosis (ALS). The free radical theory of aging postulates that free radical
reactions with biomolecules, such as proteins and lipid membranes, are responsible for
the functional deterioration related to aging (Harman, 1969). This theory was later refined
to include the concept that mitochondria play a key role in aging acting as the major
source and target of oxidants (Miquel et al., 1980). It was proposed that there is a
correlation between mitochondrial oxidant production and longevity in mammalian
species (Miquel et al., 1980). Interestingly, caloric restriction (CR) can increase life span
and resistance to various age-related disorder in rodents (Review in (Koubova and
Guarente, 2003)).
In the CNS, evidence shows increased oxidative stress in aged animals when
compared to that in young animals (Floyd, 1999; Poon et al., 2004a, b). Mitochondrial
dysfunction plays a significant role in this increased oxidative damage. Injured
mitochondrial enzymes in aged animal lead to increased oxidative stress (Ventura et al.,
2002). Mitochondria in aged animals are enlarged with vacuolization, cristae rupture and
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the accumulation of paracrystalline inclusions (Floyd, 1999), consistent with the notion
that mitochondria are targets of increased oxidative stress in aged brains (Sastre et al.,
2003). Also, mitochondrial decay is a main contributor of accelerated aging (Atamna et
al., 2002; Ames, 2003). Age-related increase in mtDNA deletion (common deletion) was
found in elderly brains (Ozawa et al., 1990), causing diminished mitochondrial
bioenergetics diminishment in aged brains (Barja, 1999). Such increased oxidative stress
and mitochondrial dysfunction cause oxidation of proteins, thereby leading to their
dysfunction in most cases (Agarwal and Sohal, 1994; Agrawal et al., 1996; Butterfield et
al., 1997; Aksenova et al., 1998; Sohal et al., 2002; Butterfield, 2004). However,
oxidation of proteins during aging and age-related neurodegenerative disorders is rather
specific (Stadtman, 1992; Agarwal and Sohal, 1994; Agrawal et al., 1996; Butterfield and
Stadtman, 1997; Stadtman, 2001; Castegna et al., 2002b; Castegna et al., 2002a; Castegna
et al., 2003; Keller et al., 2004; Poon et al., 2004e). It is well established that CR can
reduce age-related oxidative stress (Sohal and Weindruch, 1996; Lass et al., 1998;
Parsons, 2000; Pamplona et al., 2002; Koubova and Guarente, 2003) and protein
oxidation in brains (Dubey et al., 1996; Guo et al., 2000a; de Oliveira et al., 2003). Along
with reduced protein oxidation, CR is also believed to contribute to the improvement of
age-related learning and memory deficit (Ingram et al., 1987; Moroi-Fetters et al., 1989),
as well as the improvement of the plasticity and recovery of the CNS (Mattson, 2000a).
Although the beneficial effects of CR on brains are well established, the
mechanism(s) of its action remains unclear. Two general mechanisms were proposed: (1)
CR reduces mitochondrial metabolism, thus decreases the level of mitochondrial radical
production, or (2) CR induces mild metabolic stress response by an increased production
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of neurotrophic proteins, therefore priming neurons against apoptosis (Mattson, 2000b;
Koubova and Guarente, 2003). In order to gain insight into the beneficial effects of CR
on oxidative stress, we located the brain regions that are benefited the most from reduced
oxidation. Then we used the non-biased based parallel proteomics approaches to identify
the proteins that are altered in oxidation and expression in these brain regions of CR aged
rats when compared to those in age control rats.
E2 Experimental procedures
Subjects
All animal protocols were approved by the University of Catania Laboratory
Animal Care Advisory Committee (Prot. Number 8488). Male Wistar rats purchased from
Harlan (Udine, Italy) were maintained in a temperature and humidity-controlled room
with a 12-h light:dark cycle and divided in two experimental groups. Control rats were
fed ad libitum up to 28 months of age a certified diet prepared according to the
recommendations of the AIN (In 100g of ad linitum, 53g Dextrin-Maltose, 25g oil
mixture, 22g casein, with additional 0.5g methionine, 3.5g salt mixture and 1.2g vitamin
mixture). The CR group, received at 12 months of age up to 28 months the same diet
except for a lower caloric intake. CR regimen was accomplished starting at month 12 and
continued until sacrifice, according to the “alternate day feeding” method, which is
equivalent to a reduction of caloric intake to about 60% compared to the `ad libitum´ fed
controls of the same age (Goodrick et al., 1983). In brief: the food was available all the
time for the ad libitum fed controls, while it was given every two days and remained
available for 24 h. Both groups were fasted for one day before scarified. Caloric restricted
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old rats weighed significantly less (-57%) compared to old rats fed normal caloric diet (p
<0.001).
Sample Preparation and Methods Employed
The brain samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM
NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4) and containing protease inhibitor
leupeptin (0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5 µg/mL), and PMSF
(40 µg/mL). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The
supernatant was extracted to determine the concentration by the BCA method (Pierce,
IL).
Immunochemistry
Levels of 3-nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) and protein carbonyls
were determined immunochemically as previously described (Poon et al., 2004d). Protein
carbonyl levels were determined as adducts of 2,4-dinitrophenylhydrazine (DNPH)
(Stadtman, 1992; Aksenov et al., 1997). The 2,4-dinitrophenyl hydrazone (DNP) adduct
of the carbonyls is detected on nitrocellulose paper using a primary rabbit antibody
(Intergen) specific for DNP-protein adducts (1:100). HNE and 3-NT levels were
determined in the same manner. The HNE levels were detected using a primary rabbit
antibody (Alpha Diagnostics) specific for HNE-modified protein (1:8000) and the 3-NT
levels were detected by primary rabbit antibody (Chemicon) specific for 3-NT (1:100).
The same secondary goat anti-rabbit IgG (Sigma) antibody was used in all applications.
The resultant stain was developed by application of Sigma-Fast (BCIP/NBT) tablets; and
the line densities were quantified by Scion-Image software package.
Two-dimensional gel electrophoresis
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Samples of the proteins in the whole brains were prepared as previously described
(Poon et al., 2004e). Briefly, 200μg of protein were applied to a pH 3-10 ReadyStrip™
IPG strip (Bio-Rad, Hercules, CA) for isoelectric focusing and Linear Gradient (8-16%)
Precast criterion Tris-HCl gels (Bio-Rad) were used to separate proteins according to
their molecular weight (MrW). Sypro Ruby stain was used to stain the gel for 2 hours,
following which the gels were placed in deionized water overnight for destaining.
Western Blotting
Western blotting for 2D gels was performed as previously described (Poon et al.,
2004e). 200μg of the brain protein were incubated with 10mM 2,4-dinitrophenyl
hydrazine (DNPH) solution (2N HCl) at room temperature (25°C) for 20 min. No
derivitization step is preformed for the measurement of the protein 3-NT levels. The gels
were prepared in the same manner as for 2D-electrophoresis. The proteins from the
second dimension electrophoresis gels were transferred onto nitrocellulose paper (BioRad) using a Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2 hrs. The
2,4-dinitrophenyl hydrazone (DNP) adducts of the carbonyls and the 3-NT of the brain
proteins were detected immunochemically.
Image Analysis
The gels and nitrocellulose blots were scanned and saved in TIF format using a
Storm 860 Scanner (Molecular Dynamics) and Scanjet 3300C (Hewlett Packard),
respectively. PDQuest (Bio-Rad) was the software used for matching and analysis of
visualized protein spots among differential gels and oxyblots. After completion of spot
matching, the normalized intensity of each protein spot from individual gels (or oxyblots)
was compared between groups using statistical analysis.
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Trypsin digestion
Samples were digested using the techniques previously described (Poon et al.,
2004e). Briefly, the selected protein spots were excised and washed with ammonium
bicarbonate (NH4HCO3), then acetonitrile at room temperature. The gel pieces were
digested with 20 ng/µl modified trypsin (Promega, Madison, WI) and incubated at 37°C
overnight in a shaking incubator.
Mass Spectrometry
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10
mg/mL in 0.1% TFA:ACN, 1:1, v/v). The mixture (1 μL) was deposited onto a fast
evaporation nitrocellulose matrix surface and analyzed with a TofSpec 2E (Micromass,
UK) MALDI-TOF mass spectrometer in reflectron mode. The mass axis was adjusted
with trypsin autohydrolysis peaks (m/z 2239.14, 2211.10, or 842.51) as lock masses. The
MALDI spectra used for protein identification from tryptic fragments were searched
against the NCBI protein databases using the MASCOT search engine
(http://www.matrixscience.com). Peptide mass fingerprinting used the assumption that
peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at
cysteine residues. Up to 1 missed trypsin cleavage was allowed. Mass tolerance of 150
ppm was the window of error allowed for matching the peptide mass values. Such search
results in a probability-based Mowse score for each spectrum to indicate the probability
that the match between the database and the spectra is a random event. Such a probability
is 10 (-Mowse score/10).

Statistics
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The averages of specific carbonyl level, specific 3-NT level and protein level
obtained from individual CR rats were compared with the averages of age-matched
control by Student's t tests. A value of p < 0.05 was considered statistically significant.
Only the proteins in CR aged brains that were significantly different from age matched
control brains assessed by the Student’s t-test were selected for identification. Similar
statistical analysis are usually used for proteomics data analysis (Castegna et al., 2002b;
Korolainen et al., 2002; Maurer et al., 2005). Sophisticated statistical analysises for
microarray data are not compatible for proteomics data (Boguski and McIntosh, 2003;
Maurer et al., 2005).

E3 Results
In order to locate the brain regions that are mostly affected by protein oxidation
by CR, we measured the bulk protein 3-NT, HNE and carbonyl levels of cortex (CX),
substantia nigra (SN), septum pellucidum (SP), striatum (ST), hippocampus (HP) and
cerebellum (CB). We found that CR generally reduces protein oxidation in all aged rat
brain regions. However, only certain brain regions of the aged rats show statistically
significant decrease in oxidative modification by CR. Aged rats with CR show significant
decreases in protein carbonyl levels in SN (32%) and ST (19%) compared to those of age
matched controls (Fig. E1). With regard to protein-bound HNE levels, significant
decreased values are observed in CX (13%) and HP (12%) of aged rats with CR (Fig.
E2). We also show a significant reduction of protein 3-NT levels in SN (26%) and HP
(38%) of aged rats with CR (Fig. E3).
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Figure E1
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Figure E2
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Figure E3
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In the HP of CR rats, the specific 3-NT levels of three proteins, malate
dehydrogenase (MDH), phosphoglycerate kinase 1 (PKG1) and 14-3-3 zeta protein (143-3Z), are significantly decreased (Table E1). Figure E4 shows these proteins on the
representative 2D western blots of the HP for CR rat and age matched control. Moreover,
expression levels of four proteins were significantly decreased in the HP of CR aged rats.
These proteins are DLP1 splice variant 1 (DLP1), mitochondrial aconitase (ACO2),
dihydrolipoamide dehydrogenase (DLDH), neuroprotective peptide H3 (NPH3), and
eukaryotic translation initiation factor 5A (eIF-5A). Also, the expression level of an
unnamed protein product (UNP1) was decreased (Table E2). This protein is indicated in
the rat genome and shows a similar sequence to elongation factor 2 (EF-2). However, the
function and additional information are yet to be discovered. Figure E5 shows these
proteins on the representative 2D electrophoresis gels of the HP of CR rat and aged
match control.
In the ST of CR rats, the specific carbonyl levels of six proteins were decreased.
These proteins are pyruvate kinase M2 (PKM2), α-enolase (ENO1), inositol
monophosphatase (INSP1), and F1-Atpase Chain B (ATP-F1B) (Table E3). Fig E6
indicates these proteins on the representative 2D western blots of the ST of CR rat and
aged match control. Moreover, expression levels of phosphoglycerate kinase 1 (PKG1),
inosine monophosphate cyclohydrolase (IMPCH) and F1-Atpase Chain A (ATP-F1A)
were significantly increased in the ST of CR rats (Table E4). Fig E7 indicates these
proteins on the representative 2D electrophoresis gels of the ST of CR rat and aged match
control.
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Table E1: Proteins with decreased 3-NT levels in HP of CR aged rats.

Protein

Control
(n=5)
A.U. ± S.E.M.*

CR
(n=5)
A.U. ± S.E.M.*

Fold
Change

p value

malate
dehydrogenase
(MDH)

0.418 ± 0.127

0.099 ± 0.046

4.2 ↓

p < 0.05

phosphoglycerate
kinase 1 (PKG1)

0.392 ± 0.056

0.081 ± 0.013

4.8 ↓

P < 0.001

14-3-3 Zeta protein

0.028 ± 0.010

0.010 ± 0.002

2.8 ↓

p < 0.0005

* A.U., arbitrary unit obtained from the ratio of specific 3-NT level and protein level.
S.E.M., standard error of mean
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Figure E4
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Table E2: Altered protein levels in HP of CR aged rats.

Protein

Control
(n =6)
A.U. ± S.E.M.*

CR
(n=6)
A.U. ± S.E.M.*

Fold
Change

p value

DLP1 splice variant 1
(DLP1)

466 ± 53

257 ± 48

1.8 ↓

p < 0.05

mitochondrial aconitase
(ACO2)

1839 ± 277

720 ± 247

2.6 ↓

p < 0.05

Dihydrolipoamide
dehydrogenase (DLDH)

2395 ± 195

1240 ± 168

1.9 ↓

p < 0.005

Neuroprotective peptide
2143 ± 221
H3 (NPH3)

994 ± 207

2.2 ↓

p < 0.01

similar to Eukaryotic
translation initiation
factor 5A (eIF-5A)

5251 ± 615

2477 ± 648

2.1 ↓

p < 0.05

unnamed protein
product 1 (UNP 1)

638 ± 103

951 ± 37

1.5 ↑

p < 0.05

* A.U., arbitrary unit obtained from indicating protein level. S.E.M., standard error of
mean
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Figure E5
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Table E3: Proteins with decreased specific carbonyl levels in ST of CR aged rats.
Control
(n=6)
A.U. ± S.E.M.*

Protein

CR
(n=5)
A.U. ± S.E.M.*

Fold
change

p value

pyruvate kinase M2
(PKM2)

0.454

±

0.217

0.016

±

0.010

28 ↓

p=

0.05

α-enolase (ENO1)

0.489

±

0.242

0.003

±

0.001

163 ↓

p=

0.05

Inositol
monophosphatase
(INSP1)

1.560

±

0.413

0.415

±

0.133

4↓

p<

0.05

F1-ATPase Chain B
(ATP-F1B)

2.10

±

0.98

0.016

±

0.007

131 ↓

p<

0.05

* A.U., arbitrary unit obtained from the ratio of specific carbonyl level and protein level.
S.E.M., standard error of mean
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Figure E6
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Table E4: Altered proteins levels in ST of CR aged rats.

Protein

Control
(n=6)
A.U. ± S.E.M.*

CR
(n=5)
A.U. ± S.E.M.*

Fold
Change

p value

phosphoglycerate
kinase 1 (PGK1)

1433

±

303

421 ± 33

3.4 ↓

p<

0.05

F1-ATPase Chain A
(ATP-F1A)

1243

±

141

556 ± 68

2.2 ↓

p<

0.005

Inosine
monophosphate
cyclohydrolase
(IMPCH)

549

±

191

10 ± 1

54.9 ↓

p<

0.05

* A.U., arbitrary unit obtained from indicating protein level. S.E.M., standard error of
mean
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Figure E7
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The identifications of the proteins were performed by matching the obtained mass
spectrum to the spectrum in the NCBI database. The Mowse score indicates the
probability that the match is a random event; high Mowse score indicates the match is
unlikely to be a random event. Prior results suggest that the accuracy of protein
identification by mass spectrometry is equivalent to immunochemical identification and
immunochemical identification confirmed the identification (Castegna et al., 2002b). The
identification of the proteins is summarized in Table E5.

E4 Discussion
Consistent with other laboratories (Dubey et al., 1996; Radak et al., 1998; Forster
et al., 2000), we show that oxidative modification of proteins (indicated by the protein
carbonyl, 3-NT, and HNE levels) is generally decreased in all brain regions of CR aged
rats when compared to those of the age matched control. It is possible that reduction of
oxidative stress parameters could be in part due to effects of metal ions, particularly iron
ion, since elevated non-heme iron in the aged brain is attenuated by CR (Cook and Yu,
1998).
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Table E5: Summary of proteins identified by mass spectrometry

Identified Protein

# Peptides % Coverage
Probability
pI, MrW Mowse
gi accession # matched of matched
of a random
(kD)
Score
identification hit
peptides

malate dehydrogenase gi|42476181
(MDH)

8

36

8.93, 36.1

94

3.98 X 10 -10

phosphoglycerate
gi|40254752
kinase 1 (PGK1) (HP)

19

58

8.02, 44.9

160

1.00 X 10-16

gi|13487931

16

64

4.73, 28.0

123

5.01 X 10-13

DLP1 splice variant 1 gi|2435480
(DLP1)

4

42

5.64, 13.3

64

3.98 X 10-07

gi|40538860

19

27

7.87, 86.1

224

3.98 X 10-23

gi|40786469

13

32

7.96, 54.6

75

3.16 X 10-08

gi|8393910

10

74

5.48, 20.9

97

2.00 X 10-10

4

47

5.08, 17.0

62

6.31 X 10-07

6

8

N/A

62

6.31 X 10-07

14-3-3 zeta protein

mitochondrial
aconitase (ACO2)
Dihydrolipoamide
dehydrogenase
(DLDH)
Neuroprotective
peptide H3 (NPH3)

similar to Eukaryotic
gi|27672956
translation initiation
factor 5A (eIF-5A)
unnamed protein
product 1 (UNP1)

gi|56082

Table 5 continued on the next page.
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Table E5: Summary of proteins identified by mass spectrometry (Contiuned)

Identified Protein

# Peptides % Coverage
Probability
pI, MrW Mowse
gi accession # matched of matched
of a random
(kD)
Score
identification hit
peptides

pyruvate kinase M2
(PKM2)

gi|206205

12

28

7.15, 58.3

72

6.31 X 10-08

α-enolase (ENO1)

gi|22096350

20

59

5.84, 47.5

195

3.16 X 10-20

gi|14091736

9

36

5.17, 30.8

87

2.00 X 10-09

gi|6729935

17

57

4.95, 51.3

196

2.51 X 10-20

phosphoglycerate
gi|40254752
kinase 1 (PGK1) (ST)

16

48

8.02, 44.9

169

1.26 X10 -17

F1-ATPase Chain A
(ATP-F1A)

gi|6729934

16

43

8.28, 55.4

196

2.51 X10 -20

gi|2541906

10

24

6.72, 64.7

76

2.51 X10 -08

Inositol
monophosphatase
(INSP1)
F1-ATPase Chain B
(ATP-F1B)

Inosine
monophosphate
cyclohydrolase
(IMPCH)
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Among the brain regions, HP shows a dramatic decrease in protein carbonyl,
HNE and 3-NT levels in CR aged rats brains even though the decrease of the protein
carbonyl level is not statistically significant. The vulnerability to age-related protein
oxidation and structural changes of HP in brain are well established (Dubey et al., 1996;
Aksenova et al., 1998; Miller and O'Callaghan, 2003). Also, CR imposes a significant
reduction of protein oxidation in HP of rats (Dubey et al., 1996; Aksenova et al., 1998).
Since HP in the CR aged rats shows the most significant decrease (38%) of the protein 3NT level and is relevant to Alzheimer’s disease (AD) pathology (Kantarci and Jack,
2003), we used parallel proteomic analysis to specifically identify the proteins that were
decreased in specific 3-NT levels as well as those with the altered expression. Although
tyrosine nitrosylation is a formal oxidation of the protein, it should be noted that
nitrosylation of proteins is not only determined by ROS levels but is also affected by
NOS activity. Thus, 3-NT is not simply reflective of ROS, but also reflects RNS.
Moreover, we used the same technique to identify the proteins with reduced specific
carbonyl levels or altered expression levels in ST of CR aged brains, because ST is
another brain region that is vulnerable to protein oxidation and lipid peroxidation (Zhang
et al., 1994; Driver et al., 2000), and relevant to age-related neurodegenerative disorders
such as PD and Huntington’s disease (HD)(Golembiowska et al., 2002; Levesque et al.,
2003).
Although SN of CR rats show significant decrease of specific carbonyl and 3-NT
levels when compared to the aged match controls, limited amount of proteins are
harvested from SN due to the small size of SN. Therefore, parallel proteomic analysis of
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SN is not possible. Also, proteomic analysis of HNE-modified protein is not performed
because the majority of the HNE-modified proteins are membrane proteins that cannot be
easily dissolved in solution for 2D-electrophoresis.
HP
HP plays an important role in both memory and learning. Age-related increased
oxidative stress in HP of aged animals causes structural alteration (Dubey et al., 1996;
Aksenova et al., 1998; Miller and O'Callaghan, 2003). Moreover, synaptic loss and
increased protein oxidation in HP is the major pathology of AD (Scheff and Price, 2003).
Consistent with the notion that CR can reduce protein oxidation in HP of aged rats
(Dubey et al., 1996; Aksenova et al., 1998), we show that the 3-NT levels of HP is
significantly decreased in HP of CR aged rats when compared to age matched control.
Furthermore, we identified that the specific proteins that are reduced in 3-NT levels are
MDH, PKG1 and 14-3-3 zeta protein. Along with the reduced 3-NT level, the expression
of DLP1, ACO2, DLDH, NPH3, eIF-5A and UNP1 are also significantly altered in HP of
CR rats.
PGK1 catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate
in glycolysis, and MDH is located within the mitochondrial matrix to connect glycolysis
to mitochondrial respiration. Both of these reactions convert ADP to ATP to ensure
maximum glutamate accumulation into presynaptic vesicles. Moreover, activity of these
enzymes are decreased during aging (Oliver et al., 1987; Hrachovina and Mourek, 1990),
possibly due to oxidative modification (Oliver et al., 1987). Consistent with this notion,
increased protein levels of PGK1 as a function of age (Boraldi et al., 2003) maybe a
compensatory response to oxidative stress. Our study shows that reduced nitration of
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MDH in HP of aged rats by CR indicates that the CR-induced activity increase is
possibly due to reduced nitration of MDH and the reduced 3-NT level in HP of aged
rats, indicating that CR can possibly increase PGK1 activity in HP of this important
region in aged rats. Both of these changes result in increasing ATP availability, synaptic
plasticity, learning and memory, antioxidant defense and neuronal recovery as well as
preventing neuronal cells from glutamate toxicity.
ACO2 and DLDH (E3 component of pyruvate dehydrogenase complex, and αketoglutarate dehydrogenase) are mitochondrial matrix enzymes involved in the Kreb’s
cycle. Age-related activity alteration (Leong et al., 1981; Ksiezak-Reding et al., 1984;
Rajeswari and Radha, 1984; Curti and Benzi, 1989, 1990; Yan et al., 1997; Das et al.,
2001) and oxidative inhibition (Radi et al., 2002; Kumar et al., 2003; Samikkannu et al.,
2003) of these enzymes are observed. Also stress-mediated increased expression of
ACO2 is observed, suggesting that increased expression of ACO2 is a compensatory
response to its oxidative inactivation. In our current study, we show that CR decreased
the level of ACO2 and DLDH in HP of aged rats, indicating the loss of the compensatory
response to oxidative stress is likely due to the improvement of normal mitochondrial
functions that are brought about by CR-mediated oxidative stress release.
Increased protein levels of PGK1 as a function of age (Boraldi et al., 2003) maybe
a compensatory response to oxidative stress. Here we show that CR can reduce the 3-NT
level in HP of aged rats, indicating that CR can possibly increase PGK1 activity in HP of
this important region in aged rats, thus increasing ATP availability as well as preventing
neuronal cells from glutamate toxicity.
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14-3-3Z protein is involved in a number of cellular functions including signal
transduction, protein trafficking and metabolism and mitochondrial import (Alam et al.,
1994; Dougherty and Morrison, 2004). Oxidative insults cause dissociation of 14-3-3
complex and activate JNK and p38 pathways, thus initiating apoptosis (Goldman et al.,
2004). Here we show that CR can reduce the oxidative modification of 14-3-3Z, thus
maintaining normal cell functions and preventing apoptosis in aged brains.
DLP1 is a novel dynamin-like protein expressed in rat tissues. Dynamin is
involved in receptor-mediated endocytosis and intercellular trafficking. Since dynamin
interacts with phosphatidylinositol 3-kinase (PI3K) (Harrison-Findik et al., 2001), it is
likely in signaling and in addition may possibly promote apoptosis. Moreover, altered
endocytic function in dendrites in older neurons is associated with the increased level of
dynamin (Blanpied et al., 2003). Taken together, increased level of dynamin or DLP1
alters intercellular trafficking and initiates apoptosis in neuronal cells. Our current study
shows that CR can possibly prevent these alterations by decreasing the protein level of
DLP1, thus protecting cells from apoptosis.
NPH3 is involved in various functions in the CNS, such as binding to
phosphatidylethanolamine, enhancing acetylcholine synthesis and inhibiting Raf-kinase.
This protein also acts as a lipid carrier and binding protein that plays a significant role in
membrane organization (Frayne et al., 1998), a process that is critical to mitochondrial
integrity. The mRNA and protein levels of NPH3 are significantly increased in aged
human HP and senescence-accelerated mice (Matsukawa et al., 1999; Yuasa et al., 2001).
Therefore, up-regulation of NPH3 as a function of age is a likely response to oxidative
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stress. In our current study, CR reduces oxidative stress; thus, a decreased level of NPH3
in aged CR mice when compared to their age controls are observed.
eIF-5A is a translation initiation factor that is involved in the initiation of protein
synthesis. Since eIF-5A plays a pivotal role in regulation of protein synthesis, it is an
important determinant of cell proliferation and senescence (Thompson et al., 2004).
Inhibition of eIF-5A induces apoptosis (Tome et al., 1997), indicating that the eIF-5A
activity is critical to normal cell functions. However, inactivation of eIF-5A by chemical
modification inhibits cell growth and diminishes 30% of protein synthesis (Kang and
Hershey, 1994). This study reflects that eIF-5A is required for translation of specific
mRNAs selectively. Our current study shows that the impaired protein synthesis in aged
brains (Finch and Morgan, 1990; Sastre et al., 2003) was possibly improved by increased
eIF-5A protein levels in the HP of the CR rats. This change thereby provides sufficient
protein in neuronal cells for normal cell function in CR aged rats to compensate the
impaired protein synthesis in aged brains.
UNP1 is identified as a protein that shares high similarity to the primary structure
of elongation factor 2(EF-2), an enzyme that catalyzes the translocation step of peptide
elongation in protein biosynthesis. UNP1 (pI = 8, Mw = 96kD) shows a slightly higher
molecular weight (Mw) and dramatic shift of isoelectric point (pI) when compared to EF2 (pI = 6.65, Mw = 95kD). Interestingly, these Mw and pI alterations are also observed in
oxidatively modified protein (Weber et al., 2004). Therefore, UNP1 is possibly the
oxidized form of EF-2 and a decreased level of UNP1 could implicate less inactive forms
of EF-2. Since oxidative modification of EF-2 contributes to the impaired protein
synthesis in aged rat brains (Finch and Morgan, 1990; Parrado et al., 1999; Sastre et al.,
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2003), we speculate that our study may imply that EF-2 modification is possibly reduced
by CR, thus restoring the normal protein syntheses protein process in aged brains.
ST
The ST is best known for its role in movement, but it is also involved in a variety
of other cognitive processes involving executive function. ST show increased protein
oxidation and lipid peroxidation as a function of age(Zhang et al., 1994; Driver et al.,
2000). Moreover, increased oxidative stress is observed in the ST of PD and HD patients
(Review in (Babior, 1999; Browne et al., 1999; Jenner, 2003)). These studies indicate that
age-related protein oxidation plays critical roles in the impaired function of ST. However,
CR can modulate these oxidative stresses in ST (Dubey et al., 1996; Bruce-Keller et al.,
1999) and improve dopamine function in ST of aged animals (Diao et al., 1997; Carr et
al., 2003). Consistent with these studies, we show here that the protein carbonyl level of
ST is reduced. Also we found that the specific carbonyl levels of INSP1, PKM2, ENO1,
ATP-F1B and are decreased and the expression levels of PKG1, IMPCH, and ATP-F1A
were significantly increased.
INSP1 plays a significant role in controlling the intracellular inositol level by
dephosphorylating inositol monophosphate(s) to produce inositol (Atack, 1996), which
can then be used to produce phosphatidyl inositol (PI) to activate the PI signal
transduction pathway (Atack and Schapiro, 2002). INSP1 activity is decreased in aged
mice brains when compared to the adult mice brains (Patishi et al., 1996). Decreased
INSP1 activity can be brought about by modifications of the oxidation-sensitive thiol
residues in INSP1 (Knowles et al., 1992). In the current study, we found that oxidation of
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INSP1 in aged rat ST is reduced by CR, thus possibly improving its function for the PI
signal transduction pathway in aged rats brains.
PKM2 ENO1, and PGK1 are all glycolytic enzymes that are involved in ATP
production. Activity alteration and oxidation of these enzymes were demonstrated.
(Sharma et al., 1980; Vitorica et al., 1981; Sharma and Rothstein, 1984; Oliver et al.,
1987; Pastoris et al., 2000; Castegna et al., 2002a; Poon et al., 2004e). Here, we showed
that decreased carbonyl level of PKM2 and ENO1 in the CR old rats could lead to
improved activity, and thus to improved ATP production in CR old rat brain. Moreover,
the abnormally increased level of PKG1 in aged brains (Boraldi et al., 2003) is also
decreased in the ST of CR, suggesting CR can improve cellular metabolism, thereby
conserving energy and materials in neurons in brain aging.
Inosine monophorsphate cyclohydrolase (IMPCH) is a bifunctional protein that
catalyzes the last two steps of de novo purine biosynthesis , which is further used for
mRNA and DNA synthesis. The de novo synthesis of inosine monophorsphate plays a
role in the regulation of glutamate levels since glutamine is a substrate of the first step of
this process. Alteration of inosine monophorsphate concentration in aged cardio muscle
imply that IMPCH is altered as a function of age (Wegelin et al., 1996). Moreover,
inhibition of IMPCH can retard cell growth (Szabados et al., 1998), suggesting IMPCH
play an important role in normal cell functions. In the current study, we show that the
level of IMPCH in ST of CR rats is significantly lower than that of age matched control.
Since CR reduces oxidative stress, most of mRNA will not be oxidatively modified and
therefore will be successfully translated. This results in less demand of mRNA for protein
synthesis. Therefore, down-regulation of IMPCH might be a result of decreased demand
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for mRNA nucleotide and improved glutamate control caused by CR mediated oxidative
stress release.
ATP-F1A and ATP-F1B are members of the F1 synthase (ATP F1) enzymatic
complex that binds ADP, phosphate and ATP for the synthesis of ATP during oxidative
phosphorylation. Post-transcriptionally increased levels of ATP-F1A are observed as a
function of age in the cerebral cortex of rats (Nicoletti et al., 1995; Nicoletti et al., 1998),
suggesting abnormal ATP F1 regulation in aged brains. Such abnormality can cause
deregulation of ATP concentration equilibrium. The current proteomics study shows the
ATP-FA specific carbonyl level is decreased and the ATP-FB level is decreased by CR,
suggesting that the altered ATP production in aged brains can be improved, at least
partially, by CR. This improved ATP production is necessary for neuronal recovery.
E5 Conclusion
The striking feature of these proteins is that they are all involved in three impaired
processes in aged brains: glutamate regulation, mitochondria associated metabolism and
protein synthesis (Fig E8). Dysregulation of glutamate levels cause receptor-mediated
toxicity and abnormal calcium levels (Foster and Kumar, 2002). Mitochondrial
dysfunction mediates increased oxidative stress and apoptosis cascades as well as
impaired energy metabolism (Cottrell and Turnbull, 2000). Impaired protein synthesis
alters of the homeostatic state of enzymes necessary for normal cell function, thus
impairing the maintenance, repair and normal metabolic functioning of the cell (Rattan,
1996). All of these processes contribute to the decline of function in the CNS of aged
animals (Rattan, 1996; Cottrell and Turnbull, 2000; Foster and Kumar, 2002). CR can
improve these functional declines. Evidence shows that regulation of glutamate levels is
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improved in CR aged brains (Magnusson, 1997a, b; Guo et al., 2000a). Furthermore,
improvement of mitochondrial dysfunction by CR is well established and recently
reviewed (Sohal et al., 1994; Lambert et al., 2004). Moreover, CR increases the serum
level of growth hormone, thus stimulating protein synthesis (Norrelund et al., 2002).
Therefore, our results support the hypothesis that CR induces a mild metabolic stress
response by increasing the production of neurotrophic proteins, therefore priming
neurons against apoptosis. Moreover, we pinpoint that the improved glutamate
regulation, mitochondrial function and protein synthesis in aged brain by CR is, at least
partially, due to the CR-mediated alteration of the oxidation or the expression of PKM2,
ENO1, INSP1, ATP-F1B, PKG1, IMPCH, ATP-F1A MDH, PKG1 and 14-3-3 zeta
protein, DLP1, ACO2, DLDH, NPH3, eIF-5A and UNP1. Our results provide a valuable
insight into the mechanism of CR on oxidative stress reduction and functional
improvements in the aged CNS. CR has been suggested as a potential strategy to reduce
risk of age-related neurodegenerative disorder (Mattson, 2003), which the present study
imply maybe due reduction in oxidative damage and changed expression of specific
hippocampal and striatal proteins
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Figure E8
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Appendix F:
Proteomic Identification of Differentially Expressed Proteins in the Aging Murine
Olfactory System and Transcriptional Analysis of the Associated Genes
F1 Introduction
Olfactory impairment and anosmia (loss of sense of smell) have been associated
with aging in humans (Murphy et al., 2002) as well as with several age-associated
neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases (Mesholam
et al., 1998). Many neuroanatomical and immunohistochemical changes have been
documented in the olfactory epithelium (OE) and olfactory bulbs (OB) of aging humans.
These include a reduction surface area and an increase in susceptibility to apoptosis of the
OE and a reduction of OB size and cell number (Kovacs, 2004). In the human OE,
reduced adrenergic innervation of blood vessels and glands (Chen et al., 1993) and
decreased levels of xenobiotic metabolizing enzymes with age (Krishna et al., 1995)
suggest impaired secretory and vasomotor responses to environmental stressors. The agerelated reduction in HSP70 expression by human olfactory receptor neurons (Getchell et
al., 1995) suggests a specific neuronal impairment in stress responses that may contribute
to the loss of olfactory sensibility with age. In the human OB of elderly subjects, high
levels of lipofuscin as well as the presence of numerous microglia, occasional β-amyloid
fibrils and rare neurofibrillary tangles have also been observed (Getchell et al., 2002).
Molecular alterations in the aging murine olfactory epithelium have been reported
at the transcriptional level in OE of senescence accelerated mouse models (Getchell et al.,
1995; Getchell et al., 2003), where there was a down regulation of PI3-kinase and ERK
signaling, up-regulated oxidative stress indicators, possible disruption of the extracellular
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matrix and a marked immunosenescence were observed. However, the precise cellular
changes occurring in the normally aging murine olfactory system, both at the protein and
genomic level, have not been reported previously. In this study, we utilized an unbiased
fundamental proteomic analysis as a discovery-based method to identify significantly
regulated proteins in the aging OE and OB. We report significant changes in the
molecular architecture of the aging murine olfactory epithelium and bulb at the protein
and transcriptional levels. Our study provides the basis on which to formulate hypothesisdriven experiments to determine how the significantly regulated proteins are modulated
in aging.
F2 Experimental procedures
The following experiments are performed with collaboration with Radhika A.
Vaishnav.
Animals and tissue harvesting from old and young mice
A total of 16 C57BL/6 male mice were obtained from Harlan, US and were of two
ages: the first group consisted of eight 80-week old mice that were maintained as part of
the National Institute on Aging Aged Rodent Colonies, and the second group consisted of
eight 6-week old mice. Throughout the text the first group is called “old” mice and the
second group called “young” mice to identify and characterize protein and genomic agerelated changes. Six week old mice were chosen for this study as they are sexually
mature, young adults with a functionally developed olfactory system. The mice were
maintained in an animal facility at the Department of Laboratory Animal Research on a
12 h light:dark cycle in Bioclean units with sterile-filtered air and provided food and
water ad libitum. All protocols were implemented in accordance with NIH guidelines
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and approved by the University of Kentucky Institutional Animal Care and Use
Committee. The body weights for the old mice ranged from 32 to 35 g and for the young
mice from 19 to 24 g. Following euthanasia with CO2, microdissection was performed to
isolate the OE and the OB following a procedure previously reported (Getchell et al.,
2002; Getchell et al., 2004). Immediately following tissue harvesting, the tissues were
weighed and snap frozen in liquid N2. For the old mice, the average OE weight and SD
was 24.5 +/- 8.3 mg and for the OB was 32.6 +/- 3.3 mg; for the young mice, the average
OE weight was 13.8 +/- 2.3 mg and for the OB was 25.4 +/- 5.3 mg. The OEs and OBs
from five old and five young mice were used for proteomic analysis; the OEs and OBs
from three old mice and three young mice were used for RNA extraction.
Proteomics sample preparation
The OE and OB samples were homogenized in a lysis buffer (10 mM HEPES,
137 mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4 and containing the
protease inhibitors leupeptin (0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5
µg/mL), and PMSF (40 µg/mL)). Homogenates were centrifuged at 15,800 g for 10 min
to remove debris. The supernatant was extracted to determine the concentration by the
BCA method (Pierce, Rockford, IL, USA).
Two-dimensional gel electrophoresis
Samples of the proteins in the OE and OB were prepared as previously described
(Poon et al., 2004e). Five individual gels for OE of old mice and five individual gels for
OE of young mice (a total of ten) were run. Similarly, a total of ten gels were run for OB.
Briefly, 200 μg of protein were applied to a pH 3-10 ReadyStrip™ IPG strip (Bio-Rad,
Hercules, CA) for isoelectric focusing (IEF), based on the pI or Isoelectric pH of the
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protein. The focused IEF strip was stored at –80oC until second dimension
electrophoresis was performed. For second dimension electrophoresis, Linear Gradient
(8-16%) Precast criterion Tris-HCl gels (Bio-Rad, Hercules, CA) were used to separate
proteins according to their molecular weight (MrW). Precision ProteinTM Standards (BioRad, Hercules, CA) were run along with the samples. After electrophoresis, the gels were
incubated in fixing solution for 20 min. Sypro Ruby stain were used to stain the gels for 2
hours. The gels were placed in deionized water overnight for destaining.
Image analysis
The gels were scanned and saved in TIF format using a Storm 860 Scanner
(Molecular Dynamics). PDQuest (Bio-Rad, Hercules, CA) was used for matching and
analysis of visualized protein spots among differential gels. The principles of measuring
intensity values by 2-D analysis software were similar to those of densitometric
measurement. The average mode of background subtraction was used to normalize
intensity values, which represents the amount of protein per spot. After completion of
spot matching, the normalized intensity of each protein spot from individual gels was
compared between groups using statistical analysis.
Trypsin digestion
Samples were digested using the techniques previously described (Poon et al.,
2004e) Briefly, the selected protein spots were excised and washed with ammonium
bicarbonate (NH4HCO3), then acetonitrile at room temperature. The protein spots were
incubated with dithiothreitol, then iodoacetamide solutions. The gel pieces were digested
with 20 ng/µl modified trypsin (Promega, Madison, WI) in 25 mM NH4HCO3 with the
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minimal volume to cover the gel pieces. The gel pieces were chopped into smaller pieces
and incubated at 37°C overnight in a shaking incubator.
Mass spectrometry
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10
mg/mL in 0.1% TFA:ACN, 1:1, v/v). The mixture (1 μL) was deposited onto a fast
evaporation nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and
analyzed with a TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in
reflectron mode. The mass axis was adjusted with trypsin autohydrolysis peaks (m/z
2239.14, 2211.10, or 842.51) as lock masses. The MALDI spectra used for protein
identification from tryptic fragments were searched against the NCBI protein databases
using the MASCOT search engine (http://www.matrixscience.com). Peptide mass
fingerprinting used the assumption that peptides are monoisotopic, oxidized at
methionine residues and carbamidomethylated at cysteine residues. Up to one missed
trypsin cleavage was allowed. Mass tolerance of 150 ppm was the window of error
allowed for matching the peptide mass values.
Immunochemical analysis
The linearity of the anti-cyclophilin A (PPIA) and anti-ferritin heavy chain
(FTH1) antibody was measured by loading different amounts of brain protein from
mouse tissue (OE for PPIA and OB for FTH1) into the slots. Briefly, 2 μL of the samples
(2 μg/μL) were treated with an equal volume of Laemmli buffer (0.125M Trizma base,
4%SDS, 20% glycerol) for 20 minutes. Levels of PPIA and FTH1 were measured by slotblot with 1μg of protein from OE or OB per slot, respectively. The slot blots were
detected on the nitrocellulose paper using a primary rabbit anti-cyclophilin A antibody
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(1:500, UpState, Lake Placid, NY) and anti-FTH1 antibody (1:500, Alpha-Diagnostic,
San Antonio, TX) and then a secondary anti-mouse IgG (Sigma, St. Louis, MO)
antibody. The resultant stain was developed by application of Sigma-Fast 5-bromo-4chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) tablets followed by
density measurement by Scion-Image software package (Scion, MD).
RNA extraction from mouse OE and OB tissue and reverse transcription (RT)
RNA was extracted from the tissue (OE and OB) harvested from three old and
three young mice. Frozen tissue was homogenized in 1 ml of Tri-reagent using a sterile,
RNase-free dounce. The tissue was further disrupted using a Qiashredder column
(Qiagen, Inc., Valencia, CA) as per the manufacturer’s protocol. RNA was extracted
according to the TRI-reagent method (Molecular Research Center, Inc., Cincinnati, OH)
and was further purified as per the Qiagen RNeasy mini kit RNA Cleanup Protocol
(Qiagen, Inc., Valencia, CA). The concentration and quality of the RNA were assessed by
spectrophotometry (Beckman Coulter, Inc., Fullerton, CA) and with Bioanalyzer (Agilent
Technologies, Palo Alto, CA). Reverse transcription was performed as per the protocol in
the GeneAmp RNA PCR kit (Applied Biosystems, Inc., Foster City, CA).
Primer design
For real-time PCR validation studies, we used the following primer sequences
(forward primer; reverse primer; annealing temperature; reference):
OE: Aco2 [tgggtggtgattggagatga; atctgggtctcgttgaaggt; 53 C; (Tabuchi et al., 2003)];
Aldh2 [acctggataaagccaatt; tacccagtttatcaggagc; 50 C; (Rout and Armant, 2002)]; Ppia
(ccagggtggtgactttacac; cggaaatggtgatcttcttg; 53 C; MGI:3026778).

382

OB: Mdh1 (tggaccacaaccgagcaaa; tccccagataatgacattctttacatc; 55 C; Primer Express);
Eno1 (tattgcgcctgctcggtta; tccatctcgatcagcttgt; 55 C; Primer Express); Dnm1
(atgccctcaagatcgctaagg; cgtcccgcgcatctgt; 55 C; Primer Express); Fth1
[(gatcaacctggagttgtatgcc; gatattctgccatgccagcttc; 55 C; (Carper et al., 2001)]; Atp5a1
(tggtggaattctcttcaggtta; ccaaacacgacaactccaacatt; 55 C; Primer Express); Omp
[gacattcttctagctgctcc; cagctttggccagcaggg, 55 C, (Buiakova et al., 1994)]. All primer pairs
spanned at least one intron to allow for distinction of mRNA from possible genomic
DNA amplification.
Real-time polymerase chain reaction
A cDNA amount equivalent to 10 ng total RNA per well was used for real-time
RT-PCR analysis. Experimental samples, standards and no-template controls were all run
in triplicate. Standard curves were plotted for standards with concentrations of cDNA
equivalent to 10 ng, 5 ng, 3.75 ng and 2.5 ng of RNA. Each reaction mix (one well)
consisted of 1× QuantiTect SYBR Green PCR Master Mix, cDNA, DEPC water, and 300
nM each of forward and reverse primers. The real-time PCR reaction was carried out on
a ABI Prism 7000 (Applied Biosystems, Inc.) using the following parameters: 50 °C for 2
min; 95 °C for 15 min; 40 cycles of 94 °C for 15 s, specific primer annealing temperature
(see Primer design) for 30 s, and 72 °C for 1 min. Finally, a dissociation protocol was
also run at the end of each run to verify the presence of a single product with the
appropriate melting point temperature for each amplicon. To further ascertain the
specificity and size of the PCR products, the products were run alongside molecular
weight markers on a 2% agarose gel in 1xTAE at 100V for 50 min. The gel was stained
with ethidium bromide (Sigma) and visualized using UV light.
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The data were analyzed by setting a specific threshold for each gene at the
approximate midpoint of the exponential phase of amplification. The resultant threshold
cycle (CT) values for each replicate were averaged. Control and experimental conditions
were evaluated statistically using an unpaired t-test. Standard curves were generated for
each gene of interest and R2 values were calculated. Using the standard curves, CT values were converted to relative amounts of cDNA (the change in CT value inversely
correlates with the direction of change of gene expression). Fold-changes and technical
p-values (using a t-test) were computed between OE/OB of three young and three old
mice.
F3 Results
Proteomic analysis of the agng olfactory epithelium
In comparison to OE of young mice, the OE of old mice had 9 proteins that were
differentially expressed (7 up- and 2 down-regulated) (Fig. F1, left). Seven of the 9
proteins were matched to the protein database with statistical confidence of which 6 had
protein names assigned to their accession numbers. Fig. F2 shows representative gels for
the OE from old and young mice. The proteins that were expressed differentially in the
OE of old vs young mice are summarized in Table F1. Fig. F3 shows the relative
expression levels of these nine proteins in the OE of old mice as compared to that of
young mice. All the mass spectra (not shown) of the peptides were matched to the mass
spectra in MSDB protein databases. A probability-based Mowse score was assigned for
each protein identified to indicate the probability that the match between the database and
the experimental protein is a random event. Scores greater than 62 were considered
significant. Thus, if a match has a score higher than 62, the match as a random event has
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the probability lower than 0.05. All protein identifications agreed with the expected MrW
and pI range based on their positions on the gel. Aldolase 1 (ALDO1), cyclophilin A
(peptidyl prolyl isomerase A or PPIA), mitochondrial aconitase 2 (ACO2), an unnamed
protein product (spot number 8007) and two unidentified proteins (spot numbers 405 and
6401) were up-regulated; and mitochondrial aldehyde dehydrogenase 2 (ALDH2) and
albumin 1 (ALB1) were both down-regulated in the OE of the old mice as compared to
that of the young mice. The identified proteins are listed in Table F2.
Immunochemical validation of PPLA
To confirm the proteomic data for PPIA, we carried out immunochemical analysis
using slot-blot technology. We showed that our antibody-antigen reaction was linear (Fig.
F4, top) and that the level of PPIA was significantly greater (1.3 fold) in the OE of old
mice when compared to that of the young mice (Fig. F4, bottom).
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Figure F2
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Figuure F3
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Transcriptional analysis of selected proteins in the aging olfactory epithelium
Based on their relevance to aging and the proteomics findings, the genes selected
for transcriptional analysis of the OE were Aco2, Ppia and Aldh2. Of these, Aco2 and
Aldh2, for example, are both mitochondrial enzymes involved in metabolism and in the
maintenance of intracellular homeostasis. Aco2 is a TCA cycle enzyme that is a specific
target of mitochondrial oxidative stress during aging while Aldh2 is proposed to protect
cells against oxidative stress. The third gene chosen for transcriptional analysis by real
time RT-PCR was Ppia, which has been shown to be a protector against oxidative stress.
The gene Aldo1, which is associated with aging and oxidative stress as well, was not
chosen for transcriptional analysis as it exists in multiple isoforms in mouse tissues.
Although ALB1 protein was also identified and found to be down-regulated in the old
OE, the lower levels of ALB1 may reflect a reduced blood flow or constricted blood
vessels in the OE with aging, or, alternatively, its identification could also be a sampling
artifact of obtaining highly vascularized tissue and hence was not selected for
transcriptional analysis.
Real-time RT-PCR was carried out using RNA extracted from OE of 3 young and
3 old mice for the genes Aco2, Ppia and Aldh2 as well as Omp (olfactory marker protein).
The resultant amplification curves were plotted and CT (the cycle number for which
amplification is at half of maximal value) was determined (Fig. F5). Using standard curve
analysis, relative quantities were calculated for OE genes from old and young mice,
based on their relative mean CT values. The specificity of the PCR reaction was
confirmed by (a) matching the amplicon melting temperature obtained by dissociation
curve analysis to the calculated melting temperature (Fig. F5, insets 1-3) and (b) the
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presence of a single band of correct size on an ethidium bromide-stained 2% agarose gel
(Fig F5., inset 4). A two-tailed unpaired t-test was carried out to determine the statistical
significance of any regulation of the genes assayed (Table F3).
Based upon the real-time RT-PCR analysis, the transcripts for Aco2 was
determined to be present and significantly (p<0.05) up-regulated 1.4-fold in the OE of old
mice as compared to young (Table F3). This up-regulation was in concordance with the
increase in the protein level of ACO2 the aged OE. The transcripts for Ppia and Aldh2
were expressed in the OE but showed no significant difference between old and young
mice. Aldh2 transcripts were also relatively less abundant (higher CT ). We used the
expression of Omp mRNA, which is expressed in mature olfactory receptor neurons
(Buiakova et al., 1994), as an internal standard to evaluate degenerative effects at the
transcriptional level. We showed that Omp transcripts were highly abundant in the OE of
both old and young mice, and were significantly down-regulated 1.2-fold in the old
compared to young mouse OE (Fig. F5).
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Proteomic analysis of the aging olfactory bulb
In comparison to OB of young mice, the OB of old mice had 20 proteins that were
differentially expressed (Fig. F1) of which 6 matched to the database with statistical
confidence. Figure F6 shows the representative gels from OB of old and young mice. The
proteins that were expressed differentially in the OB of old vs young mice are
summarized in Table F4. In Figure. F7, we have shown the relative expression of these
20 proteins in OB of old mice as compared young mice. ATP synthase isoform 1
(ATP5A1), enolase 1 (ENO1), ferritin heavy chain (FTH1), malate dehydrogenase 1
(MDH1), tropomyosin alpha 3 chain (TPM3) and 10 non-identified proteins (spot
numbers 109, 110, 1102, 1501, 1605, 1702, 4204, 4901, 5302, 5506, 6106) were upregulated; and dynamin-1 (DNM1) and four other proteins (spot numbers 504, 2704,
4201 and 6204) which were not identified were down-regulated in OB of the old mice as
compared to the young mice. Table F5 lists the proteins identified.
Immunochemical validation of FTH1
To confirm our data for FTH1, we carried out slot-blot analysis. We demonstrated
that the antibody showed linearity against FTH1 (Fig. F8, top) and that the level of FTH1
was significantly higher (2.7 fold) in the OB of old mice than of young mice (Fig. F8,
bottom).

396

Figure F6

397

398

Figure F7

399

400

Figure F8

401

Transcriptional analysis of selected proteins in the afing olfactory bulb
The proteomic analysis served as a basis for the selection of genes to study at the
transcriptional level. Of the proteins that were significantly regulated and identified in the
OB and based on their known functions and relevance to our study, we chose to further
analyze Atp5a1, Eno1, Fth1, Mdh1 and Dnm1 as well as Omp using real-time RT-PCR
analysis (Fig. F9). The specificity of the PCR reaction was confirmed by (a) matching the
amplicon melting temperature obtained by dissociation curve analysis to the calculated
melting temperature (Fig. F9, insets 1-5) and (b) the presence of a single band of correct
size on an ethidium bromide-stained 2% agarose gel (Fig F9, inset 6). We determined that
the transcripts for Dnm1 and Fth1 were present and significantly (p<0.05) downregulated 1.2- and up-regulated 1.1-fold, respectively, in the OB of old mice compared to
the young (Table F6). These results are in concordance with the proteomic data. In
contrast, the transcripts for Mdh1, Atp5a1 and Eno1, while present, were not significantly
different between the old and young mouse OBs. As anticipated, Omp mRNA was
expressed at a much lower level overall in the OB than in OE, and was not differentially
expressed between old and young mouse OBs (Fig. F9).
`
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Figure F9
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F4 Discussion
We have shown that proteomic changes occur in the aging murine OE and OB
and have defined whether the proteins identified are regulated at the transcriptional or
post-transcriptional levels. Upon examination of the proteomic and transcriptional data,
we observed that the proteins and/or transcripts that were regulated in the aging olfactory
epithelium and bulb fell into three broadly-defined functional groups, with some in more
than one of these groups: namely, metabolism (primarily mitochondrial metabolism);
transport/motility; and stress response (Fig. E10).
Metabolism:
Of the proteins involved in metabolism, ACO2, ALDH2, ATP5A1 and MDH1 are
mitochondrial enzymes, while ALDO1 and ENO1 are cytosolic. ACO2, a mitochondrial
matrix enzyme involved in the Kreb’s cycle, was found to be up-regulated in the OE of
old mice as compared to the young mice. ACO2 is a known selective target of oxidation
during aging/oxidative stress (Sastre et al., 2003) and is also known to be specifically
inhibited by peroxynitrite, leading to mitochondrial dysfunction (Radi et al., 2002). The
up-regulation of ACO2 seen here in the aged OE may be a result of an accumulation of
inactive enzyme that may be either oxidized, nitrated or both, resulting in the impairment
of mitochondrial respiration. Transcriptional up-regulation of Aco2 with aging may be a
cellular response to oxidative stress for compensation for this lack of active enzyme.
ALDH2, also a mitochondrial enzyme, was down-regulated in the OE of old
mice. This enzyme is a known target for oxidation under conditions of oxidative stress
(Reverter-Branchat et al., 2004) and is thought to be protective against oxidative stress
(Ohsawa et al., 2003). Also, this enzyme has been associated with age-associated
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neurodegenerative diseases such as AD. The levels of ALDH2 were found to be higher in
the cerebral cortex of AD patients (Picklo et al., 2001) and its deficiency has been
associated with an increased risk of AD and elevated oxidative stress(Kim et al., 2004;
Ohta et al., 2004). We found the protein levels of this enzyme to be down-regulated in the
OE of old mice as compared to the young mice. This may result in an increased
susceptibility to oxidative stress in the OE of old mice.
ATP5A1, another mitochondrial protein and a key metabolic/bioenergetic
component of the cell, was observed to be higher in the OB of old mice as compared to
young. ATP5A1 is responsible for proton transport and oxidative phosphorylation as part
of the mitochondrial electron transport chain. In a microarray study, Atp5a1 was shown
to be down-regulated in aging human brains (Lu et al., 2004). The protein product is seen
to accumulate as a fluorophore in lipofuscin granules in the aging brain (Szweda et al.,
2003). The protein has been shown to accumulate in the cerebral cortex of aging rats
(Nicoletti et al., 1998) and also in the cytosol of degenerating neurons in AD brains
(Sergeant et al., 2003). It is possible that in the mouse OB, accumulation of ATP5A1
(possibly cytosolic) with aging could lead to a decrease in available active mitochondrial
ATP5A1, and, consequentially, a decline in mitochondrial ATP production.
Another mitochondrial metabolic enzyme which was seen to be up-regulated in
the OB of old mice was MDH1. This protein was shown to be expressed in the olfactory
cortex (Sandberg et al., 1984). This enzyme is located within the mitochondrial matrix
and is involved in the malate-aspartate shuttle, which is the connecting link between
glycolysis and mitochondrial respiration. This protein transfers NADH across the
mitochondrial membrane to respiratory complex I. The up-regulation of MDH1 in the
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aging OB may be compensatory for the reduced activity of ATP synthase downstream in
the electron transport chain.
ALDO1 is a brain-specific glycolytic enzyme that we have shown to be upregulated in the OE of old mice. The gene Aldo1 is highly expressed in the olfactory
mucosa (Genter et al., 2003; Tietjen et al., 2003) as determined by microarray analysis.
Evidence suggests that protein levels of glycolytic enzymes, including ALDO1, may be
up-regulated during aging in order to compensate for the metabolic decline of
mitochondrial respiration (Kopsidas et al., 2000). ALDO1 is also a target of oxidation
under oxidative stress conditions (Reverter-Branchat et al., 2004) and has been shown to
have reduced activity with aging in the rat lens (Bours et al., 1988).
ENO1, a key glycolytic enzyme and also known as α-enolase (a subunit of brainspecific enolase) (Keller et al., 1994), was up-regulated in the OB of old mice. We found
that ENO1 was post-transcriptionally regulated, which may indicate reduced proteasomal
degradation of this protein as a result of ENO1 possibly being oxidized/nitrated or due to
decreased activity of the proteasome during aging (Keller et al., 2004). ENO1 is a
specific target of oxidation under oxidative stress and is also found to be both oxidized
and nitrated in brains of AD patients (Castegna et al., 2002a; Castegna et al., 2003;
Reverter-Branchat et al., 2004). Also, in AD brains, ENO1 is known to be up-regulated at
the protein level (Schonberger et al., 2001). Interestingly, similar to ALDO1, an upregulation of this enzyme may be part of a glycolytic compensation for mitochondrial
metabolic decline in the OB.
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Transport/Motility and Stress response:
While recognizing the overlapping transport and/or stress-associated roles of
some of the metabolic enzymes described above, we have grouped the remaining proteins
into these two categories based on what appears to be their primary function.
FTH1, which we showed to be highly up-regulated in the OB of old mice, is a
transport protein primarily involved in iron homeostasis. We also confirmed this result
immunochemically and proceeded to demonstrate that Fth1 is up-regulated at the
transcriptional level as well in the OB of old mice. The gene for Fth1 was reported to be
expressed in the olfactory sensory nerves (Tietjen et al., 2003) and the protein has been
localized in oligodendrocytes and astrocytes of various human brain regions (Connor et
al., 1990). Brains of Fth-/- mice show characteristics of increased oxidative stress
(Thompson et al., 2003). Interestingly, both Fth1 and Aco2 mRNAs contain iron
responsive elements (IREs), and their translation to protein is regulated by iron levels
though the mediation of iron binding proteins (Schalinske et al., 1998). Iron (II) promotes
lipid and protein oxidation in oxidative stress conditions, and the levels of this metal ion
have been shown to increase in aging and neurodegenerative diseases, with high
accumulation in lipofuscin granules (Killilea et al., 2004; Terman and Brunk, 2004).
Thus, FTH1 may be up-regulated in response to elevated oxidative stress and may be
exerting a protective effect in the aging olfactory system by sequestering the increased
levels of iron ions.
PPIA, also known as cyclophilin A, is an abundant protein belonging to the
immunophilin family that is the primary target for the immunosuppressant cyclosporin A
in humans (Jin et al., 2004). Cyclosporin A is a neuroprotector under conditions of
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ischemic injury and acts via modulation of the mitochondrial permeability transition pore
dynamics and maintenance of mitochondrial homeostasis (Sullivan et al., 1999;
Crompton, 2004). PPIA is a pro-inflammatory cytokine that is secreted by macrophages
(Jin et al., 2004), among other cells, in response to oxidative stress. The known functions
of this protein include the activation of NF-κB-mediated inflammatory response in
endothelial cells (Jin et al., 2004) and chaperone activity under stress in vitro (Ou et al.,
2001). The Ppia gene is expressed in olfactory sensory neurons as shown by single-cell
microarray studies (Tietjen et al., 2003). In the OE of old mice, we showed an upregulation of PPIA protein levels that we confirmed by immunochemical analysis. An upregulation of PPIA suggests a response to increased oxidative stress in the aging OE
which would aid in protection via its chaperone activity and/or may be functioning in an
anti-apoptotic manner. ENO1, which was described above under metabolism, also has
chaperone activity.
TPM3, another protein that was up-regulated in old OB, is an actin-binding
protein. TPM3 undergoes iron (II)-mediated oxidation under oxidative stress, that targets
this protein for proteasomal degradation (Drake et al., 2002). Altered levels of TPM3
may affect anterograde/retrograde transport in the olfactory neurons and/or mitochondrial
movement leading to nerve ending loss in aging mice.
DNM1, a protein involved in cellular motor activity and receptor-mediated
endocytosis, has been localized in the olfactory system. The protein is co-localized with
clathrin in cell bodies, dendrites and dendritic knobs of olfactory receptor neurons
(Rankin et al., 1999). DNM1 has been shown to be expressed in rat OB where it forms a
stable complex with endophilin3 (ENDO3), an inhibitor of clathrin-mediated endocytosis
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and synaptojanin-1 and co-localizes with dopamine D2R receptors at the synaptic termini
of olfactory sensory neurons (Faire et al., 1992; Sugiura et al., 2004). At the
transcriptional level, dynamin-1-like gene was observed to be down-regulated in the
aging human brain (Lu et al., 2004). Here, we have shown that DNM1 protein is downregulated in the OB of old mice. Interestingly, the this protein was also down-regulated at
the transcriptional level. Our results are indicative of altered neurotransmitter reuptake by
olfactory neuronal synapses with aging.
Our results are the first demonstration of proteomic changes occurring in the
normally aging olfactory system. These alterations in the protein profile of the aging
olfactory epithelium and olfactory bulb are specific to the pathways involving
mitochondrial and cytosolic metabolism, intracellular transport and altered response to
stress. Ongoing studies of the olfactory system in age-related neurodegenerative disorders
will benefit from the studies of aged OE and OB reported here.
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Appendix G
Exercise Mediated Protein Oxidative Modification in Plasma is Induced by Lipid
peroxidation End Product, 4-Hydroxynonenal, but Not 3-Nitrotyrosine
G1 Introduction
Free radicals and reactive oxygen species (ROS) are produced continuously in
cells as part of the metabolic process. When oxygen is partially reduced, free radicals are
formed to attack cell components. The free radicals then form longer-live toxic species
that can migrate to sites distant from where they were produced. These toxic species and
free radicals are collectively called reactive oxygen species (ROS) and reactive nitrogen
species (RNS) (Halliwell and Gutteridge, 1992). ROS and RNS cause lipid peroxidation
and protein oxidation to modify the function of proteins and lipids in biological system
(Butterfield and Stadtman, 1997). Several antioxidant defense mechanisms have evolved
to protect cell components from the attack of ROS and RNS. Oxidative stress is described
as the state of imbalance resulting from the production of ROS and RNS that exceed the
capacity of these antioxidant defense systems. The central nervous system (CNS) is more
susceptible to oxidative stress than other tissues because it has a high content of
unsaturated fatty acids, high oxygen consumption per unit weight, high content of lipid
peroxidation key ingredients such as iron and ascorbate, and a relative scarcity of
antioxidant defenses systems (Floyd, 1999).
Oxidative stress mediated by peroxidation of arachidonic acid (AA) or linoeic
acid forms 4-hydroxynonenal (HNE) (Esterbauer et al., 1991). Since HNE is more stable
than free radicals, it is able to diffuse to sites that are distant from its formation and cause
broader damage (Butterfield and Stadtman, 1997). HNE can form covalent adducts with
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histidine, lysine and cysteine residues in proteins (Butterfield and Stadtman, 1997), thus
consequent HNE-modified protein levels serve as a good marker for lipid peroxidation.
One of the most commonly used methods to quantify protein oxidation is by
measuring the protein carbonyl level (Esterbauer et al., 1991; Butterfield and Stadtman,
1997). Carbonyl groups are introduced to proteins by either direct free radical reactions,
or covalent reaction with lipid peroxidation end products (Esterbauer et al., 1991;
Butterfield and Stadtman, 1997). Protein carbonyl levels are generally detected by their
2,4-dinitrophenylhydrazone (DNP-) adducts. However, it should be noted that the
quantity of the protein carbonyl levels depends not only on its formation, but also on the
degradation rate of the oxidized protein.
The protein 3-nitrotyrosine (3-NT) content is another way to assess oxidative
modification of proteins by oxidative stress. 3-NT forms when peroxynitrite radicals
(ONOO.-) reacts with the ortho position of the aromatic ring on tyrosine residues of
proteins (Beckman and Koppenol, 1996; Butterfield and Stadtman, 1997).
Physical exercise increases the metabolic rate and production of ROS as oxidative
phosphorylation increases to meet the higher ATP demand for physical activity.
Mitochondria are a significant oxidant source in cells because 1-2 % of the electron flow
in the electron transport chain in mitochondria results in generation of free radicals
(Calabrese et al., 2000). Physical activity also increases the generation of free radicals in
several other ways. Some examples include production by catecholamines release,
prostanoid metabolism, xanthine oxidase, NAD(P)H oxidase and tissue repairing
macrophages during exercise (Jackson, 2000). However, the specific reactive species that
modify proteins during exercise is poorly understood. In an effort to understand the
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oxidative modification of proteins during exercise, we measured protein carbonyl, HNE
and 3-NT levels in two different systems. The plasma of trained and untrained runners
was examed after a long distance run to test the hypothesis that trained runners would
have less oxidative stress. Brain regions of young rats that exercised on treadmill for one
week were compared to these from non-exercised rates to test the hypothesis that young
rats would not slow any elevated oxidative modification of protein following excercise.
G2 Experimental Procedures
Subjects
Human subject are trained. Details regarding the training protocol are summarized
in Table 1. The non-trained subjects are served as control.
Sixteen male albino Sprague-Dawley rats aged 2 months were maintained in
individual cages and fed a standard diet without limitations; room temperature was kept
at 21 ± 2°C; 12 hours of light was automatically alternated to 12 hours of dark.
After one week of acclimatization, eight animals were randomly chosen for
exercise. The exercise was produced on a specific treadmill for rats, with four lanes. The
aim of the training protocol was to provide a gradually increasing effort and to reach in
11 weeks 60% VO2max; such workload was sustained for further 3 weeks. Control
animals were placed on not running treadmills during the training sessions. Animals were
sacrificed within 48 hours from the last training session.
Animal handling, the training protocol, and mode of sacrifice were approved by
the Ethical Committee on the Use of Laboratory Animals of the Health Authority of
Milan (Italy).
Sacrifice and brain regions conservation
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Rats were anesthetized (100 mg/kg ip heparinized sodium thiopental); blood was
drawn by cardiac puncture, then the brains of the animals were removed and dissected
into cortex, striatum, hippocampus, and cerebellum. Brains regions were immediately
placed in liquid nitrogen and, once frozen, stored at -80°C.
Protein carbonyl, 3-Nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) detection
Detection of protein carbonyl, 3-NT and HNE levels were performed as described
previously using Slot Blot® (Farr et al., 2003; Poon et al., 2004d). Levels of 3-NT, HNE
and protein carbonyls were determined immunochemically. Protein carbonyl levels were
determined as adducts of 2,4-dinitrophenylhydrazine (DNPH) (Stadtman, 1992;
Butterfield and Stadtman, 1997). Samples (5μL) were treated with an equal volume of
12% SDS. Samples were then derivatized with 10 μL of 20 mM 2,4-DNPH (Chemicon,
CA) for 20 minutes. The reaction was stopped by addition of neutralizing reagent (7.5 μL
of 2M Tris 30% glycerol buffer, pH = 8.0). Levels of protein carbonyls were measured
by using the slot-blot technique with 250 ng of protein loaded per slot. The (DNP-adduct
of the carbonyls is detected on nitrocellulose paper using a primary rabbit antibody
(Chemicon, CA) specific for DNP-protein adducts (1:100) followed by a secondary goat
anti-rabbit IgG (Sigma) antibody. The resultant stain was developed by application of
SigmaFast (BCIP/NBT) tablets; and the line densities were quantified by Scion Image
software package. HNE and 3-NT levels were determined in the same manner. Samples
(5μL) were treated with an equal volume of 12% SDS. Samples were then further
denatured with 10 μL of Laemmli buffer (0.125M Trizma base, 4%SDS, 20% glycerol)
for 20 minutes. Levels of 3-NT and HNE were measured by using the Slot Blot ®
technique: 500 ng of protein per slot for protein 3-NT levels and 250 ng of protein per
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slot for HNE levels. The HNE levels were detected on the nitrocellulose paper using a
primary rabbit antibody (Alpha Diagnostics, TX) specific for HNE-modified protein
(1:8000). The 3-NT levels were detected by primary rabbit antibody (Chemicon, CA)
specific for 3-NT (1:100). The same secondary goat anti-rabbit IgG (Sigma) antibody
was then used. The resultant stain was developed by application of SigmaFast
(BCIP/NBT) tablets and the line densities were also quantified by Scion Image software
package.
G3 Results
The details of the runners tested in this study are listed in Table F1. We observed
a general increase of protein oxidation in the plasma of trained runners after distance
running. However, no significant difference is observed in the untrained runners. Fig. F1
shows the protein carbonyl, HNE and 3-NT levels of post-event runners as the percentage
control of the respective pre-event runner. That is, each runner served as her/his own
control. The protein carbonyl level is significantly increased 92% in post-event trained
runner. Lipid peroxidation index, protein-HNE levels were significantly increased 30% in
the plasma of the post-event trained runners. However, the protein 3-NT level is not
significantly different in the plasma between the trained runners. No significant different
in terms of carbonyl, HNE and 3-NT levels is observed in untrained runners after the long
distance run.
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Table G1: Details of trained and untrained runners

Trained
(n=6)
Untrained
(n=4)

Age (years)

Weight (Kg)

Height (cm)

Vo2max
(ml·min-1·kg-1)

25.5±6.0

66.3±8.4

175.3±5.0

59.8±5.2*

26.8±3.7

68.0±13.9

169.0±8.6

49.8±5.1

* Vo2max is significantly higher in trained runners than the untrained runners,
p<0.05
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Figure G1
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Figure G2
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We observed a general decrease in different brain regions in the rats exercised for
1 week when compared to those of non-exercised rat (Fig F2). However, the oxidative
parameters decrement is not statistically significant.
G4 Discussion
It is well established that exercise induces free radical formation and oxidative
stress in cells (reviewed in (Urso and Clarkson, 2003)). However, the specific reactive
species that modified with the proteins are not known. Consistent with other studies, our
study shows that following physical activity, such as running, increased oxidative
carbonyl modification in proteins is depend on the preconditioning. Our results also
indicate that lipid peroxidation end product, HNE, contributes to protein modification as
the protein HNE level is significantly increased in the plasma of post-event trained
runners. Our data suggest that lipid peroxidation is, at least partially, associated with
protein oxidative modification during physical activity with pre-conditioned runners.
Since regular exercise increases the number and activity of mitochondria in muscles
(Takekura and Yoshioka, 1989), pre-conditioned runners may have more mitochondria to
produce free radicals to modify proteins. The protein 3-NT level was not significantly
altered in the plasma of the runners the distance running, indicating ONOO.- likely is not
involved in the protein modification during physical activity. Since nitric oxide (NO)
from nitric oxide synthase (NOS) is necessary to react with superoxide (O2.-) for ONOO.formation, NO acts as the limiting reagent during the formation of ONOO.-. Therefore, no
significant alteration of protein 3-NT level in the plasma of the runner during physical
activity is most likely due to limited amount of ONOO.- produced. Although free 3-NT
levels in serum increased after the first day of running and remained elevated during a 4-
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day race (Radak et al., 2003), the elevated free 3-NT level most likely result from NO
production by tissue-repairing macrophages (Woods et al., 1993; Vivekananda et al.,
1994; Lu et al., 1999; Sugiura et al., 2000; Cho et al., 2001; Sugiura et al., 2002; Summan
et al., 2003). Since only chronic exercise increases NOS gene expression in endothelial
cells of rats (Liu et al., 2000; Yang et al., 2002), it is likely that there was not sufficient
time for tissue repair to begin when the plasma was obtained after the distance run of the
current study; thus, no alteration of protein 3-NT level was observed in this study.
Unlike a one-time exercise event, regular exercise can reduce oxidative stress by
up-regulation of antioxidant defense (reviewed in (Fitts et al., 1991; Sen, 1995; Dekkers
et al., 1996; Moller et al., 1996; Fielding and Meydani, 1997; Niess et al., 1999; Powers
et al., 1999; Sen, 1999; Coudert and Van Praagh, 2000; Leeuwenburgh and Heinecke,
2001; Radak et al., 2001a; Yeo and Davidge, 2001)). However, exercise mediated
oxidative stress in the CNS is highly dependent on the physical activity conditions
(Somani et al., 1995; Somani and Husain, 1996; Somani et al., 1996; Somani and Husain,
1997; Itoh et al., 1998; Radak et al., 2001c; Radak et al., 2001b; Devi and Kiran, 2004).
Regular exercise can improve cognitive function and decrease oxidative damage in brains
from aged rat; (Radak et al., 2001c), suggesting up-regulation of the antioxidant defense
play significant role in the cognitive improvement (Somani et al., 1995). Consistent with
this notion, our study shows slight reduction of protein carbonyl and 3-NT levels in the
cortex, striatum, hippocampus, and cerebellum of the exercised young rats when
comparing to those of non-exercise rats, although these reductions are not statistically
significant. It is surprising that HNE levels are not altered in different brain regions with
the exception of hippocampus. Since the hippocampus plays a significant role in
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cognitive function and regular exercise improve cognitive function in aged rats (Radak et
al., 2001c), one could speculate that regular exercise can improves cognitive function in
aged rats by decreased protein oxidation in hippocampus. This is consistent with the
previous findings that hypoxia-induced free radicals damage in brain was minimal in
young rodent compared to aged rodents. However, only young rats were used in this
study, which could lead to speculation that whether significant alterations would be
observed in aged rats (Howard et al., 1996). Nevertheless, our study shows that the
oxidative stress induced by regular physical activity does not contribute significant
changes in protein carbonyl, 3-NT, and HNE levels in the cortex, striatum, hippocampus
and cerebellum of young rats, suggesting the protein oxidation and up-regulation of
antioxidant is not significantly altered in different brain regions by physical activity.
Consistent with this notion, lipid peroxidation is observed in the liver and heart but not
the brains of young rats (Turgut et al., 2003).
In our current study, we found that protein oxidation occurred during the event in
trained runners. The exercise mediated protein modification was contributed to, at least
partially, by a lipid peroxidation end product, HNE while nitration of tyrosine residues
was not significant during the marathon. Also, our study shows non-significant changes
in protein oxidation in cortex, striatum, hippocampus, and cerebellum, likely consistent
with the notion that regular exercise contributes little to the cognitive function in young
animals.
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Appendix H
Data Supporting Figures and Tables

Figure 4.2
4m
512.6667
272
395.3333
482
575.3333
414.6667
415.3333
504.6667

4m + LA
471.3333
562
658.3333
476.3333
422.3333
457
446

12m
590
701.3333
530.3333
533.6667
638.3333
611.3333
514.6667

12m+ LA
617
590
588.6667
494
643.6667
598
582.6667

Figure 4.3
4m
5.067
4.78
5.217
5.2
5.38
5.4

12m
4.9
6.08
3.86
4.78
3.86
3.86
4.28
4.1

4m LA
5.066
5.24
5.1
4.5
4.44
4.48
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12m LA
5.88
5.1
6.375
6.19
4
4.167

Figure 4.4
4m
121.062
81.784
97.66233
90.19433
143.7967
115.9037
138.6333

4mLA
143.301
123.493
140.1367
198.902
155.5957
152.9763
190.7983

12m
174.9807
130.231
112.3627
154.9603
165.3887
234.8503
162.1289

12mLA
96.35267
102.6487
157.0183
188.7003
106.249
178.121
138.1817

Figure 6.1
4m
87.70764
130.2326
71.7608
128.9037
79.73422
110.299
82.39203
108.9701

12m
51.82724
99.66777
45.18272
26.57807
35.8804
33.22259
55.81395
54.48505

4m OX
53.8206
73.75415
55.81395
27.90698
53.8206
73.75415
17.9402
93.68771

Figure 6.2
12 m
4m
71.94287 104.8497
95.09075 101.5769
98.78012 109.7292
94.13865 99.79173
47.26702 92.53198
99.01815 91.34186
94.85272 94.07914
86.75989 106.0994

4 m ox.
97.35198
93.6626
92.53198
78.66706
94.79322
85.09372
81.64237
97.76852

424

Figure 6.3
12 m
99.85422
98.6368
97.99833
101.9121
98.07641
103.327
106.2532
100.8654
3.113715

4m
92.80272
92.936
99.81291
98.93544
98.7654
96.77182
99.93216
97.13663
3.093735

4 m ox.
101.6687
84.43914
92.17193
89.05432
96.55432
94.68619
102.765
94.47708
6.585941

Figure 8.3
4m
2.2495
2.3645
2.697
2.926
2.863
2.849

12mR
2.0905
2.2905
2.2685
2.4825
2.011
2.505

12mA
2.359
2.496
2.3185
2.553
2.439
2.6695
2.5715

Figure
8.4
4m
671.6667
692
820.3333
744
477.3333
450
387.3333
456

12mR
666
497.3333
579
580.7778
464
444.6667
372.3333
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12mA
464
478
433.3333
369.6667
282.6667
347.3333

Figure
8.5
4m
294.3333
274.3333
281.6667
283.4444
367.6667
393.3333
395

12mR
355.3333
327.3333
353
326.6667
120.1588
482.3333
402.6667
375.6667
357.3333

12mA
302
317.6667
336
295
352.3333
351
387
399.6667

Figure
8.6
4m
12mR
12mA
213.6667 350
189
457.6667 291.6667 254.3333
377 569.6667 253.6667
310.6667 589 182.6667
595.3333 488
453
596.3333 503 429.3333
Figure 8.7
4m
290.012
244.379
113.962
162.4545
183.0235
162.7415
155.5454

12mR
12mA
259.227 207.5885
250.961 233.242
277.472 208.863
241.14 141.054
257.2
140.198
192.084 146.4505
165.692
178.888

Figure
10.3A
Young
332.3333
302
373.6667
393
325

Old
444.3333
557.3333
548.3333
449.6667
510

426

Figure
10.3B
Young
7686
11812
10933
12444
12912

Old
13101
13994
15165
14487
14471

Figure
10.5A
GS level
Young
91.9259
99.26599
97.51835
89.12967
122.1601

Old
71.65327
65.71129
103.2856
77.24572
72.35232

GS
activity
young
Old
317.6667 358.5
328.5 262.6667
350
278
292.6667 282.5
296.3333
262

Young
60.05136
80.06798
135.3688
98.72795
125.7839

Old
94.7411
123.4944
127.0997
115.2668
46.31038

Young
311.6667
433.3333
408.6667
408.3333
421.6667

Fig 10.5B
LDH level
Young
60.05136
80.06798
135.3688
98.72795
125.7839

Old
437.3333
393
501.3333
562.3333
486.3333

LDH activity
Young
311.6667
433.3333
408.6667
408.3333
421.6667

Old
94.7411
123.4944
127.0997
115.2668
46.31038
Fig 10.6
Young
187
130
177
213
61

427

Old
308
184
268
202
247

Old
437.3333
393
501.3333
562.3333
486.3333

Fig 10.7
Young
289
379
262
244
253
285.4

Old
426
443
309
374
421
394.6

Figure
10.8
Young
98
70
71
93
96

Old
105
156
91
120
161

Control 1
Control 2
Control 3
Control 4
Control 5
Control 6

Age
(years)
86
74
86
90
76
79

Gender
Female
Male
Female
Female
Female
Male

Brain
Weight
(g)
1300
1400
1150
1110
1315
1240

PMI
3.75
4
1.75
4
2
1.75

MCI 1
MCI 2
MCI 3
MCI 4
MCI 5
MCI 6

91
93
87
87
88
82

Female
Female
Male
Male
Female
Female

1155
1050
1200
1170
1080
1075

5
2.75
3.5
2.25
2.25
3

Figure
11.1
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Figure
11.7
Pin 1
Control
1100
3247
2171
1963
2942
3736
Figure
11.8
Pin 1
Control

MCI
2287
4775
5128
2465
5026
6036

MCI
13.969
17.1
16.353
18.5125 14.235
14.975
16.97
17.052 15.928
17.069
15.3

GS
Control
244
281
210
322
313
430

Figure
11.2
Control
486
752.5
506
666
828
602

MCI
560
905
979
762
1108
831

MCI
347
359
444
509
458
425

ENO
Control
187
169
147
178
192
190

GS
Control
MCI
0.6615 0.5015
0.743667 0.65
0.780667 0.613667
0.947667 0.658333
0.887333 0.709
0.6615 0.5015

ENO
Control
5.75
4.607
5.381
10.6075
4.375
5.143

Figure B4
Control
ALS
102.0759 100.8769
95.03014 69.19992
134.4713 64.46098
92.17774 58.45801
76.24488 60.99797

429

MCI
234
214
216
207
226
322

PK3
Control
261
304
290
394
346
294

MCI
353
362
450
441
461
413

MCI
2.071
2.161
3.25
6.289
3.536
1.393

PK3
Control
-2.303
-2.08467
-2.34333
-2.8
-3.83
-2.61

MCI
-1.93133
-1.87467
-1.996
-2.093
-1.9
-2.08467

Cortex
Old
140.9353
133.7701
116.1151
122.9876
107.2662
138.0382
103.3813
100 123.2134
6.964833 6.108613
Young
75.32374
115.9116
117.1942
84.46275
107.482
99.62561

Ave
SEM

Young
105.4859
106.3724
94.51411
101.4596
92.16803

Septum
Old
109.4044
125.3918
122.4138
113.8483
106.2656

Old + CAN
117.4101
96.81767
63.88489
84.23811
103.5971
104.2306

Sub. Nigra
Young
Old Old + CAN
141.3428 122.6148 103.5336
76.58537 137.8049 93.41463
69.25795 126.2195 120.8481
111.2195 120.6098 120.2439
89.39929 128.6219 113.0742
112.1951 124.0283 101.7073

95.02975
7.634555

100 126.6499 108.8036
10.93849 2.5043 4.171804

Old + CAN
89.92524
107.21
83.73087
110.9718
103.5956

Septum
Young
Old Old + CAN
104.5136 113.1902 101.227
101.4899 101.7528 119.3258
93.99649 106.6854 100.3067
103.8202 100.7011 125.3933
92.19101 108.8764 104.2507
103.9888 121.3409 118.8431

100 115.4648 99.0867
2.422125 3.109904 4.421166

Young
80.96291
110.0196
115.7455
89.98035
101.4001
101.8914

100 108.7578 111.5578
2.236955 3.142553 4.111115

Hippocampus
Old
Old + CAN
108.4746 85.08966
123.1147 104.3478
98.64898 95.01351
132.0236 97.56817
128.2908 121.8075

100 118.1105 100.7653
5.21746 5.751288 5.57015
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Cerebellum
Young
Old Old + CAN
93.02514 99.79869 85.80697
129.2782 121.993 101.7032
92.86294 65.07297 110.6245
84.83374 89.61882 73.0738
85.45546 95.62044 101.0065
110.3674 87.18573 121.389
104.1772 117.4371 93.91042
100 96.67525 98.21635
6.504889 7.272681 6.007058

Figure
D2
Young
101.0695
101.1348
94.65241
94.32577
104.5394
104.2781
Ave
SEM

Cortex
Old
109.0909
111.749
116.0547
107.3431
113.9037
104.2781

Old + CAN
96.25668
89.91989
97.86096
89.31909
97.86096
101.0695

100 110.4033 95.38119
1.845114 1.77584 1.932157

Young
103.1674
86.21473
94.11765
104.8978
86.87783
108.8874
115.8371
100
4.255666
Young
100.1764
84.63826
101.5873
115.3617
96.64903
101.5873
100
4.034293

Septum
Old
Old + CAN
119.457 95.9276
108.2063 101.6867
134.8416 86.87783
107.6224 101.9786
117.6471 81.44796
105.2871 105.3844
95.9276 87.78281
112.7127 94.44083
4.737443 3.455962
Hippocampus
Old
Old + CAN
111.4638 104.4092
115.56 102.3786
108.642 94.53263
104.2616 91.97225
107.231 101.5873
111.4638 90.38652
98.76543
109.7704 97.71884
1.605434 2.232788
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Sub. Nigra
Young
Old Old + CAN
104.0248 103.096 105.8824
87.84466 96.69903 77.59223
100.3096 110.5263 104.9536
116.0388 88.7767 86.67961
95.66563 103.096 117.0279
96.1165 93.6699 113.7087
120.743
100 99.31065 103.7982
3.895122 3.183558 6.066786
Septum
Young
Old Old + CAN
98.68766 106.0367 117.5853
91.45667 99.75415 93.76152
97.6378 107.0866 115.4856
103.8107 104.0873 106.7609
101.8373 115.4856 102.8871
104.7326 96.61955 109.158
101.8373 94.48819 111.2861
100 103.3654 108.1321
1.85563 2.914311 3.048574
Septum
Young
Old Old + CAN
105.8824 90.65744 92.04152
80.7377 81.86475 111.0656
81.6609 98.2699 100.5123
119.2623 123.668 119.3648
103.8062 87.19723 90.65744
108.6505 169.5697 77.50865
86.50519 99.65398
100 105.3903 98.68632
6.330654 11.91429 5.21496

Figure
D3

Ave
SEM

Young
91.49041
110.9944
102.9021
89.12909
104.4761
99.87647
101.1313
100
2.850317

Cortex
Old
103.6891
97.65287
100.7378
90.98209
88.1456
113.9592
85.98131
97.30687
3.722921

Old + CAN
93.35957
123.2242
93.75307
104.8796
97.49139
57.99876
111.5593
97.46655
7.723462

Young
106.5205
90.97545
110.0274
113.0723
93.15068
95.95222
90.30137
100
3.627788

Septum
Old
97.53425
139.3497
90.9589
160.8494
108.1644
136.7618
96.54795
118.5952
10.17513

Old + CAN
84.60274
119.4426
89.42466
135.5674
92.49315
141.1413
78.46575
105.8768
9.71363

Septum
Young
Old Old + CAN
101.1757 104.5348 93.78569
86.79879 96.74169 87.47061
90.29224 99.56332 93.3826
121.7333 108.8344 110.5811
87.51592 87.51592 117.707
106.242 93.24841 123.8217
106.242 76.05096 97.07006
100 95.21278 103.4027
4.820613 4.151846 5.255156

Young
93.03268
107.6813
107.626
102.9433
87.66152
89.37545
111.6798
100
3.702962

Hippocampus
Old
Old + CAN
116.1388 84.11452
113.2807 83.3453
112.8959 87.45883
130.9404 99.71285
101.3428 88.97897
142.1393 119.3108
97.28908 101.5455
116.2896 94.92383
5.951935 4.887979

Septum
Young
Old Old + CAN
104.1871 107.776 132.3545
80.98988 77.27784 56.86164
93.20283 132.137 107.3116
120.9786 104.7807 89.25759
107.1234 108.4285 131.1582
98.0315 92.12598 116.4763
95.48668 124.0892 98.09679
100 106.6593 104.5024
4.731377 6.961303 9.976902
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Sub. Nigra
Young
Old Old + CAN
102.3589 113.6479 91.65965
107.6813 142.1393 83.3453
96.12468 110.615 122.4937
102.9433 130.9404 99.71285
101.5164 110.1938
100
89.37545 113.2807 119.3108
100 120.1362 102.7537
2.604021 5.414389 5.807383

Figure F4
young
old
104.5188557 128.9895
102.9746424 140.9488
104.6814044 132.0404
92.00260078 134.8471
95.82249675 125.9387
Figure F5
young
old
216
224
187.3333 249.5
159.3333 185.3333
172
153.5
237.6667 180.5
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